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Abstract	  
The	  extracellular	  domain	  of	  Toll-­‐like	   receptors	   (TLRs)	   recognises	  highly	  specific	  pathogen-­‐associated	  molecular	  patterns	  in	  innate	  immunity.	  This	  causes	  molecular	   rearrangement	   of	   the	   intracellular	   Toll/Interleukin-­‐1	   (TIR)	   domains	  of	   the	   TLRs	   allowing	   recruitment	   of	   downstream	   adaptor	   proteins	   via	  heterotypic	   TIR-­‐TIR	   protein	   interactions.	   This	   in	   turn	   initiates	   a	   signalling	  cascade	   leading	   to	   proinflammatory	   immune	   responses.	   Recent	   work	   has	  indicated	   that	   TIR-­‐like	   proteins	   (TLPs)	   from	   pathogenic	   bacteria	   contain	   TIR	  domains	  and	  interfere	  with	  host	  TLR	  signalling.	  Bacterial	  TLPs	  are	  suggested	  to	  bind	   to	   the	   TIR	   domains	   of	   host	   TLRs	   and/or	   the	   adaptor	   proteins,	   thereby	  inhibiting	  intracellular	  signalling.	  This	   project	   focuses	   on	   characterisation	   of	   the	   TLPs	   from	   the	   highly	  pathogenic	   bacteria	   Yersinia	   pestis	   (YpTLP)	   and	   Burkholderia	   pseudomallei	  (BpTLP).	  The	  aim	  of	  the	  project	  was	  to	  produce	  soluble,	  pure	  and	  stable	  TLPs	  of	  yields	   suitable	   for	   functional	   and	   structural	   studies.	   Bacterial	   TLPs	   were	  expressed	   in	   E.	   coli.	   Expression	   of	   the	   full-­‐length	   YpTLP	   and	   BpTLP	   using	  pWaldo-­‐GFPe	  yielded	  2.78	  mg/l	  and	  2.52	  mg/l	  respectively.	  Protein	  purification	  steps	   were	   complicated	   by	   protein	   precipitation,	   possible	   degradation	   and	  misfolding.	   Subsequent	   efforts	   focused	   on	   the	   expression	   of	   the	   TIR	   only	  domain/homologue	   regions:	   YpTIR	   and	  BpTIR.	   Soluble	  YpTIR	   and	  BpTIR	  were	  expressed	   using	   pET26b.	   GST	   pull	   down	   assays	   indicated	   positive	   interactions	  between	  His-­‐tagged	  YpTIR/BpTIR	   and	  GST-­‐tagged	  human	  MyD88-­‐TIR,	   a	  major	  adaptor	   protein,	   revealing	   MyD88	   as	   a	   potential	   target	   of	   the	   bacterial	   TLPs.	  However	  expression	  yields	  of	  pure	  protein	  were	  too	  low	  to	  allow	  further	  studies.	  YpTIR	  and	  BpTIR	  were	  then	  expressed	  as	  fusions	  with	  an	  N-­‐terminal	  GB1	  tag	   using	   GEV2.	   Subsequent	   purification	   produced	   highly	   pure	   GB1-­‐YpTIR	   (5	  mg/l).	  NMR	  analysis	   indicated	   that	   the	  protein	  was	   folded	  and	   likely	   to	  be	   in	  a	  dimeric	  form,	  a	  finding	  confirmed	  by	  gel	  filtration.	  Native	  and	  derivative	  crystals	  of	   YpTIR	   were	   obtained,	   and	   native	   diffraction	   datasets	   collected	   to	   2.95	   Å.	  Further	  work	  includes	  obtaining	  the	  phase	  information.	  It	  is	  anticipated	  that	  the	  crystal	   structure	   of	   YpTIR	  will	   provide	   insight	   into	   the	  molecular	   basis	   of	   TIR	  signalling	  and	  evidence	  of	  evolutionary	  conservation	  among	  TIR	  domains.	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Abbreviations	  	   	  AC	   Affinity	  Chromatography	  AD	   Anomalous	  Dispersion	  	  AEC	   Anion	  Exchange	  Chromatography	  Ala	   Alanine	  Amp	   Ampicillin	  Arg	   Arginine	  Asn	   Asparagine	  Asp	   Aspartic	  acid	  ATP	   Adenosine	  Triphosphate	  AtTIR	   Arabidopsis	  thaliana	  Toll/Interleukin-­‐1	  Receptor	  	  
β2AR-­‐T4L	   β2	  adrenergic	  receptor-­‐T4-­‐lysozyme	  	  BB	  Loop	  	   Loop	  connecting	  strand	  βB	  and	  helix	  αB	  in	  TIR	  Domains	  Bcl-­‐2	   B-­‐cell	  lymphoma	  2	  Bis-­‐Tris	  	   Bis-­‐(2-­‐hydroxy-­‐ethyl)-­‐amino-­‐tris(hydroxymethyl)-­‐methane	  BME	   β-­‐mercaptoethanol	  BpTIR	   Burkholderia	  pseudomallei	  Toll/Interleukin-­‐1	  Receptor	  (TIR)	  BpTLP	   Burkholderia	  pseudomallei	  Toll/Interleukin-­‐1	  Receptor	  (TIR)-­‐like	  Protein	  bR	   Bacteriorhodopsin	  Btp1	   Brucella	  TIR-­‐containing	  Protein	  1	  	  C12E9	   Polyoxyethylene(9)dodecyl	  ether	  	  C8E4	   Octyltetraoxyethylene	  CaCl2	   Calcium	  chloride	  Cam	   Chloramphenicol	  	  CARD	   Caspase	  Recruitment	  Domain	  CCD	   Charge-­‐coupled	  Device	  CCP4	   Collaborative	  Computational	  Project,	  Number	  4	  	  CD	   Circular	  Dichroism	  	  CDC	   Centres	  for	  Disease	  Control	  and	  Prevention	  Che	  Y	   Chemotaxis	  Protein	  Y	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CMC	   Critical	  Micelle	  Concentration	  	  CMP-­‐Sia	   Cytidine-­‐5’-­‐monophosphate-­‐sialic	  acid	  transporter	  CoCl2.6H20	   Cobalt	  chloride	  hexahydrate	  CpG	   Cytosine-­‐phosphate-­‐Guanine	  CPM	   N-­‐[4-­‐(7-­‐diethylamino-­‐4-­‐methyl-­‐3-­‐coumarinyl)phenyl]maleimide	  	  CSB	   Centre	  for	  Structural	  Biology	  	  CsCl	   Caesium	  chloride	  Cu	   Copper	  CV	   Column	  Volume	  Cyt	  bo3	   Cytochrome	  bo3	  ubiquinol	  oxidase	  	  DC	   Dendritic	  Cell	  DCIP	   2,6-­‐dichloroindophenol	  	  DDM	   n-­‐dodecyl-­‐β-­‐D-­‐maltopyranoside	  	  DLS	   Diamond	  Light	  Source	  	  DM	   n-­‐decyl-­‐β-­‐D-­‐maltopyranoside	  	  DPC	   Dodecyl	  phosphocholine	  	  ds	  DNA	   Double-­‐stranded	  Deoxyribonucleic	  Acid	  DSS	   4,4-­‐dimethyl-­‐4-­‐silapentane-­‐1-­‐sulphonic	  acid	  Dstl	   Defense	  Science	  and	  Technology	  Laboratory	  DTT	   Dithiothreitol	  ECD	   Ectodomain	  ECF	   Enhanced	  Chemifluorescence	  Substrate	  EDTA	   Ethylenediaminetetraacetic	  acid	  	  ESRF	   European	  Synchrotron	  Radiation	  Facility	  	  FID	   Free	  Induction	  Decay	  FRET	   Fluorescence	  Resonance	  Energy	  Transfer	  	  FSEC	   Fluorescence-­‐based	  Size	  Exlcusion	  Chromatography	  (SEC)	  	  GB1	   B1	  immunoglobulin-­‐binding	  domain	  of	  streptococcal	  protein	  G	  GFP	   Green	  Fluorescent	  Protein	  Glu	   Glutamic	  acid	  Gly	   Glycine	  GST	   Glutathione-­‐S-­‐transferase	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HEPES	   (4-­‐(2-­‐hydroxyethyl)-­‐1-­‐piperazineethanesulfonic	  acid)	  Hg	   Mercury	  His	   Histidine	  His6	   Polyhistidine	  tag	  hMyD88	   Human	  Myeloid	  Differentiation	  Factor	  88	  HSP	   Heat	  Shock	  Protein	  HSQC	   Heteronuclear	  Single-­‐Quantum	  Correlation	  	  hTLR	   Human	  Toll-­‐like	  Receptor	  IFN	   Interferon	  IκK	   Inhibitor	  of	  Nuclear	  Factor	  kappaB	  (IκB)	  Kinase	  	  IL-­‐1β	   Interleukin-­‐1β	  IL-­‐1R	   Interleukin-­‐1	  Receptor	  IL-­‐1RAPL	   Interleukin-­‐1	  Receptor	  Accessory	  Protein	  Like	  	  IMAC	   Immobilised	  Metal	  Affinity	  Chromatography	  	  IPTG	   Isopropyl-­‐D-­‐thiogalactopyranoside	  	  IR	   Isomorphous	  Replacement	  	  IRAK	   IL-­‐1	  Receptor-­‐associated	  Kinase	  IRF	   Interferon	  Response	  Factor	  	  IκB	   Inhibitor	  of	  Nuclear	  Factor	  kappaB	  (NFκB)	  K2HPO4	   Dipotassium	  hydrogen	  phosphate	  Kan	   Kanamycin	  LB	   Luria-­‐Bertani	  medium	  LDAO	   Lauryl	  dimethylamine	  oxide	  	  LDS	   Loading	  Sample	  Buffer	  	  LGP2	   Laboratory	  of	  Genetics	  and	  Physiology	  2	  LPS	   Lipopolysaccharide	  LRR	   Leucine-­‐Rich	  Repeat	  Lys	   Lysine	  M9	   Minimal	  media	  for	  15N	  labelling	  MAD/SAD	   Multiple/Single	  wavelength	  Anomalous	  Dispersion	  	  Mal	   MyD88	  adaptor	  like	  	  MAPK	   Mitogen-­‐activated	  Protein	  Kinase	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Mb	   Molybdenum	  MDA5	   Melanoma	  Differentiation-­‐associated	  Gene	  5	  	  Met	   Methionine	  MgSO4	  	   Magnesium	  chloride	  MHz	   Mega	  Hertz	  MIR/SIR	  	   Multiple/Single	  wavelength	  Isomorphous	  Replacement	  	  MIRAS/SIRAS	   Multiple/Single	  Isomorphous	  Replacement	  with	  Anomalous	  Scattering	  	  MNG	   Maltose-­‐Neopentyl	  Glycol	  	  Mops	   3-­‐(N-­‐morpholino)propanesulphonic	  acid	  MR	   Molecular	  Replacement	  Mw	   Molecular	  weight	  	  MWCO	   Molecular	  Weight	  Cut-­‐off	  	  MyD88	   Myeloid	  Differentiation	  Factor	  88	  	  NaBr	   Sodium	  bromide	  NaCl	   Sodium	  chloride	  NaH2PO4	   Sodium	  dihydrogen	  Phosphate	  NaI	   Sodium	  iodide	  NaOH	   Sodium	  hydroxide	  NDSB	   Non	  Detergent	  sulphobetaines	  NFκB	   Nuclear	  Factor	  kappa-­‐light-­‐chain-­‐enhancer	  of	  activated	  B	  cells	  Ni2+-­‐NTA	  	   Nickel-­‐Nitrilotriacetic	  acid	  NLR	   Nucleotide-­‐binding	  Oligomerisation	  Domain	  (NOD)-­‐like	  Receptors	  NMR	   Nuclear	  Magnetic	  Resonance	  NOD	   Nucleotide-­‐binding	  Oligomerisation	  Domain	  NV10	   NVoy	  Polymer	  10	  OD600	   Optical	  density	  at	  600	  nm	  OG	   n-­‐octyl-­‐β-­‐D-­‐glucopyranoside	  	  Pam3CSK4	   Tripalmitoyl	  Cysteinyl	  Seryl	  tetralysine	  PAMP	   Pathogen-­‐associated	  Molecular	  Pattern	  PBS	   Phosphate	  Buffered	  Saline	  	  PCR	   Polymerase	  Chain	  Reaction	  	  PDC	   Protein-­‐Detergent	  Complex	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PdTIR	   Paracoccus	  denitrificans	  Toll/Interleukin-­‐1	  Receptor	  	  PdTLP	   Paracoccus	  denitrificans	  TIR-­‐like	  Protein	  	  PEG	   Polyethylene	  glycol	  	  Phe	   Phenylalanine	  pI	   Isoelectric	  point	  PMSF	   Phenylmethanesulphonylfluoride	  PolyI:C	   Polyinosinic:polycytidylic	  acid	  	  ppm	   Parts	  per	  million	  Pro	   Proline	  PRR	   Pathogen	  Recognition	  Receptor	  Pt	   Platinum	  PVDF	   Polyvinylidene	  difluoride	  	  RbCl	   Rubidium	  chloride	  RF	   Radiofrequency	  RFU	   Relative	  Fluorescence	  Unit/s	  	  Rho	   Bovine	  rhodopsin	  	  RIG-­‐I	   Retinoic	  acid-­‐Inducible	  Gene-­‐I	  RLR	   Retinoic	  acid-­‐Inducible	  Gene	  (RIG)-­‐I-­‐like	  Receptor	  rpm	   Revolutions	  per	  minute	  SARM	   Sterile	  α-­‐(SAM)	  and	  heat-­‐armadillo(ARM)	  motif	  containing	  protein	  SDS-­‐PAGE	   Sodium	  Dodecyl	  Sulphate-­‐Polyacrylamide	  Gel	  Electrophoresis	  SEC	   Size	  Exclusion	  Chromatography	  Ser	   Serine	  SIGIRR	   Single	  Immunoglobulin	  IL-­‐1R-­‐related	  molecule	  SipB	   Salmonella	  Invasion	  Protein	  B	  SLE	   Systemic	  Lupus	  Erythematosus	  	  SQR	   Succinate:quinone	  oxidoreductase	  	  ss	  RNA	   Single-­‐stranded	  Ribonucleic	  Acid	  SV40	   Simian	  Virus	  40	  TBS	   Tris-­‐buffered	  Saline	  	  Tcp	   Toll/Interleukin-­‐1	  Receptor	  (TIR)	  Domain	  Containing	  Protein	  TcpB	   TIR	  domain-­‐containing	  protein	  (Tcp)	  in	  Brucella	  melitensis	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TcpC	   TIR	  domain-­‐containing	  protein	  (Tcp)	  in	  Escherichia	  coli	  CFT073	  Th	   T-­‐helper	  Cell	  TIR	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  2	  Fig	  2.1	   In-­‐gel	  fluorescence	  analysis	  of	  TLP-­‐GFP	  expression	  Fig	  2.2	   Monitoring	  YpTLP-­‐GFP	  expression	  among	  different	  expression	  strains	  Fig	  2.3	   In-­‐gel	  fluorescence	  analysis	  of	  optimised	  YpTLP-­‐GFP	  expression	  Fig	  2.4	   Western	  Blot	  analysis	  of	  YpTLP-­‐GFP	  localisation	  in	  cellular	  fractions	  Fig	  2.5	   SDS-­‐PAGE	  analysis	  of	  Ni2+-­‐NTA	  purified	  YpTLP-­‐GFP	  	  Fig	  2.6	   SDS-­‐PAGE	  analysis	  of	  purified	  YpTLP-­‐GFP	  SEC	  profiles	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Fig	  2.7	   In-­‐gel	  fluorescence	  analysis	  of	  optimised	  BpTLP-­‐GFP	  expression	  	  Fig	  2.8	   SDS-­‐PAGE	  analysis	  of	  BpTLP-­‐GFP	  Ni2+-­‐NTA	  purification	  Fig	  2.9	   In-­‐gel	  fluorescence	  analysis	  of	  BpTLP-­‐GFP	  Ni2+-­‐NTA	  purification	  Fig	  2.10	   In-­‐gel	  fluorescence	  analysis	  of	  BpTLP-­‐GFP	  TEV-­‐digestion	  Fig	  2.11	   SDS-­‐PAGE	  analysis	  of	  purified	  BpTLP	  SEC	  profile	  Fig	  2.12	   Western	  Blot	  analysis	  of	  TLP	  expression	  Fig	  2.13	   Western	  Blot	  analysis	  of	  YpTIR	  expression	  Fig	  2.14	   SDS-­‐PAGE	  analysis	  of	  insoluble	  YpTIR	  purification	  Fig	  2.15	   SDS-­‐PAGE	  analysis	  of	  YpTIR	  IMAC	  purification	  Fig	  2.16	   SDS-­‐PAGE	  analysis	  of	  YpTIR	  SEC	  profile	  Fig	  2.17	   SDS-­‐PAGE	  analysis	  of	  YpTIR	  AEC	  profile	  Fig	  2.18	   Western	  Blot	  analysis	  of	  BpTIR	  expression	  Fig	  2.19	   Analysis	  of	  BpTIR	  purification	  Fig	  2.20	   SDS-­‐PAGE	  analysis	  of	  TIR	  long-­‐term	  stability	  Fig	  2.21	   Western	  Blot	  analysis	  of	  GB1-­‐YpTIR	  expression	  Fig	  2.22	   SDS-­‐PAGE	  analysis	  of	  GB1-­‐YpTIR	  Co2+	  IMAC	  purification	  Fig	  2.23	   SDS-­‐PAGE	  analysis	  of	  GB1-­‐YpTIR	  SEC	  profiles	  Fig	  2.24	   Western	  Blot	  analysis	  of	  GB1-­‐BpTIR	  expression	  Fig	  2.25	   SDS-­‐PAGE	  analysis	  of	  GB1-­‐BpTIR	  Co2+	  IMAC	  purification	  Fig	  2.26	   SDS-­‐PAGE	  analysis	  of	  GB1-­‐BpTIR2	  SEC	  profile	  	   Chapter	  3	  Fig	  3.1	   Nuclear	  magnetic	  resonance	  in	  terms	  of	  energy	  levels	  Fig	  3.2	   Schematic	  illustration	  of	  Equilibrium	  Magnetisation	  Fig	  3.3	   Schematic	  to	  illustrate	  the	  oscillating	  RF	  field	  by	  two	  counter-­‐rotating	  fields	  Fig	  3.4	   Schematic	  representation	  of	  Larmor	  Precesssion,	  FID	  and	  Processing	  Fig	  3.5	   Schematic	  representations	  of	  1D	  and	  2D	  NMR	  spectra	  	  Fig	  3.6	   Schematic	  representation	  of	  an	  NMR	  lineshape	  Fig	  3.7	   Expression	  and	  purification	  of	  GST-­‐MyD88-­‐TIR	  Fig	  3.8	   SEC	  Purification	  of	  GST-­‐MyD88-­‐TIR	  	  Fig	  3.9	   SDS-­‐PAGE	  analysis	  of	  GST-­‐MyD88-­‐TIR	  AEC	  Purification	  Fig	  3.10	   Pull	  down	  assay	  using	  YpTIR	  and	  GST-­‐MyD88-­‐TIR	  Fig	  3.11	   Purification	  of	  co-­‐expressed	  YpTIR	  and	  GST-­‐MyD88-­‐TIR	  proteins	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Fig	  3.12	   Pull	  down	  assay	  using	  BpTIR	  and	  GST-­‐MyD88-­‐TIR	  Fig	  3.13	   Pull	  down	  assays	  using	  GB1-­‐YpTIR-­‐His	  proteins	  with/out	  GST-­‐MyD88-­‐TIR	  Fig	  3.14	   Pull	  down	  assay	  using	  GB1-­‐YpTIR1	  and	  control	  GST	  	  Fig	  3.15	   Pull	  down	  assay	  using	  control	  GB1-­‐SV40-­‐His	  and	  GST-­‐MyD88-­‐TIR	  Fig	  3.16	   Interaction	  of	  the	  P173H	  mutants	  of	  GB1-­‐YpTIR-­‐His	  with	  GST-­‐MyD88-­‐TIR	  	  Fig	  3.17	   1D	  (1H)	  NMR	  spectra	  of	  GST	  and	  GST-­‐MyD88-­‐TIR	  Fig	  3.18	   2D	  (1H/15N)	  HSQC	  spectra	  of	  GB1-­‐YpTIR	  with/out	  GST-­‐MyD88-­‐TIR	  Fig	  3.19	   Preparation	  of	  Cleaved	  MyD88-­‐TIR	  sample	  Fig	  3.20	   Expression	  and	  purification	  of	  GB1-­‐MyD88-­‐TIR	  Fig	  3.21	   Co2+	  IMAC	  and	  subsequent	  SEC	  purification	  of	  GB1-­‐MyD88-­‐TIR	  Fig	  3.22	   1D	  (1H)	  NMR	  spectra	  of	  GB1-­‐MyD88-­‐TIR	  Fig	  3.23	   SEC	  Purification	  of	  GB1-­‐MyD88-­‐TIR	  in	  the	  presence	  of	  DTT	  Fig	  3.24	   2D	  (1H/15N)	  HSQC	  spectra	  of	  15N-­‐GB1-­‐YpTIR	  with/out	  GB1-­‐MyD88-­‐TIR	  Fig	  3.25	   2D	  HSQC	  spectra	  of	  15N-­‐GB1-­‐YpTIR	  with/out	  GB1-­‐MyD88-­‐TIR	  (9.5–10.5	  ppm)	  	  	   Chapter	  4	  Fig	  4.1	   Phase	  diagram	  and	  the	  vapour	  diffusion	  method	  for	  protein	  crystallisation	  Fig	  4.2	   Schematic	  illustration	  of	  the	  crystal	  unit	  cell	  and	  the	  asymmetric	  unit	  Fig	  4.3	   Schematic	  representation	  of	  Bragg’s	  law	  Fig	  4.4	   Schematic	  representation	  of	  the	  Ewald	  Sphere	  Fig	  4.5	   Schematic	  representation	  of	  the	  molecular	  replacement	  method	  	  Fig	  4.6	   1D	  (1H)	  NMR	  spectra	  of	  YpTIR1-­‐His,	  GB1-­‐YpTIR1-­‐His	  and	  GB1	  Fig	  4.7	   Analysis	  of	  domain	  overlap	  in	  GB1-­‐YpTIR2-­‐His	  by	  NMR	  and	  SDS-­‐PAGE	  	  Fig	  4.8	   1D	  (1H)	  NMR	  spectra	  of	  GB1-­‐YpTIR1-­‐His	  in	  differing	  pH	  buffers	  	  Fig	  4.9	   1D	  (1H)	  NMR	  spectra	  of	  GB1-­‐YpTIR1-­‐His	  in	  differing	  buffer	  conditions	  	  Fig	  4.10	   2D	  (1H/15N)	  HSQC	  NMR	  spectra	  of	  GB1-­‐YpTIR1-­‐His	  	  Fig	  4.11	   Initial	  crystals	  of	  GB1-­‐YpTIR2-­‐His	  Fig	  4.12	   Optimisation	  of	  GB1-­‐YpTIR2-­‐His	  crystals	  in	  sitting	  drops	  Fig	  4.13	   A	  typical	  GB1-­‐YpTIR2-­‐His	  crystal	  and	  corresponding	  diffraction	  pattern	  Fig	  4.14	   Optimisation	  of	  equilibrium	  dynamics	  for	  GB1-­‐YpTIR2-­‐His	  crystals	  Fig	  4.15	   Diffraction	  image	  of	  the	  optimised	  GB1-­‐YpTIR2-­‐His	  crystal	  	  Fig	  4.16	   Density	  map	  of	  the	  MR	  solution	  for	  GB1-­‐YpTIR2-­‐His	  dataset	  using	  Phaser	  Fig	  4.17	   Optimisation	  of	  the	  SeMet	  labelled	  GB1-­‐YpTIR2-­‐His	  crystals	  
	  	   21	  
Fig	  4.18	   Diffraction	  images	  of	  the	  SeMet	  labelled	  GB1-­‐YpTIR2-­‐His	  crystals	  	   Chapter	  6	  Fig	  6.1	   Schematic	  to	  illustrate	  the	  formation	  of	  membrane	  protein-­‐detergent	  complexes	  Fig	  6.2	   Chemical	  structures	  of	  amphiphiles	  Fig	  6.3	   SDS-­‐PAGE	  analysis	  of	  the	  long-­‐term	  stability	  of	  SQR	  Fig	  6.4	   Thermal	  stability	  profiles	  for	  Cyt	  bo3,	  CMP-­‐Sia	  and	  SQR	  Fig	  6.5	   SDS-­‐PAGE	  analysis	  of	  protein	  aggregation	  post	  SQR	  thermostability	  assay	  Fig	  6.6	   Melting	  temperatures	  (°C)	  of	  SQR	  using	  circular	  dichroism	  	  Fig	  6.7	   SEC	  analysis	  of	  the	  quaternary	  structure	  of	  SQR	  upon	  heating	  Fig	  6.8	   Analysis	  of	  the	  succinate-­‐Q1-­‐DCIP	  reductase	  activity	  of	  SQR	  Fig	  6.9	   Thermal	  stability	  of	  SQR	  at	  equivalent	  concentration	  above	  CMC	  Fig	  6.10	   SEC	  analysis	  of	  SQR	  at	  equivalent	  micelle	  concentrations	  of	  MNG-­‐3	  and	  DDM	  
	  




	  	   22	  
Chapter	  1	  	  
Introduction	  
	  
1.1	   Overview	  
Innate	   immunity	  provides	   the	   first	   line	  of	  host	  defense	  against	   invading	  pathogens.	   Pattern	   recognition	   receptors	   (PRRs)	   including	   the	   Toll-­‐like	  receptors	   (TLRs)	   recognise	   pathogen-­‐associated	   molecular	   patterns	   (PAMPs).	  The	   TLRs	   contain	   an	   extracellular	   leucine-­‐rich	   repeat	   (LRR)	   domain	   that	  recognises	   and	   binds	   to	   specific	   microbial	   ligands	   (Akira	   and	   Takeda,	   2004).	  Linked	  to	  the	  LRR	  domain	  by	  a	  single	  transmembrane	  domain	  (Hashimoto	  et	  al.,	  1988)	  is	  a	  cytoplasmically	  located	  Toll/Interleukin-­‐1	  receptor	  (TIR)	  domain	  that	  mediates	  downstream	  signalling	  (Gay	  and	  Keith,	  1991).	  TLR	  signalling	  pathways	  activate	   transcription	   factors	   that	   regulate	   the	   induction	   of	   proinflammatory	  cytokines	  and	  co-­‐stimulatory	  molecules	   (Akira	   et	  al.,	   2006).	  This	   in	   turn	  elicits	  innate	  immune	  responses	  against	  the	  invading	  pathogens	  (Fig	  1.1).	  Recently	   bacterial	   homologues	   of	   TIR	   domains	   have	   been	   identified	  (Newman	  et	  al.,	  2006).	  It	  has	  been	  suggested	  that	  the	  bacterial	  TIR	  homologues	  have	   roles	   in	   subverting	   the	   host	   innate	   immune	   response	   by	   interfering	  with	  the	  TLR	  signalling	  pathway.	  Although	  the	  detailed	  molecular	  mechanisms	  remain	  unclear,	   there	   is	   data	   to	   indicate	   that	   the	   pathogenic	   bacterial	   TIR	   domains	  interact	   with	   the	   TIR	   domains	   of	   the	   human	   TLRs	   and/or	   the	   cytoplasmic	  adaptors	  (Cirl	  et	  al.,	  2008;	  Radhakrishnan	  and	  Splitter,	  2010;	  Radhakrishnan	  et	  
al.,	  2009;	  Sengupta	  et	  al.,	  2010).	  Such	  an	  interaction	  is	  suggested	  to	  inhibit	  TLR	  signalling	  and	  lead	  to	  an	  attenuated	  host	  innate	  immune	  response	  (Fig	  1.1).	  It	  is	  possible	   that	   the	   subversion	   of	   the	   TLR	   signalling	   pathway	   by	   bacterial	   TIR	  homologues	   leads	   to	   enhanced	   proliferation	   of	   the	   pathogenic	   bacteria	   in	   the	  host	  system,	  thereby	  serving	  as	  a	  host	  evasion	  strategy.	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Fig	  1.1	  Schematic	  of	  the	  host	  TLR	  pathway	  and	  its	  subversion	  by	  bacterial	  TIR	  homologues	  Toll-­‐like	  receptors	  (TLRs)	  recognise	  and	  bind	  to	  pathogen-­‐associated	  molecular	  patterns	  (PAMPs).	  Heterotypic	  TIR-­‐TIR	  interactions	  between	  the	  TIR	  domains	  of	  the	  TLRs	  and	  the	  downstream	  adaptors	  initiate	  the	  TLR	  signalling	  cascade.	  This	  results	  in	  the	  activation	  of	  transcription	  factors	  to	  elicit	  innate	  immune	  responses	  against	  the	  evading	  pathogens.	  Bacterial	  TIR	  homologues	  are	  suggested	  to	  subvert	  the	  host	  innate	  immunity.	  Bacterial	  TIR	  homologues	  possibly	  interact	  with	  the	  human	  TIR	  proteins	  to	  interfere	  with	  TLR	  signalling	  
	  
1.2	   Innate	  Immunity	  
The	   innate	   immune	   system	   is	   the	   first	   line	   of	   host-­‐defense	   against	  invading	  microbial	  pathogens	   including	  bacteria,	   fungi,	  viruses	  and	  protozoans.	  It	   is	   an	   evolutionarily	   conserved	   system	   mediated	   by	   phagocytes	   such	   as	   the	  macrophages	  and	  dendritic	  cells	  (DCs)	  that	  either	  directly	  engulf	  the	  pathogens	  through	   phagocytosis	   or	   induce	   inflammatory	   responses	   including	   the	  production	   of	   cytokines,	   chemokines	   and	   co-­‐stimulatory	   factors	   (Janeway	   and	  Medzhitov,	  2002;	  Kumar	   et	  al.,	   2009a).	   	  The	   innate	   immune	  system	  recognises	  conserved	   PAMPs	   through	   germ	   line-­‐encoded	   PRRs,	   as	   suggested	   by	   Charles	  Janeway,	  Jr.	  (Janeway,	  1989)	  over	  20	  years	  ago.	  PRRs	  are	  capable	  of	  differential	  but	  overlapping	  microbial	  recognition	  and	  include	  TLRs,	  retinoic	  acid-­‐inducible	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gene	   (RIG)-­‐I-­‐like	   receptors	   (RLRs)	   and	   nucleotide-­‐binding	   oligomerisation	  domain	   (NOD)-­‐like	   receptors	   (NLRs)	   (Kawai	   and	   Akira,	   2009;	   Kumagai	   et	   al.,	  2008;	  Kumar	  et	  al.,	  2009a).	  	  	  
1.2.1	  Pattern	  Recognition	  Receptors	  (PRRs)	  	  RLRs	   and	   NLRs	   are	   recently	   identified	   cytosolic	   PRRs	   that	   detect	  intracellular	   PAMPs	   (Kawai	   and	   Akira,	   2009;	   Meylan	   et	   al.,	   2006).	   RLRs	  specifically	  recognise	  viral	  RNA	  and	  replicating	  DNA	  viruses	  in	  the	  cytoplasm	  of	  most	   cell	   types,	   and	   elicit	   innate	   immune	   responses	   through	   the	   induction	   of	  type	   I	   interferons	   (IFNs)	   and	   inflammatory	   cytokines	   (Fig	  1.2)	   (Yoneyama	  and	  Fujita,	   2008;	   Kumar	   et	   al.,	   2009a).	   Members	   of	   the	   RLR	   family	   include	   RIG-­‐I,	  melanoma	  differentiation-­‐associated	  gene	  5	  (MDA5)	  and	  Laboratory	  of	  Genetics	  and	   Physiology	   2	   (LGP2)	   proteins	   that	   contain	   a	   central	   RNA	   helicase	   domain	  (Kumar	   et	   al.,	   2009a;	   Meylan	   et	   al.,	   2006;	   Kawai	   and	   Akira,	   2009).	   RIG-­‐I	   and	  MDA5	  also	  contain	  two	  N-­‐terminal	  caspase	  recruitment	  domains	  (CARDs)	  crucial	  for	  activating	  downstream	  signalling	  (Fig	  1.2)	  (Kumar	  et	  al.,	  2009a;	  Meylan	  et	  al.,	  2006).	  RLRs	   activate	   the	  nuclear	   factor	   kappa	  B	   (NFκB)	   and	  mitogen-­‐activated	  protein	  kinase	  (MAPK)	  pathways	   that	  regulate	  expression	  of	   immunogenic	  and	  inflammatory	  genes	  (Fig	  1.2)	  (Kawai	  and	  Akira,	  2009).	  	  NLRs	   recognise	   various	   intracellular	   PAMPs	   including	   bacteria,	   fungi,	  DNA	  and	  RNA	  viruses	  (Meylan	  et	  al.,	  2006).	  Like	  the	  RLRs,	  the	  NLRs	  activate	  the	  NFκB	   and	  MAPK	  pathways	   (Fig	   1.2)	   (Kumar	   et	   al.,	   2009a).	  However	   the	  NLRs	  also	  activate	  the	  caspase-­‐1	  inflammasome,	  which	  leads	  to	  the	  induction	  of	  the	  IL-­‐1	   family	   of	   cytokines	   (Fig	   1.2)	   (Kumar	   et	   al.,	   2009a;	  Meylan	   et	   al.,	   2006).	   The	  NLRs	  contain	  a	  C-­‐terminal	  LRR	  domain,	  a	  central	  NOD	  domain	  and	  a	  variable	  N-­‐terminal	  domain	  responsible	  for	  signalling.	  In	  the	  case	  of	  NOD1	  and	  NOD2	  this	  is	  an	  N-­‐terminal	  CARD	  (Fig	  1.2)	  (Fritz	  et	  al.,	  2006;	  Ting	  et	  al.,	  2008).	  The	  NLRs	  have	  been	   shown	   to	   be	   associated	   with	   a	   number	   of	   immunological	   disorders.	   For	  example,	   mutations	   in	   NOD2	   are	   linked	   with	   Crohn’s	   disease	   (Hampe	   et	   al.,	  2001)	  and	  Blau	  syndrome	  (Miceli-­‐Richard	  et	  al.,	  2001).	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Fig	  1.2	  Schematic	  overview	  of	  innate	  immune	  signalling	  pathways	  TLRs,	  containing	  an	  LRR	  ectodomain	  and	  an	  intracellular	  TIR	  domain	  are	  located	  on	  the	  cell	  surface	  or	  in	  endosomes.	  RLRs	  and	  NLRs	  are	  both	  cytosolic	  PRRs.	  RLRs	  contain	  a	  central	  RNA	  helicase	  domain	  and	  in	  the	  case	  of	  RIG-­‐I	  and	  MDA5	  contain	  two	  N-­‐terminal	  CARDs.	  NLRs	  contain	  a	  C-­‐terminal	  LRR,	  a	  central	  NOD	  and	  a	  variable	  signalling	  N-­‐terminal	  domain,	  which	  is	  a	  CARD	  in	  the	  case	  of	  NOD1	  and	  NOD2.	  Homotypic	  TIR	  and	  CARD	  interactions	  initiate	  the	  TLR,	  and	  the	  RLR	  and	  NLR	  pathways,	  respectively.	  The	  TLR	  and	  RLR	  pathways	  converge	  in	  the	  activation	  of	  IRFs,	  NFκB	  and	  MAPK	  signalling	  pathways.	  The	  NLR	  pathway	  leads	  to	  activation	  of	  the	  NFκB	  and	  MAPK	  signalling	  pathway	  and	  the	  inflammasome	  (Monie	  et	  al.,	  2009a;	  Kumar	  et	  al.,	  2009a;	  Kawai	  and	  Akira,	  2009;	  Monie	  et	  al.,	  2009b)	  
	  The	   best-­‐studied	   PRRs	   are	   the	   TLRs,	   type	   I	   transmembrane	   sensory	  receptors	   that	   recognise	   a	   range	   of	   pathogenic	   bacterial,	   fungal,	   viral	   and	  parasitic-­‐protozoal	  PAMPs.	  The	  principal	   role	  of	   the	  TLRs	   is	   the	   recognition	  of	  PAMPs	   and	   the	   regulation	   of	   the	   innate	   immune	   responses	   however	   they	   also	  play	  important	  functions	  in	  shaping	  adaptive	  immune	  responses,	  particularly	  in	  collaboration	   with	   other	   PRRs.	   For	   instance,	   in	   vivo	   studies	   have	   shown	   that	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1.3	   Toll-­like	  Receptors	  	  
The	  Toll	  gene	  was	  first	  identified	  in	  the	  fruitfly	  Drosophila	  melanogaster,	  originally	  on	  account	  of	  its	  role	  in	  dorso-­‐ventral	  embryonic	  polarity.	  Hashimoto	  
et	   al.	   (1988)	   showed	   that	   the	   integral	   membrane	   protein	   Toll,	   contained	   a	  cytoplasmic	  domain	  and	  a	  large	  putative	  extracytoplasmic	  domain	  containing	  at	  least	   15	   repeats	   of	   a	   24	   amino	   acid	   long	   leucine-­‐rich	   sequence.	   Subsequently,	  Lemaitre	  et	  al.	   (1996)	  demonstrated	   that	   the	  Toll	  gene	  mediates	   the	  adult	   fly’s	  immunity	   against	   fungal	   infections,	   by	   regulating	   formation	   of	   the	   antifungal	  peptide	  drosomycin.	  The	  term	  ‘Toll-­‐like	  receptors’	  (TLRs)	  refers	  to	  Toll-­‐receptor	  homologues	  found	  in	  mammals.	  Normura	  et	  al.	  (1994)	  identified	  the	  first	  human	  homologue	   of	   the	   Drosophila	   Toll	   receptor,	   now	   called	   TLR1.	   Subsequently	  Medzhitov	   et	   al.	   (1997)	   identified	   human	   TLR4.	   The	   extracellular	   N-­‐terminal	  LRR	   domain	   and	   the	   intracellular	   C-­‐terminal	   TIR	   domains	   of	   TLRs	   can	   be	  schematically	  represented	  as	  follows	  (Fig	  1.3).	  	  
	  
Fig	  1.3	  Schematic	  of	  a	  Toll-­like	  receptor	  TLRs	  contain	  an	  extracellular	  N-­‐terminal	  LRR	  domain	  specialised	  in	  recognising	  microbial	  products.	  The	  intracellular	  TIR	  domain	  of	  TLRs	  mediate	  downstream	  signalling	  	   	  Ten	   TLRs	   are	   encoded	   in	   the	   human	   genome	   (Knapp,	   2010),	   each	   of	  which	  has	  evolved	  to	  recognise	  certain	  microbe-­‐associated	  patterns	  over	  a	  broad	  range	  of	  microbes.	  For	  instance,	  TLRs	  signal	  the	  presence	  of	  triacyl	  lipopeptides	  (Pam3CSK4;	   TLR1/2),	   peptidoglycan	   and	   zymosan	   (TLR2),	   double-­‐stranded	  ribonucleic	   acid	   (ds	   RNA;	   TLR3),	   lipopolysaccharides	   (LPS)	   of	   Gram-­‐negative	  bacteria	  (TLR4),	  flagellin	  (TLR5),	  single-­‐stranded	  RNA	  (ss	  RNA;	  TLR7	  and	  TLR8)	  and	  unmethylated	  CpG	  DNA	  (TLR9)	  (Table	  1.1)	  (Kumar	  et	  al.,	  2009b;	  Janeway	  et	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al.,	   2004;	   Knapp,	   2010;	   Gay	   and	   Gangloff,	   2007).	   The	   ligand	   for	   TLR10	   is	  currently	  unknown.	  	  
Table	  1.1	  Microbial	  ligands	  that	  activate	  the	  TLRs	  	  
TLR	   Location	  of	  TLR	   Microbial	  Ligands	   Origin	  of	  Ligands	  
TLR1/2	   Plasma	  membrane	  (cell	  surface)	   Triacyl	  lipopeptides	  (Pam3CSK4)	   Various	  bacteria,	  mycoplasma	  	   	   Porin	  PorB	   Neisseria	  meningitidis	  
TLR2	   Plasma	  membrane	  (cell	  surface)	   Lipoprotein/lipopeptides	   Various	  pathogens	  
	   	   Peptidoglycan	   Gram-­‐positive	  bacteria	  	   	   Lipoarabinomannan	   Mycobacteria	  
	   	   Zymosan	   Fungi	  
TLR3	   Endosome	   PolyI:C	  ds	  RNA	   Viruses	  
TLR4	   Plasma	  membrane	  (cell	  surface)	   LPS	   Gram-­‐negative	  bacteria	  	   	   Hsp60	  and	  Hsp70	   Host	  
TLR5	   Plasma	  membrane	  (cell	  surface)	   Flagellin	   Flagellated	  bacteria	  
TLR6/2	   Plasma	  membrane	  (cell	  surface)	   Diacyl	  lipopeptides	   Mycoplasma	  
TLR7/8	   Endosome	   ss	  RNA	   Viruses	  
TLR9	   Endosome	   Unmethylated	  CpG	  DNA	   Viral	  and	  bacterial	  DNA	  
Representative	  microbial	  ligands	  for	  human	  TLRs	  are	  presented	  for	  clarity	  (Knapp,	  2010;	  Kumar	  et	  
al.,	  2009b;	  Gay	  and	  Gangloff,	  2007)	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1.3.1	  The	  Extracellular	  LRR	  Domain	  	  	  TLRs	  have	  an	  ectodomain	  (ECD)	  containing	  16	  to	  28	  LRRs	  (Jin	  et	  al.,	  2007;	  Choe	  et	  al.,	  2005;	  Medzhitov	  et	  al.,	  1997),	  one	  of	  the	  signature	  motifs	  of	  pattern-­‐recognition	  receptors.	  The	  human	  TLR3	  ECD	  structure	  (Fig	  1.4)	  revealed	  a	  large	  horseshoe-­‐shaped	  solenoid	  assembly	  containing	  23	  LRRs	  (Choe	  et	  al.,	  2005).	  The	  LRR	  motifs	  are	  comprised	  of	  20-­‐30	  amino	  acid	  residues	  containing	  a	  conserved	  “LxxLxLxxN”	  motif	   (Jin	   et	   al.,	   2007).	   ECDs	   are	   responsible	   for	   recognising	   and	  binding	   to	  conserved	  patterns	   in	  diverse	  microbial	  molecules.	  This	   triggers	   the	  recruitment	  of	  specific	  adaptor	  proteins	  to	  the	  intracellular	  TIR	  domains,	  which	  in	  turn	  initiates	  a	  series	  of	  signalling	  cascades	  to	  stimulate	  and	  coordinate	  innate	  and	   adaptive	   immune	   responses	   respectively	   (Jin	   et	   al.,	   2007).	   The	   TLR3	   ECD	  recognises	  and	  binds	  ds	  viral	  RNA.	  This	  causes	  the	  intracellular	  TIR	  domains	  of	  TLR3	  to	  employ	  the	  adaptor	  protein	  TRIF	  to	  initiate	  the	  signalling	  cascade.	  As	  a	  result,	   TLR3	   activates	   genes	   for	   the	   secretion	   of	   antiviral	   cytokines	   including	  interferon	  (IFN-­‐β)	  (Choe	  et	  al.,	  2005).	  	  	  
	  
Fig	  1.4	  Crystal	  structure	  of	  the	  ectodomain	  of	  human	  TLR3	  	  	  Structure	  of	  the	  human	  TLR3	  ECD	  (Protein	  Data	  Bank;	  PDB	  entry	  1ZIW)	  displaying	  the	  N-­‐	  and	  C-­‐	  terminals	  and	  23	  LRR	  repeats	  (Choe	  et	  al.,	  2005).	  The	  β-­‐strands	  are	  displayed	  as	  in	  yellow,	  α-­‐helices	  in	  red	  and	  connecting	  loops	  in	  green.	  The	  figure	  was	  generated	  using	  MacPyMOL	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  The	   TLR	   ECDs	   are	   suggested	   to	   pre-­‐exist	   as	   inactive	   dimers	   in	   a	  membranous	   environment.	   Triantafilou	   et	   al.	   (2006)	   showed	   that	   TLR2	   was	  associated	   with	   TLR1	   and	   TLR6	   based	   on	   fluorescence	   resonance	   energy	  transfer	   (FRET)	   analysis	   of	   human	   monocytes	   before	   stimulation	   with	   the	  bacterial	   ligands.	   Upon	   activation,	   the	   TLR2/1	   and	   TLR2/6	   heterodimers	   are	  differentially	   internalised	   and	   targeted	   to	   the	   Golgi	   apparatus	   in	   specific	  responses	  to	  different	  bacterial	  ligands	  (Triantafilou	  et	  al.,	  2006).	  Similarly,	  Latz	  
et	  al.	  (2007)	  have	  shown	  that	  the	  TLR9	  ECDs	  pre-­‐exist	  as	   inactive	  homodimers	  based	   on	   combined	   results	   from	   FRET	   analysis,	   circular	   dichroism	   (CD)	  spectroscopy,	   co-­‐immunoprecipitation	   and	   receptor	   cross-­‐linking	   experiments.	  In	  addition,	  the	  study	  revealed	  that	  the	  ligand	  CpG	  DNA	  induces	  formation	  of	  an	  activated	  comformation	  of	  the	  TLR9	  dimers.	  Although	  these	  findings	  suggest	  the	  preformed	   dimeric	   state	   of	   the	   TLR	   ECDs,	   further	   work	   is	   required	   to	   fully	  understand	  whether	   or	   not	   this	   is	   the	   case.	   For	   instance,	   the	   ECD	   structure	   of	  human	  TLR3	  does	  not	  indicate	  a	  homodimer	  (Choe	  et	  al.,	  2005)	  as	  in	  the	  case	  of	  the	  structure	  of	  TLR3	  in	  the	  presence	  of	  its	  ligand,	  ds	  RNA	  (Liu	  et	  al.,	  2008).	  Different	   TLR	   ECDs	   form	   specific	   homodimers	   or	   heterodimers.	   TLR3,	  TLR4,	   TLR5	   and	  TLR9	   signal	   as	   homodimers	   while	   TLR1,	   TLR2,	   TLR6	   and	  possibly	   the	   closely	   related	  TLR10	   signal	   as	  heterodimers	   (Brown	   et	   al.,	   2006;	  O'Neill	   and	   Bowie,	   2007).	   It	   has	   been	   shown	   that	   the	   homodimerised	  cytoplasmic	  domains	  of	  TLR1,	  TLR2	  and	  TLR6	  do	  not	  activate	  NFκB,	  while	  TLR2	  in	   combination	   with	   either	   TLR1/6	   efficiently	   activates	   NFκB	   (Brown	   et	   al.,	  2006).	   The	  TLR7	   to	   TLR9	   subset	   of	   TLRs	   exhibit	   interactive	   functional	   effects.	  TLR8	   can	   heterodimerise	   with	   and	   inhibit	   TLR7	   and	   TLR9,	   while	   TLR9	   can	  heterodimerise	  with	  and	  inhibit	  TLR7	  (Wang	  et	  al.,	  2006).	  	  Despite	   the	  variety	  of	  TLRs	  and	   the	  range	  of	   ligands	   they	  can	  recognise,	  the	   TLR	   ECDs	   share	   a	   conserved	   horseshoe-­‐shaped	   architecture	   (Fig	   1.5).	  Additionally,	   the	  crystal	  structures	  of	   the	   ligand-­‐induced	  TLR1-­‐TLR2-­‐Pam3CSK4	  complex	  (Fig	  1.5a)	  (Jin	  et	  al.,	  2007),	  the	  TLR3-­‐dsRNA	  complex	  (Fig	  1.3b)	  (Liu	  et	  
al.,	   2008)	   and	   the	   TLR4-­‐MD-­‐2-­‐LPS	   complex	   (Fig	   1.5c)	   (Park	   et	   al.,	   2009)	   all	  indicate	   m-­‐shaped	   receptor	   dimers	   composed	   of	   the	   two	   horseshoe-­‐shaped	  monomers	  arranged	  symmetrically.	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Fig	  1.5	  Crystal	  structures	  of	  ligand-­induced	  TLR	  dimers	  	  	  Structures	  of	  TLR1-­‐TLR2-­‐Pam3CSK4	  (PDB	  entry	  2Z7X),	  TLR3-­‐dsRNA	  (PDB	  entry	  3CIY)	  and	  TLR4-­‐MD2-­‐LPS	  (PDB	  entry	  3FXI)	  illustrating	  the	  formation	  of	  m-­‐shaped	  TLR	  dimers.	  The	  monomers	  are	  arranged	  symmetrically	  with	  their	  C-­‐termini	  converging	  in	  the	  centre	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FRET	  analysis	   has	   indicated	   that	   upon	  CpG	  DNA-­‐induced	   activation,	   the	  cytoplasmic	   TIR	   domains	   of	   activated	   TLR9	   dimers	   are	   brought	   in	   close	  proximity	  (Latz	   et	  al.,	  2007).	  The	  dimeric	  arrangements	  reported	   in	   the	  crystal	  structures	   of	   the	   ligand-­‐activated	   TLR	   ECD	   complexes	   all	   exhibit	   a	   close	  association	   of	   their	   C-­‐terminal	   regions	   in	   the	   centre	   of	   the	  molecule	   (Fig	   1.5).	  This	  close	  association	  of	  the	  C-­‐terminal	  regions	  of	  the	  ECD	  is	  suggested	  to	  have	  a	  role	   in	   mediating	   association	   of	   the	   intracellular	   TIR	   domains	   to	   provide	   a	  molecular	  scaffold	  for	  recruitment	  of	  adaptor	  proteins	  (Park	  et	  al.,	  2009;	  Liu	  et	  
al.,	   2008;	   Jin	   et	   al.,	   2007;	   Latz	   et	   al.,	   2007).	  However	   it	   is	   not	   possible	   to	   fully	  ascertain	   the	   precise	   roles	   of	   the	   different	   regions	   of	   the	   ECD	   in	   promoting	  structural	  rearrangements	  of	  the	  TIR	  domains	  in	  the	  absence	  of	  the	  structure	  of	  a	  whole	  TLR	  dimer	  both	  with	  and	  without	  ligand.	  
	  
1.3.2	  The	  Intracellular	  TIR	  Domain	  	  The	  intracellular	  cytoplasmic	  domain	  of	  TLRs	  spans	  150-­‐200	  amino	  acid	  residues	   (Khan	   et	   al.,	   2004).	   It	   is	   named	   the	   Toll/Interleukin-­‐1	   receptor	   (TIR)	  domain,	   as	   it	   shares	   sequence	   homology	  with	   the	   cytoplasmic	   domains	   of	   the	  
Drosophila	  Toll	  receptor	  and	  the	  Interleukin-­‐1	  receptor	  (IL-­‐1R)	  superfamily	  (Gay	  and	  Keith,	  1991;	  Janeway	  et	  al.,	  2004;	  Janeway	  and	  Medzhitov,	  2000).	  Although	  detailed	   mechanisms	   remain	   unknown,	   the	   suggested	   principal	   role	   of	   TIR	  domains	  is	  to	  mediate	  heterotypic	  protein-­‐protein	  interactions	  between	  receptor	  and	  adaptor	  molecules	  in	  the	  signal	  transduction	  process	  (Xu	  et	  al.,	  2000;	  Tao	  et	  
al.,	  2002;	  Gautam	  et	  al.,	  2006).	  	  TIR	   domains	   share	   common	   sequence	   motifs,	   called	   box	   1	   [(F/Y)-­‐DAFISY)],	  box	  2	  (GYKLC-­‐RD-­‐PG)	  and	  box	  3	  (a	  conserved	  W	  surrounded	  by	  basic	  residues),	  of	  which	  boxes	  1	  and	  2	  are	  vital	  for	  mediating	  signalling	  (Brown	  et	  al.,	  2006;	   Slack	   et	   al.,	   2000).	   Alanine	   scanning	   mutagenesis	   of	   the	   TIR	   domain	   of	  human	  IL-­‐1R1	  has	  shown	  that	  the	  box	  1	  and	  2	  motifs	  and	  in	  particular	  box	  2	  are	  crucial	  for	  coupling	  to	  the	  NFκB	  and	  stress	  kinase	  pathways	  and	  the	  activation	  of	  receptor-­‐associated	  protein	  kinases	  (Slack	  et	  al.,	  2000).	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The	   structure	   of	   the	   human	  TIR	   domain	   of	   TLR1	   reveals	   a	   central	   five-­‐stranded	  parallel	  β-­‐sheet	  (βA	  -­‐	  βE)	  surrounded	  by	  five	  helices	  (αA	  -­‐	  αE)	  and	  the	  connecting	   loops	   (Fig	   1.6a)	   (Xu	   et	   al.,	   2000).	   The	   architecture	   of	   the	   β-­‐sheet	  strands	   is	   similar	   to	   that	   in	   the	   bacterial	   chemotaxis	   protein	   Che	   Y	   (Fig	   1.6b)	  (Stock	  et	  al.,	  1989;	  Santoro	  et	  al.,	  1995).	  The	   functionally	  relevant	  BB	   loop	  (Fig	  1.6a)	  connects	  strand	  βB	  and	  helix	  αB,	  which	  protrudes	  out	  from	  the	  main	  core	  of	  the	  protein	  in	  most	  structures	  of	  TIR	  domains	  (Fig	  1.6a)	  (Xu	  et	  al.,	  2000;	  Khan	  
et	  al.,	  2004;	  Nyman	  et	  al.,	  2008;	  Ohnishi	  et	  al.,	  2009).	  	  	  
	  
Fig	  1.6	  Crystal	  structures	  of	  the	  TIR	  domain	  of	  human	  TLR1	  and	  E.	  coli	  Che	  Y	  (a)	  Structure	  of	  the	  TIR	  domain	  of	  human	  TLR1	  in	  green	  (Protein	  Data	  Bank;	  PDB	  entry	  1FYV)	  with	  the	  N-­‐	  and	  C-­‐	  termini	  and	  the	  BB	  loop	  indicated	  (Xu	  et	  al.,	  2000).	  (b)	  Structure	  of	  the	  chemotaxis	  protein	  Che	  Y	  from	  E.	  coli	  in	  pink	  (PDB	  entry	  1CYE)	  (Santoro	  et	  al.,	  1995).	  The	  figures	  were	  generated	  using	  MacPymol	  
	  	   Interestingly,	   whilst	   the	   TIR	   domains	   of	   human	   TLRs	   exhibit	   20-­‐30%	  sequence	   identity,	   the	   crystal	   structures	   reveal	   significant	   conformational	  differences	  (Fig	  1.5).	  For	  instance,	  large	  conformational	  differences	  are	  observed	  between	  the	  structures	  of	  the	  TIR	  domains	  of	  TLR1	  and	  TLR2	  which	  share	  50%	  sequence	   identity	   (Fig	   1.7a)	   (Xu	   et	   al.,	   2000).	   The	   regions	   of	   the	   proteins	   that	  exhibit	   the	   largest	   conformational	  variation	   include	  helices	  αB	  and	  αD	  and	   the	  loops	   BB,	   CD	   and	  DD	   (Fig	   1.7b-­‐c).	   Such	   structural	   diversity	   is	   suggested	   to	   be	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crucial	   for	   the	   specificity	  of	   signal	   transduction	   from	  different	   receptors	   (Xu	   et	  
al.,	  2000;	  Watters	  et	  al.,	  2007).	  	  	  
	  
	  
Fig	  1.7	  Sequence	  and	  structure	  conservation	  between	  the	  TIR	  domains	  of	  TLR1	  and	  TLR2	  (a)	  Alignment	  of	  the	  TIR	  domain	  sequences	  of	  human	  TLR1	  and	  TLR2	  using	  CLC	  Sequence	  Viewer	  6.	  The	  residues	  in	  red	  indicate	  100%	  conservation.	  Structures	  of	  the	  TIR	  domains	  of	  human	  TLR1	  (green;	  PDB	  entry	  1FYV)	  and	  human	  TLR2	  (red;	  PDB	  entry	  1FYW)	  are	  superimposed.	  The	  N-­‐	  and	  C-­‐	  termini	  and	  the	  regions	  exhibiting	  conformational	  differences	  between	  the	  two	  structures	  are	  labelled	  (Xu	  et	  al.,	  2000).	  	  These	  structures	  are	  shown	  as	  superimposed	  (b)	  cartoons	  and	  (c)	  ribbons	  	  	  
	  	   35	  
1.4	   Biological	  Role	  of	  TIR	  Domains	  
1.4.1	  Functional	  Role	  of	  the	  BB	  loop	  The	  BB	   loop	   in	   box	  2	   is	   the	   region	   of	   key	   functional	   significance	   of	   TIR	  domains.	  It	  contains	  about	  10	  residues,	  of	  which	  4	  are	  highly	  conserved;	  Arg	  at	  the	   BB3	   position,	   Asp	   at	   the	   BB4	   position,	   Pro	   at	   the	   BB7	   position	   (the	   Lpsd	  mutation	  point)	  and	  Gly	  at	  the	  BB8	  position	  (Fig	  1.8)	  (Xu	  et	  al.,	  2000;	  Khan	  et	  al.,	  2004).	   These	   residues	   are	   usually	   located	   in	   the	   RDφφPG	   motif,	   where	   φ	  represents	  a	  hydrophobic	  residue	  (Fig	  1.8)	  (Xu	  et	  al.,	  2000).	  The	  Pro	  residue	  at	  the	  BB7	  position	  among	  Toll	  homologues	  is	  critical	  for	  TLR-­‐mediated	  signalling	  (Xu	  et	  al.,	  2000;	  Bartfai	  et	  al.,	  2003;	  Nyman	  et	  al.,	  2008).	  	  	  
	  
Fig	  1.8	  Sequence	  alignment	  of	  the	  BB	  loop	  in	  TIR	  domains	  The	  BB	  loop	  residues	  present	  in	  the	  TIR	  domains	  of	  human	  TLR2,	  TLR4,	  TLR1,	  TLR10	  and	  IL-­‐1RAPL	  have	  been	  aligned	  using	  CLC	  Sequence	  Viewer	  6.	  Sequence	  conservation	  is	  colour	  coded	  ranging	  from	  blue	  (0%)	  to	  red	  (100%).	  Conservation	  is	  also	  indicated	  by	  the	  bar	  plot	  in	  purple	  
	  	   The	  importance	  of	  the	  Pro	  residue	  in	  the	  BB	  loop	  of	  TIR	  domains	  is	  best	  illustrated	   by	   the	   Pro	   to	   His	   point-­‐mutation	   studies	   on	   the	   TIR	   domains	   of	  mammalian	   TLRs.	   The	   Pro712His	   mutant	   of	   the	   murine	   TLR4-­‐TIR	   prevents	  interaction	  with	  the	  downstream	  adaptor	  protein,	  MyD88	  (Poltorak	  et	  al.,	  1998).	  This	  renders	  the	  mice	  unable	  to	  respond	  to	  LPS	  and	  to	  counteract	  Gram-­‐negative	  bacterial	   infections	   despite	   an	   otherwise	  normally	   functioning	   immune	   system	  (Poltorak	   et	   al.,	   1998).	   The	   equivalent	   Pro674His	   mutant	   in	   hTLR10	   reduces	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both	   the	   signalling	   capacity	   and	   the	   interaction	   of	   the	   receptor	   with	   MyD88	  (Hasan	   et	   al.,	   2005).	   In	   addition,	   the	   Pro681His	   mutant	   of	   the	   hTLR2-­‐TIR	   is	  reported	  to	  interfere	  with	  signal	  transduction	  in	  response	  to	  stimulation	  by	  yeast	  and	  Gram-­‐positive	  bacteria	   and	  also	  abolished	   interaction	  with	  MyD88	  despite	  maintaining	   structural	   integrity	   (Xu	   et	   al.,	   2000).	   These	   data	   strongly	   indicate	  that	   the	  Pro	  residue	   in	  the	  BB	  loop	  of	  TIR	  domains	  has	  a	  key	  role	   in	  mediating	  TIR-­‐TIR	  heterotypic	  interactions	  with	  MyD88.	  	  Related	   studies	   have	   shown	   that	   synthetic	   mimics	   of	   the	   BB	   loop	   of	  MyD88	  can	   inhibit	   the	   interaction	  between	   the	  TIR	  domains	  of	  murine	  MyD88	  and	  IL-­‐1R	  (Bartfai	  et	  al.,	  2003).	  In	  addition	  to	  reduced	  signalling	  to	  NFκB,	  it	  was	  also	   shown	   that	   these	   synthetic	  mimics	   inhibited	   in	   vitro	  homodimerisation	   of	  the	   TIR	   domains	   of	   hMyD88	   (Loiarro	   et	   al.,	   2005).	   These	   studies	   indicate	   the	  importance	   of	   the	   BB	   loop	   of	   MyD88-­‐TIR	   in	   signalling	   to	   NFκB.	   However	   its	  contribution	   to	  domain	  homodimerisation	   is	   not	   fully	   clear	   because	   the	   recent	  structure	  of	  the	  isolated	  hMyD88-­‐TIR	  (Ohnishi	  et	  al.,	  2009),	  as	  discussed	  later	  in	  the	  chapter,	  did	  not	  reveal	  a	  homodimer.	  	  In	  contrast,	  other	  studies	  have	  shown	  that	  the	  Pro714His	  mutant	  of	   the	  hTLR4-­‐TIR	   does	   not	   affect	   the	   interaction	   of	   the	   receptor	  with	  MyD88	   or	  Mal	  (MyD88-­‐adaptor	  like)	  (Dunne	  et	  al.,	  2003).	  Mal	  is	  recruited	  by	  TLR4	  in	  addition	  to	  MyD88	   for	  signal	   transduction	   (Horng	   et	  al.,	  2002).	  Furthermore,	   the	  Pro	   to	  His	  mutants	  of	  the	  TIR	  domains	  of	  MyD88	  and	  Mal	  were	  shown	  to	  interact	  with	  TLR4	   (Dunne	   et	   al.,	   2003).	   These	   studies	   suggest	   that	   in	   some	   cases	   residues	  other	  than	  the	  conserved	  Pro	  in	  the	  BB	  loop	  are	  involved	  in	  TIR-­‐TIR	  heterotypic	  interactions.	  However	  the	  precise	  roles	  of	  either	  the	  BB	  loop	  or	  other	  regions	  of	  the	  TIR	  domains	  in	  mediating	  protein	  interactions	  are	  not	  fully	  understood	  yet.	  	  	  
1.4.2	  Structure	  of	  the	  BB	  Loop	  The	  BB	   loop	   is	   a	   prominent	   surface	   feature	  of	   the	   structures	   of	   the	  TIR	  domains	  of	  human	  TLR1	  (Fig	  1.9b),	  TLR2,	  IL-­‐1RAPL	  and	  TLR10	  (Xu	  et	  al.,	  2000;	  Tao	  et	  al.,	  2002;	  Khan	  et	  al.,	  2004;	  Nyman	  et	  al.,	  2008).	  Common	  features	  in	  the	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structures	  of	  the	  TIR	  domains	  of	  TLR1,	  TLR2	  and	  IL-­‐1RAPL	  include	  salt-­‐bridges	  between	   Arg	   at	   the	   BB3	   position	   and	   the	   corresponding	   BB4	   residue	   (Asn	   in	  TLR1;	  Asp	   in	  TLR2	  and	   IL-­‐1RAPL)	   as	  well	   as	   the	   conserved	  Glu	   residue	   at	   the	  
αA13	  position	  of	  helix	  αA	  (Fig	  1.9c)	  (Xu	  et	  al.,	  2000;	  Khan	  et	  al.,	  2004).	  	  	  	  
	  
Fig	  1.9	  Structural	  analysis	  of	  the	  BB	  loop	  in	  TIR	  domains	  Structure	  of	  the	  TIR	  domain	  of	  human	  TLR1	  (PDB	  entry	  1FYV)	  is	  represented	  as	  (a)	  surface	  and	  (b)	  ribbon	  schematics.	  The	  structure	  was	  generated	  using	  MacPymol.	  The	  residues	  contained	  in	  the	  BB	  loop	  are	  coloured	  and	  labelled.	  The	  side	  chains	  of	  the	  BB	  loop	  residues	  are	  indicated	  in	  (c)	  as	  well	  as	  the	  glutamatic	  acid	  residue	  in	  helix	  αA	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Mutational	  analysis	  of	  the	  residues	  of	  the	  BB3,	  BB4,	  BB7	  and	  BB8	  residues	  of	   the	  BB	   loop	  as	  well	   as	   the	   conserved	  αA13	   residue	  of	   the	  human	  TLR4	  and	  
Drosophila	   Toll	   (Xu	   et	   al.,	   2000)	   resulted	   in	   reduced	   signalling	   activity	   in	  transfection	   assays	   compared	   to	   wild-­‐type	   TIR	   domains.	   These	   mutagenesis	  studies	   revealed	   the	   importance	   of	   each	   of	   these	   residues	   in	   the	   receptors	   for	  signalling.	  Furthermore,	  the	  double	  mutant	  at	  the	  BB3	  and	  αA13	  positions	  fully	  abolished	  the	  receptor	  signalling	  activity,	  thereby	  suggesting	  that	  the	  salt-­‐bridge	  between	  these	  residues	  is	  crucial	  for	  activity	  of	  the	  TIR	  domain	  (Xu	  et	  al.,	  2000).	  However	   it	   is	   not	   known	   whether	   the	   conformation	   observed	   in	   the	   crystal	  structure	  is	  the	  active	  conformation	  (Xu	  et	  al,	  2000)	  of	  the	  BB	  loop.	  The	  conformational	  difference	  observed	  in	  the	  BB	  loop	  of	  the	  TIR	  domain	  of	  TLR2	   compared	   to	   the	  TIR	  of	  TLR1	   is	   likely	   to	  be	   the	   result	   of	   a	   cacodylate	  modification	  of	  Cys	  βB4	  situated	  below	  the	  loop	  (Fig	  1.7bc)	  (Xu	  et	  al.,	  2000)	  due	  to	   the	   presence	   of	   100	   mM	   cacodylate	   in	   the	   crystallisation	   buffer	   (Xu	   et	   al.,	  2000).	   The	   subsequent	   crystal	   structure	   of	   the	   Cys713Ser	   mutant	   of	   the	   TIR	  domain	   of	   TLR2	   indicated	   that	   the	   BB	   loop	   can	   adopt	   a	   number	   of	   different	  conformations	  (Tao	  et	  al.,	  2002).	  Although	  this	  structure	  is	  discussed	  in	  detail	  in	  the	   next	   section,	   two	   different	   BB	   loop	   conformations	   were	   observed	   in	   the	  Cys713Ser	  mutant	  of	  the	  TIR	  domain	  of	  TLR2,	  which	  were	  different	  to	  that	  of	  the	  wild-­‐type	   (Tao	   et	   al.,	   2002).	   These	   different	   conformations	  may	  be	   relevant	   to	  the	   dynamic	   function	   of	   TIR	   domains	   in	   TLR2-­‐mediated	   signal	   transduction,	  since	   TLR2	   in	   combination	   with	   other	   TLRs	   recognises	   a	   wide	   variety	   of	  microbial	  ligands	  (Knapp,	  2010;	  Gay	  and	  Gangloff,	  2007).	  There	   are	   further	   differences	   in	   the	   conformation	   of	   the	  BB	   loop	   in	   the	  TIR	  domain	  of	  human	  TLR1	  compared	  with	  that	  of	  IL-­‐1RAPL.	  The	  side	  chain	  of	  the	  Phe-­‐BB5	  residue	   in	   the	  TIR	  domain	  of	  TLR1	   faces	   the	  solvent	  while	   that	  of	  the	  Leu-­‐BB5	  residue	  in	  the	  TIR	  domain	  of	  IL-­‐1RAPL	  lies	  buried	  in	  the	  structure	  (Fig	  1.10)	  (Khan	  et	  al.,	  2004).	  The	  Pro-­‐BB7	  (the	  Lpsd	  mutation	  point)	  residue	  is	  ~5	  Å	  apart	  in	  the	  structures	  of	  the	  TIR	  domains	  of	  TLR1	  and	  IL-­‐1RAPL	  (Fig	  1.10)	  (Khan	  et	  al.,	  2004).	  In	  addition,	  the	  residue	  at	  position	  BB8	  in	  IL-­‐1RAPL	  is	  a	  Thr	  rather	   than	   the	  Gly	   observed	   in	   the	   TIR	   domains	   of	   the	   human	  TLRs.	   The	  TIR	  domain	   of	   human	   IL-­‐1RAPL	   therefore	   contains	   a	   unique	   hydrogen	   bond	   that	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links	   the	   Thr	   residues	   at	   the	   BB8	   and	   BB10	   positions	   (Fig	   1.10)	   (Khan	   et	   al.,	  2004),	   which	   may	   have	   a	   role	   in	   stabilising	   a	   specific	   BB	   loop	   conformation.	  These	   differences	   could	   relate	   to	   the	   different	   mechanisms	   of	   recruitment	   of	  downstream	  adaptors	  by	  proteins	  of	  the	  closely	  related	  but	  different	  TLR	  and	  IL-­‐1R	  families.	  	  
	  
Fig	  1.10	  Superimposition	  of	  the	  BB	  loops	  of	  human	  TLR1	  and	  IL-­1RAPL	  The	  BB	  loops	  in	  the	  TIR	  domains	  of	  human	  TLR1	  (green;	  PDB	  entry	  1FYV)	  and	  IL-­‐1RAPL	  (yellow;	  PDB	  entry	  1T3G)	  including	  the	  ends	  of	  helix	  αA	  have	  been	  superimposed	  using	  MacPymol	  and	  displayed	  in	  stereo-­‐view.	  The	  side	  chains	  of	  the	  BB3-­‐5,	  BB7-­‐8,	  BB10	  and	  αA13	  residues	  are	  indicated.	  These	  residues	  contribute	  to	  conformational	  differences	  between	  the	  two	  structures.	  The	  main	  chain	  of	  the	  Gly	  residue	  at	  BB8	  position	  of	  the	  TLR1-­‐TIR	  is	  indicated	  in	  pink	  
	  
1.4.3	  Role	  of	  the	  BB	  Loop	  in	  TIR	  Dimerisation	  It	  has	  been	  suggested	  that	  the	  BB	  loop	  plays	  a	  role	  in	  the	  formation	  of	  the	  dimer	   interface	   of	   TIR	   domains	   of	   TLRs.	   A	   tetramer	   of	   the	   molecule	   was	  observed	   in	   the	   crystals	   of	   the	   TIR	   domain	   of	   TLR1,	   which	   contains	   two	  disulphide	   bridges	   between	   Cys707	   residues	   of	   adjacent	  monomers	   (Xu	   et	   al.,	  2000).	  The	  main	  regions	  of	  the	  protein	  involved	  in	  the	  dimer	  interface	  are	  the	  αC	  helix	   and	   the	   BB	   loops	   (Xu	   et	   al.,	   2000).	   The	   structure	   of	   TLR2-­‐TIR	   was	   not	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analysed	   for	   its	   multimeric	   state	   as	   it	   was	   possibly	   affected	   by	   cacodylate	  modification	  of	   the	  Cys713	  residue	  (Xu	  et	  al.,	  2000).	  The	  subsequent	  structural	  studies	   on	   the	   Cys713Ser	   mutant	   of	   TLR2-­‐TIR	   revealed	   the	   AB	   and	   CD	  asymmetric	  dimers	  of	  the	  TIR	  domain	  (Fig	  1.11)	  (Tao	  et	  al.,	  2002).	  	  	  
	  
Fig	  1.11	  Crystal	  structure	  of	  the	  Cys713Ser	  mutant	  of	  the	  TIR	  domain	  of	  human	  TLR2	  Structure	  of	  the	  Cys713Ser	  mutant	  of	  the	  human	  TLR2-­‐TIR	  (PDB	  entry	  1O77)	  is	  represented	  as	  a	  cartoon	  schematic	  using	  MacPymol.	  Molecules	  A,	  B,	  C	  and	  D	  are	  arranged	  in	  a	  side-­‐by-­‐side	  fashion	  in	  the	  tetramer.	  The	  BB	  and	  DD	  loops	  and	  disulphide	  links	  at	  the	  N-­‐termini	  are	  indicated	  
	  The	  dimer	   interface	  showed	  associations	  of	   the	  BB	   loop	  and	  αB	  helix	  of	  one	   molecule	   with	   the	   αD	   and	   the	   DD	   loop	   of	   another	   molecule.	   In	   addition,	  residues	  at	  the	  AB	  dimer	  interface	  were	  important	  for	  receptor	  signalling	  based	  on	   mutagenesis	   studies.	   The	   observation	   of	   the	   asymmetric	   AB	   dimer	   was	  suggested	   to	   be	   biologically	   relevant	   in	   reflecting	   the	   heterodimeric	   signalling	  complexes	   where	   molecules	   A	   and	   B	   correspond	   to	   TLR2	   and	   TLR1/6	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respectively.	  Gautam	  et	  al.	  (2006)	  have	  further	  explored	  residues	  in	  the	  DD	  loop	  of	  TLR2-­‐TIR	  critical	   for	   interacting	  with	  the	  BB	  loop	  of	  TLR1-­‐TIR	  domain	  using	  mutagenesis	  and	  subsequent	  computer	  modelling	  studies,	  also	  supported	  by	   in	  
vitro	  cell-­‐based	  reporter	  assays.	  Despite	  the	  Cys713Ser	  mutation	  to	  minimise	  Cys	  modifications	   in	   the	   structure,	   the	   asymmetric	   dimer	   interface	   included	   a	  disulphide	   bond	   between	   the	   Cys640	   and	   Cys750	   residues	   of	   two	   adjacent	  molecules	  (Fig	  1.11)	  (Tao	  et	  al.,	  2002).	  	  Similarly,	   an	   asymmetric	   dimer	   of	   the	   TIR	   domain	   of	   human	   IL-­‐1RAPL	  was	   observed	   (Khan	   et	   al.,	   2004).	   The	  monomers	   shared	   an	   extensive	   contact	  interface	  involving	  helices	  αB,	  αC	  and	  αD	  (Khan	  et	  al.,	  2004).	  The	  dimer	  interface	  also	  showed	  associations	  of	  helix	  αB	  and	  BB	  loop	  of	  one	  monomer	  with	  the	  αD	  helix	  of	  another	  (Khan	  et	  al.,	  2004).	  In	  addition,	  the	  Ser488	  residue	  in	  helix	  αC’	  is	  situated	  at	  the	  centre	  of	  the	  dimer	  interface	  forming	  a	  tight	  hydrogen	  bond	  with	  Ser488	  of	  the	  other	  monomer	  (Khan	  et	  al.,	  2004).	  This	  association	  is	  suggested	  as	   biologically	   relevant	   though	   a	   similar	   contact	   for	   the	   equivalent	   residue	   of	  Cys707	   at	   the	   centre	   of	   the	   dimer	   interface	   in	   the	   TIR	   domain	   of	   TLR1	   was	  initially	   regarded	  as	  a	   crystallographic	  artefact	   (Xu	   et	  al.,	   2000).	  However,	   it	   is	  possible	   that	   the	   Cys707-­‐mediated	   dimer	   of	   TLR1-­‐TIR	   is	   biologically	   relevant.	  The	   functionally	   relevant	   AB	   asymmetric	   dimer	   of	   the	   Cys713Ser	   mutant	   of	  TLR2-­‐TIR	   also	   indicated	   disulphide	   bonds.	   Besides,	   the	   dimer	   interfaces	   in	   all	  these	  receptors	  share	  contributions	  from	  the	  BB	  loop.	  The	   recent	   structure	   of	   the	   TIR	   domain	   of	   human	   TLR10	   revealed	   a	  symmetric	  dimer	  in	  the	  crystallographic	  asymmetric	  unit	  (Fig	  1.12a)	  (Nyman	  et	  
al.,	  2008).	  It	  was	  suggested	  that	  the	  conserved	  and	  hydrophobic	  residues	  of	  the	  BB	  loop	  including	  Tyr-­‐BB1,	  Phe-­‐BB5	  and	  Pro-­‐BB7,	  and	  Ile678	  contributed	  both	  to	   the	   dimer	   interface	   and	   stabilisation	   of	   the	   observed	   BB	   loop	   conformation	  (Nyman	  et	  al.,	  2008).	  Despite	  its	  role	  in	  the	  dimer	  interface,	  a	  large	  part	  of	  the	  BB	  loop	   in	   the	   TIR	   domain	   of	   TLR10	   is	   also	   exposed	   to	   the	   surrounding	   solvent	  forming	   an	   extended	   patch	   of	   highly	   conserved	   residues	   (Nyman	   et	   al.,	   2008).	  These	   residues	   include	   the	   BB2,	   BB3,	   BB4,	   BB6,	   BB7	   and	   BB8	   residues	   (Fig	  1.12b).	  It	  is	  possible	  that	  this	  extended	  patch	  acts	  as	  the	  scaffold	  for	  recruitment	  of	  TIR	  domain-­‐containing	  adaptor	  proteins	  (Nyman	  et	  al.,	  2008).	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Fig	  1.12	  Crystal	  structures	  of	  the	  TIR	  domain	  of	  human	  TLR10	  The	  structures	  of	  the	  TIR	  domains	  of	  human	  TLR10	  (PDB	  entry	  2J67)	  are	  represented	  as	  (a)	  cartoon	  and	  (b)	  surface	  schematics	  using	  MacPymol.	  The	  dimer	  monomers,	  coloured	  purple	  and	  green,	  are	  arranged	  symmetrically.	  The	  BB	  loops	  are	  coloured	  pink	  and	  orange.	  The	  key	  residues	  involved	  in	  the	  extended	  patch	  are	  labelled	  in	  (b)	  
	  In	   addition,	   the	   TIR	   domain	   of	   human	   TLR4	   has	   been	   structurally	  modelled	  as	  a	  homodimer	   (Nunez	  Miguel	   et	  al.,	  2007).	  The	  model	   revealed	   the	  importance	  of	  the	  BB	  loop	  residues	  in	  contributing	  to	  the	  extensive	  homodimer	  interface.	   In	  particular,	   the	  Phe-­‐BB5	  residues	  of	   the	   two	  monomers	   interact	  by	  forming	   an	   aromatic	   linkage	   (Nunez	   Miguel	   et	   al.,	   2007).	   Additionally,	   it	   was	  shown	   that	   the	   Pro-­‐BB7	   residue	   was	   important	   in	   maintaining	   a	   rigid	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conformation	   on	   the	   BB	   loop,	   such	   that	   its	   substitution	   would	   distort	   the	  architecture	   of	   the	   homodimer	   interface	   (Nunez	   Miguel	   et	   al.,	   2007).	   The	  importance	  of	   the	  BB	   loop	  residues	   in	   the	  TIR	  domain	  of	  TLR4,	  such	  as	   that	  of	  His-­‐BB1	   and	   Pro-­‐BB7	   residues,	   was	   further	   supported	   by	   functional	   studies	  including	  mutagenesis	  (Nunez	  Miguel	  et	  al.,	  2007).	  	  TLR4	   signalling	   recruits	   two	   sets	   of	   adaptor	  proteins,	  MyD88	  and	  TRIF.	  For	  each	  pathway,	  TLR4	  recruits	  different	  sorting	  adaptors,	  MyD88	  adaptor	  like	  (Mal)	   and	  TRIF-­‐related	  adaptor	  molecule	   (TRAM)	   (Fitzgerald	  and	  Chen,	  2006).	  The	   structures	   of	   Mal	   and	   TRAM	   were	   also	   modelled	   to	   analyse	   protein	  interaction	  with	  the	  TIR	  domain	  of	  TLR4	  using	  molecular	  docking	  (Nunez	  Miguel	  
et	   al.,	   2007).	   On	   the	   basis	   of	   the	  model	   it	   was	   suggested	   that	   the	   homodimer	  interface	   of	   the	   TIR	   domain	   of	   TLR4	   serves	   as	   a	   scaffold	   for	   recruitment	   of	  adaptor	  proteins	  (Nunez	  Miguel	  et	  al.,	  2007).	  Mal	  and	  TRAM	  bound	  to	  the	  same	  binding	   site	   at	   the	   homodimer	   interface	   whilst	   there	   were	   indications	   for	  additional	   binding	   sites	   potentially	   for	   the	   second	   adaptors,	   MyD88	   and	   TRIF	  (Nunez	  Miguel	   et	  al.,	  2007).	  The	  BB	   loops	  of	  all	   the	   three	  model	  structures	  are	  suggested	  to	  play	  a	  role	  in	  determining	  binding	  specificity	  (Nunez	  Miguel	  et	  al.,	  2007).	   However	   it	   was	   not	   possible	   to	   ascertain	   whether	   an	   activated	   TIR	  homodimer	  of	  TLR4	  can	  recruit	  Mal	  and	  TRAM	  in	  parallel	  or	   if	   the	  recruitment	  was	  mutually	  exclusive	  (Nunez	  Miguel	  et	  al.,	  2007).	  	  	  
1.5	   The	  TLR	  Signalling	  Pathway	  
	   A	   general	   mechanism	   for	   TLR	   action	   in	   mammalian	   cells	   can	   be	  summarised	  as	  follows	  (Fig	  1.13).	  The	  TLR	  molecules	  exist	  as	  preformed	  dimers	  with	  the	  TLR	  ECDs	  linked	  to	  the	  cytoplasmic	  TIR	  domains	  by	  a	  transmembrane	  helix	   (Triantafilou	   et	   al.,	   2006;	   Latz	   et	   al.,	   2007).	   When	   membrane-­‐bound	  dimeric	   TLRs	   recognise	   PAMPs	   through	   their	   LRR	   domains,	   they	   are	   activated	  upon	   ligand	  binding	   (Triantafilou	   et	   al.,	   2006;	   Latz	   et	   al.,	   2007).	   Subsequently,	  their	   intracellular	   TIR	   domains	   recruit	   and	   interact	   with	   the	   homologous	   TIR	  domain	  of	  a	  downstream	  adaptor	  protein	  (Tao	  et	  al.,	  2002;	  Janeway	  et	  al.,	  2004;	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Eto	  et	  al.,	  2003).	  As	  mentioned	  earlier,	  TLRs	  can	  recruit	  MyD88	  and	  TRIF.	  Here	  the	  MyD88-­‐dependent	  pathway	  is	  detailed.	  	  
	  
Fig	  1.13	  Schematic	  illustration	  of	  mammalian	  TLR	  signalling	  pathway	  The	  mammalian	  TLRs	  (green)	  are	  activated	  upon	  ligand	  (red)	  binding	  and	  their	  intracellular	  TIR	  domains	  (cyan)	  recruit	  the	  downstream	  adaptor	  protein	  such	  as	  MyD88.	  This	  in	  turn	  activates	  IRAK	  via	  death	  domain	  (pink)	  interactions.	  TRAF6	  (blue)	  activates	  the	  IKK	  complex	  (orange).	  The	  phosphorylated	  IkB	  (light	  green)	  releases	  active	  NFκB	  (purple)	  that	  translocates	  into	  the	  nucleus	  and	  activates	  the	  transcription	  of	  inflammatory	  genes	  in	  order	  to	  elicit	  innate	  immune	  response	  against	  the	  ligand,	  PAMPs	  in	  this	  case	  (Low	  et	  al.,	  2007;	  Janeway	  et	  al.,	  2004)	  
	  Of	   the	   MyD88-­‐dependent	   TLR	   signalling	   pathways,	   TLR2-­‐	   and	   TLR4-­‐mediated	  pathways	  use	  Mal	  as	   the	  sorting	  adaptor	   to	  recruit	  MyD88	  (Horng	   et	  
al.,	  2002;	  Kagan	  and	  Medzhitov,	  2006).	  The	  recruitment	  of	  MyD88	  activates	  IL-­‐1	  receptor-­‐associated	   kinases	   (IRAK)	   via	   the	   interaction	   of	   death	   domains	  (Janeway	  et	  al.,	  2004).	  These	  in	  turn	  associate	  with	  tumour	  necrosis	  factor	  (TNF)	  receptor-­‐associated	   factor	  6	   (TRAF6)	  and	  activate	   the	   IB	  kinase	   (IKK)	  complex	  (Eto	  et	  al.,	  2003).	  The	  activated	  IKK	  phosphorylates	  IκB,	  a	  cytosolic	  inhibitor	  that	  tethers	  NF-­‐κB,	  and	  directs	  the	  IκBs	  to	  degradation	  by	  ubiquitination-­‐dependent	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proteolysis,	   thereby	   releasing	   the	   active	   dimeric	   transcription	   factor,	   NF-­‐κB	  (Janeway	  et	  al.,	  2004;	  Eto	  et	  al.,	  2003).	  The	  released	  NF-­‐κB	  translocates	  into	  the	  nucleus	   and	   activates	   the	   transcription	   of	   several	   inflammatory	   genes.	   This	  series	  of	  signalling	  cascades	  is	  essential	  for	  initial	  host	  defense	  against	  microbes.	  Although	  activation	  of	  signal	  transduction	  by	  all	  TLRs	  culminates	  in	  activation	  of	  inflammatory	  genes,	  the	  transcriptional	  responses	  differ.	  	  	  
1.6	   TIR-­domain	  containing	  Adaptor	  Proteins	  
The	  TIR	  domain	  is	  evolutionarily	  conserved	  among	  the	  TLRs,	  IL-­‐1Rs	  and	  the	  cytoplasmic	  TIR	  containing	  adaptor	  molecules.	  There	  are	  five	  TIR	  containing	  adaptor	  molecules	  characterised	  to	  date;	  MyD88,	  Mal,	  TRIF,	  TRAM	  and	  sterile	  α-­‐(SAM)	   and	   heat-­‐armadillo	   (ARM)	   motif	   containing	   protein	   (SARM)	   (Fig	   1.14)	  (Kenny	   and	   O'Neill,	   2008;	   O'Neill	   et	   al.,	   2003).	   MyD88	   is	   recruited	   for	  downstream	  signalling	  by	  all	  TLRs	  and	  IL-­‐1Rs	  except	  TLR3	  (Brown	  et	  al.,	  2006).	  TLR1,	   TLR2,	   TLR4	   and	   TLR6	   additionally	   recruit	   Mal,	   which	   mediates	   the	  interactions	  between	  the	  TIR	  domains	  of	  TLRs	  and	  MyD88	  (Horng	  et	  al.,	  2002).	  The	   MyD88-­‐independent	   pathways	   mediated	   by	   TLR3	   and	   TLR4	   recruit	   TRIF	  instead	  (Yamamoto	  et	  al.,	  2003).	  TLR4	  recruits	  TRAM	  in	  addition	  to	  TRIF	  to	  link	  between	  the	  TIR	  domain	  of	  TLR4	  and	  TRIF	  (Rowe	  et	  al.,	  2006).	  In	  contrast	  to	  the	  other	   adaptors,	   SARM	   is	   a	   negative	   regulator	   of	   TRIF	   signalling	   (O'Neill	   et	   al.,	  2003;	  Carty	  et	  al.,	  2006).	  All	  these	  adaptors	  except	  SARM	  trigger	  the	  cascade	  of	  TIR-­‐mediated	  signalling	  pathways	  leading	  to	  the	  activation	  of	  NF-­‐κB,	  MAPK	  and	  IRFs,	  which	   induce	   the	   transcription	  of	  proinflammatory	  cytokines,	   type	   I	   IFNs	  and	  chemokines	  (Fig	  1.14).	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Fig	  1.14	  Overview	  of	  TLR/	  IL-­1R	  signalling	  through	  TIR	  domain	  containing	  adaptors	  	  The	  receptors	  IL-­‐1R,	  TLR1,	  TLR2,	  TLR4,	  TLR5	  and	  TLR6	  are	  expressed	  on	  the	  cell	  surface	  while	  receptors	  TLR3,	  TLR7,	  TLR8	  and	  TLR9	  are	  expressed	  on	  endosomal	  membranes.	  The	  cytoplasmic	  TIR	  domain	  containing	  adaptors	  MyD88,	  Mal,	  TRIF	  and	  TRAM	  are	  differentially	  recruited	  by	  TLR/	  IL-­‐1R	  complexes	  to	  positively	  regulate	  the	  activation	  of	  transcription	  factors	  NF-­‐κB	  and	  IRFs	  while	  SARM	  negatively	  regulates	  TRIF	  (O'Neill	  and	  Bowie,	  2007;	  Kumar	  et	  al.,	  2009a).	  
	  The	   NMR	   solution	   structure	   of	   human	   MyD88-­‐TIR	   revealed	   a	   similar	  overall	   fold	   to	   the	  known	  human	  TIR	  domain	   structures	   (Ohnishi	   et	   al.,	   2009).	  However	  comparison	  of	  the	  MyD88-­‐TIR	  structure	  with	  that	  of	  TLR2-­‐TIR,	  which	  shares	  the	  highest	  sequence	  similarity,	  revealed	  that	  there	  were	  large	  differences	  in	  the	  conformation	  of	  the	  BB	  loop	  in	  the	  two	  structures.	  Although	  in	  both	  cases	  the	  BB	  loops	  are	  exposed	  to	  the	  solvent,	  the	  loop	  orientations	  are	  different	  (Fig	  1.15)	   (Ohnishi	   et	   al.,	   2009).	   This	   is	   because	   the	   helix	  αB	   is	   shorter	   in	   the	   TIR	  domain	  of	  MyD88	  than	  in	  TLR2.	  The	  additional	  three	  residues	  that	  are	  involved	  in	   the	   helix	   αB	   in	   TLR2-­‐TIR	   adopt	   an	   extended	   conformation	   in	   MyD88-­‐TIR	  resulting	   in	   a	   structural	   difference	   to	   the	   C-­‐terminal	   region	   of	   the	   BB	   loop	  (Ohnishi	  et	  al.,	  2009).	  It	  was	  also	  suggested	  that	  the	  BB	  loop	  in	  the	  TIR	  domain	  of	  MyD88	   had	   conformational	   flexibility	   in	   solution	   based	   on	   broad	  NMR	   signals	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from	  the	  corresponding	  residues	  in	  the	  surrounding	  region	  (Ohnishi	  et	  al.,	  2009).	  This	   could	   relate	   to	   its	   functional	   role	   interacting	   with	   the	   TIR	   domains	   of	   a	  range	  of	  TLRs	  and	  IL-­‐1Rs.	  	   	  
	  
Fig	  1.15	  Structures	  of	  the	  TIR	  domains	  of	  human	  MyD88	  and	  TLR2	  The	  structures	  of	  the	  TIR	  domains	  of	  human	  MyD88	  (blue;	  PDB	  entry	  2Z5V)	  and	  human	  TLR2	  (red;	  PDB	  entry	  1FYW)	  are	  superimposed.	  The	  N-­‐	  and	  C-­‐	  terminals	  and	  the	  BB	  loops	  are	  indicated.	  	  These	  structures	  were	  derived	  as	  (a)	  cartoons	  and	  (b)	  ribbons	  using	  MacPyMOL	  	  In	   combination	   with	   mutagenesis	   and	   NFκB	   reporter	   studies,	   it	   was	  shown	  that	  there	  were	  two	  binding	  sites	  for	  Mal	  on	  the	  MyD88-­‐TIR	  surface.	  Since	  these	   binding	   sites	   are	   located	   on	   opposite	  molecular	   surfaces	   of	   MyD88-­‐TIR,	  two	   Mal-­‐TIR	   molecules	   are	   suggested	   to	   bind	   simultaneously	   to	   MyD88-­‐TIR	  (Ohnishi	   et	  al.,	  2009).	  An	  additional	   third	  possible	   functional	  site	  could	  bind	  to	  the	  TIR	  domain	  of	  TLR4	  (Kagan	  and	  Medzhitov,	  2006).	  However,	  GST	  pull	  down	  showed	  that	  Mal-­‐TIR	  binds	  to	  the	  TIR	  domain	  of	  human	  TLR4	  while	  MyD88-­‐TIR	  does	  not	  (Ohnishi	  et	  al.,	  2009),	  a	  finding	  consistent	  with	  previous	  studies	  (Brown	  
et	   al.,	   2006).	   In	   addition,	   the	   three	   suggested	   functional	   sites	   also	   contain	  residues	   of	   the	   conserved	   boxes	   1-­‐3	   of	   TIR	   domains.	   Overall,	   Ohnishi	   et	   al.	  (2009)	   have	   highlighted	   the	   importance	   of	   MyD88-­‐TIR	   as	   part	   of	   a	   dynamic	  adaptor	   protein	   potentially	   providing	   multiple	   interaction	   surfaces	   for	   the	  cytosolic	   TIR	   complex	   formation	   although	   further	  work	  will	   clarify	   the	   precise	  molecular	  details	  of	  these	  interactions.	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1.7	   Microbial	  Strategies	  against	  TLRs	  
	   One	   of	   the	   microbial	   strategies	   for	   successful	   host	   evasion	   requires	  manipulation	  of	  the	  TLR-­‐activated	  signalling	  pathway	  (Underhill,	  2004).	  This	  can	  be	   best	   described	   under	   three	   categories	   as	   follows.	   Firstly,	   it	   is	   possible	   that	  microbes	   modify	   their	   PAMPs,	   which	   serve	   as	   less	   stimulatory	   ligands	   for	  recognition	   by	   TLRs	   (Fig	   1.16;a).	   For	   instance,	   certain	   Gram-­‐negative	   bacteria	  have	   long	  been	  known	  to	  produce	  modified	   lipid	  A	  component	  of	  LPS	  with	   low	  virulence.	   These	   bacteria	   include	  Porphyromonas	   gingivalis,	   Helicobacter	   pylori	  and	   Chlamydia	   trachomatis,	   all	   associated	   with	   chronic	   inflammatory	   diseases	  (Fujiwara	   et	   al.,	   1990;	   Ingalls	   et	   al.,	   1995;	   Muotiala	   et	   al.,	   1992).	   In	   addition,	  
Yersinia	  pestis	  can	  produce	  a	  modified	  lipid	  A	  component	  that	  is	  less	  stimulatory	  through	  TLR4	  (Kawahara	  et	  al.,	  2002).	  	  
	  
Fig	  1.16	  Postulated	  microbial	  strategies	  for	  manipulating	  TLRs	  	  Microbes	  are	  suggested	  to	  manipulate	  TLRs	  by	  (a)	  modifying	  expression	  or	  structure	  of	  PAMPs	  to	  prevent	  recognition	  (b)	  directly	  interfering	  with	  TLR	  signalling	  (c)	  activating	  other	  receptors	  in	  parallel	  with	  TLRs	  possibly	  leading	  to	  an	  attenuated	  response,	  adapted	  from	  (Underhill,	  2004)	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Secondly,	   it	   is	   possible	   that	  microbes	  modify	   the	   consequences	   of	   TLR-­‐activated	   signalling	   (Fig	  1.16;b).	   Instances	  of	   pathogen	   interference	  with	  NFκB	  signalling	   have	   been	   reported.	   Examples	   include	   the	   Yersinia	   virulence	   factor	  YopJ,	  which	  is	  injected	  into	  host	  target	  cells	  using	  a	  Type	  III	  secretion	  system	  and	  acts	  as	  a	  deubiquitinase	  to	  inhibit	  NFκB	  and	  MAPK	  activation	  (Zhou	  et	  al.,	  2005).	  YopJ	  has	  been	  identified	  as	  a	  deubiquitinating	  protease	  that	  negatively	  regulates	  the	   host	   cell	   response	   by	   cleaving	   ubiquitin	  moieties	   from	   important	   proteins	  like	   TRAF2,	   TRAF6	   and	   IκB	   (Zhou	   et	   al.,	   2005).	   Similarly,	   vaccinia	   virus	   (VV)	  proteins	   A46R	   and	   A52R	   are	   reported	   as	   putative	   antagonists	   of	   host	   TIR	  domain-­‐dependent	  intracellular	  signalling	  (Bowie	  et	  al.,	  2000).	  Expression	  of	  VV	  protein	   A52R,	   suggested	   to	   contain	   a	   homologous	   TIR	   domain,	   was	   shown	   to	  interfere	   with	   signalling	   through	   TLRs	   and	   the	   IL-­‐1R,	   without	   affecting	   NFκB	  activation	   by	   TNF	   receptor	   signalling	   (Bowie	   et	   al.,	   2000).	   Additional	   studies	  have	  revealed	  that	  the	  A52R	  protein	  associates	  directly	  with	  IRAK-­‐2	  and	  TRAF6,	  which	  are	  signalling	  molecules	  required	  for	  TLR	  signal	  transduction	  (Harte	  et	  al.,	  2003).	   The	   VV	   A46R	   was	   reported	   to	   target	   the	   host	   TIR	   adaptors	   including	  MyD88,	  Mal,	  TRIF	  and	  TRAM,	  thereby	  disrupting	  downstream	  activation	  of	  NFκB	  and	  MAPK	  (Stack	  et	  al.,	  2005).	  Previously,	  it	  was	  suggested	  that	  A46R	  contained	  a	  viral	  TIR	  domain	  however	  recently	   it	  has	  been	  analysed	  by	  bioinformatics	   to	  contain	  a	  Bcl-­‐2	  fold	  instead	  (Spear	  et	  al.,	  2009).	  Thirdly,	   it	   is	   possible	   that	   microbes	   interact	   with	   receptors	   other	   than	  TLRs	   to	  modify	   the	   consequences	   of	   TLR-­‐activated	   signalling	   (Fig	   1.16;c).	   For	  example,	  Candida	  albicans	  is	  a	  fungal	  pathogen	  that	  grows	  in	  budding	  yeast	  and	  filamentous	  forms	  in	  order	  to	   fully	   function	  as	  a	  pathogen.	  Dectin-­‐1,	  a	  receptor	  for	  β-­‐glucans	   in	   fungal	   cell	  walls	   can	   collaborate	  with	  TLR2	   and	   induce	   strong	  inflammatory	   responses	   against	   zymosan	   (Gantner	   et	   al.,	   2003).	   The	   cell	   wall	  structure	   during	   filamentous	   growth	   cannot	   permit	   the	   activation	   of	   Dectin-­‐1	  (Underhill,	   2004).	   This	   in	   turn	   causes	   weaker	   inflammatory	   responses	   as	   the	  Dectin-­‐1	  pathway	  cannot	  collaborate	  with	  TLR2	  pathway.	  It	   is	  possible	  that	  the	  failure	   of	   Dectin-­‐1	   activation	   by	   filaments	   is	   a	   microbial	   strategy	   to	   attenuate	  TLR2-­‐mediated	  response	  (Underhill,	  2004)	  although	  further	  studies	  are	  required	  to	  prove	  this.	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1.8	   Bacterial	  TIR	  Domains	  	  
Bacterial	  homologues	  of	  the	  human	  TIR	  domain	  were	  searched	  in	  order	  to	  identify	  potential	  virulence	  factors	  of	  the	  innate	  immune	  system.	  Bioinformatics	  searches	   of	   bacterial	   genomes	   identified	   >200	   TIR	   homologues	   including	   TIR-­‐like	  protein	  A	  (tlpA)	  in	  Staphylococcus	  aureus,	  Brucella	  melitensis	  and	  Salmonella	  
enterica	  serovar	  Enteriditis	  (Newman	  et	  al.	  2006).	  Sequence	  alignment	  with	  the	  TIR	   domains	   of	   human	   TLR6,	   TLR4	   and	   MyD88,	   reveals	   the	   high	   sequence	  homology	  of	   the	   tlpA	  sequences	   in	   the	  box	  1	   region	   (Fig	  1.17)	   (Newman	   et	  al.,	  2006).	   Subsequent	   work	   identified	   Paracoccus	   denitrificans	   TIR-­‐like	   protein	  (PdTLP)	   as	   a	   highly	   homologous	   protein	   to	   Salmonella	   tlpA,	   sharing	   39%	  sequence	  similarity	  over	  255	  residues	  (Low	  et	  al.,	  2007).	  	  	  
	  
Fig	  1.17	  Alignment	  and	  domain	  organisation	  of	  selected	  human	  and	  bacterial	  TIR	  	  The	  selected	  sequences	  include	  those	  of	  bacterial	  TIR	  homologues	  from	  Paracoccus	  denitrificans	  (Pd-­‐TIR),	  Brucella	  melitensis	  (Bm-­‐TIR),	  Salmonella	  enterica	  (Se-­‐TIR),	  Escherichia	  coli	  CFT073	  (Ec-­‐TIR)	  and	  Staphylococcus	  aureus	  (Sa-­‐TIR).	  The	  human	  TIR	  sequences	  from	  TLR6,	  TLR2,	  TLR4	  and	  MyD88	  are	  included.	  The	  sequences	  were	  aligned	  using	  CLC	  Sequence	  Viewer	  6.	  Sequence	  conservation	  is	  colour	  coded	  ranging	  from	  blue	  (0%)	  to	  red	  (100%).	  The	  characteristic	  box	  1,	  2	  and	  3	  sequences	  of	  TIR	  domains	  are	  indicated.	  A	  schematic	  for	  the	  domain	  organisation	  of	  selected	  bacterial	  and	  human	  TIR	  containing	  proteins	  is	  illustrated	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Similarly,	   Cirl	   et	   al.	   (2008)	   have	   identified	   bacterial	   TIR	   homologues	   in	  
Brucella	   melitensis	   and	   the	   uropathogenic	   CFT073	   strain	   of	   Escherichia	   coli,	  which	  were	   termed	  TIR	  domain	   containing-­‐proteins	  B	  and	  C	   (TcpB	  and	  TcpC).	  The	   sequences	  of	   these	  bacterial	  TIR	  homologues	  display	  a	  highly	  homologous	  box	   1	   region,	   which	   is	   known	   to	   play	   an	   important	   role	   in	   mediating	   TLR	  signalling	  (Fig	  1.17)	  (Slack	  et	  al.,	  2000).	  These	  bacterial	  TIR	  homologues	  are	  230	  to	  310	  amino	  acids	  long.	  Amino	  acid	  analysis	  of	  these	  proteins	  indicated	  that	  the	  conserved	  TIR	  domain	  is	  located	  in	  the	  C-­‐terminal	  region	  and	  that	  the	  N-­‐terminal	  region	  is	  comprised	  of	  a	  highly	  α-­‐helical	  coiled	  coil	  domain	  (Fig	  1.17)	  (Cirl	  et	  al.,	  2008;	   Low	   et	   al.,	   2007;	   Newman	   et	   al.,	   2006).	   This	  was	   supported	   by	   circular	  dichroism	  analysis	   on	   the	  N-­‐terminal	   region	  of	   PdTLP	   that	   indicated	   a	   high	  α-­‐helical	   content	   (Low	   et	   al.,	   2007).	   The	   N-­‐terminal	   region	   of	   these	   proteins	   is	  variable	   with	   no	   homology	   to	   known	   proteins.	   For	   instance,	   the	   N-­‐terminal	  region	  has	  been	  annotated	  as	  a	  putative	  transmembrane	  segment	  in	  the	  case	  of	  TcpC	  (Cirl	  et	  al.,	  2008).	  	  Recently	   a	   more	   comprehensive	   bioinformatics	   analysis	   by	   Spear	   et	   al.	  (2009)	  has	  identified	  922	  bacterial	  TIR	  domains	  across	  a	  wide	  range	  of	  bacterial	  phyla.	   These	   bacterial	   TIR	   domains	  were	   revealed	   to	   co-­‐occur	  with	   a	   range	   of	  different	  domains	   (Spear	   et	   al.,	   2009).	  Examples	   include	   the	  presence	  of	   an	  N-­‐terminal	   TIR	   domain	   followed	   by	   C-­‐terminal	   tetratricopeptide	   (TRR)	   repeats,	  common	  protein-­‐protein	  interaction	  domains,	  in	  Frankia	  sp.	  (Spear	  et	  al.,	  2009).	  Bacterial	   TIR	   containing	   proteins	   in	   Beggiatos	   sp.	   contain	   an	   N-­‐terminal	  Mettallophos	   domain	   involved	   in	   phosphorylation,	   while	   in	   Clostridium	  
thermocellum	   it	   contains	   C-­‐terminal	   trypsin,	   a	   serine-­‐protease	   domain,	   and	   in	  
Mariprofundus	   ferroxydans	   a	   C-­‐terminal	   Mrr-­‐cat,	   a	   type	   IV	   restriction	  endonuclease	  domain	  (Spear	  et	  al.,	  2009).	  	  	  
1.8.1	  Roles	  of	  Bacterial	  TIR	  Domains	  The	   majority	   of	   studies	   on	   bacterial	   TIR	   homologues	   have	   focused	   on	  their	   potential	   role	   as	   virulence	   factors.	   Newman	   et	   al.	   (2006)	   showed	   that	  
Salmonella	   tlpA	   suppresses	   the	   induction	   of	   NFκB	   by	   the	   mammalian	   TIR-­‐
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containing	   proteins	   TLR4,	   IL-­‐1R	   and	   MyD88	   but	   does	   not	   suppress	   NFκB	  activation	   induced	   by	   TNFα.	   TlpA	   has	   been	   reported	   to	   mimic	   the	   virulence	  factor	  SipB	   in	   inducing	  caspase-­‐1	   (Newman	   et	  al.,	   2006).	  The	  disruption	  of	   the	  tlpA	  gene	  resulted	  in	  a	  less	  virulent	  strain	  that	  demonstrated	  a	  reduced	  ability	  to	  survive	   in	   an	   in	   vivo	  mammalian	   cell	   culture	  model	   (Newman	   et	   al.,	   2006).	   In	  addition,	  this	  strain	  was	  also	  defective	  in	  IL-­‐1β	  secretion	  although	  it	  is	  not	  fully	  clear	   how	   IL-­‐1β	   assists	   pathogenesis	   (Newman	   et	   al.,	   2006).	   The	  disruption	   of	  the	   tlpA	   gene	   in	  mouse	   infection	  models	   also	   led	   to	   reduced	   lethality	   in	  mice	  (Newman	  et	  al.,	  2006).	  Analysis	  of	  the	  regions	  around	  the	  tlpA	  gene	  revealed	  that	  these	  sequences	  encoded	  for	  proteins	  of	  phage	  origin	  and	  pilin-­‐related	  domains	  (Newman	  et	  al.,	  2006).	  Since	  pilins	  are	  cell-­‐adhesive	  extracellular	  proteins,	  it	  was	  suggested	   that	  proteins	   encoded	  within	   this	   genomic	   region	   including	   tlpA	  are	  secreted	  (Newman	  et	  al.,	  2006).	  	  Similarly,	  Cirl	  et	  al.	   (2008)	   showed	   that	  TcpC	  and	  TcpB	  suppress	  TLR2-­‐	  and	   TLR4-­‐mediated	   activation	   of	   NFκB	   but	   do	   not	   suppress	   the	   activation	   of	  NFκB	  induced	  by	  the	  TIR-­‐independent	  cytokine	  TNF.	  TcpB	  and	  the	  purified	  TIR	  domain	   of	   TcpC	   (TcpC-­‐TIR)	   were	   also	   shown	   to	   interact	   with	   endogenous	  MyD88	  in	  mammalian	  cells	  (Cirl	  et	  al.,	  2008).	  Notably,	  TcpC-­‐TIR	  did	  not	  interact	  with	  TLR2-­‐TIR,	  TRIF,	  IRAK1	  and	  IRAK4	  (Cirl	  et	  al.,	  2008).	  TcpB	  was	  not	  assessed	  for	   interaction	   with	   these	   proteins.	   TcpC	   was	   further	   related	   to	   enhanced	  virulence	   in	   mouse	   models	   of	   acute	   kidney	   infections	   when	   compared	   with	   a	  deletion	   strain	   of	   TcpC	   (Cirl	   et	   al.,	   2008).	   TcpC	   was	   reported	   as	   a	   secretory	  protein	  possibly	  using	  the	  type	  I	  secretion	  system	  although	  detailed	  mechanisms	  are	  unknown	  (Cirl	  et	  al.,	  2008).	  The	  purified	  TcpC-­‐TIR	  was	  shown	  to	  internalise	  into	  host	  macrophages	  and	   interfere	  with	  TLR-­‐mediated	  TNF	   induction	  (Cirl	   et	  
al.,	  2008).	  	  Subsequent	   work	   on	   Brucella	   sp.	   TcpB	   has	   highlighted	   its	   high	   (53%)	  sequence	  similarity	  with	  the	  human	  adaptor	  protein	  Mal	  (Radhakrishnan	  et	  al.,	  2009).	   While	   Mal	   contributes	   to	   dendritic	   cell	   (DC)	   maturation	   (Horng	   et	   al.,	  2001),	  TcpB	  was	  shown	  to	   inhibit	  maturation	  of	   the	  DCs	   infected	  with	  Brucella	  (Salcedo	   et	   al.,	   2008).	   TcpB	   was	   shown	   to	   mimic	   Mal	   by	   binding	  phosphoinositides	   through	   its	  N-­‐terminal	  domain	  (Radhakrishnan	   et	  al.,	  2009).	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This	   allows	   Mal	   to	   recruit	   MyD88	   from	   the	   cytosol	   to	   the	   plasma	   membrane	  bringing	   it	   closer	   to	   the	  TIR	  domains	   of	   TLR2	   and	  TLR4	   (Fitzgerald	   and	  Chen,	  2006).	  It	  was	  suggested	  that	  TcpB	  mimics	  and	  targets	  Mal	   in	  order	  to	  suppress	  TLR-­‐2	   and	   TLR-­‐4	   mediated	   pathways	   (Radhakrishnan	   et	   al.,	   2009).	   Point	  mutations	  in	  the	  N-­‐terminal	  domain	  and	  the	  C-­‐terminal	  TIR	  domains	  of	  Mal	  and	  TcpB	  have	  abolished	  their	  respective	  NFκB	  activation	  and	  suppression	  activities	  (Radhakrishnan	   et	  al.,	  2009;	  Fitzgerald	  and	  Chen,	  2006).	   In	  addition,	  TcpB	  was	  shown	   to	   target	   degradation	   of	   phosphorylated	  Mal	   and	   thereby	   suppress	   the	  TLR4-­‐mediated	  pathway	  (Sengupta	  et	  al.,	  2010).	  Recently	  TcpB	  was	  reported	  to	  inhibit	   IκBα-­‐mediated	   NFκB	   activation	   (Radhakrishnan	   and	   Splitter,	   2010)	  following	  internalisation	  into	  murine	  macrophages.	  	   The	  PdTLP-­‐TIR	  domain	  (PdTIR)	  has	  been	  shown	  to	  interact	  with	  human	  TLR4-­‐TIR	  and	  murine	  MyD88-­‐TIR	  using	  GST	  pull-­‐down	  assays	  (Low	  et	  al.,	  2007),	  and	  human	  MyD88-­‐TIR	  using	  co-­‐immunoprecipitation	  (Chan	  et	  al.,	  2009a).	  The	  crystal	   structure	   of	   PdTIR	   indicates	   an	   overall	   fold	   identical	   to	   the	   known	  structures	  of	  the	  human	  TIR	  domains	  (Fig	  1.18;	  TLR1-­‐TIR)	  (Chan	  et	  al.,	  2009a).	  The	   PdTIR	   structure	   revealed	   two	   symmetric	   dimers	   in	   the	   crystallographic	  asymmetric	  unit	  (Chan	  et	  al.,	  2009a).	  Unlike	  the	  homodimer	  interface	  observed	  in	   the	   structure	   of	   the	   human	   TLR10-­‐TIR	   involving	   mainly	   the	   BB	   loops,	   the	  dimer	  interface	  in	  PdTIR	  involves	  the	  αD-­‐helix,	  the	  DD-­‐	  and	  EE-­‐loops	  leaving	  the	  BB-­‐loops	   highly	   exposed	   on	   the	   surface	   of	   the	  molecules	   (Chan	   et	   al.,	   2009a).	  PdTIR	  uses	  a	  large	  network	  of	  hydrogen	  bonds	  between	  the	  adjacent	  monomers	  to	  mediate	  its	  dimerisation	  interface	  (Chan	  et	  al.,	  2009a).	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Fig	  1.18	  Structures	  of	  the	  TIR	  domains	  of	  bacterial	  PdTIR	  and	  human	  TLR1	  The	  structures	  of	  the	  TIR	  domains	  of	  bacterial	  PdTIR	  (purple;	  PDB	  entry	  3H16)	  and	  human	  TLR1	  (green;	  PDB	  entry	  1FYV)	  are	  superimposed.	  The	  N-­‐	  and	  C-­‐	  terminals	  and	  the	  BB	  loops	  are	  indicated.	  	  These	  structures	  were	  derived	  as	  (a)	  cartoons	  and	  (b)	  ribbons	  using	  MacPyMOL	  
	  The	   structure	   of	   PdTIR	   supports	   the	   theory	   that	   bacteria	   use	   structural	  mimicry	  to	  subvert	  the	  TIR-­‐mediated	  TLR	  pathway	  with	  the	  highly	  exposed	  BB	  loop	  suggested	  to	  serve	  as	  a	  scaffold	  for	  interaction	  with	  the	  human	  TIR	  proteins	  of	   the	  TLR	   signalling	  pathway	   (Chan	   et	   al.,	   2009a).	  However	   it	   is	   unlikely	   that	  PdTIR	  has	  a	  role	  in	  eukaryotic	  pathogenesis.	  Although	  much	  work	  supports	  the	  subversion	  theory	  of	  bacterial	  TIR	  proteins,	  recent	  studies	  by	  Spear	  et	  al.	  (2009)	  present	   a	   broader	   role	   of	   bacterial	   TIR	   domains	   as	   general	   purpose	   protein-­‐protein	  interaction	  domains	  serving	  diverse	  roles	  in	  different	  bacteria	  (Spear	  et	  
al.,	   2009).	   Collectively,	   it	   is	   possible	   that	   bacterial	   TIR	   domains	   are	   generic	  signalling	   domains,	   which	   play	   an	   important	   role	   in	   subverting	   the	   host	   TLR	  signalling	   pathway	   in	   pathogenic	   bacteria.	   The	   postulated	   subversion	  mechanism	   of	   the	   TLR	   signalling	   pathway	   by	   pathogenic	   bacterial	   TIR	   can	   be	  summarised	  as	  outlined	  in	  (Fig	  1.19).	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Fig	  1.19	  Schematic	  of	  the	  postulated	  subversion	  mechanism	  by	  pathogenic	  bacterial	  TIR	  	  Pathogenic	  bacterial	  TIR	  suppresses	  the	  NFκB	  activation	  to	  subvert	  the	  host	  TLR	  signalling.	  Postulated	  subversion	  mechanisms	  include	  interference	  with	  the	  TIR	  domains	  of	  host	  (a)	  TLRs	  and	  adaptor	  proteins	  such	  as	  (b)	  Mal	  and	  (c)	  MyD88	  
	  
1.9	   Bacterial	  TIR	  Targets	  
This	  research	  project	  focuses	  on	  characterisation	  studies	  of	  bacterial	  TIR	  homologues	   present	   in	   the	   highly	   pathogenic	   bacteria:	   Yersinia	   pestis	   and	  
Burkholderia	  pseudomallei	  (Spear	  et	  al.,	  2009,	  Spear	  et	  al.,	  unpublished	  data).	  The	  source	  organisms	  Y.	   pestis	  and	  B.	   pseudomallei	  are	   classified	  under	  Centres	   for	  Disease	  Control	  and	  Prevention	  (CDC)	  as	  potential	  bioterrorism	  agents.	  	  
1.9.1	  Yersinia	  pestis	  	   	   	   	  
Y.	   pestis	   is	   the	   causative	   agent	   of	   plague	   and	   has	   been	   identified	   as	   a	  possible	   bioterrorism	   threat	   on	   account	   of	   its	   potential	   to	   cause	   pneumonic	  plague	   (Inglesby	   et	   al.,	   2002).	   Pneumonic	   plague	   can	   be	   transmitted	   from	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person/animal	  to	  person	  via	  the	  inhalation	  of	  contaminated	  air	  droplets.	  This	  is	  followed	  by	  a	  short	  incubation	  period	  of	  2-­‐3	  days	  and	  a	  high	  mortality	  rate,	  even	  if	   treated.	   The	   human	   pathogen	  Y.	   pestis	   is	   reported	   to	   have	   emerged	   from	  Y.	  
pseudotuberculosis	   among	   the	   Central	   Asian	   countries	   including	   China,	   Russia,	  Kazakhastan	  and	  Mongolia	  before	  it	  was	  spread	  worldwide	  during	  the	  course	  of	  the	  third	  pandemic	  (Li	  et	  al.,	  2009;	  Achtman	  et	  al.,	  1999).	  	  
Yersinia	  harbour	  an	  extrachromosomal	  70	  kb	  virulence	  plasmid,	  referred	  to	  as	  the	  Yop	  (Yersinia	  outer	  protein)	  virulon,	  which	  encodes	  a	  type	  III	  secretion	  system	   (TTSS).	   The	   TTTS	   functions	   to	   transport	   the	   virulent	   Yop	   effector	  proteins	   (YopH,	   YopM,	   YopT,	   YopE,	   YpkA/YopO	   and	   YopJ)	   from	   the	   bacterial	  cytoplasm	   into	   the	  host	   cytosol	   (Lemaitre	   et	   al.,	   2006a;	  Navarro	   et	   al.,	   2005b).	  These	  Yop	  effectors	  interfere	  with	  mammalian	  cell	  signalling	  pathways,	  thereby	  favouring	   bacterial	   survival	   in	   the	   host.	   The	   effector	   protein	   YopJ,	   has	   been	  consistently	  reported	  to	  block	  the	  NFκB	  pathway,	  which	  results	   in	  reduction	  of	  production	   and	   secretion	   of	   various	   adhesion	   molecules,	   chemokines	   and	  cytokines	   such	   as	   TNF-­‐α	   and	   IL-­‐8	   involved	   in	   innate	   immunity.	   This	   in	   turn	  allows	   Yersinia	   to	   inhibit	   the	   recruitment	   and	   activation	   of	   macrophages	   and	  natural	   killer	   (NK)	   cells	   to	   the	   site	   of	   infection	   and	   thereby,	   evade	   the	   host	  inflammatory	   response	   (Navarro	   et	   al.,	   2005b;	   Lemaitre	   et	   al.,	   2006a;	  Ruckdeschel	   et	   al.,	   1998;	   Ruckdeschel	   et	   al.,	   1997;	   Ruckdeschel	   et	   al.,	   2001;	  Schesser	  et	  al.,	  1998).	  	  	  
	  
1.9.2	  Burkholderia	  pseudomallei	  	   	  
B.	   pseudomallei	   is	   the	   causative	   agent	   of	   melioidosis,	   which	   is	   a	   fatal	  disease.	  It	  is	  contracted	  through	  soil	  or	  water	  contamination	  of	  skin	  abrasions	  or	  inhalation	   of	   the	   soil	   bacterium,	   B.	   pseudomallei	   from	   natural	   sources.	   The	  organism	  is	  reported	  as	  a	  common	  cause	  of	  human	  pneumonia	  and	  septicemiae	  in	  areas	  of	  endemicity,	  such	  as	  the	  tsunami	  disaster	  in	  Southeast	  Asian	  countries	  in	  December	  2004	  (Tuanyok	  et	  al.,	  2006).	  Melioidosis	  can	  take	  a	  dormant	  form	  with	  an	  infected	  person	  showing	  no	  signs	  of	  infection	  for	  months,	  years	  or	  even	  decades	  (Tuanyok	  et	  al.,	  2006).	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Various	  in	  vitro	  studies	  have	  demonstrated	  an	  improved	  understanding	  of	  pathogenesis	  and	  virulence	  of	  B.	  pseudomallei	   in	  tissue	  culture	  models,	  wherein	  the	  bacterium	  can	   invade	  both	  phagocytic	   and	  nonphagocytic	   cells	   followed	  by	  intracellular	  multiplication	  and	  intercellular	  spread	  however	  the	  mechanisms	  for	  bacterial	  survival	  in	  host	  tissues	  are	  not	  fully	  understood	  (Tuanyok	  et	  al.,	  2006).	  Several	   eukaryotic	   host	   models,	   such	   as	   Caenorhabditis	   elegans	   and	   higher	  animals,	   have	   been	   used	   to	   study	   bacterial	   virulence	   and	   to	   identify	   virulence	  determinants	   for	   B.	   pseudomallei	   infection.	   These	   include	   genes	   involved	   in	  bacterial	  growth	  and	  multiplication,	  in	  biochemical	  pathways	  such	  as	  glycolysis,	  known	  virulence	  genes	  for	  capsular	  biosynthesis,	  the	  TTSS,	  flagellar	  biosyntheis	  and	   secreted	   hydrolytic	   enzymes	   such	   as	   phospholipases	   and	   proteases	  (Tuanyok	  et	  al.,	  2006).	  	  	  	  
1.9.3	   Identification	  by	  Bioinformatics	  Analysis	  Briefly,	   the	   bioinformatics	   program	   SaturatedBlast	  was	   used	   to	   identify	  bacterial	   TIR	   homologues	   in	   Y.	   pestis	   and	   B.	   pseudomallei	   (Spear	   et	   al.,	  unpublished	   data,	   Spear	   et	   al.,	   2009).	   Multiple	   human	   TIR	   protein	   sequences	  were	  used	  as	  seeds	  for	  the	  searches.	  Identified	  bacterial	  sequences	  were	  further	  analysed	   using	   reverse	   SaturatedBlast,	   FUGUE	   secondary	   structure	   prediction	  and	  ClustalW	  multiple	  alignment.	  Subsequently,	  the	  bacterial	  TIR	  homologue	  in	  
Y.	   pestis	   was	   confirmed	   as	   a	   TIR	   domain	   containing	   protein	   revealing	  homologous	   box	   1	   and	   2	   regions	   characteristic	   of	   TIR	   domains	   (Fig	   1.20a).	  However	  subsequent	  bioinformatics	  analysis	  on	  the	  bacterial	  TIR	  homologue	  in	  
B.	   pseudomallei	   gave	   mixed	   results.	   The	   reverse	   SaturatedBlast	   analysis	  produced	  only	  two	  human	  TIR	  domains	  and	  the	  FUGUE	  analysis	  did	  not	  confirm	  its	   identity	  as	  a	  TIR	  domain.	  However	  the	  multiple	  alignment	  analysis	  revealed	  high	  sequence	  conservation	  in	  the	  box	  2	  region	  (Fig	  1.20b).	  In	  addition,	  it	  shared	  similar	  levels	  of	  confidence	  in	  its	  identity	  as	  a	  TIR	  domain	  when	  compared	  with	  VV	  A46R,	  which	  was	  previously	  considered	  as	  the	  only	  viral	  TIR	  domain.	  Based	  on	   the	   assumption	   that	  TIR	  domains	  have	   resulted	   from	  convergent	   evolution,	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thereby	  having	  low	  sequence	  similarities,	  the	  TIR	  homologue	  in	  B.	  pseudomallei	  was	  initially	  investigated	  (see	  Chapters	  3	  and	  5)	  alongside	  that	  in	  Y.	  pestis.	  
	  
	  
Fig	  1.20	  Multiple	  sequence	  alignment	  of	  YpTIR	  and	  BpTIR	  (a)	  Sequence	  alignment	  of	  YpTIR	  with	  the	  TIR	  domains	  of	  human	  single	  immunoglobulin	  IL-­‐1R-­‐related	  molecule	  (SIGIRR),	  TLR4,	  TLR6	  and	  MyD88	  (dstl)	  (b)	  Sequence	  alignment	  of	  BpTIR	  with	  the	  TIR	  domains	  of	  human	  TLR4,	  TLR2,	  SIGIRR	  and	  TLR5	  (dstl).	  CLC	  Sequence	  Viewer	  6	  was	  used	  to	  align	  sequences.	  Sequence	  conservation	  ranges	  from	  blue	  (0%)	  to	  red	  (100%)	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1.9.4	  Nomenclature	  of	  Bacterial	  TIR	  Targets	  Bacterial	   TIR	   homologues	   have	   been	   given	   a	   variety	   of	   names	   in	   the	  literature.	  Newman	  et	  al.	  (2006)	  use	  TIR-­‐like	  protein	  A	  (tlpA).	  The	  Pascual	  group	  use	  P.	  denitrificans	  TIR-­‐like	  protein	  (PdTLP)	  for	  the	  full-­‐length	  protein	  and	  PdTIR	  for	   the	  TIR	  domain	  (Low	   et	  al.,	  2007;	  Chan	   et	  al.,	  2009a).	  Cirl	  et	  al.	  (2008)	  use	  TIR-­‐containing	   proteins	   (Tcps)	   and	   Salcedo	   et	   al.	   (2008)	   use	   Brucella	   TIR-­‐containing	   protein	   (Btp1).	   The	   bacterial	   TIR	   homologue	   in	   Y.	   pestis	   is	   a	   TIR-­‐containing	   protein.	   However	   for	   clarity	   the	   nomenclature,	   “TIR-­‐like	   protein	  (TLP)”	  and	  “TIR”	  domain,	  have	  been	  used	  for	  the	  full-­‐length	  proteins	  and	  the	  TIR	  domain/homologue	   regions	   respectively	   of	   both	   proteins.	   The	   acronyms	   used	  are	  Y.	   pestis	  TIR-­‐like	   protein	   (YpTLP)	   and	   YpTIR,	   and	  B.	   pseudomallei	  TIR-­‐like	  protein	  (BpTLP)	  and	  BpTIR.	  	  
	  
1.10	  Aims	  of	  the	  Project	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Chapter	  2	  
Development	   of	   Protein	   Expression	  
and	  Purification	  Strategies	  	  
	  
2.1	   Introduction	  
Structural	   and	   functional	   analyses	   typically	   require	   milligram	   (mg)	  quantities	   of	   pure	   and	   stable	   protein.	   The	   aim	   of	   the	   research	   outlined	   in	   this	  chapter	  was	   to	   develop	   overexpression	   and	   purification	   strategies	   for	   the	   full-­‐length	   TIR-­‐like	   proteins	   and	   the	   truncated	   TIR	   domain/homologue	   containing	  proteins	   from	  Y.	  pestis	   (YpTLP/YpTIR)	  and	  B.	  pseudomallei	   (BpTLP/BpTIR)	   for	  subsequent	   characterisation.	   A	   few	   different	   expression	   vector	   systems	   have	  been	  used	  for	  overexpression	  of	  these	  proteins.	  The	  pWaldo-­‐GFPe	  system	  has	  been	  used	  to	  express	  these	  novel	  bacterial	  TLPs	   with	   a	   C-­‐terminal	   GFP-­‐His	   tag.	   The	   presence	   of	   the	   green	   fluorescent	  protein	   (GFP)	   allows	   assessment	   of	   the	   expression	   level	   and	   analysis	   of	   the	  integrity	  of	  the	  protein	  at	  the	  expression,	  extraction	  and	  purification	  steps.	  This	  system	   allows	   the	   optimisation	   of	   protein	   yield	   through	   rapid	   assessment	   of	   a	  range	  of	   expression	  and	  purification	   conditions.	  Additionally,	  GFP	   fluorescence	  has	   been	   reported	   as	   a	   sensitive	   folding	   indicator,	   allowing	   differentiation	  between	   soluble	   expression	   of	   the	   GFP	   fusion	   protein	   and	   inclusion	   body	  formation	  (Drew	  et	  al.,	  2001).	  It	  has	  been	  reported	  that	  GFP	  does	  not	  fluoresce	  when	  the	  fusion	  protein	  forms	  inclusion	  bodies	  (Drew	  et	  al.,	  2001).	  	  Since	  the	  yields	  of	  usable	  protein	  from	  the	  pWaldo-­‐GFP	  system	  were	  very	  low,	   expression	   of	   both	   YpTLP	   and	   BpTLP	   was	   attempted	   using	   the	   pET26b	  vector.	  Previous	  work	  has	  utilised	  the	  pET26b	  vector	   for	  expression	  of	   the	  TIR	  domains	   of	   human	   TLR1,	   TLR2	   and	   IL-­‐1RAPL,	   which	   subsequently	   gave	   high-­‐
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resolution	  crystal	  structures	  (Khan	  et	  al.,	  2004;	  Xu	  et	  al.,	  2000).	  However,	  it	  was	  not	  possible	  to	  express	  the	  full-­‐length	  bacterial	  TLPs	  using	  pET26b	  system.	  Since	  several	  structures	  have	  been	  obtained	  of	  the	  TIR	  domains,	  attempts	  were	  made	  to	   express	   the	   core	   TIR	   domain/homologue	   regions	   for	   the	   bacterial	   targets	  YpTIR	   and	   BpTIR.	   It	   was	   possible	   to	   obtain	   pure	   soluble	   TIR	   proteins	   using	  pET26b	   submitted	   to	   functional	   analysis.	   However	   preliminary	   structural	  analysis	  on	  YpTIR	  indicated	  that	  it	  was	  partially	  unfolded	  and	  unstable.	  Besides	  its	  final	  soluble	  yield	  was	  inadequate	  for	  structural	  characterisation.	  	  The	  bacterial	  TIR	  proteins	  were	  subsequently	  expressed	  using	  the	  GEV2	  vector.	  The	  N-­‐terminal	  GB1	  tag	  of	  the	  recombinant	  protein	  is	  known	  to	  enhance	  the	  overall	  expression	  yield,	  solubility,	  stability	  and	  rapid	  NMR	  screening	  for	  the	  folded	  state	  of	  the	  downstream	  protein	  (Huth	  et	  al.,	  1997).	  A	  number	  of	  bacterial	  TIR	   constructs	   of	   varying	   lengths	   were	   designed	   based	   on	   the	   bioinformatics	  program,	   3D	   Jury	   (http://meta.bioinfo.pl/submit_wizard.pl),	   for	   production	   of	  folded	   stable	   protein.	   3D	   Jury	   generates	   consensus	   structure	   predictions	   for	  protein	  sequences	  (Ginalski	  et	  al.,	  2003)	   incorporating	  positions	  and	   lengths	  of	  
α-­‐helices	   and	   β-­‐strands.	   Expression	   constructs	   were	   designed	   based	   on	   such	  predictions	   to	   avoid	   interrupting	   continuous	   stretches	   of	   secondary	   structure	  (Appendix	  3).	  The	  best	  expressing	  fusion	  proteins	  were	  submitted	  to	  structural	  and	  functional	  analysis.	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2.2	   Materials	  and	  Methods	  
2.2.1	  Bacterial	  Strains,	  Plasmids	  and	  Growth	  Conditions	  
E.	   coli	   strains	   used	   in	   this	   work	   for	   cloning	   and	   expression	   (Table	   2.1)	  were	  grown	  in	  Luria-­‐Bertani	  medium	  (LB,	  Merck).	  Bacterial	  expression	  plasmids	  used	  in	  this	  study	  include	  the	  pET28a-­‐derived	  pWaldo-­‐GFPe	  vector	  (Waldo	  et	  al.,	  1999)	   to	  produce	  C-­‐terminal	  GFP-­‐His	   fusions,	   the	  pET26b	   (Novagen)	  vector	   to	  express	   C-­‐terminal	   His-­‐tagged	   proteins,	   and	   the	   GEV2	   (Addgene)	   vector	   for	  expression	   of	   proteins	   fused	   to	   an	   N-­‐terminal	   GB1	   tag	   (B1	   immunoglobulin	  binding	  domain	  of	   Streptococcal	   protein	  G)	   (Huth	  et	   al.,	  1997)	   along	  with	   a	  C-­‐terminal	  His	  tag.	  Illustrative	  vector	  maps	  are	  included	  in	  Appendix	  1.	  	  
Table	  2.1	  E.	  coli	  strains	  used	  for	  cloning	  and	  expression	  	  
E.	  coli	  Strains	   Genotype	   Source	  
Cloning	  Strains	   	   	  	  DH5α	  	   F–	  φ80lacZΔM15	  Δ(lacZYA-­‐argF)	  U169	  recA1	  endA1hsdR17	   Invitrogen	  	  	  	   (rk-­‐,	  mk+)	  phoA	  supE44	  λ–	  thi	  –1	  gyrA96	  relA1	  	   	  	  TOP10	   F–	  mcrA	  Δ(mrr-­hsdRMS-­‐mcrBC)	  φ80lacZΔM15	  ΔlacX74	   Invitrogen	  	  	   deoR	  recA1araD139	  Δ(araA-­‐leu)7697	  galU	  galKrpsL	  endA1	  nupG	  Mach1	   F–	  φ80(lacZ)ΔM15	  ΔlacX74	  hsdR(rK–mK+)	  ΔrecA1398	  endA1	  tonA	  	  	  	  	   Invitrogen	  
Expression	  Strains	   	   	  	  BL21(DE3)pLysS	   E.	  coli	  B	  F–	  dcm	  ompT	  hsdS(rB–mB–)	  gal	  λ(DE3)[pLysS	  CamR]	   Stratagene	  BL21-­‐Gold(DE3)	   E.	  coli	  B	  F–	  ompT	  hsdS(rB–mB–)	  dcm+	  TetR	  gal	  λ(DE3)	  endA	  Hte	   Stratagene	  BL21-­‐Star™(DE3)	  	   F-­‐	  ompT	  hsdSB	  (rB-­‐mB-­‐)	  gal	  dcm	  rne131	  (DE3)	   Invitrogen	  BL21(Codon)PlusDE3-­‐RP	  	   E.	  coli	  B	  F–	  dcm+	  ompT	  hsdS(rB–mB–)	  TetR	  gal	  λ(DE3)	  endA	  Hte	  	   Stratagene	  	  	   	  [argU	  proL	  CamR]	   	  	  Origami2(DE3)pLysS	  	   D(ara-­leu)7697	  DlacX74	  DphoA	  PvuII	  phoR	  araD139	  ahpC	  gale	  galK	  rpsL	   Novagen	  	  	   (DE3)	  F′[lac+	  lacIq	  pro]	  gor522::Tn10	  trxB	  pLysS	  [CamR,	  StrR,	  TetR]	  Rosetta-­‐gami	  2(DE3)	  	   D(ara-­‐leu)7697	  DlacX74	  DphoA	  PvuII	  phoR	  araD139	  ahpC	  galE	  galK	  rpsL	   Novagen	  	  	   (DE3)	  F′[lac+	  lacIq	  pro]	  gor522::Tn10	  trxB	  pLysSRARE2	  [CamR,	  StrR,	  TetR]	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2.2.2	  Oligonucleotide	  Primers	  	  
	   Primers	  (MWG	  Biotech)	  used	  for	  amplifying	  the	  different	  genes	  are	  listed	  in	  Table	  2.2.	  The	  genes	  from	  Y.	  pestis	  (YPO1883)	  and	  B.	  pseudomallei	  (BPSL0748)	  coding	  for	  TIR-­‐like	  proteins	  were	  amplified	  by	  polymerase	  chain	  reaction	  (PCR)	  from	  genomic	  DNA	  provided	  by	  Dstl.	  Details	  on	  GEV2	  construct	  design	  using	  3D	  Jury	   models	   are	   included	   in	   Appendix	   3.	   Primary	   sequence	   analyses	   of	   the	  protein	  constructs	  are	  tabulated	  in	  Appendix	  4.	  
Table	  2.2	  Primers	  used	  for	  generating	  different	  expression	  plasmids	  
Constructs	   Residues	   Plasmid	  	   Nucleotide	  sequence	  (5’-­3’)	  	  YpTLP-­‐GFP-­‐His	   1-­‐358	   pWaldo-­‐GFPe	   CTCGAGATGGCAAGCTGCATCC	  	  	   	   	   GGATCCCACAATCTTGTTTACAGTCTCG	  BpTLP-­‐GFP-­‐His	   1-­‐352	   pWaldo-­‐GFPe	   CTCGAGATGAACCATCCAAGTGTCTTCC	  	  	   	   	   GGATCCAACACTTTCGCCGTCTGCTTC	  YpTLP-­‐His	   1-­‐358	   pET26b	  	  	  	   GGATCCAGCAAGCTGCATCCCCCCAAAG	  	  	   	   	   CTCGAGCACAATCTTGTTTACAGTCTCGATAAATATTTC	  BpTLP-­‐His	   1-­‐352	   pET26b	  	  	  	   GGATCCAAACCATCCAAGTGTCTTCCATC	  	  	   	   	   CTCGAGAACACTTTCGCCGTCTGCTTC	  YpTIR-­‐1-­‐His	   130-­‐285	   pET26b	  	  	  	   GGATCCATCCATCTGGAAGCCAAATTTAATTCGAG	  	  	  	  	  	   	   	   CTCGAGGGCTTCATCAAAACTCTGAGATGC	  BpTIR-­‐1-­‐His	   228-­‐352	   pET26b	  	  	  	   GGATCCAGCCGAGCATGCACAGGTGAAG	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	   	   CTCGAGAACACTTTCGCCGTCTGCTTCATCG	  GB1-­‐YpTIR1-­‐His	  	   130-­‐285	   GEV2	  	  	  	   CGCGGATCCATCTGGAAGCCAAATTTAATTC	  	  	   	   	   CCGCTCGAGGGCTTCATCAAAACTCTGAG	  GB1-­‐YpTIR2-­‐His	   137-­‐273	   GEV2	  	  	  	   CGCGGATCCATTCGAGTTTTTATTAGCC	  	  	   	   	   CCGCTCGAGAATTAGTGCTTGTTGTATTC	  GB1-­‐YpTIR3-­‐His	  	   137-­‐246	   GEV2	  	  	  	   CGCGGATCCATTCGAGTTTTTATTAGCC	  	  	   	   	   CCGCTCGAGATTATCGAGGCTCCCTTTAAC	  GB1-­‐BpTIR1-­‐His	   228-­‐352	   GEV2	  	  	  	   CGCGGATCCGCCGAGCATGCACAGGTGAAGATTG	  	  	   	   	   CCGCTCGAGAACACTTTCGCCGTCTGCTTCATCGC	  GB1-­‐BpTIR2-­‐His	   220-­‐352	   GEV2	  	  	  	   CGCGGATCCGATGACGTGCCCGATATTCCGCCCG	  	  	   	  	   	  	   CCGCTCGAGAACACTTTCGCCGTCTGCTTCATCGC	  Underlined	   sequences	   CTCGAG	   and	   GGATCC	   correspond	   to	   restriction	   sites,	   XhoI	   and	   BamHI,	  incorporated	  into	  the	  forward	  and	  reverse	  primers	  respectively.	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2.2.3	  Construction	  of	  Expression	  Plasmids	  	  The	  touchdown	  PCR	  protocol	  was	  applied	  to	  amplify	  TLP	  constructs	  using	  Roche	  Expand	  Long	  Polymerase,	  and	  truncated	  TIR	  constructs	  using	  Phusion	  HF	  DNA	   Polymerase	   (Finnzymes),	   supplemented	   with	   2%	   DMSO.	   PCR	   products	  were	   gel-­‐purified	   on	   1.2%	   agarose	   pre-­‐cast	   E-­‐gel®	   (Invitrogen)	   cassettes,	   and	  cloned	   into	   the	   TOPO	   vector	   (Invitrogen).	   All	   clones	   were	   assessed	   by	   DNA	  sequencing.	  Inserts	  with	  the	  correct	  sequence	  were	  cloned	  into	  the	  appropriate	  vectors	  using	  standard	  molecular	  biology	  techniques.	  Briefly,	  double	  digestion	  was	  performed	  at	  37	  °C	  for	  4	  hr	  using	  restriction	  enzymes	  XhoI	  and	  BamHI	  (New	  England	  Biolabs).	  Digested	  vectors	  were	  treated	  with	   shrimp	   alkaline	   phosphatase	   (Promega)	   at	   37	   °C	   for	   1	   hr	   before	   ligation.	  Pellet	  paint	  (Novagen)	  was	  used	  for	  vector	  concentration	  prior	  to	  ligation	  in	  the	  case	   of	   pWaldo-­‐GFPe.	   Ligation	   was	   performed	   using	   T4	   DNA	   ligase	   (New	  England	  Biolabs)	  at	  16	  °C	  overnight.	  Ligation	  reactions	  (5	  ng)	  were	  transformed	  into	   cloning	   strains	   DH5α	   or	   Mach1	   (50	   µl).	   Colony	   PCR	   (Promega	   GoTaq®	  Polymerase)	   was	   performed	   to	   screen	   positive	   clones	   prior	   to	   transformation	  into	  expression	  strains.	  	  
The	  pWaldo-­GFPe	  system	  
2.2.4	  Expression	  using	  the	  pWaldo-­GFPe	  vector	  	  	   TLP-­‐GFP	   fusion	  constructs	  were	   transformed	   into	  BL21(DE3)pLysS	  cells	  (Drew	   et	   al.,	   2006).	   YpTLP-­‐GFP	   was	   also	   transformed	   into	   other	   expression	  strains	   including	   BL21(Codon)PlusDE3-­‐RP,	   Rosetta-­‐gami2(DE3)	   and	  Origami2(DE3)pLysS	   (Table	   2.1).	  Overnight	   cultures	  were	   diluted	   (1:50)	   in	   LB	  with	   kanamycin	   (Kan	   50	   µg/ml)	   and	   chloramphenicol	   (Cam	   35	   µg/ml),	   and	  incubated	  at	  37	  °C,	  235	  rpm.	  Protein	  expression	  was	  induced	  at	  OD600~0.4,	  using	  isopropyl-­‐D-­‐thiogalactopyranoside	  (IPTG:	  0.1	  mM/0.4	  mM)	  for	  4	  hr/22	  hr	  at	  25	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°C/30	   °C.	   Small	   and	   large-­‐scale	   expression	  were	  performed	   in	  1	  ml	   and	  1	   litre	  cultures	  respectively,	  unless	  specified	  otherwise.	  
2.2.5	  Relative	  Fluorescence	  Units	  and	  In-­gel	  Fluorescence	  	   1	   ml	   aliquots	   of	   cell	   culture	   pellets	   were	   resuspended	   in	   200	   µl	  phosphate	  buffered	  saline	  (PBS).	  A	  100	  µl	  aliquot	  of	  the	  resuspension	  was	  used	  to	  measure	   GFP	   fluorescence	  with	   a	  microplate	   spectrofluorometer	   set	   at	   485	  nm	  excitation	  and	  512	  nm	  emission	  wavelengths.	  The	  obtained	  GFP	  fluorescence	  (Y)	  in	  relative	  fluorescence	  units	  (RFU)	  was	  processed	  as	  follows,	  to	  estimate	  the	  amount	   of	   folded	   GFP	   relating	   to	   protein	   expression.	   To	   remove	   background	  noise,	   1000	  was	   deducted	   from	   Y	  and	   the	   value	  multiplied	   by	   1.5	   (dampening	  factor	  empirically	  determined	  for	  GFP	  in	  E.	  coli	  (Drew	  et	  al.,	  2006).	  	  From	  calibration	  curve	  of	  purified	  GFP	  standard	  used	  as	  reference:	  	   12,	  000	  RFU	  	   =	  30	  mg/l	  (for	  100	  µl	  volume	  of	  cells)	  thus,	   Y	  RFU	  	   	   =	  0.0025	  x	  1.5(Y	  -­‐1000)	  mg/l	  In	  1-­‐ml	  volume	  of	  cells,	  
	   Y	  RFU	   	   =	  0.0025	  x	  1.5(Y	  -­‐1000)/5	  =	  Z	  mg/l	  Now,	  the	  amount	  of	  GFP	  per	  litre	  of	  culture	  =	  Z	  mg	  thus,	  	   the	  amount	  of	  desired	  protein	  =	  Z	  x	  (Mw	  of	  protein	  /28	  kDa)	  mg	  where	  28	  kDa	  is	  the	  Molecular	  weight	  (Mw)	  of	  purified	  GFP	  	  	   Novex®	  12%	  Tris-­‐HCl-­‐Glycine	  gels	  and	  the	  XCell	  SureLock™	  Mini-­‐Cell	  system	  (Invitrogen)	  were	  used	  for	  sodium	  dodecyl	  sulphate-­‐polyacrylamide	  gel	  (SDS-­‐PAGE)	  analysis	  of	  GFP-­‐His	  fusion	  proteins.	  Protein	  samples	  were	  mixed	  1:1	  with	   Solubilisation	   Buffer	   [SB:	   200	   mM	   Tris-­‐HCl	   pH	   8.8,	   20%	   Glycerol,	   5	   mM	  EDTA	  pH	  8.0,	  0.02%	  bromophenol	  blue,	  4%	  SDS	  and	  0.05	  M	  DDT]	  (Drew	  et	  al.,	  2006).	   After	   protein	   separation,	   gels	   were	   rinsed	  with	   distilled	  water	   and	   the	  fluorescent	  protein	  bands	  visualised	  at	  515	  nm	  emission	  and	  460	  nm	  excitation	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wavelengths	   using	   a	   CCD	   camera	   system	   (Fujifilm	   LAS-­‐3000).	   The	   exposure	  times	  were	  varied	  to	  adjust	   for	   the	  optimum	  fluorescence	   intensity	   to	  visualise	  the	  protein	  bands.	  	  
	  
2.2.6	  Purification	  of	  YpTLP-­GFP	  
	   Cells	  from	  a	  large-­‐scale	  culture	  were	  harvested	  by	  centrifugation	  at	  4,000	  g,	  4	   °C	   for	   15	  min.	   The	   cell	   pellet	  was	   resuspended	   in	   Buffer	   A	   [50	  mM	  HEPES-­‐NaOH	   pH	   7.5,	   250	   mM	   NaCl,	   20	   mM	   imidazole,	   2	   mM	   DTT]	   including	   [1	   µl	  rLysozyme	  (Novagen)	  and	  1	  Roche	  protease	  inhibitor	  tablet]	  and	  incubated	  for	  1	  hr	  at	  4	  °C.	  The	  cells	  were	  sonicated	  on	  ice,	  using	  an	  sVCx500	  sonicator	  (Sonics),	  for	   5-­‐15	   mins	   (9	   sec	   on/off)	   based	   on	   the	   translucency	   of	   resuspension.	   The	  sample	  was	  further	  centrifuged	  at	  12,000	  g,	  4	  °C	  for	  15	  min	  to	  remove	  unbroken	  cells.	  	  	   The	  extracted	   soluble	  protein	   fraction	  was	  purified	  by	   immobilised	  metal	  affinity	   chromatography	   (IMAC)	   using	   Ni2+-­‐NTA	   resin	   (Qiagen).	   The	   resin	   was	  pre-­‐equilibrated	  with	  Buffer	  A	   and	   incubated	  with	   the	   sample	   for	   2	   hr	   at	   4	   °C	  with	  gentle	  agitation.	  The	  resin	  was	  applied	  onto	  a	  drip	  column	  and	  washed	  with	  20	  column	  volumes	  (CV)	  of	  Buffer	  A,	   followed	  by	  protein	  elution	  with	  Buffer	  A	  containing	  250	  mM	  imidazole.	  The	  purified	  YpTLP-­‐GFP	  eluate	  was	  subjected	  to	  a	  second	  Ni2+-­‐NTA	  purification.	  The	  eluate	  was	   concentrated	   to	   a	  500	  µl	   volume	  using	  a	  30	  kDa	  molecular	  weight	  cut-­‐off	  (MWCO)	  membrane	  and	  loaded	  onto	  a	  size	   exclusion	   chromatography	   (SEC)	   column	   (Superdex	   200	   GL	   10/300,	   GE	  Healthcare).	   The	   column	   was	   pre-­‐equilibrated	   with	   Buffer	   B	   [50	   mM	   HEPES-­‐NaOH	   pH	   7.5,	   250	  mM	  NaCl].	   1	  ml	   fractions	  were	   eluted	   at	   a	   flow	   rate	   of	   0.4	  ml/min.	   200	  µl	   of	   the	   eluted	   fractions	  were	   transferred	  onto	  96-­‐well	   plates	   to	  measure	  GFP	  fluorescence,	  also	  analysed	  by	  SDS-­‐PAGE.	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2.2.7	  Purification	  of	  BpTLP-­GFP	  	   The	  soluble	  protein	  fraction	  for	  BpTLP-­‐GFP	  was	  extracted	  as	  described	  in	  Section	  2.2.6	  except	  that	  the	  cell	  disrupter	  (Constant	  Systems)	  was	  used	  to	  lyse	  the	  cells	  with	   two	  passes	  at	  25,000	  psi.	  Ni2+-­‐NTA	  IMAC	  purification	   for	  BpTLP-­‐GFP	  was	  optimised	  using	  different	  imidazole	  concentrations	  [20,	  50,	  60,	  70,	  80,	  90,	   100	   and	   125	   mM]	   in	   the	   wash	   buffer.	   Subsequently,	   Ni2+-­‐NTA	   IMAC	   for	  BpTLP-­‐GFP	  utilised	  Buffer	   including	  stabilising	  agents	  [25	  mM	  Tris-­‐HCl	  pH	  8.5,	  300	  mM	  NaCl,	  20	  mM	  imidazole,	  5%	  glycerol,	  10	  mM	  BME,	  0.5	  mM	  PMSF,	  0.3%	  Triton	   X-­‐100,	   1	   µl	   rLysozyme	   and	   1	   µg/mL	   DNaseI	   with	   10	   mM	   MgCl2]	   and	  successive	  washing	  steps	  with	  20	  mM	  and	  50	  mM	  imidazole	  respectively.	  	  Protein	   eluate	   was	   dialysed	   overnight	   at	   4	   °C	   in	   a	   30	   kDa	   MWCO	  membrane	   to	   remove	   imidazole	   and	   also	   to	   allow	   TEV	   digestion.	   Equimolar	  amounts	  of	  TEV	  protease	  were	  added	  to	   the	  protein	  sample.	  The	  pWaldo-­‐GFPe	  vector	   includes	   a	   TEV	   protease	   recognition	   site	   for	   removal	   of	   the	   GFP-­‐8His	  moiety	  during	  purification	  (Appendix	  1)	  (Drew	  et	  al.,	  2006).	  The	  digested	  sample	  was	  filtered	  through	  a	  0.22	  µm	  filter	  and	  passed	  through	  a	  1	  ml	  His-­‐Trap	  column	  (Amersham	  Biosciences)	   for	  reverse	  His	   IMAC	  purification.	  SEC	  was	  performed	  on	   the	   sample	   as	   described	   in	   Section	   2.2.6.	   SDS-­‐PAGE	   and	   N-­‐terminal	  sequencing	  were	  used	  to	  analyse	  the	  eluted	  samples.	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  pET26b	  vector	  system	  
2.2.8	  Expression	  using	  the	  pET26b	  Vector	  	  pET26b	   expression	   constructs	   for	   full-­‐length	   TLPs	   and	   truncated	   TIR	  proteins	   were	   transformed	   into	   BL21(DE3)Gold	   cells	   (Table	   2.1).	   Overnight	  cultures	  were	  diluted	   (1:50)	   in	   LB	  with	  Kan	  35	  µg/ml	   (37°C	   at	   235	   rpm),	   and	  incubated	   at	   30°C	   to	   an	   OD600	   ~0.6.	   Small	   and	   large-­‐scale	   expression	   was	  performed	  using	  50	  ml	  and	  1	   litre	  cultures	  respectively.	  Large-­‐scale	  expression	  of	   TIR	   proteins	   was	   performed	   using	   50-­‐litre	   bioreactors.	   James	   Mansfield	  operated	   the	   bioreactor	   in	   the	   Centre	   for	   Structural	   Biology	   (CSB)	   Bioreactor	  suite,	   Imperial	  College	  London.	  Expression	  was	   induced	  using	  1	  mM	  IPTG	  for	  4	  hr/16	  hr	  at	  15	  °C,	  18	  °C	  or	  20	  °C.	  Cells	  were	  harvested	  by	  centrifugation	  at	  4,000	  
g,	   4	   °C	   for	   15	   min.	   Cellular	   fractions	   were	   separated	   to	   determine	   protein	  localisation.	  All	  procedures	  were	  carried	  out	  at	  4	  °C.	  Cells	  were	  resuspended	  (10-­‐fold)	  in	  resuspension	  buffer	  [30	  mM	  Tris-­‐HCl	  pH	  8.0,	  20%	  sucrose,	  1	  mM	  EDTA]	  and	  incubated	  for	  30	  min.	  After	  centrifugation	  at	  10,000	  g	  for	  10	  min,	  the	  pellet	  was	  thoroughly	  resuspended	  in	  ice-­‐cold	  5	  mM	  MgSO4	   and	   incubated	   for	   10	   min	   to	   release	   the	   periplasmic	   proteins.	   On	  repeating	   the	   centrifugation	   run,	   the	   supernatant	   was	   collected	   as	   the	  periplasmic	  fraction	  and	  the	  pellet	  contained	  the	  spheroplasts.	  The	  spheroplasts	  were	  weighed	  and	  resuspended	  (1	  g	  in	  5	  ml)	  in	  lysis	  buffer	  [50	  mM	  Tris-­‐HCl	  pH	  8.0,	  50	  mM	  NaCl].	  The	  soluble	  cytoplasmic	  fraction	  was	  extracted	  as	  described	  in	  Section	   2.2.6	   and	   the	   pellet	   after	   centrifugation	  was	   collected	   as	   the	   insoluble	  cytoplasmic	  fraction	  (inclusion	  bodies).	  	  	  
2.2.9	  SDS-­PAGE	  and	  Western	  Blot	  Analysis	  NuPAGE®	   4-­‐12%	   Bis-­‐Tris	   gels	   (Invitrogen)	   were	   used	   for	   SDS-­‐PAGE	  analysis	   of	   protein	   samples,	   which	   were	   mixed	   with	   NuPAGE®	   LDS	   Sample	  Buffer	  (Invitrogen)	  and	  heat-­‐denatured	  at	  85	  °C	  for	  3	  min	  prior	  to	  loading	  on	  the	  gel.	   In	   the	   case	   of	   whole	   cells,	   Benzonase®	   Nuclease	   (Novagen)	   was	   added	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(1:20)	  to	  the	  samples.	  After	  separation,	   the	  gels	  were	  either	  Coomassie-­‐stained	  in	  Imperial	  Protein	  Stain	  (Pierce)	  or	  directly	  used	  for	  Western	  blot.	  Polyvinylidene	   difluoride	   (PVDF)	   blotting	   membranes	   were	   used	   for	  Western	   blot	   analysis	   using	   the	   XCell	   II	   Blot	   Module	   (Invitrogen).	   For	   His-­‐tagged	  proteins,	  membranes	  were	  blocked	  at	  4°C	  overnight	  with	  mouse	  anti-­‐His	  tag	  antibody	  (Dianova)	  diluted	  (1:5000)	   in	  5%	  skimmed	  milk	  prepared	   in	  PBS.	  After	   several	   washing	   steps	   using	   Tris-­‐buffered	   saline	   (TBS)	   with	   0.2%	   v/v	  Tween	  20	  (BDH),	  membranes	  were	  treated	  for	  1	  hr	  (room	  temperature)	  with	  a	  secondary	   antibody,	   goat	   anti-­‐Mouse	   IgG	   Alkaline	   Phosphatase	   (Sigma)	   at	  1:20,000	   dilution.	   His-­‐tagged	   proteins	   were	   then	   fluorescence-­‐detected	   by	  Amersham	   ECF	   plus	   Detection	   System	   (GE	   Healthcare)	   using	   the	   CCD	   camera	  (Fujifilm	  LAS-­‐3000).	  	  
	  
2.2.10	  Purification	  under	  Denaturing	  Conditions	  The	   insoluble	   cytoplasmic	   fraction	   was	   purified	   under	   denaturing	  conditions	  using	  Ni2+-­‐NTA	  resin.	  The	  pellet	  containing	  the	  insoluble	  cytoplasmic	  fraction	  for	  YpTLP	  was	  solubilised	  (1	  g	  in	  5	  ml)	  in	  denaturing	  lysis	  Buffer	  C	  [50	  mM	  K2HPO4,	  10	  mM	  Tris-­‐HCl,	  8	  M	  urea,	  pH	  8.0]	  for	  15	  min	  at	  room	  temperature.	  The	   lysate	   was	   centrifuged	   at	   10,000	   g,	   20	   °C	   for	   20	   min	   to	   remove	   cellular	  debris.	  Cleared	  lysate	  was	  incubated	  with	  pre-­‐equilibrated	  Ni2+-­‐NTA	  resin	  for	  30	  min	  at	  room	  temperature.	  The	  resin	  was	  washed	  with	  20	  CV	  of	  Buffer	  C	  at	  pH	  6.3	  and	  eluted	  with	  Buffer	  C	  at	  pH	  5.9.	  Insoluble	  YpTIR	  was	  purified	  in	  a	  similar	  way	  using	  denaturing	  lysis	  buffer	  D	  [20mM	  Mops,	  10	  mM	  Tris-­‐HCl,	  8	  M	  urea,	  10	  mM	  BME,	  0.5	  mM	  PMSF,	  pH	  8.0]	  and	  including	  elution	  steps	  at	  pH	  5.9	  and	  pH	  4.5.	  YpTIR	  eluate	  was	  diluted	  (20-­‐fold)	   in	  refolding	  buffer	   [20	  mM	  Mops,	  10	  mM	   BME,	   pH	   7.0]	   by	   adding	   protein	   dropwise	   (~1	   drop/10	   sec)	   under	   rapid	  stirring	  at	   room	  temperature.	  The	  sample	  was	   incubated	  at	  4	   °C	  overnight	  and	  then	  concentrated	  using	  a	  10	  kDa	  MWCO	   filter.	  The	   sample	  was	  centrifuged	  at	  18,000	  g,	  4	  °C	  for	  10	  min	  and	  filtered	  through	  a	  0.22	  µM	  filter.	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2.2.11	  Purification	  under	  Native	  Conditions	  
	   Soluble	   protein	   was	   purified	   using	   Ni2+-­‐NTA	   resin	   under	   native	  conditions,	   as	   described	   in	   Section	   2.2.6	   with	   the	   following	   amendments.	   The	  lysis	  buffer	  [20	  mM	  Tris-­‐HCl,	  300	  mM	  NaCl,	  5	  mM	  imidazole,	  5%	  (v/v)	  glycerol,	  10	  mM	  BME,	  0.5	  mM	  PMSF,	  pH	  7.8]	  was	  used.	  Protein	  was	  batch-­‐bound	  with	  the	  resin	   for	  1	  hr	  at	  4	  °C.	  Protein	  elution	  steps	   included	  elution	  with	  150	  mM,	  250	  mM	  and/or	  500	  mM	  imidazole.	   IMAC	  purification	  was	  also	  repeated	  using	  Co2+	  resin	  (Clontech).	  	  	   SEC	   and	   anion	   exchange	   chromatography	   (AEC)	   were	   used	   to	   further	  purify	   the	  TIR	  proteins.	  SEC	  was	  performed	  as	  described	   in	  Section	  2.2.6	  using	  buffer	   [20	  mM	  Tris-­‐HCl,	   150	  mM	  NaCl,	   5	  mM	  DTT,	  pH	  7.8].	   For	  AEC,	   the	  Co2+-­‐IMAC	  eluate	  was	  diluted	  (5-­‐fold)	  in	  buffer	  [20	  mM	  Tris-­‐HCl,	  10	  mM	  BME,	  pH	  7.8]	  prior	   to	   loading	  onto	   the	  pre-­‐equilibrated	  Mono	  Q	  column	  (HR	  5/5,	  Amersham	  Biosciences,	  CV-­‐1	  ml).	  After	  a	  10	  CV	  wash	  step,	  the	  sample	  was	  eluted	  with	  a	  salt	  gradient	   of	   0-­‐0.5	   M	   NaCl	   over	   20	   CV	   at	   a	   flow	   rate	   of	   0.5	   ml/min.	   Stabilising	  agents	   [5	  mM	  DTT,	   10%	   (v/v)	   glycerol,	   0.03%	  Triton	  X-­‐100,	   50	  mM	  L-­‐Arg,	   50	  mM	  L-­‐Glu,	   50	  mM	  NDSB-­‐195,	   1%	  NV10]	  were	   added	   to	   purification	   buffers	   at	  different	  stages	  in	  an	  attempt	  to	  reduce	  protein	  aggregation	  and	  precipitation.	  	  	  
The	  GEV2	  vector	  system	  
2.2.12	  Expression	  using	  the	  GEV2	  Vector	  Constructs	   of	   differing	   lengths	   (Table	   2.2)	   were	   expressed	   for	   YpTIR:	  GB1-­‐YpTIR1	   (Ser130	   to	   Ala285),	   GB1-­‐YpTIR2	   (Ile137	   to	   Ile273)	   and	   GB1-­‐YpTIR3	   (Ile137	   to	   Asn246),	   and	   BpTIR:	   GB1-­‐BpTIR1	   (Ala228	   to	   Val352)	   and	  GB1-­‐BpTIR2	   (Asp220	   to	   Val352).	   All	   the	   constructs	   were	   transformed	   into	  BL21(DE3)Star™	   cells	   (Table	   2.1).	   The	   expression	   protocol	   was	   adapted	   from	  Huth	   et	   al.	   (1997).	   100	   ml	   LB	   containing	   Ampicillin	   (Amp	   100	   µg/ml)	   was	  inoculated	  with	  glycerol	  stocks	  (of	  cell	  cultures	  previously	  made)	  and	  the	  culture	  incubated	   at	   37	   °C,	   300	   rpm	   over	   16	   hr	   to	   reach	   saturation	   (OD600~4).	   These	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cultures	  were	   diluted	   fourfold	  with	  medium,	   shaken	   at	   37	   °C,	   300	   rpm	   for	   10	  min,	   and	   then	   induced	  with	   IPTG	   at	   37	   °C,	   25	   °C	   or	   15	   °C	   for	   4	   hr.	   Cells	  were	  harvested	  at	  4,000	  g,	  4	  °C	  for	  15	  min.	  The	   soluble	   fraction	  was	   extracted	   as	   described	   in	   Section	   2.2.6	   except	  that	  the	  cells	  were	  resuspended	  (5-­‐fold)	  in	  Buffer	  [20	  mM	  HEPES-­‐NaOH,	  250	  mM	  NaCl,	   2	  mM	  BME,	  0.5	  mM	  PMSF,	   pH	  7.0]	   and	   sonication	  was	  performed	  on	   ice	  only	  for	  2-­‐3	  mins	  (3	  sec	  on/off)	  based	  on	  the	  translucency	  of	  the	  solution.	  	  
2.2.13	  Purification	  of	  GB1-­TIR-­His	  	  GB1-­‐TIR	  proteins	  were	  purified	  using	  Co2+-­‐resin	  as	  described	   in	  Section	  2.2.11	  except	  for	  that	  the	  proteins	  were	  resusupended	  in	  buffer	  [20	  mM	  HEPES-­‐NaOH,	  250	  mM	  NaCl,	  2	  mM	  BME,	  0.5	  mM	  PMSF,	  pH	  7.0]	  and	  eluted	  with	  150	  mM	  imidazole.	  SEC	  was	  performed	  on	  the	  eluate	  as	  described	  in	  Section	  2.2.6	  using	  buffer	  [20	  mM	  Tris-­‐HCl,	  150	  mM	  NaCl,	  pH	  7.0].	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2.3	   Results	  
The	  pWaldo-­GFPe	  system	  
2.3.1	  Expression	  of	  TLP-­GFP	  Fusions	  	   	   Following	  expression	  in	  BL21(DE3)pLysS	  cells	  using	  0.4	  mM	  IPTG	  at	  25°C	  for	  4	  hr,	  measurement	  of	  the	  whole	  cell	  fluorescence	  gave	  readings	  of	  2258	  RFU	  for	   YpTLP-­‐GFP	   and	   3615	   RFU	   for	   BpTLP-­‐GFP.	   This	   corresponds	   to	   expression	  levels	  of	  1.38	  mg/l	  for	  YpTLP	  and	  2.80	  mg/l	  for	  BpTLP.	  Analysis	  of	  the	  proteins	  by	  in-­‐gel	  fluorescence	  (Fig	  2.1)	  revealed	  the	  proteins	  as	  single	  bands	  of	  ~60	  kDa	  in	   size	   corresponding	   to	   the	   size	   of	   the	   full	   length	   (~39	  KDa)	  protein	   fused	   to	  GFP	  (~28	  kDa).	  
	  
Fig	  2.1	  In-­gel	  fluorescence	  analysis	  of	  TLP-­GFP	  expression	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  M	  indicates	  the	  fluorescent	  molecular	  weight	  marker,	  G	  indicates	  purified	  GFP,	  1	  and	  2	  correspond	  to	  YpTLP	  and	  BpTLP	  expressed	  from	  different	  bacterial	  colonies	  	  
2.3.2	  Optimisation	  of	  YpTLP-­GFP	  Expression	  	  In	  order	  to	  improve	  the	  expression	  for	  YpTLP-­‐GFP,	  a	  number	  of	  different	  expression	  strains	  were	   tested.	  Based	  on	  protein	  expression	   levels	   (Fig	  2.2a,c),	  the	  best	  expression	  strain	  for	  YpTLP-­‐GFP	  (induced	  with	  0.4	  mM	  IPTG	  at	  25	  °C	  for	  3	  hr)	  was	  BL21(DE3)pLysS.	  It	  should	  be	  noted	  that	  the	  cell	  growth	  was	  higher	  in	  pLysS	  strains	  possibly	   indicating	  that	  the	  expressed	  protein	   is	   toxic	  to	  the	  cells	  (Fig	  2.2b,c).	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Fig	  2.2	   Monitoring	  YpTLP-­GFP	  expression	  among	  different	  expression	  strains	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  The	  measurements	  of	  (a)	  RFU	  and	  (b)	  culture	  OD	  (600	  nm)	  were	  taken	  at	  one	  hourly	  intervals	  and	  over	  a	  period	  of	  3	  hr,	  which	  are	  (c)	  tabulated	  above	  
	  	   Further	  optimisation	  of	  the	  induction	  conditions	  for	  YpTLP-­‐GFP	  (Fig	  2.3b)	  indicated	  that	   the	  best	  conditions	  were	  0.1	  mM	  IPTG	  at	  30	  °C	   for	  4	  hr	  (Fig	  2.3;	  condition	  1*	  pertaining	  to	  a	  shorter	  induction	  period	  than	  condition	  5).	  	  
	  
Fig	  2.3	   In-­gel	  fluorescence	  analysis	  of	  optimised	  YpTLP-­GFP	  expression	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  M	  indicates	  the	  fluorescent	  molecular	  weight	  marker,	  lanes	  1-­‐7	  contain	  protein	  expressed	  under	  the	  conditions	  detailed	  in	  the	  table,	  C	  indicates	  uninduced	  control	  sample,	  1*	  indicates	  the	  best	  induction	  condition	  for	  YpTLP-­‐GFP	  also	  pertaining	  to	  a	  shorter	  post-­‐induction	  period	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Large-­‐scale	   expression	   trials	   revealed	   that	   YpTLP-­‐GFP	   was	   expressed	  largely	  as	  insoluble	  aggregates	  based	  on	  the	  location	  of	  the	  fluorescent	  protein	  in	  the	   insoluble	   pellet	   (Fig	   2.4;	   I)	   although	   induction	   was	   performed	   at	   lower	  temperatures	  of	  15	  °C	  and	  18	  °C	  in	  order	  to	  minimise	  this.	  	  
	  
Fig	  2.4	  Western	  Blot	  analysis	  of	  YpTLP-­GFP	  localisation	  in	  cellular	  fractions	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Expression	  induced	  using	  0.1	  mM	  IPTG	  at	  reduced	  temperatures	  15	  °C	  and	  18	  °C	  for	  4	  hr.	  S	  indicates	  soluble	  fraction	  and	  I	  indicates	  insoluble	  fraction	  
	  
2.3.3	  Purification	  of	  YpTLP-­GFP	  Ni2+-­‐NTA	   IMAC,	   the	   first	   purification	   step	   for	   YpTLP-­‐GFP,	   produced	  relatively	   impure	   protein	   (Fig	   2.5;	   E1).	   The	   purity	   of	   the	   sample	   improved	  considerably	   after	   a	   second	  Ni2+-­‐NTA	   step	  using	  50	  mM	   imidazole	   in	   the	  wash	  buffer	  (Fig	  2.5;	  E2).	  
	  
Fig	  2.5	  SDS-­PAGE	  analysis	  of	  Ni2+-­NTA	  purified	  YpTLP-­GFP	  	  M	  indicates	  the	  molecular	  weight	  marker,	  E1	  and	  E2	  indicate	  protein	  eluates	  from	  the	  first	  and	  second	  Ni2+-­‐NTA	  purifications,	  respectively	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The	  purified	  eluate	  was	  analysed	  by	  size	  exclusion	  chromatography	  (SEC)	  at	   UV	   absorption	   280	   nm	   (Fig	   2.6a),	   the	   fluorescence-­‐based	   SEC	   (FSEC)	   (Fig	  2.6b)	  and	  subsequent	  SDS-­‐PAGE	  (Fig	  2.6c).	  Purified	  YpTLP-­‐GFP	  elutes	  first	  from	  the	  SEC	  column	  together	  with	  a	  higher	  molecular	  weight	  contaminant	  (Fig	  2.6a,c;	  fractions	  9-­‐11).	  FSEC	  shows	   that	   there	   is	  a	  higher	  concentration	  of	   free	  GFP	   in	  the	   sample	   eluting	   as	   the	   second	   peak	   (Fig	   2.6b,c:	   fractions	   14-­‐16)	   strongly	  suggesting	  that	  the	  protein	  complex	  is	  unstable	  and	  prone	  to	  degradation.	  
	  
	  
Fig	  2.6	  SDS-­PAGE	  analysis	  of	  purified	  YpTLP-­GFP	  SEC	  profiles	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  The	  purified	  YpTLP-­‐GFP	  was	  loaded	  onto	  Superdex	  200	  column	  and	  analysed	  by	  (a)	  UV	  absorption	  trace	  at	  280	  nm,	  (b)	  FSEC	  and	  (c)	  SDS-­‐PAGE.	  Fractions	  9-­‐11	  correspond	  to	  YpTLP-­‐GFP	  and	  fractions	  14-­‐16	  correspond	  to	  GFP	  	  
2.3.4	  Optimisation	  of	  BpTLP-­GFP	  Expression	  	  
	   The	   best	   expression	   condition	   for	   BpTLP-­‐GFP	   among	   the	   range	   of	  conditions	   tested	  was	   induction	  with	  0.4	  mM	   IPTG	  at	  30	   °C	   for	  22	  hr	   (Fig	  2.7;	  condition	   6).	   However,	   when	   BpTLP-­‐GFP	   was	   expressed	   in	   large-­‐scale	  bioreactors,	   the	  post-­‐induction	  period	  was	  reduced	   to	  4	  hr	  based	  on	  very	   little	  difference	  in	  protein	  levels	  between	  the	  4	  hr	  and	  the	  22	  hr	  samples.	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Fig	  2.7	   In-­gel	  fluorescence	  analysis	  of	  optimised	  BpTLP-­GFP	  expression	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  M	  indicates	  the	  fluorescent	  molecular	  weight	  marker,	  lanes	  1-­‐7	  contain	  protein	  expressed	  under	  the	  conditions	  detailed	  in	  the	  table,	  C	  indicates	  uninduced	  control	  sample,	  6*	  indicates	  the	  best	  induction	  condition	  for	  BpTLP-­‐GFP	  	  	  
2.3.5	  Purification	  of	  BpTLP-­GFP	  Expression	  	  
	   Preliminary	  Ni2+-­‐NTA	  purification	  produced	  impure	  protein.	  Optimisation	  of	  the	  purification	  step	  using	  a	  range	  of	  different	  imidazole	  concentrations	  in	  the	  wash	  buffer	   revealed	   that	   a	  50	  mM	   imidazole	  wash	   step	   (Fig	  2.8;	   Lane	  2)	  was	  optimum	   for	   removal	   of	   non-­‐specifically	   bound	   proteins	   without	   losing	   TLP-­‐fusion	  proteins	  (Fig	  2.8).	  
	  
Fig	  2.8	  SDS-­PAGE	  analysis	  of	  BpTLP-­GFP	  Ni2+-­NTA	  purification	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  M	  indicates	  molecular	  weight	  marker,	  Lanes	  1-­‐9	  indicate	  20,	  50,	  60,	  70,	  80,	  90,	  100,	  125	  and	  250	  mM	  imidazole	  wash	  steps	  respectively	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Loss	   of	   protein	   was	   observed	   during	   different	   stages	   of	   BpTLP-­‐GFP	  purification	  as	   a	   result	   of	   insoluble	  precipitation,	  degradation	  and	  aggregation.	  The	  presence	  of	  the	  GFP	  allows	  reasonably	  accurate	  assessment	  of	  the	  amounts	  of	   protein	   remaining	   after	   each	  preparation	   step	   (Fig	  2.9b).	  Of	   the	  3.6	  mg/l	   of	  BpTLP-­‐GFP	  expressed	  in	  a	  5	  litre	  bioreactor	  culture,	  almost	  two-­‐thirds	  of	  protein	  was	  lost	  in	  the	  insoluble	  fraction	  after	  cell	  lysis	  (Fig	  2.9a;	  Lane	  4)	  and	  almost	  half	  of	   the	  soluble	  BpTLP-­‐GFP	   lost	   in	   the	   lysate	   flowthrough	  during	  Ni2+-­‐NTA	   IMAC	  (Fig	   2.9a;	   Lane	   5),	   recovering	   0.26	   mg/l	   protein	   as	   eluate.	   Furthermore,	   the	  purified	  protein	  complex	  is	  subject	  to	  degradation	  (Fig	  2.9;	  Lane	  8).	  This	  is	  more	  evident	  in	  the	  sample	  left	  overnight	  on	  ice	  (Fig	  2.10;	  Lane	  2).	  
	  
Fig	  2.9	  In-­gel	  fluorescence	  analysis	  of	  BpTLP-­GFP	  Ni2+-­NTA	  purification	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  M	  indicates	  molecular	  weight	  marker,	  Lane	  1	  indicates	  whole	  cells,	  Lane	  2	  indicates	  lysed	  cells,	  Lane	  3	  indicates	  soluble	  protein,	  Lane	  4	  indicates	  insoluble	  protein,	  Lane	  5	  indicates	  lysate	  flowthrough,	  Lane	  6	  indicates	  25	  mM	  imidazole	  wash,	  Lane	  7	  indicates	  50	  mM	  imidazole	  wash	  and	  Lane	  8	  indicates	  BpTLP-­‐GFP	  eluate	  
	  Owing	   to	   better	   soluble	   yield	   after	   IMAC	   in	   comparison	   to	   YpTLP-­‐GFP,	  TEV	  cleavage	  was	  performed	  on	  BpTLP-­‐GFP	  to	  attain	  native	  BpTLP	  without	  the	  tag.	   The	   overnight	   TEV-­‐digestion	   of	   the	   BpTLP-­‐GFP	   complex	   was	   almost	  complete	   as	   revealed	   by	   in-­‐gel	   fluorescence	   (Fig	   2.10;	   Lane	   3).	   However,	   the	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TEV-­‐digested	   BpTLP	   sample	   showed	   heavy	   precipitation,	   which	   was	   filtered	  prior	  to	  reverse	  His-­‐purification.	  	  
	  
Fig	  2.10	  In-­gel	  fluorescence	  analysis	  of	  BpTLP-­GFP	  TEV-­digestion	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  M	  indicates	  fluorescent	  molecular	  weight	  marker,	  Lane	  1	  indicates	  lysed	  cells,	  Lane	  2	  indicates	  purified	  BpTLP-­‐GFP	  left	  overnight	  on	  ice	  and	  Lane	  3	  indicates	  TEV-­‐digested	  BpTLP	  	   The	  flowthrough	  from	  the	  reverse	  His-­‐purification	  contained	  BpTLP	  and	  a	  number	  of	  other	  protein	  bands	  (Fig	  2.11b;	  E).	  SEC	  of	  the	  sample	  yielded	  multiple	  peaks	  (Fig	  2.11a)	  including	  a	  large	  aggregation	  peak	  (Fig	  2.11a;	  Peak	  1),	  possibly	  containing	  BpTLP	  (~40	  kDa)	  (Fig	  2.11b;	  Lane	  1).	  Peaks	  2-­‐3	  contained	  a	  ~40	  kDa	  and	   a	   ~60	   kDa	   proteins	   (Fig	   2.11).	   Peaks	   4-­‐5	   contained	  mainly	   smaller	   sized	  contaminants	  and	  peaks	  6-­‐7	  contained	  no	  detectable	  protein	  (Fig	  2.11).	  The	  ~40	  kDa	  protein	  band	  was	  confirmed	  as	  BpTLP	  by	  N-­‐terminal	  sequencing	  while	  the	  larger	  ~60	  kDa	  band	  was	  identified	  as	  E.	  coli	  heat	  shock	  protein	  (HSP60).	  
	  
Fig	  2.11	  SDS-­PAGE	  analysis	  of	  purified	  BpTLP	  SEC	  profile	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  The	  purified	  BpTLP-­‐GFP	  was	  loaded	  onto	  Superdex	  200	  and	  analysed	  by	  (a)	  UV	  absorption	  at	  280	  nm	  and	  (b)	  SDS-­‐PAGE.	  M	  indicates	  molecular	  weight	  marker,	  E	  indicates	  concentrated	  sample	  containing	  BpTLP,	  Lanes	  1-­‐7	  correspond	  to	  SEC	  protein	  peaks	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The	  pET26b	  vector	  system	  
2.3.6	  Expression	  of	  the	  Full-­length	  TLP	  The	   low	  yields	   and	  poor	   stability	  meant	   that	   it	  was	   impossible	   to	  work	  with	   the	   GFP	   fusion	   proteins.	   The	   next	   approach	   was	   based	   on	   the	   pET26b	  vector	   system,	  which	  had	  been	   successfully	  used	   for	   the	  production	  of	   the	  TIR	  domains	  of	  human	  TLR1	  and	  TLR2	  (Xu	  et	  al.,	  2000).	  Expression	  of	   the	  TLPs	   in	  BL21(DE3)Gold	  cells	  was	  induced	  using	  0.4	  mM	  IPTG	  at	  20	  °C	  for	  4	  hr	  and	  16	  hr.	  In	   both	   cases,	   the	   protein	   was	   exclusively	   located	   in	   the	   insoluble	   fraction	  indicating	   the	   formation	   of	   inclusion	   bodies	   (Fig	   2.12).	   Insoluble	   YpTLP	   was	  purified	   under	   denaturing	   conditions	   to	   produce	   pure	   protein;	   however;	  refolding	  has	  not	  been	  attempted.	  	  
	  
Fig	  2.12	  Western	  Blot	  analysis	  of	  TLP	  expression	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Expression	  induced	  using	  0.4	  mM	  IPTG	  at	  20	  °C	  for	  4	  hr.	  M	  indicates	  molecular	  weight	  marker,	  T	  indicates	  total	  cell	  fraction,	  P	  indicates	  periplasmic	  fraction,	  S	  indicates	  soluble	  cytoplasmic	  fraction	  and	  I	  indicates	  insoluble	  cytoplasmic	  fraction	  	  
2.3.7	  Expression	  of	  the	  Truncated	  YpTIR	  	  The	   truncated	   YpTIR	   protein	   corresponding	   to	   the	   core	   TIR	   domain	  homologue	   (Ser130	   to	  Ala285)	  of	   the	  YpTLP	  protein	  was	   also	   expressed	  using	  the	   pET26b.	   Expression	   was	   induced	   using	   1	   mM	   IPTG	   for	   4	   hr	   and	   16	   hr.	  Cellular	   fractionation	   for	   YpTIR	   indicated	   some	   soluble	   protein	   in	   the	  cytoplasmic	   and	   periplasmic	   fractions	   when	   induced	   at	   20	   °C.	   Subsequent	  expression	  of	  YpTIR	  at	   lower	   induction	  temperatures	  of	  15	  °C	  and	  18	  °C	   led	  to	  more	  soluble	  protein	  expression.	  Fig	  2.13	  shows	  YpTIR	  expression	  in	  whole	  cells	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over	   4	   hr	   post-­‐induction	   and	   protein	   localised	   in	   soluble	   (S)	   and	   insoluble	  fractions	  (I)	  when	  induced	  at	  15	  °C.	  	  
	  
Fig	  2.13	  Western	  Blot	  analysis	  of	  YpTIR	  expression	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Expression	  induced	  using	  1	  mM	  IPTG	  at	  15	  °C	  for	  4	  hr.	  M	  indicates	  molecular	  weight	  marker,	  Lanes	  1-­‐4	  correspond	  to	  post-­‐induction	  period	  over	  1-­‐4	  hr,	  S	  indicates	  soluble	  fraction	  and	  I	  indicates	  insoluble	  fraction	  	  
2.3.8	  Purification	  of	  the	  Insoluble	  YpTIR	  	  The	   insoluble	   YpTIR	   was	   purified	   using	   Ni2+-­‐NTA	   under	   denaturing	  conditions.	  Highly	  pure	  protein	  was	  present	  in	  the	  flowthrough	  washed	  at	  pH	  6.3	  (W)	  and	  fractions	  eluted	  at	  pH	  5.9	  (E1)	  and	  pH	  4.5	  (E2)	  (Fig	  2.14).	  However,	   it	  was	  not	  possible	  to	  recover	  YpTIR	  after	  refolding	  by	  rapid	  dilution.	  
	  
Fig	  2.14	  SDS-­PAGE	  analysis	  of	  insoluble	  YpTIR	  purification	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  M	  indicates	  molecular	  weight	  marker,	  W	  indicates	  wash	  flowthrough	  at	  pH	  6.3,	  E1	  and	  E2	  indicate	  YpTIR	  eluates	  at	  pH	  5.9	  and	  pH	  4.5	  respectively]	  
	  
2.3.9	  Purification	  of	  the	  Soluble	  YpTIR	  	  Soluble	   YpTIR	   was	   initially	   purified	   using	   Ni2+-­‐NTA	   IMAC,	   which	   was	  followed	  by	  a	  second	  Ni2+-­‐NTA	  purification	  using	  a	  lower	  resin	  volume.	  However,	  
	  	   81	  
it	  was	   not	   possible	   to	   isolate	   pure	   YpTIR	   (Fig	   2.15;	   E1).	   The	   use	   of	   Co2+	   resin	  considerably	   improved	   the	  purity	  of	   soluble	  YpTIR	   (Fig	  2.15;	  E2).	  This	  protein	  was	  submitted	  to	  anion	  exchange	  chromatography	  (AEC)	  using	  Mono	  Q	  or	  SEC	  in	  an	  attempt	  to	  improve	  the	  purity	  of	  the	  sample.	  	  
	  
Fig	  2.15	  SDS-­PAGE	  analysis	  of	  YpTIR	  IMAC	  purification	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  M	  indicates	  molecular	  weight	  marker,	  E1	  and	  E2	  indicate	  YpTIR	  eluates	  from	  Ni2+-­‐NTA	  and	  Co2+	  IMAC	  purifications	  respectively	  	  SEC	  separated	  the	  sample	  into	  4	  peaks,	  of	  which	  peak	  1	  is	  within	  the	  void	  volume	   of	   the	   column,	   indicating	   protein	   aggregation	   (Fig	   2.16a).	   	   Peaks	   2-­‐3	  contain	  YpTIR	   in	   the	  presence	  of	   a	  higher	  molecular	  weight	   contaminant	   (~70	  kDa)	  and	  Peak	  4	   contains	  YpTIR	   in	   the	  presence	  of	   a	   slightly	  higher	  molecular	  weight	  contaminant	  (~28kDa)	  (Fig	  2.16).	  	  
	  
Fig	  2.16	  SDS-­PAGE	  analysis	  of	  YpTIR	  SEC	  profile	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  The	  purified	  YpTIR	  was	  loaded	  onto	  Superdex	  200	  column	  and	  analysed	  by	  (a)	  UV	  absorption	  at	  280	  nm	  and	  (b)	  SDS-­‐PAGE.	  M	  indicates	  molecular	  weight	  marker,	  E	  indicates	  Co2+	  IMAC	  eluate,	  Lanes	  1-­‐4	  correspond	  to	  SEC	  protein	  peaks	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AEC	  using	  Mono	  Q	  separated	  YpTIR	   into	  three	  distinct	  peaks	  (Fig	  2.17a;	  Peaks	  1-­‐3),	  and	  an	  irregular	  peak	  (Fig	  2.17a;	  Peak	  4).	  All	  peaks	  contained	  YpTIR.	  Peaks	   1	   and	   4	   contained	   highly	   pure	   YpTIR	   (Fig	   2.17b;	   Lanes	   1,4).	   Peak	   2	  contained	  YpTIR	  with	  a	   larger	  molecular	  weight	   contaminant	   (~70	  kDa)	  while	  Peak	  3	   contained	   an	   additional	   contaminant	   (~28	  kDa)	   (Fig	   2.17b;	   Lanes	   2,3).	  The	  ~70	  kDa	  protein	  was	  identified	  as	  E.	  coli	  heat	  shock	  protein	  HSP70	  and	  the	  ~28	  kDa	  protein	  was	  also	  identified	  as	  YpTIR	  by	  mass	  spectrometry.	  The	  overall	  yield	  of	  purified	  protein	  from	  a	  50-­‐litre	  culture	  was	  0.64	  mg/l.	  	  
	  
Fig	  2.17	  SDS-­PAGE	  analysis	  of	  YpTIR	  AEC	  profile	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  The	  purified	  YpTIR	  was	  loaded	  onto	  Superdex	  200	  and	  analysed	  by	  (a)	  UV	  absorption	  at	  280	  nm	  and	  (b)	  SDS-­‐PAGE.	  M	  indicates	  molecular	  weight	  marker,	  E	  indicates	  Co2+	  IMAC	  eluate,	  Lanes	  1-­‐4	  correspond	  to	  AEC	  protein	  peaks	  
	  
2.3.10	  Expression	  of	  the	  Truncated	  BpTIR	  	  
	   The	   truncated	   BpTIR	   protein	   corresponding	   to	   the	   core	   TIR	   domain	  homologue	   (Ala228	   to	   Val352)	   was	   expressed	   using	   pET26b.	   Expression	   in	  BL21(DE3)Gold	  cells	  were	  induced	  with	  1	  mM	  IPTG	  at	  low	  temperatures	  of	  15	  °C	  and	   18	   °C.	  Whole	   cells	   were	   separated	   into	   soluble	   and	   insoluble	   fractions	   to	  analyse	   protein	   localisation.	   Soluble	   protein	   expression	   was	   observed	   in	   cells	  harvested	  4	  hr	  and	  16	  hr	  post-­‐induction	  (Fig	  2.18).	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Fig	  2.18	  Western	  Blot	  analysis	  of	  BpTIR	  expression	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Expression	  using	  1	  mM	  IPTG.	  M	  indicates	  molecular	  weight	  marker,	  Lane	  1	  indicates	  induction	  at	  15	  °C	  for	  4	  hr,	  Lane	  2	  indicates	  induction	  at	  18	  °C	  for	  4	  hr,	  Lane	  3	  indicates	  induction	  at	  15	  °C	  for	  16	  hr,	  Lane	  4	  indicates	  induction	  at	  18	  °C	  for	  16	  hr]	  
	  
2.3.11	  Purification	  of	  the	  Soluble	  BpTIR	  	  
	   Co2+	   IMAC	   purification	   produced	   relatively	   pure	   BpTIR	   (Fig	   2.19a;	   E).	  However,	   large	   quantities	   of	   protein	   were	   lost	   through	   precipitation	   during	  concentration.	   The	   SEC	   profile	   for	   the	   concentrated	   sample	   indicated	   that	   the	  protein	   was	   aggregated	   (Fig	   2.19b;	   Peak	   1,	   void	   volume)	   and	   the	   presence	   of	  multiple	   peaks	   (Fig	   2.19b)	   suggested	   the	   protein	   was	   unstable	   and	   subject	   to	  significant	  degradation.	  The	  yields	  of	  the	  protein	  in	  each	  peak	  were	  too	  low	  (<3	  ng)	  to	  allow	  SDS-­‐PAGE	  analysis	  despite	  concentrating	  the	  samples	  10-­‐fold	  prior	  to	  loading	  onto	  the	  gel.	  	  
	  
Fig	  2.19	  Analysis	  of	  BpTIR	  purification	  (a)	  SDS-­‐PAGE	  analysis	  of	  BpTIR	  Co2+	  IMAC	  purification.	  M	  indicates	  molecular	  weight	  marker,	  F	  indicates	  lysate	  flowthrough,	  W1,	  W2	  and	  W3	  indicate	  0,	  5	  and	  20	  mM	  imidazole	  wash	  steps	  respectively,	  E	  indicates	  BpTIR	  eluate.	  The	  purified	  BpTIR	  was	  loaded	  onto	  Superdex	  200	  column	  and	  analysed	  by	  (b)	  UV	  absorption	  at	  280	  nm	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2.3.12	  Stabilisation	  of	  the	  Purified	  TIR	  proteins	  	  	   The	   additive	   NV10,	   a	   carbohydrate	   polymer	   known	   to	   increase	   protein	  stability	   and	   solubility,	   greatly	   improved	   stabilisation	   of	   the	   purified	   TIR	  proteins.	  1%	  NV10	  was	  added	  to	  purified	  YpTIR	  after	  the	  final	  purification	  step	  of	  AEC	  using	  Mono	  Q,	  enabling	  sample	  concentration	  up	  to	  3	  mg/ml	  in	  contrast	  to	  1.5	  mg/ml	   in	   the	   absence	  of	  NV10.	   It	  was	  also	  possible	   to	   recover	  1	  mg/ml	  BpTIR	  upon	  concentration	  of	  the	  Co2+	  IMAC	  eluate	  in	  the	  presence	  of	  1%	  NV10	  in	  contrast	  to	  almost	  total	  protein	  loss	  through	  precipitation	  and	  aggregation	  in	  its	  absence.	  Both	  proteins	  revealed	  long-­‐term	  stability	  in	  the	  presence	  of	  1%	  NV10	  over	  a	  period	  of	  12	  days	  when	  incubated	  at	  4	  °C	  and	  20	  °C	  (Fig	  2.20).	  
	  
Fig	  2.20	  SDS-­PAGE	  analysis	  of	  TIR	  long-­term	  stability	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Stabilisation	  profiles	  of	  pure	  TIR	  proteins	  (a)	  YpTIR	  and	  (b)	  BpTIR,	  in	  the	  presence	  of	  1%	  NV10	  monitored	  at	  4	  °C	  and	  20	  °C	  over	  a	  period	  of	  12	  days.	  M	  indicates	  molecular	  weight	  marker,	  Lane	  1	  indicates	  sample	  on	  day	  1,	  Lanes	  2	  and	  3	  indicate	  samples	  on	  day	  4	  at	  4	  °C	  and	  20	  °C,	  Lanes	  4	  and	  5	  indicate	  samples	  on	  day	  7	  at	  4	  °C	  and	  20	  °C,	  Lanes	  6	  and	  7	  indicate	  samples	  on	  day	  12	  at	  4	  °C	  and	  20	  °C,	  respectively	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The	  GEV2	  vector	  system	  
2.3.13	  Expression	  of	  GB1-­YpTIR	  proteins	  	  
	   The	  amounts	  of	  YpTIR	  and	  BpTIR	  obtained	  even	  with	  optimised	  protocols	  precluded	  extensive	  further	  studies.	  So	  an	  alternative	  system	  was	  employed	  for	  expression.	   In	   this	   case,	   constructs	   of	   differing	   lengths	  were	   generated	   (Table	  2.2)	   in	  order	   to	   identify	   the	  most	   stable	   construct	   that	   is	   suited	   to	   subsequent	  studies.	   Soluble	   protein	   (S)	   was	   expressed	   in	   BL21(DE3)Star	   cells	   for	   all	   the	  three	  GB1-­‐YpTIR	  constructs	  when	   induced	  with	  1	  mM	  IPTG	  at	   temperatures	  of	  15	  °C,	  25	  °C	  and	  37	  °C	  for	  4	  hr.	  Fig	  2.21	  shows	  localisation	  of	  the	  expressed	  GB1-­‐tagged	  YpTIR	  when	  induced	  at	  25	  °C	  for	  4	  hr.	  	  
	  
Fig	  2.21	  Western	  Blot	  analysis	  of	  GB1-­YpTIR	  expression	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Expression	  using	  1	  mM	  IPTG	  induced	  at	  25	  °C	  for	  4	  hr.	  M	  indicates	  molecular	  weight	  marker,	  T	  indicates	  total	  cell	  fraction,	  S	  indicates	  soluble	  fraction,	  I	  indicates	  insoluble	  fraction	  	  
2.3.14	  Purification	  of	  GB1-­YpTIR	  proteins	  	  GB1-­‐YpTIR	  proteins	  showed	  drastic	  improvement	  in	  purity,	  stability	  and	  yield	   (Fig	   2.22)	   in	   comparison	   with	   the	   previous	   constructs.	   All	   the	   proteins	  were	  purified	  to	  high	  homogeneity	  after	  one-­‐step	  Co2+	  IMAC	  purification,	  which	  could	   also	   be	   easily	   concentrated	   to	   ~10	   mg/ml	   suggesting	   a	   much	   greater	  stability	  than	  observed	  for	  the	  other	  constructs	  (Fig	  2.22).	  The	  purified	  protein	  yields	   for	   each	   GB1-­‐YpTIR	   protein	   was	   compared	   across	   different	   induction	  temperatures	   (Fig	   2.22d).	   The	   protein	   yield	   for	   pure	   GB1-­‐YpTIR1	   and	   GB1-­‐YpTIR2	  (~5	  mg/l)	  were	  more	  than	  10-­‐fold	  higher	  compared	  to	  YpTIR	  produced	  using	  pET26b	  (~0.64	  mg/l).	  The	  protein	  yield	  for	  pure	  GB1-­‐YpTIR3,	  the	  shortest	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construct	   of	   the	   three,	   was	   much	   lower	   (0.6	   mg/l)	   than	   the	   two	   longer	  constructs,	  indicating	  that	  the	  protein	  was	  unstable.	  	  
	  
Fig	  2.22	  SDS-­PAGE	  analysis	  of	  GB1-­YpTIR	  Co2+	  IMAC	  purification	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Purification	  of	  (a)	  GB1-­‐YpTIR1	  (b)	  GB1-­‐YpTIR2	  and	  (c)	  GB1-­‐YpTIR3,	  expressed	  using	  1	  mM	  IPTG	  and	  induced	  at	  37	  °C,	  25	  °C	  and	  15	  °C	  for	  4	  hr.	  M	  indicates	  molecular	  weight	  marker,	  L	  indicates	  lysate	  flowthrough,	  W	  indicates	  wash	  flowthrough,	  E	  indicates	  eluate.	  (d)	  Pure	  soluble	  protein	  yields	  are	  tabulated.	  	  
	   Large-­‐scale	   (2	   litre)	   expression	   of	   all	   three	   GB1-­‐YpTIR	   proteins	   was	  carried	   out	  with	   an	   induction	   temperature	   of	   25	   °C	   based	   on	   the	   best	   protein	  yields	  (Fig	  2.22).	  The	  proteins	  were	  purified	  by	  Co2+	  IMAC.	  The	  SEC	  profiles	  for	  GB1-­‐YpTIR1	  and	  GB1-­‐YpTIR2	  indicate	  highly	  purified,	  stable	  and	  monodisperse	  proteins	  (Fig	  2.23a).	  These	  peaks	  also	  suggest	  that	  the	  proteins	  exist	  in	  a	  dimeric	  state	   in	   solution	   based	   on	   their	   higher	   retention	   volumes	   than	   expected	   for	   a	  monomeric	   ~25	   kDa	   protein	   (Fig	   2.23a).	   This	   is	   further	   supported	   by	   the	  presence	   of	   higher	  molecular	   weight	   bands	   (~50	   kDa)	   on	   SDS-­‐PAGE	   gels	   (Fig	  2.22	   and	   2.23b)	   indicative	   of	   protein	   dimers.	   Owing	   to	   the	   low	   protein	   yield,	  GB1-­‐YpTIR3	   has	   not	   been	   used	   for	   subsequent	   protein	   characterisation.	   In	  addition,	  the	  SEC	  profile	  (Fig	  2.23a)	  for	  GB1-­‐YpTIR3	  was	  not	  monodisperse.	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Fig	  2.23	  SDS-­PAGE	  analysis	  of	  GB1-­YpTIR	  SEC	  profiles	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  The	  purified	  GB1-­‐YpTIR	  proteins	  were	  loaded	  onto	  Superdex	  200	  column	  and	  analysed	  by	  (a)	  UV	  absorption	  at	  280	  nm	  and	  (b)	  SDS-­‐PAGE.	  M	  indicates	  molecular	  weight	  markers,	  Lanes	  1-­‐3	  correspond	  to	  GB1-­‐YpTIR1-­‐3	  proteins	  respectively	  
	  
2.3.15	  Expression	  of	  GB1-­BpTIR	  proteins	  	  Soluble	  protein	   (S)	  was	  expressed	   in	  BL21(DE3)Star	   cells	   for	  both	  GB1-­‐BpTIR	  constructs	  when	  induced	  with	  1	  mM	  IPTG	  at	  temperatures	  of	  15	  °C,	  25	  °C	  and	   37	   °C	   for	   4	   hr.	   Fig	   2.24	   shows	   localization	   of	   expressed	   GB1-­‐BpTIR	  when	  induced	  using	  1	  mM	  IPTG	  at	  25	  °C	  for	  4	  hr.	  
	  
Fig	  2.24	  Western	  Blot	  analysis	  of	  GB1-­BpTIR	  expression	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Expression	  using	  1	  mM	  IPTG	  induced	  at	  25	  °C	  for	  4	  hr.	  M	  indicates	  molecular	  weight	  marker,	  T	  indicates	  total	  cell	  protein,	  S	  indicates	  soluble	  protein,	  I	  indicates	  insoluble	  protein	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2.3.16	  Purification	  of	  GB1-­BpTIR	  proteins	  	  Both	  GB1-­‐BpTIR1	  and	  GB1-­‐BpTIR2	  constructs	  induced	  at	  15	  °C,	  25	  °C	  and	  37	   °C	   were	   purified	   by	   Co2+	   IMAC.	   Although	   the	   proteins	   were	   not	   pure,	   the	  predominant	   protein	   in	   the	   sample	  was	   GB1-­‐BpTIR,	   as	   analysed	   by	   SDS-­‐PAGE	  (Fig	   2.25a,b).	   The	   soluble	   protein	   yields	  were	  much	   better	   (0.5-­‐0.9	  mg/l)	   (Fig	  2.25c)	  in	  comparison	  to	  BpTIR	  produced	  using	  pET26b	  (<0.1	  mg/l).	  	  
	  
Fig	  2.25	  SDS-­PAGE	  analysis	  of	  GB1-­BpTIR	  Co2+	  IMAC	  purification	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Purification	  of	  (a)	  GB1-­‐BpTIR1	  and	  (b)	  GB1-­‐BpTIR2,	  expressed	  using	  1	  mM	  IPTG	  induction	  at	  37	  °C,	  25	  °C	  and	  15	  °C	  for	  4	  hr.	  M	  indicates	  molecular	  weight	  marker,	  L	  indicates	  lysate	  flowthrough,	  W	  indicates	  wash	  flowthrough	  and	  E	  indicates	  eluate.	  (d)	  Soluble	  protein	  yields	  are	  tabulated	  	  	  Large-­‐scale	   expression	   was	   carried	   out	   only	   for	   GB1-­‐BpTIR2,	   induced	  using	  1	  mM	  IPTG	  at	  25	  °C	  for	  4	  hr.	  Again,	  GB1-­‐BpTIR2	  is	  a	  more	  stable	  protein	  compared	   to	   BpTIR	   produced	   using	   pET26b,	   which	   was	   mainly	   lost	   due	   to	  precipitation	   during	   protein	   concentration.	   However,	   the	   SEC	   profile	   for	   GB1-­‐BpTIR2	   (Fig	   2.26a)	   indicates	   heavy	   protein	   aggregation	   (Peak	   1)	   along	   with	  some	  soluble	  GB1-­‐BpTIR2	  (Peak	  2)	  eluting	  at	  a	  slightly	  lower	  retention	  volume	  than	   expected	   for	   a	  monomeric	   protein	   sized	  ~21	   kDa.	   Together	   this	   suggests	  that	   GB1-­‐BpTIR2	   is	   unstable	   in	   solution	   and	   that	   it	   possibly	   exists	   as	   a	   dimer,	  also	   supported	   by	   the	   presence	   of	   a	   higher	  molecular	  weight	   band	   of	   the	   size	  ~40	  kDa	  on	  SDS-­‐PAGE	  gels	  (Fig	  2.25	  and	  2.26b).	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2.4	   Discussion	  	  
Using	   the	  pWaldo-­‐GFPe	  vector,	  GFP	   fusions	  of	   the	   full-­‐length	  TLPs	  were	  expressed	   in	  a	  soluble	   form	  but	   these	  were	  extremely	  unstable,	  being	  prone	  to	  both	  degradation	  and	  aggregation.	  The	  overall	   soluble	  protein	  yield	  of	  purified	  TLPs	  was	  <0.5	  mg/l,	  which	   is	   very	   low	  compared	   to	   the	  published	  value	  of	  20	  mg/l	   for	   the	   bacterial	   TLP	   from	   Paracoccus	   denitrificans	   (Low	   et	   al.,	   2007).	  BpTLP-­‐GFP	  was	  found	  to	  be	  expressed	  as	  inclusion	  bodies	  (67%)	  and	  co-­‐purified	  with	  high	  amounts	  of	   the	  E.	   coli	  molecular	  chaperonin,	  HSP60.	  The	  overall	   low	  soluble	  expression	  levels,	  protein	  degradation	  and	  aggregation	  together	  with	  the	  presence	  of	  HSP60	  as	  a	  major	  contaminant	  are	  strongly	  suggestive	  that	  BpTLP-­‐GFP	  is	  at	  least	  partially	  unfolded.	  	  GFP	  fluorescence	  has	  been	  reported	  as	  a	  sensitive	  folding	  indicator	  based	  on	  the	  assumption	  that	  proper	  tertiary	  folding	  of	  the	  GFP	  moiety	  will	  only	  take	  place	   if	   the	   protein	   fused	   to	   the	  N-­‐terminus	   is	   also	   folded	   (Waldo	   et	   al.,	   1999;	  Cody	   et	   al.,	   1993).	   However,	   the	   GFP-­‐fusion	   system	   fails	   to	   report	   aggregated	  states	   of	   the	   N-­‐terminal	   domain	   as	   triggered	   by	   the	   formation	   of	   misfolding	  intermediates,	   improper	   disulfide	   bonds	   or	   other	   structures	   leading	   to	  insolubility	   that	   are	   generated	   only	   after	   translation	   and	   release	   of	   the	  polypeptide	  from	  the	  ribosome	  (Waldo	  et	  al.,	  1999)	  when	  the	  GFP	  chromophore	  has	  already	  formed.	  This	  is	  a	  likely	  explanation	  for	  why	  BpTLP-­‐GFP	  expresses	  as	  inclusion	  bodies	  (67%)	  but	  retains	  its	  ability	  to	  fluoresce.	   
E.	  coli	  HSP60,	  also	  called	  as	  GroEL	  together	  with	   its	  co-­‐factor	  GroES	   is	  a	  molecular	   chaperone.	   The	   GroEL-­‐GroES	   complex	   binds	   to	   unfolded	   protein	  (polypeptide),	   refolds	   it	  within	   the	   GroEL	   central	   cavity	   and	   then	   releases	   the	  folded	  protein	  using	  an	  ATP-­‐dependent	   reaction	  cycle	   (Yokokawa	   et	  al.,	   2006).	  The	   association	   of	   BpTLP-­‐GFP	  with	   high	   amounts	   of	  HSP60	   is	   indicative	   of	   its	  misfolded	   state.	   Since	   the	   full-­‐length	   TLPs	   were	   only	   expressed	   as	   inclusion	  bodies	  using	  pET26b,	   it	   is	  possible	  that	  the	  highly	  soluble	  GFP	  was	  responsible	  for	  maintaining	  the	  fusion	  protein	  in	  solution	  (Graslund	  et	  al.,	  2008).	  Indeed	  the	  protein	  aggregated	  further	  after	  removal	  of	  the	  GFP	  tag.	  Subsequently,	  attempts	  were	  not	  made	  to	  express	  bacterial	  TLPs	  with	  solubility	  tags.	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   The	  pET26b	  vector	  was	  used	  to	  produce	  human	  TIR	  proteins	  for	  structural	  studies	  (Khan	  et	  al.,	  2004;	  Xu	  et	  al.,	  2000).	  It	  incorporates	  a	  pelB	  signal	  sequence	  and	  a	  C-­‐terminal	  His	  tag	  downstream	  to	  the	  protein	  of	  interest.	  This	  vector	  was	  used	  to	  incorporate	  a	  C-­‐terminal	  His	  tag	  (personal	  communication,	  Liang	  Tong),	  and	  not	  for	  specifically	  targeting	  the	  human	  TIR	  proteins	  to	  the	  periplasm.	  Full-­‐length	  TLPs	  were	  only	  expressed	  as	  insoluble	  aggregates	  using	  pET26b.	  Protein	  refolding	   has	   not	   been	   attempted	   on	   full-­‐length	   YpTLP,	   however	   it	   was	   not	  possible	  to	  refold	  denatured	  YpTIR	  by	  rapid	  dilution.	  	  	   Bioinformatics	  analysis	  predicted	  the	   location	  of	  unstructured/disordered	  regions	  within	  the	  full-­‐length	  bacterial	  TLP	  sequences	  (Phyre,	  DisEmbl,	  GlobPlot	  and	  Ronn)	  (Chapter	  4).	  It	  was	  also	  noted	  that	  human	  TIR	  proteins	  deposited	  in	  the	   PDB	   have	   been	   structurally	   characterised	   by	   X-­‐ray	   crystallography	   or	  solution	  NMR	  for	  the	  core	  TIR	  domains	  (~150	  amino	  acids)	  (Chan	  et	  al.,	  2009a;	  Nyman	  et	  al.,	  2008;	  Ohnishi	  et	  al.,	  2009;	  Khan	  et	  al.,	  2004;	  Tao	  et	  al.,	  2002;	  Xu	  et	  
al.,	  2000).	  Subsequently,	  constructs	  were	  designed	  which	  allowed	  expression	  of	  core	  bacterial	  TIR	  domains,	  based	  on	  the	  bioinformatics	  analysis	  and	  comparison	  with	  the	  structurally	  characterised	  TIR	  domains.	  	  	   Soluble	   TIR	   protein	   was	   produced	   using	   pET26b,	   the	   yield	   improving	   to	  ~33%	  when	  induction	  was	  performed	  at	  the	  lower	  temperature	  of	  15	  °C.	  It	  was	  possible	  to	  obtain	  highly	  purified	  YpTIR	  using	  pET26b,	  which	  was	  higher	  in	  yield	  and	  stability	  compared	  to	  YpTLP-­‐GFP.	  The	  final	  soluble	  yield	  for	  YpTIR	  was	  0.64	  mg/l	  from	  a	  50-­‐litre	  bioreactor	  culture.	  BpTIR	  was	  less	  stable	  than	  YpTIR	  with	  a	  soluble	  yield	  of	  <0.1	  mg/l.	  Though	  YpTIR	  and	  BpTIR	  were	  used	  for	  preliminary	  analyses,	  the	  yields	  were	  too	  low	  to	  allow	  structural	  studies.	  In	  addition,	  YpTIR	  was	   shown	   to	  be	  misfolded	  by	   subsequent	  1D-­‐NMR	  analysis	   (Chapter	  4).	  Thus	  alternative	  expression	  approach	  was	  used	  aiming	  at	  structural	  studies.	  Human	   TIR-­‐adaptors	   (Mal,	   TRIF)	   have	   been	   expressed	   using	   the	   GEV2	  vector	   to	   incorporate	   GB1	   and	   His	   tags	   (Wang	   et	   al.,	   unpublished	   work).	  Expression	   of	   YpTIR	   and	   BpTIR	   as	   GB1-­‐TIR	   fusions	   considerably	   improved	  soluble	  protein	  expression	  levels,	  purity,	  stability	  and	  overall	  yield	  compared	  to	  the	   previous	   constructs.	   The	   proteins	   were	   purified	   by	   one-­‐step	   Co2+	   IMAC	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purification	  and	  the	  soluble	  protein	  yields	  were	  at	  least	  10-­‐fold	  higher	  than	  the	  proteins	  obtained	  using	  alternative	  systems.	  Among	  the	  three	  YpTIR	  constructs	  of	   varying	   lengths,	   GB1-­‐YpTIR1	   and	  GB1-­‐YpTIR2	  were	   submitted	   to	   functional	  analysis,	  NMR	  characterisation	  and	  crystallisation	  trials	  (Chapters	  3	  and	  4).	  	  The	  shortest	  YpTIR	  construct,	  GB1-­‐YpTIR3	  had	  a	  relatively	  poor	  yield	  in	  addition	  to	  a	  polydisperse	  SEC	  profile	  suggesting	  that	  possibly	  residues	  important	  to	  preserve	  its	   protein	   structure	   and	   integrity,	   have	   been	   excluded.	   GB1-­‐YpTIR3	  was	   only	  used	   for	  GST-­‐Pull	   down	  assays	   (Chapter	  3).	  Among	   the	  BpTIR	   constructs,	   only	  the	   shorter	   construct,	  GB1-­‐BpTIR2	  has	  been	   further	   analysed	  by	   SEC	   to	   reveal	  heavy	   aggregation	   and	   some	   soluble	   protein.	   Further	   work	   is	   required	   to	  stabilise	   this	   construct.	   Analysis	   of	   the	   longer	   GB1-­‐BpTIR1	   construct	   is	   also	  required	  in	  order	  to	  assess	  its	  suitability	  for	  further	  analyses.	  Overall,	  the	  GEV2	  vector	  represents	  a	  powerful	  tool	  for	  the	  expression	  of	  these	  TIR	  domains.	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Chapter	  3	  	  
Investigation	  of	  Heterotypic	  Protein-­
Protein	  Interactions	  
	  
3.1	   Introduction	  
3.1.1	  Functional	  Role	  of	  Bacterial	  TIR	  Domains	  	  Pathogenic	   bacterial	   TIR	   homologues	   are	   suggested	   to	   limit	   host	   innate	  immunity	   by	   interfering	   with	   TLR	   signalling	   (Newman	   et	   al.,	   2006;	   Cirl	   et	   al.,	  2008).	  There	  are	  ten	  human	  TLRs	  in	  addition	  to	  IL-­‐1R	  proteins	  and	  five	  adaptor	  proteins;	  the	  TIR	  domains	  of	  all	  of	  these	  could	  be	  potential	  targets	  of	  pathogenic	  bacterial	  TIR	  domains.	  Of	  the	  five	  TIR-­‐containing	  human	  adaptors	  (MyD88,	  Mal,	  TRIF,	  TRAM,	  SARM),	  MyD88	  is	  involved	  in	  signalling	  to	  NFκB	  in	  pathways	  of	  all	  the	  known	  TLRs	  with	  the	  exception	  of	  TLR3	  (Akira	  et	  al.,	  2006).	  TLR3	  exclusively	  uses	  the	  TRIF-­‐dependent	  signalling	  pathway	  to	  activate	  IRF-­‐3	  (Yamamoto	  et	  al.,	  2003).	  TLR4	  can	  use	  both	  the	  MyD88-­‐dependent	  and	  TRIF-­‐dependent	  pathways	  to	  activate	  NFκB	  and	  IRF-­‐3	  respectively	  (Fitzgerald	  et	  al.,	  2003).	  	  	  The	  TIR	  domain	  of	  human	  MyD88	  was	   selected	  as	   the	  putative	  partner	  protein	  to	  assess	  protein	  interaction	  with	  YpTIR	  and	  BpTIR.	  MyD88	  is	  the	  best-­‐studied	  human	  adaptor	  protein	  to	  date	  (Bonnert,	  1997;	  Ohnishi	  et	  al.,	  2009).	  In	  the	   TLR2-­‐	   and	   TLR4-­‐mediated	   signalling	   pathways,	  Mal	   functions	   as	   a	   sorting	  adaptor	  to	  recruit	  MyD88	  (Horng	  et	  al.,	  2002;	  Kagan	  and	  Medzhitov,	  2006)	  that	  in	  turn	  transmits	  the	  signal	  to	  NFκB	  activation	  (Kawai	  and	  Akira,	  2007).	  In	  vitro	  GST	  pull	   down	   and	   co-­‐immunoprecipitation	   assays	   have	   showed	   that	   bacterial	  TIR	  domains	  in	  the	  uropathogenic	  strain	  of	  E.	  coli	  CFT073	  (TcpC)	  and	  Paracoccus	  
denitrificans	   (PdTIR)	   respectively	   interact	   with	   human	  MyD88-­‐TIR	   (Cirl	   et	   al.,	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2008;	   Chan	   et	   al.,	   2009b).	   Similarly,	   the	   TIR-­‐containing	   protein	   in	   Brucella	  
melitensis	   (TcpB)	  has	  been	   shown	   to	   interact	  with	  hMyD88-­‐TIR	  using	  GST-­‐pull	  down	  assay	  (Cirl	  et	  al.,	  2008)	  although	  co-­‐immunoprecipitation	  studies	  indicated	  no	   interaction	   between	   the	   Brucella	   TcpB	   and	   hMyD88-­‐TIR	   (Sengupta	   et	   al.,	  2010).	  Brucella	  TcpB	  was	  also	  shown	  to	  mimic	  Mal	  by	  binding	  phosphoinositides	  (Radhakrishnan	   et	   al.,	   2009)	   and	   subvert	   the	   TLR2-­‐	   and	   TLR4-­‐mediated	  pathways	  by	  targeting	  degradation	  of	  Mal	  (Sengupta	   et	  al.,	  2010).	   It	   is	  possible	  that	   pathogenic	   bacterial	   TIR	   domains	   from	   different	   bacteria	   target	   specific	  human	  TIR	  domains.	  	  	  In	   this	   study,	   in	   vitro	  GST	  pull	   down	  assay	  was	  employed	   to	   investigate	  protein	  interactions	  between	  YpTIR/BpTIR	  and	  human	  MyD88-­‐TIR	  and	  to	  assess	  the	   effect	   of	   the	   Pro173His	   mutation	   within	   the	   box	   2	   region	   of	   YpTIR.	   This	  single-­‐point	  mutation	   is	   equivalent	   to	   that	   in	   the	   TIR	   domain	   of	  murine	   TLR4	  (Pro712His),	   which	   disrupts	   the	   host	   immune	   response	   to	   lipopolysaccharide	  (LPS)	  (Poltorak	  et	  al.,	  1998).	  In	  the	  TIR	  domains	  of	  TLR2	  (Pro681His)	  (Xu	  et	  al.,	  2000)	   and	   TLR10	   (Pro674His)	   (Nyman	   et	   al.,	   2008),	   the	   equivalent	   point-­‐mutation	   disrupts	   interaction	   with	   human	   MyD88-­‐TIR	   emphasising	   the	  importance	   of	   this	   residue	   in	   mediating	   TIR	   interactions.	   However,	   the	  equivalent	  residue	  mutation	   in	  hTLR4	  (Pro714His)	  does	  not	  affect	   its	  ability	   to	  interact	   with	   MyD88-­‐TIR	   (Dunne	   et	   al.,	   2003).	   Further	   studies	   of	   the	   TIR-­‐mediated	  heterotypic	  complexes	  are	  required	  to	  clarify	  these	  mechanisms.	  	  Nuclear	   magnetic	   resonance	   (NMR)	   spectroscopy	   was	   used	   to	   further	  assess	   the	   heterotypic	   TIR-­‐TIR	   interactions	   between	   YpTIR	   and	   hMyD88-­‐TIR.	  NMR	  titration	  has	  been	  used	  to	  study	  the	   interactions	  between	  human	  MyD88-­‐TIR	  and	  Mal-­‐TIR	  by	  2D	  NMR	  spectroscopy	  (Ohnishi	  et	  al.,	  2009).	   In	  addition	  to	  detecting	   complex	   formation	   between	   these	   proteins	   by	   NMR,	   it	   was	   also	  possible	   to	   determine	   residues	   important	   for	   this	   interaction	   using	   alanine	  mutants	   of	   MyD88-­‐TIR	   (Ohnishi	   et	   al.,	   2009).	   The	   next	   few	   sections	   (Sections	  3.1.2	   to	   3.1.10)	   describe	   how	   the	   NMR	   phenomenon	   arises.	   The	   NMR	   spectra	  used	  in	  this	  study	  are	  discussed	  in	  Chapters	  3	  and	  4.	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3.1.2	  Protein	  NMR	  Spectroscopy	  
	   NMR	   spectroscopy	   is	   an	   invaluable	   technique	   to	   obtain	   high-­‐resolution	  structural	   information	  on	   small	   to	  medium-­‐sized	   (routinely	  ~25	  kDa)	  proteins	  and	   dynamical	   information	   on	   large	   proteins	   (up	   to	   600	   kDa).	   In	   this	   study,	  primarily	  one-­‐dimensional	   (1D	  1H)	  NMR	  was	  used	   to	  assess	   the	   folded	  state	  of	  proteins.	  Subsequently,	   transverse	  relaxation	  optimised	  spectroscopy	  (TROSY)-­‐type	   heteronuclear	   single-­‐quantum	   correlation	   (HSQC)	   two-­‐dimensional	   (2D	  1H/15N)	   spectroscopy	   was	   employed	   to	   study	   protein-­‐protein	   interactions	  between	   15N-­‐YpTIR	   and	   unlabelled	   MyD88-­‐TIR.	   An	   extensive	   description	   of	  principles	   and	   practices	   related	   to	   protein	   NMR	   spectroscopy	   is	   outside	   the	  scope	  of	  this	  thesis.	  The	  following	  sections	  aim	  to	  introduce	  the	  basic	  underlying	  NMR	  theories	  (Keeler,	  2005)	  in	  context	  with	  the	  study	  conclusions.	  	  	  
3.1.3	  The	  NMR	  Phenomenon	  
	   Nuclear	   spin	  angular	  momentum	   is	  an	   intrinsic	  property	  of	   some	  nuclei	  such	  as	  the	  spin-­‐half	  nuclei	  1H,	  13C	  and	  15N	  and	  the	  spin-­‐one	  nucleus	  2H.	  Îz	   is	  an	  operator	   that	   represents	   the	   z-­‐component	   of	   the	   nuclear	   spin	   angular	  momentum,	   a	   vector	   quantity.	   Of	   the	   operators	   that	   represent	   the	   observable	  quantities	   in	   quantum	   mechanics,	   the	   Hamiltonian	   operator	   ( )	   represents	  energy.	   The	   eigenvalues	   of	   the	  Hamiltonians	   are	   the	   available	   energy	   levels	   in	  the	   system.	   The	   eigenvalue	   equation,	   relating	   the	   eigenfunctions	   to	   the	  eigenvalues	  (multiplying	  constants)	  of	  an	  operator	  is,	  (operator)	  acting	  on	  (eigenfunction)	  =	  (eigenvalue)	  x	  (eigenfunction)	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ˆ I zψ+ 12 = +
1
2 ψ+ 12 	  and	    
€ 
ˆ I zψ− 12 = +
1
2 ψ− 12 	  or,	     
€ 
ˆ I zψm = mψm 	  where	  m	  =	  ±½	  and	    
€ 
m 	  is	  an	  eigenvalue	  of	  the	  quantum	  number	  m.	  	   The	  NMR	  phenomenon	  arises	   as	   a	   result	   of	   the	   interaction	  between	   the	  magnetic	  moment	  generated	  by	  the	  nuclear	  spin	  and	  the	  external	  magnetic	  field	  it	  is	  placed	  in.	  The	  Hamiltonian	  that	  represents	  the	  energy	  of	  this	  interaction	  is	  
€ 
ˆ H one	  spin	  	  =	  -­γBo	  Îz	  	  where	   γ	   is	   the	   gyromagnetic	   ratio,	   a	   fundamental	   property	   of	   the	   involved	  nucleus	  and	  Bo	  is	  the	  strength	  of	  the	  magnetic	  field	  applied	  along	  the	  z-­‐axis.	  Now,	  it	   can	   be	   shown	   that	   the	   eigenfunctions	   of	   Îz	   and	  
€ 
ˆ H one	   spin	   differ	   only	   by	  multiplication	  of	  the	  constant	  factor	  -­γBo	  such	  that	  the	  eigenvalue	  Em	  where	  	   	   	    
€ 
Em = −mγBo(where	  m	  =	  ±½)	  represents	  the	  two	  energy	  states	  available	  to	  a	  single	  magnetic	  spin-­‐half.	  	  
	  
3.1.4	  Energy	  Levels	  and	  NMR	  Spectra	  The	  emergence	  of	  NMR	  lines	  in	  a	  spectrum	  can	  be	  explained	  as	  a	  result	  of	  transitions	   between	   a	   set	   of	   quantised	   energy	   levels	   within	   a	   molecule.	   A	  molecule	  can	  only	  absorb	  photons	  of	   the	  energy	   that	  matches	   the	  difference	   in	  energy	   between	   two	   quantised	   energy	   levels.	   For	   a	   spin-­‐half	   nucleus,	   Em	  represents	  the	  two	  available	  energy	  levels,	  the	  α	  state	  with	  m	  =	  +½	  is	  described	  as	  ‘spin	  up’	  energy	  level	  and	  the	  β	  state	  with	  m	  =	  -­‐½	  as	  ‘spin	  down’.	  For	  1H	  and	  13C	  with	  a	  positive	  γ,	  the	  α	  state	  is	  lower	  in	  energy	  while	  the	  α	  state	  is	  higher	  in	  energy	   for	   15N	  with	   a	   negative	   γ.	   For	   a	   spin-­‐half	   nucleus	  with	   a	   positive	   γ,	   the	  allowed	  transition	  between	  levels	  α	  and	  β	  is	  defined	  by	  the	  energy	  (Fig	  3.1),	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€ 
ΔEα→β = Eβ − Eα 	  














	   	   	     
€ 
= γBo 	  	   	   	  
€ 
= h /2π( )γBo	   	   	  
	  
Fig	  3.1	  Nuclear	  magnetic	  resonance	  in	  terms	  of	  energy	  levels	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  The	  allowed	  transition	  between	  the	  energy	  levels	  Eαand	  Eβ,	  available	  to	  a	  spin-­‐half	  nuclei	  with	  a	  positive	  gyromagnetic	  ratio	  γ,	  results	  in	  an	  NMR	  line	  at	  the	  Larmor	  frequency	  -­‐νo	  (Keeler	  2005)	  	   We	  know	  that	  ,	  
€ 
ΔEα→β = hνα→β 	  	  where	   να→β	   is	   the	   frequency	   of	   the	   photon	   corresponding	   to	   the	   above	   energy	  separation.	  Thus,	  we	  can	  predict	  that	  the	  NMR	  line	  occurs	  at	  frequency,	  	   	   	  
€ 
να→β = γBo /2πHz	  The	   frequency	   separation	   corresponds	   to	   the	   radiofrequency	   region	   of	  the	  electromagnetic	  spectrum	  and	  hence	  the	  use	  of	  RF	  pulses	  in	  NMR.	  	  
3.1.5	  The	  Larmor	  Frequency	  	  
	   The	  Larmor	  frequency	  of	  the	  spin	  can	  thus	  be	  defined	  as:	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   ωo	  	  =	  -­γBo	  rad	  s-­‐1	  and/or	  νo	  =	  -­γBo/2π	  Hz	  Comparing	   the	   frequencies	   να→β	   and	   νo,	   it	   can	   be	   said	   that	   the	   transition	  between	  α	  to	  β	  states	  occurs	  at	  minus	  the	  Larmor	  frequency:	  	   	   	   	  
Since	   the	  nuclei	  of	   the	   same	   isotope	  give	  different	   chemical	   shifts	   (δ)	   in	  varying	  chemical	  environments,	  the	  Lamor	  frequency	  can	  be	  redefined	  to	  include	  the	  chemical	  shift	  as	  follows:	  	   	   	   ωo	  	  =	  -­γ	  (1	  +	  10-­‐6	  x	  δ)Bo	  and/or	  νo	  =	  -­γ	  (1	  +	  10-­‐6	  x	  δ)Bo	  /2π	  
	  
3.1.6	  The	  Vector	  Model	  	  
	   The	   nuclei	   possessing	   spin	   angular	  momentum	   have	   associated	   nuclear	  spin	  magnetic	  moment,	  indicating	  that	  the	  nuclei	  generate	  a	  small	  magnetic	  field	  behaving	  as	  tiny	  bar	  magnets.	  The	  energy	  of	  the	  interaction	  between	  the	  nuclear	  magnetic	  moment	  and	  the	  applied	  field	  relies	  on	  the	  angle	  θ	  between	  them,	  when	  an	   external	   magnetic	   field	   is	   applied	   to	   the	   nucleus.	   The	   magnetic	   moment	  parallel	   to	   the	   field	   (θ	   	   =	  0)	  produces	   the	   lowest	   energy	  arrangement	  and	   that	  anti-­‐parallel	  to	  the	  field	  (θ	  	  =	  π	  rad)	  produces	  the	  highest	  energy	  arrangement.	  Now,	   random	   thermal	   motion	   of	   the	   molecules	   opposes	   this	   minimum	  energy	  adoption	  by	  the	  magnetic	  moments	  in	  the	  NMR	  sample,	  in	  which	  all	  these	  individual	   moments	   align	   with	   the	   field.	   Since	   the	   interaction	   of	   the	   nuclear	  magnetic	  moments	  with	  the	  applied	  field	  is	  comparatively	  much	  lower	  than	  the	  energy	   of	   the	   thermal	   motion,	   the	   alignment	   of	   the	   individual	   moments	   in	   a	  sample	   is	   randomised.	  However,	   owing	   to	   a	   small	   energetic	   preference	   for	   the	  alignment	  of	  the	  magnetic	  moment	  with	  the	  field,	  there	  is	  a	  slight	  net	  alignment	  of	  the	  moments	  along	  the	  applied	  field	  upon	  averaging.	  This	  results	   in	  the	  bulk	  magnetisation	   arising	   from	   the	  many	  nuclei	   of	   the	  NMR	   sample	  parallel	   to	   the	  direction	   of	   the	   applied	   field,	   which	   can	   be	   represented	   by	   the	   bulk	  magnetisation	  vector	  (Fig	  3.2).	  	  
! 
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Fig	  3.2	  Schematic	  illustration	  of	  Equilibrium	  Magnetisation	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  The	  magnetic	  moments	  are	  oriented	  randomly	  in	  the	  absence	  of	  magnetic	  field.	  When	  a	  magnetic	  field	  is	  applied,	  the	  moments	  begin	  aligning	  with	  the	  field	  to	  adopt	  the	  minimum	  energy	  arrangement.	  After	  sufficient	  waiting,	  the	  moments	  aligning	  along	  the	  applied	  field	  become	  more	  populated	  to	  generate	  bulk	  magnetisation,	  which	  at	  equilibrium	  points	  the	  z-­‐axis	  (Keeler	  2005)	  	   There	  is	  no	  net	  magnetisation	  of	  the	  sample	  in	  the	  absence	  of	  an	  external	  magnetic	  field,	  in	  which	  the	  individual	  moments	  are	  oriented	  randomly	  (Fig	  3.2).	  When	  an	  external	  field	  is	  applied,	  the	  net	  magnetisation	  of	  the	  sample	  is	  initially	  still	  absent	  (Fig	  3.2)	  owing	  to	  the	  time	  taken	  by	  the	  magnetic	  moments	  to	  align	  along	   the	   direction	   of	   the	   field	   following	   the	   lower	   energy	   preference.	   Over	  several	  seconds,	  the	  random	  molecular	  motion	  preferentially	  populates	  magnetic	  moments	   adopting	   minimum	   energy,	   thus	   building	   up	   the	   net	   magnetisation	  vector	   along	   the	   z-­‐axis	   (Fig	   3.2).	   The	   magnetisation	   grows	   with	   populating	  moments	  aligned	  with	  the	  field	  up	  to	  a	  steady	  value,	  at	  which	  point	  the	  system	  is	  said	  to	  have	  reached	  equilibrium.	  The	  term	  relaxation	  defines	  the	  process	  of	  the	  spins	  in	  a	  magnetic	  field	  reaching	  equilibrium.	  The	  bulk	  magnetisation	  vector	  at	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equilibrium	   only	   has	   a	   z-­component,	   as	   the	   randomly	   distributed	   x-­	   and	   y-­	  components	  cancel	  out.	  	  
3.1.7	  The	  Radiofrequency	  Field	  	  The	  magnetisation	  vector	  at	  equilibrium	  is	  rotated	  from	  its	  position	  along	  the	  z-­axis	  by	  applying	  a	  very	  small	  magnetic	  field	  along	  the	  x-­axis	  such	  that	  this	  oscillating	  field	  is	  resonant	  with	  the	  Larmor	  precession	  frequency.	  For	  example,	  by	   applying	   radiofrequency	   (RF)	   power	   to	   the	   coil	   that	   is	   used	   to	   detect	   the	  precessing	  magnetisation,	   an	  RF	   field	   can	  be	   created	   along	   the	  x-­axis,	  which	   is	  the	  required	  oscillating	  magnetic	  field.	  Two	  counter-­‐rotating	  fields	  B+1	  (from	  x	  to	  
y)	  and	  B-­1	  (from	  x	  to	  -­‐y)	  rotating	  at	  the	  same	  transmitter	  frequency	  ωtx	  (Fig	  3.3),	  best	  illustrate	  the	  effect	  of	  this	  oscillating	  field.	  Both	  fields	  are	  aligned	  along	  the	  
x-­axis	  at	  time	  zero	  to	  sum	  up	  to	  a	  total	  field	  of	  2B1,	  the	  x-­components	  are	  zero	  at	  90°	   angle	   of	   rotation,	  which	   reaches	   a	  maximum	  of	   2B1	  again	   at	   180°	   angle	   of	  rotation	  (Fig	  3.3).	  	  
	  
Fig	  3.3	  Schematic	  to	  illustrate	  the	  oscillating	  RF	  field	  by	  two	  counter-­rotating	  fields	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  (a)	  The	  counter-­‐rotating	  fields	  B+1	  and	  B-­1	  rotate	  at	  the	  same	  transmitter	  frequency;	  their	  y-­‐components	  cancel	  out	  (b)	  The	  fields	  add	  up	  to	  a	  field	  linearly	  oscillating	  along	  the	  direction	  of	  x-­axis	  (c)	  Graph	  showing	  the	  variation	  of	  field	  along	  the	  x-­axis	  with	  time	  (Keeler	  2005)	  
	  
	  	   101	  
3.1.8	  Larmor	  Precession	  and	  Detection	  	  
	   When	   the	   equilibrium	  magnetisation	   vector	   is	   rotated	   away	   from	   the	  z-­axis	   by	   an	  RF	   pulse	  making	   an	   angle	  β,	   it	   precesses	   about	   the	   direction	   of	   the	  magnetic	  field	  forming	  a	  cone	  of	  constant	  angle	  β	  (Fig	  3.4a).	  The	  frequency	  of	  the	  precession	  is	  	   	   ωo	  	  =	  -­γBo	  rad	  s-­‐1	  and/or	  νo	  =	  -­γBo/2π	  Hz	  where	  γ	  is	  the	  gyromagnetic	  ratio	  and	  Bo	  is	  the	  strength	  of	  the	  applied	  field.	  This	  is	   the	   Larmor	   frequency	   (Section	   3.1.5),	   which	   is	   negative	   for	   a	   positive	   γ,	  indicating	  a	  negative	  precession	  of	  the	  magnetisation	  vector	  about	  the	  field.	  
	  
Fig	  3.4	  Schematic	  representation	  of	  Larmor	  Precesssion,	  FID	  and	  Processing	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  (a)	  When	  rotated	  away	  from	  the	  z-­axis,	  the	  equilibrium	  magnetisation	  vector	  precesses	  about	  the	  direction	  of	  the	  magnetic	  field	  forming	  a	  cone	  of	  constant	  angle.	  A	  negative	  Larmor	  frequency	  corresponds	  to	  a	  negative	  precession	  for	  a	  nucleus	  with	  positive	  gyromagentic	  ratio	  (b)	  The	  precessing	  magnetisation	  induces	  current	  in	  the	  coil	  along	  the	  x-­axis,	  which	  amplified	  and	  recorded	  gives	  the	  free	  induction	  signal	  (FID)	  (c)	  The	  mathematical	  process	  Fourier	  transform	  converts	  the	  time-­‐domain	  FID	  signal	  into	  (d)	  the	  frequency-­‐domain	  spectrum	  (Keeler	  2005)	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The	  precession	  of	   the	  magnetisation	  vector	   is	  detected	   in	  a	  pulsed	  NMR	  experiment	  by	   a	   small	   coil	   of	  wire	  wound	   round	   the	  x-­axis	   so	   that	   the	   current	  induced	   in	   the	   coil	   by	   the	   precessing	   magnetisation	   vector	   is	   amplified	   and	  recorded	   as	   the	   free	   induction	   signal	   (FID)	   (Fig	   3.4b).	   The	  measured	   FID	   is	   a	  time-­‐domain	   signal	   (Fig	   3.4c),	   subjected	   to	   Fourier	   transform,	   a	  mathematical	  procedure	  that	  converts	  the	  signals	  into	  a	  digital	  form	  (using	  computers)	  prior	  to	  generation	  of	  the	  frequency-­‐domain	  signal,	  the	  spectrum	  (Fig	  3.4d).	  
	  
3.1.9	  NMR	  Spectra	  and	  Chemical	  Shifts	  	   In	  simple	  terms,	  a	  1D	  NMR	  spectrum	  is	  a	  plot	  of	  the	  intensity	  of	  nuclear	  magnetic	  resonance	  against	  frequency	  (Fig	  3.5a)	  while	  a	  2D	  NMR	  spectrum	  is	  a	  plot	   of	   the	   intensity	   against	   two	   frequency	   axes	   (Fig	   3.5b).	   For	   example,	   2D	  (1H/15N)	  HSQC	  experiment	  correlates	  the	  shifts	  of	  two	  different	  nuclei	  types	  such	  that	  the	  intensity	  is	  plotted	  against	  frequencies	  of	  the	  15N	  chemical	  shift	  and	  that	  of	  the	  attached	  proton.	  The	  points	  of	  equal	  intensity	  in	  a	  2D	  NMR	  spectrum	  are	  adjoined	  to	  form	  countour	  plots	  (Fig	  3.5b).	  
	  
Fig	  3.5	  Schematic	  representations	  of	  1D	  and	  2D	  NMR	  spectra	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  (a)	  The	  1D	  NMR	  spectrum	  is	  a	  plot	  of	  the	  signal	  intensity	  against	  frequency	  ω	  (b)	  The	  2D	  NMR	  spectrum	  is	  a	  correlation	  plot	  of	  the	  two	  frequency	  axes	  ω1	  and	  ω2.	  Contour	  plots	  adjoining	  points	  of	  equal	  intensity	  represent	  2D	  NMR	  spectra	  (Keeler	  2005)	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   The	   frequencies	   of	   NMR	   lines	   are	   plotted	   on	   a	   chemical	   shift	   scale	   in	  ‘parts	   per	  million’	   (ppm).	   The	   chemical	   shift	   (δ)	   is	   a	   ratio	   of	   the	   difference	   in	  frequency	  separation	   from	  the	  reference	  peak	  to	   the	  reference	  peak	   frequency.	  Thereby,	   the	   peak	   positions	   on	   a	   chemical	   shift	   scale	   are	   independent	   of	   the	  static	  magnetic	  field	  strength,	  which	  allows	  comparison	  of	  frequencies	  between	  different	  spectrometers.	  
Mathematically,	  the	  chemical	  shift	  (δ)	  ppm	  =	   	  	  
where	  ν	  is	  the	  frequency	  of	  the	  peak	  of	  interest	  and	  νref	   	  is	  that	  from	  the	  agreed	  reference	  compounds	  such	  as	  tetramethylsilane	  (TMS)	  used	  in	  organic	  solvents	  and	   trimethylsilyl	   propionate	   (TSP)	   or	   4,4-­‐dimethyl-­‐4-­‐silapentane-­‐1-­‐sulphonic	  acid	  (DSS)	  for	  proteins	  in	  solution.	  	  	   The	  frequencies	  of	  the	  peaks	  in	  the	  spectrum	  are	  indirectly	  determined	  as	  the	  offset	  frequencies	  (νoffset),	  which	  are	  values	  relative	  to	  the	  receiver	  reference	  frequency	  (νrx)	  usually	  set	  by	  the	  operator	  of	  the	  spectrometer	  in	  the	  middle	  of	  the	  full	  spectrum.	  In	  practice,	  the	  frequency	  separation	  from	  the	  reference	  peak	  is	  divided	  by	  the	  νrx	  instead	  of	  the	  νref	  to	  calculate	  the	  chemical	  shift	  such	  that,	  
the	  chemical	  shift	  (δ)	  ppm	  =	   	  	  
The	  chemical	  shift	  of	  the	  nucleus	  is	  related	  to	  the	  chemical	  environment,	  thus	  changes	  in	  the	  state	  of	  protein	  such	  as	  ligand	  binding	  causes	  shift	  changes,	  which	   can	  be	  detected.	  Hence	  NMR	   is	   a	   powerful	   technique	   for	   solution-­‐based	  analysis	  of	  biomolecular	  interactions.	  	  
3.1.10	  NMR	  Linewidths	  	  	   The	   width	   of	   the	   resonance	   lineshape	   at	   half-­‐height	   is	   defined	   as	   the	  linewidth	  (Fig	  3.6),	  which	  affects	  both	  resolution	  and	  the	  signal-­‐to-­‐noise	  ratio.	  If	  the	  separation	  between	  two	  lines	  falls	  below	  their	  linewidths,	  their	  resolution	  is	  poor	  to	  the	  extent	  that	  these	  NMR	  lines	  may	  merge	  depending	  on	  the	  lineshape.	  
! 
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The	   homogeneity	   of	   linewidths	   is	   based	   on	   factors	   like	   intrinsic	   molecular	  properties,	  instrumental	  parameters	  such	  as	  homogeneous	  static	  magnetic	  field	  and	  thermal	  gradients	  within	  the	  sample.	  	  The	   integral	   of	   a	   (area	   under)	   proton	   NMR	   peak	   is	   proportional	   to	   the	  number	  of	  protons	   involved.	   If	  a	  broader	   line	   is	  given	  by	  one	  of	   the	   two	  single	  protons,	  having	  the	  same	  integral,	  this	  results	  in	  a	  reduction	  in	  peak	  height,	  also	  corresponding	   to	   reduced	   signal-­‐to-­‐noise	   ratio.	   Linewidth	   also	   tends	   to	   be	  broadened	   if	   the	   size	   of	   the	   molecule	   is	   larger	   as	   it	   is	   proportional	   to	   the	  rotational	  correlation	  time	  of	  the	  molecule,	  which	  is	  the	  time	  taken	  by	  it	  to	  rotate	  through	  an	  angle	  of	  one	  radian	  (57°).	  With	  the	  increase	  in	  the	  molecule	  size,	  the	  correlation	   times	   are	   longer	   thus	   broadening	   the	   linewidths.	   Broad	   lines	   are	  more	  subject	   to	  overlap	  and	   less	  easily	  observed	  than	  narrower	  ones.	  For	  very	  large	  systems	  signals	  may	  be	  broadened	  beyond	  detection.	  	  
	  
Fig	  3.6	  Schematic	  representation	  of	  an	  NMR	  lineshape	  The	  linewidth	  W	  is	  measured	  at	  half-­‐height	  (h/2)	  of	  the	  lineshape	  centered	  at	  νo	  (Keeler	  2005)	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3.2	   Materials	  and	  Methods	  
3.2.1	  Bacterial	  Strains	  and	  Plasmids	  	  The	  human	  MyD88	  gene	  encoding	  for	  the	  TIR	  domain	  (Gly148	  to	  Pro296)	  was	  cloned	   into	  both	  pGEX-­‐5x-­‐2	   (GE	  Healthcare)	   in	  order	   to	   incorporate	  an	  N-­‐terminal-­‐GST	   tag,	  and	  GEV2	  (Addgene)	   in	  order	   to	   incorporate	  N-­‐terminal-­‐GB1	  and	  C-­‐terminal-­‐His	  tags.	   Illustrative	  vector	  maps	  are	   included	  in	  Appendix	  1.	  E.	  
coli	  strains	  used	  for	  transformation	  and	  expression	  are	  listed	  in	  Table	  3.1.	  	  
Table	  3.1	  E.	  coli	  strains	  used	  for	  transformation	  and	  expression	  	  
E.	  coli	  Strains	   Genotype	   Source	  
Cloning	  Strain	   	   	  	  DH5α	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   F–	  φ80lacZΔM15	  Δ(lacZYA-­‐argF)	  U169	  recA1	  endA1hsdR17	   Invitrogen	  	  	  	   (rk-­‐,	  mk+)	  phoA	  supE44	  λ–	  thi	  –1	  gyrA96	  relA1	  	   	  	  
Expression	  Strain	   	   	  BL21-­‐Gold(DE3)	   E.	  coli	  B	  F–	  ompT	  hsdS(rB–mB–)	  dcm+	  TetR	  gal	  λ(DE3)	  endA	  Hte	   Stratagene	  BL21-­‐Star™(DE3)	   F-­‐	  ompT	  hsdSB	  (rB-­‐mB-­‐)	  gal	  dcm	  rne131	  (DE3)	   Stratagene	  BL21-­‐AI™	   F-­‐	  ompT	  hsdSB(rB-­‐	  mB-­‐)	  gal	  dcm	  araB::T7RNAP-­‐tetA	   Invitrogen	  
	  
3.2.2	  Generation	  of	  Expression	  Plasmids	  	  
	   Primers	   (MWG	   Biotech)	   used	   for	   amplifying	   MyD88-­‐TIR	   constructs	   are	  listed	   in	   Table	   3.2.	   The	   gene	   coding	   for	   human	  MyD88-­‐TIR	  was	   PCR-­‐amplified	  from	   a	   mammalian	   plasmid	   provided	   by	   Prof.	   Andrew	   Bowie’s	   group,	   Dublin.	  Phusion	   DNA	   Polymerase	   (Finnzymes)	   including	   2%	  DMSO	  was	   used	   for	   PCR.	  Expression	  plasmids	  were	  constructed	  as	  described	   in	  Chapter	  2;	  Section	  2.2.3.	  Two	  MyD88-­‐TIR	  constructs	  were	  designed	  for	  expression	  using	  GEV2.	  The	  GB1-­‐MyD88-­‐TIR1-­‐His	   (Gly148	   to	   Pro296)	   corresponds	   to	   the	   sequence	   length	   that	  has	   been	   used	   for	   previous	   structural	   work	   (Ohnishi	   et	   al.,	   2009;	   Rossi	   et	   al.,	  Unpublished).	  The	  shorter	  GB1-­‐MyD88-­‐TIR2	  construct	  corresponds	   to	   the	  core	  TIR	  domain	   (Phe163	   to	  Pro296).	  Owing	   to	  better	  expression	  yields	  and	  purity,	  GB1-­‐MyD88-­‐TIR2	   was	   used	   for	   NMR	   interaction	   studies.	   This	   thesis	   includes	  results	  from	  the	  GB1-­‐MyD88-­‐TIR2	  construct	  only	  referred	  to	  as	  GB1-­‐MyD88-­‐TIR	  from	  here	  onwards,	  for	  clarity.	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The	   Pro173His	  mutants	   of	   GB1-­‐YpTIR	   were	   designed	   to	   determine	   the	  importance	  of	  the	  Proline	  residue	  in	  the	  box	  2	  region	  using	  GST	  pull	  down	  assay.	  The	   Pro173His	   mutation	   was	   inserted	   in	   the	   GB1-­‐YpTIR1	   and	   GB1-­‐YpTIR2	  constructs	   using	   the	   QuikChange®	   Lightning	   Site-­‐directed	   Mutagenesis	   Kit	  (Stratagene).	  The	  primers	  used	   in	  making	   the	   constructs	   are	   included	   in	  Table	  3.2.	  All	  expression	  plasmids	  were	  analysed	  by	  DNA	  sequencing.	  
Table	  3.2	  Primers	  used	  for	  generating	  different	  expression	  plasmids	  
Constructs	   Residues	   Plasmid	  	   Nucleotide	  sequence	  (5’-­3’)	  	  GST-­‐MyD88-­‐TIR	   148-­‐296	   pGEX-­‐5x-­‐2	   GGATCCTGGGCATCACCACACTTGATGACC  	  	   	   	   CTCGAGTCAGGGCAGGGACAAGGCCTTG GB1-­‐MyD88-­‐TIR-­‐His	   163-­‐296	   GEV2	   CGCGGATCC TTCGATGCCTTCATCTGCTATTGCCCC 	   	   	   CCGCTCGAGGGGCAGGGACAAGGCCTTG GB1-­‐YpTIR-­‐His	  Mutants	   Pro173His	   GEV2	   GCCCATGAGACTATCGAACATCTCAAAGAGTGGAGAAATG 	   	   	   CATTTCTCCACTCTTTGAGATGTTCGATAGTCTCATGGGC Underlined	   sequences	   GGATCC	   and	   CTCGAG	   correspond	   to	   restriction	   sites,	   BamHI	   and	   XhoI,	  incorporated	  into	  the	  forward	  and	  reverse	  primers	  respectively.	  	  
	  
3.2.3	  Expression	  of	  GST-­MyD88-­TIR	  	  
	   	   The	   GST-­‐MyD88-­‐TIR	   construct	   was	   transformed	   into	   BL21(DE3)Star™	  cells	   for	   expression	   using	   the	   pGEX-­‐5x-­‐2	   vector.	   Expression	   was	   tested	   in	   LB	  (Merck),	  2x	  TY	  (16	  g	  tryptone,	  10	  g	  yeast	  extract,	  5	  g	  NaCl	  per	  litre)	  and	  the	  auto-­‐inducing	   ZYM-­‐5052	   (Studier,	   2005;	   Appendix	   2)	   media.	   Owing	   to	   highest	  expression	   yield	   in	   the	   auto-­‐inducing	   ZYM-­‐5052	   media,	   GST-­‐MyD88-­‐TIR	   was	  expressed	  using	  BL21-­‐AI™	  cells.	  These	  cells	  provide	  stringent	  induction	  control	  by	  the	  arabinose-­‐induced	  pBAD	  promoter	   for	  better	  expression	  yields	  (Studier,	  2005).	   Overnight	   cultures	  were	   diluted	   (1:1000)	   in	   auto-­‐inducing	  media	   ZYM-­‐5052	   (containing	   Amp	   100	   µg/ml)	   and	   incubated	   at	   37	   °C	   using	   a	   15-­‐litre	  bioreactor	  connected	  to	  an	  ADI	  1010	  bio-­‐controller	  and	  a	  PC	  running	  BioExpert	  software	  (Applikon	  Biotechnology).	  Agitation	  was	  set	  at	  400	  rpm,	  pH	  at	  6.7	  and	  dO2	   at	   ~100%	   for	   the	   entire	   run.	   The	   bioreactor	   was	   operated	   with	   the	  assistance	   of	   James	   Mansfield	   in	   the	   Centre	   for	   Structural	   Biology	   (CSB)	  Bioreactor	  suite,	   Imperial	  College	  London.	  The	   temperature	  was	  reduced	   to	  20	  °C	  at	  OD600	  ~1	  and	  the	  culture	  incubated	  until	  the	  OD600	  ~15-­‐20.	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3.2.4	  Purification	  of	  GST-­MyD88-­TIR	  	  	   	   GST-­‐MyD88-­‐TIR	   was	   purified	   by	   affinity	   chromatography	   (AC)	   using	  glutathione	   resin	   (Pierce®).	   Bacterial	   cells	  were	   resuspended	   (1	   g	   in	   5	  ml)	   in	  lysis	  buffer	  A’	  [20	  mM	  Tris-­‐HCl,	  150	  mM	  NaCl,	  2	  mM	  BME,	  pH	  7.0]	  including	  0.5	  mM	  PMSF.	  The	  soluble	  lysate	  was	  extracted	  (as	  described	  in	  Chapter	  2;	  Section	  2.2.6)	  and	  incubated	  with	  pre-­‐equilibrated	  glutathione	  resin	  for	  1	  hr	  at	  4	  °C.	  The	  slurry	  was	  loaded	  onto	  a	  column,	  washed	  with	  20	  column	  volumes	  (CV)	  of	  buffer	  A’	   and	   eluted	  with	   5	   CV	   of	   elution	   buffer	  B’	   [50	  mM	  Tris-­‐HCl,	   10	  mM	   reduced	  glutathione,	  2	  mM	  BME,	  pH	  8.0].	  	  	   	   GST-­‐MyD88-­‐TIR	  was	  expressed	  with	  high	  amounts	  of	  free	  GST.	  After	  the	  purification	   of	   GST-­‐MyD88-­‐TIR,	   removal	   of	   free	   GST	   from	   the	   sample	   was	  attempted	  by	  SEC	  and	  anion	  exchange	  chromatography	  (AEC).	  SEC	  purification	  was	   performed	   (as	   described	   in	   Chapter	   2;	   Section	   2.2.6)	   using	   buffer	   A’.	   AEC	  was	  performed	  using	  1	  ml	  HiTrap™	  DEAE	  Sepharose	  FF	  column	  pre-­‐equilibrated	  with	  buffer	  C’	  [20	  mM	  HEPES-­‐NaOH	  pH	  7.0].	  The	  GST-­‐MyD88-­‐TIR	  eluate	  from	  AC	  was	   exchanged	   into	   buffer	   C’	   using	   a	   pre-­‐equilibrated	   PD-­‐10	   column	   (GE	  Healthcare)	  prior	  to	  loading	  onto	  the	  DEAE	  FF	  column.	  The	  bound	  proteins	  were	  eluted	  using	  a	  step	  gradient	  of	  salt	  concentration	  (0,	  0.1,	  0.25,	  0.5	  and	  1	  M	  NaCl)	  in	  buffer	  C’.	  	  	  
3.2.5	  Preparation	  of	  Cleaved	  MyD88-­TIR	  	  	   In	   order	   to	   cleave	   the	   GST-­‐tag	   from	   GST-­‐MyD88-­‐TIR,	   the	   protein	   was	  diluted	  in	  cleavage	  buffer	  [50	  mM	  Tris-­‐HCl,	  100	  mM	  NaCl,	  5	  mM	  CaCl2,	  pH	  8.0].	  Samples	  were	  digested	  with	  Factor	  Xa	  (Novagen)	  using	  enzyme	  (unit)	  to	  protein	  (µg)	  ratios	  of	  1:10,	  1:20,	  1:50	  and	  1:100	  at	  18	  °C	  for	  16	  hr.	  Reverse	  glutathione-­‐AC	   and	   SEC	   purification	   were	   performed	   to	   isolate	   the	   cleaved	   MyD88-­‐TIR.	  Reverse	  glutathione-­‐AC	  was	  used	  to	  capture	  the	  contaminant	  GST	  on	  the	  column	  instead	  in	  order	  to	  isolate	  the	  cleaved	  and	  untagged	  MyD88-­‐TIR	  in	  the	  unbound	  flowthrough	   fraction.	   A	   Superdex	   75™	   HR	   5/150	   column	   (GE	  Healthcare)	  was	  used	  for	  SEC	  purification	  using	  buffer	  A’.	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3.2.6	  Purification	  of	  Co-­expressed	  MyD88-­TIR	  and	  YpTIR	  	   	   YpTIR-­‐His	   (in	   pET26b)	   and	   GST-­‐MyD88-­‐TIR	   (in	   pGEX-­‐5x-­‐2)	   constructs	  were	  both	  transformed	  (1	  µl	  each)	  into	  BL21(DE3)Gold	  cells	  (50	  µl).	  Overnight	  cultures	  were	  diluted	  (1:50)	  in	  LB	  with	  Kan	  35	  µg/ml	  and	  Amp	  100	  µg/ml,	  and	  incubated	  at	  30	  °C,	  235	  rpm	  to	  OD600	  ~	  0.6.	  Expression	  was	  induced	  using	  1	  mM	  IPTG	   for	   4	   hr	   at	   15	   °C.	   Cells	   were	   harvested	   at	   4,000	   g,	   4	   °C	   for	   10	  min.	   The	  soluble	   lysate	   was	   extracted	   and	   subsequently	   purified	   by	   Co2+	   IMAC,	   as	  described	  in	  Chapter	  2;	  Section	  2.2.11.	  Samples	  from	  expression,	  extraction	  and	  purification,	  were	  analysed	  by	  Western	  blot.	  	  
3.2.7	  Expression	  and	  Purification	  of	  GB1-­MyD88-­TIR	  	  	   	   GB1-­‐MyD88-­‐TIR-­‐His	   (Phe163	   to	  Pro296)	   and	   the	  Pro173His	  mutants	   of	  GB1-­‐YpTIR1-­‐His	   and	   GB1-­‐YpTIR2-­‐His	   were	   transformed	   into	   BL21(DE3)Star™	  cells	  and	  expressed	  as	  described	  in	  Chapter	  2;	  Section	  2.2.12.	  All	  these	  proteins	  were	  purified	  using	  Co2+	  IMAC	  with	  subsequent	  SEC	  (as	  described	  in	  Chapter	  2;	  Section	   2.2.13).	   Addition	   of	   10	   mM	   DTT	   (Sigma)	   was	   crucial	   during	   the	   SEC	  purification	  of	  GB1-­‐MyD88-­‐TIR-­‐His	  to	  reduce	  it	  to	  its	  monomeric	  state.	  	  
3.2.8	  GST	  Pull	  Down	  Assay	  	   	   GST-­‐MyD88-­‐TIR,	   the	   ‘bait’	   was	   bound	   to	   pre-­‐equilibrated	   glutathione	  resin	  as	  described	  in	  Section	  3.2.4.	  Co2+	  IMAC	  was	  used	  to	  purify	  the	  His-­‐tagged	  bacterial	   TIR	   proteins	   (YpTIR,	   BpTIR,	   GB1-­‐YpTIR1,	   GB1-­‐YpTIR2,	   GB1-­‐YpTIR3	  and	   the	   Pro173His	   mutants	   of	   GB1-­‐YpTIR1	   and	   GB1-­‐YpTIR2)	   as	   described	   in	  Chapter	   2;	   Section	   2.2.13.	   The	   purified	   bacterial	   TIR	   proteins,	   the	   ‘prey’	   were	  then	  incubated	  with	  the	  GST-­‐MyD88-­‐TIR-­‐bound	  glutathione	  resin	  for	  1	  hr	  at	  4	  °C.	  The	  resin	  was	  loaded	  onto	  a	  column,	  washed	  twice	  with	  10	  CV	  of	  buffer	  A’	  and	  eluted	  with	  5	  CV	  of	  buffer	  B’.	  The	  eluted	  proteins	  were	  concentrated	  3-­‐fold	  using	  10	   kDa	   molecular	   weight	   cut-­‐off	   (MWCO)	   filters	   except	   that	   the	   GB1-­‐YpTIR3	  eluate	  fractions	  were	  concentrated	  30-­‐fold.	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   Control	  pull	  down	  assays	  were	  performed	  using	  (a)	  GST	  control	  as	   ‘bait’	  and	  GB1-­‐YpTIR1-­‐His	   as	   ‘prey’	   and	   (b)	  GST-­‐MyD88-­‐TIR	  as	   ‘bait’	   and	  GB1-­‐SV40-­‐His	  control	  as	   ‘prey’	   in	  order	  to	  ensure	  that	  the	  interaction	  between	  YpTIR	  and	  MyD88	  was	   specific.	   GST	   pull	   down	   assays	  were	   analysed	   by	  Western	   blot	   as	  described	   in	  Chapter	  2;	   Section	  2.2.9	  except	   that	   the	  primary	  antibody	  used	   to	  probe	   GST-­‐tagged	   proteins	  was	   an	   anti-­‐GST	   Tag	   antibody	   (Merck),	   which	  was	  diluted	   (1:10,000)	   in	   Tris-­‐HCl	   buffered	   saline	   (TBS)	   supplemented	   with	   0.2%	  Tween	   20	   (BDH).	   The	   secondary	   antibody,	   goat	   anti-­‐Mouse	   IgG	   Alkaline	  Phosphatase	  (Sigma)	  was	  diluted	  (1:20,000)	  in	  TBST	  buffer.	  	  
3.2.9	  Sample	  Preparation	  for	  NMR	  GB1-­‐YpTIR1	  was	  labelled	  with	  the	  15N	  isotope	  by	  expressing	  the	  protein	  in	   minimal	   (M9)	   media	   (Appendix	   2)	   supplemented	   with	   15N-­‐labelled	   NH4Cl	  (0.07%).	  Expression	  and	  purification	  were	  performed	  as	  described	  in	  Chapter	  2;	  Sections	  2.2.12	  and	  2.2.13.	  10%	  D2O	  was	  added	  to	  all	  the	  labelled	  and	  unlabelled	  NMR	  samples	  prior	  to	  recording	  spectra	  for	  spectrometer	  field	  lock.	  Experiments	  were	  recorded	  using	  either	  a	  Bruker	  Avance	   III	  600	  (at	  600	  MHz)	  or	  Avance	   II	  800	  (at	  800	  MHz)	  spectrometer	  at	  303	  K.	  Unlabelled	  GST-­‐MyD88-­‐TIR	  was	  added	  up	  to	  1.7	  M	  equivalents	  of	  400	  µM	  of	  15N-­‐GB1-­‐YpTIR.	  Unlabelled	  GB1-­‐MyD88-­‐TIR	  was	  added	  up	  to	  1	  M	  equivalent	  of	  800	  µM	  of	   15N-­‐GB1-­‐YpTIR.	  At	  each	  titration	  point,	  1D	  (1H)	  spectra	  and	  2D	  (1H/15N)	  TROSY-­‐type	  HSQC	  spectra	  were	  acquired.	  Experiments	  were	   performed	   using	   the	   TopSpin	   software	   package.	   2D	   spectra	  were	  processed	  with	  NMRPipe	  (Delaglio	  et	  al.,	  1995).	  Spectral	  manipulation	  and	  layout	  was	  attained	  using	  NMRView	  (Johnson	  and	  Blevins,	  2004).	  Spectra	  were	  recorded	   and	   processed	  with	   the	   assistance	   of	   Dr.	   Pete	   Simpson	   in	   the	   Cross-­‐faculty	  NMR	  Centre	  at	  Imperial	  College	  London.	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3.3	   Results	   	  
3.3.1	  Expression	  and	  Purification	  of	  GST-­MyD88-­TIR	  	  GST-­‐MyD88-­‐TIR	   (P148	   to	   P296)	   was	   expressed	   in	   the	   soluble	   fraction	  using	  LB,	  2xTY	  and	  the	  auto-­‐inducing	  ZYM-­‐5052	  media	  (results	  not	  shown).	  High	  amounts	   of	   soluble	   protein	   were	   obtained	   using	   the	   auto-­‐inducing	   ZYM-­‐5052	  media	   and	   the	   pBAD	   promoter	   (Fig	   3.7b;	   Lanes	   T-­‐S).	   A	   single-­‐step	   AC	  purification	   using	   glutathione	   resin	   produced	   pure	   GST-­‐MyD88-­‐TIR;	   however,	  the	  eluate	  was	  heavily	  contaminated	  with	  free	  GST	  (Fig	  3.7;	  E).	  	  
	  
	  
Fig	  3.7	  Expression	  and	  purification	  of	  GST-­MyD88-­TIR	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  (a)	  SDS-­‐PAGE	  and	  (b)	  Western	  blot	  analysis	  of	  GST-­‐MyD88-­‐TIR	  expressed	  using	  the	  auto-­‐inducing	  ZYM-­‐5052	  media	  and	  purified	  by	  AC	  using	  glutathione	  resin.	  M	  indicates	  molecular	  weight	  maker	  marker,	  T	  indicates	  total	  cell	  fraction,	  S	  indicates	  soluble	  fraction,	  L	  indicates	  lysate	  flowthrough,	  W	  indicates	  wash,	  E	  indicates	  eluate	  
	  Subsequent	   purification	   steps	   including	   size	   exclusion	   chromatography	  (SEC)	   or	   anion	   exchange	   chromatography	   (AEC)	   were	   attempted	   in	   order	   to	  remove	  free	  GST.	  SEC	  purification	  did	  not	  separate	  free	  GST	  from	  the	  sample	  (Fig	  3.8).	  Despite	  the	  difference	  in	  sizes	  between	  GST-­‐MyD88-­‐TIR	  (~45	  kDa)	  and	  GST	  (~26	  kDa),	  both	  the	  proteins	  eluted	  together	  (Fig	  3.8b-­‐c;	  Lanes	  1-­‐3).	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Fig	  3.8	  SEC	  Purification	  of	  GST-­MyD88-­TIR	  	  The	  purified	  GST-­‐MyD88-­‐TIR	  was	  loaded	  onto	  Superdex	  200	  column	  and	  analysed	  by	  (a)	  UV	  trace	  at	  280	  nm	  and	  (b)	  SDS-­‐PAGE.	  M	  indicates	  molecular	  weight	  marker,	  lanes	  1-­‐4	  correspond	  to	  the	  protein	  peaks	  labelled	  on	  the	  SEC	  chromatogram	  
	  On	  AEC	  purification,	  both	  GST-­‐MyD88-­‐TIR	  and	  GST	  proteins	  were	   found	  in	   the	   same	  eluate	   fractions	   (Fig	  3.9;	  Lanes	  3-­‐4)	  eluted	  with	  0.25	  M	  and	  0.5	  M	  NaCl	   respectively.	   This	   is	   despite	   the	   difference	   in	   their	   theoretical	   isoelectric	  points	   (pIs):	   GST-­‐MyD88-­‐TIR	   (pI	   7.05)	   and	  GST	   (pI	   5.58).	   As	   a	   result,	   purified	  GST-­‐MyD88-­‐TIR	  (along	  with	  GST	  as	  contaminant)	  was	  used	  in	  pull	  down	  assays	  as	  bait	  protein.	  	  
	  
	  	  
Fig	  3.9	  SDS-­PAGE	  analysis	  of	  GST-­MyD88-­TIR	  AEC	  Purification	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  GST-­‐MyD88-­‐TIR	  was	  purified	  by	  glutathione-­‐AC.	  The	  sample	  was	  exchanged	  in	  20	  mM	  HEPES-­‐NaOH	  pH	  7.0	  using	  PD-­‐10	  columns.	  AEC	  was	  performed	  using	  a	  DEAE	  Sepharose	  FF	  column.	  M	  indicates	  molecular	  weight	  marker,	  L	  indicates	  lysate	  flowthrough,	  W	  indicates	  wash,	  E	  indicates	  eluate,	  lanes	  1-­‐5	  correspond	  to	  wash	  steps	  including	  0,	  0.1,	  0.25,	  0.5	  and	  1	  M	  NaCl	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3.3.2	   Interaction	  between	  YpTIR	  and	  GST-­MyD88-­TIR	  	  GST	   pull	   down	   assay	   indicated	   a	   positive	   interaction	   between	   GST-­‐MyD88-­‐TIR	  (Fig	  3.10a;	  E)	  and	  purified	  YpTIR	  produced	  using	  pET26b	  (Fig	  3.10b-­‐c;	  Lanes	  E	  and	  EC).	  
	  
Fig	  3.10	  Pull	  down	  assay	  using	  YpTIR	  and	  GST-­MyD88-­TIR	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	  	  GST	  Pull	  down	  samples	  were	  incubated	  with	  (a)	  anti-­‐GST	  and	  (b-­‐c)	  anti-­‐His	  antibodies.	  M	  indicates	  molecular	  weight	  marker,	  P	  indicates	  protein,	  L	  indicates	  lysate,	  W	  indicates	  wash,	  E	  indicates	  eluate,	  S	  indicates	  soluble	  protein	  and	  EC	  indicates	  concentrated	  eluate	  	  	  This	  interaction	  was	  confirmed	  by	  co-­‐expression	  of	  YpTIR-­‐His	  (Fig	  3.11a;	  S)	   and	   GST-­‐MyD88-­‐TIR	   (Fig	   3.11b;	   S)	   in	   the	   soluble	   fraction	   followed	   by	   co-­‐purification	  of	  YpTIR-­‐His	  (Fig	  3.11a;	  E)	  and	  GST-­‐MyD88-­‐TIR	  (Fig	  3.11b;	  E)	  using	  Co2+	  IMAC.	  These	  results	  suggest	  an	  in	  vivo	  complex	  formation.	  	  However	  due	  to	  low	  yields	  (<100	  µg/l)	  further	  analysis	  of	  the	  complex	  was	  not	  possible.	  
	  
Fig	  3.11	  Purification	  of	  co-­expressed	  YpTIR	  and	  GST-­MyD88-­TIR	  proteins	  The	  co-­‐expression	  and	  co-­‐purification	  of	  YpTIR	  and	  GST-­‐MyD88-­‐TIR	  were	  analysed	  by	  Western	  blot.	  Samples	  were	  probed	  with	  (a)	  anti-­‐His	  and	  (b)	  anti-­‐GST	  antibodies.	  M	  indicates	  molecular	  weight	  marker,	  T	  indicates	  total	  cell	  fraction,	  S	  indicates	  soluble	  fraction,	  L	  indicates	  lysate,	  W	  indicates	  wash	  and	  E	  indicates	  eluate	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3.3.3	   Interaction	  between	  BpTIR	  and	  GST-­MyD88-­TIR	  	  As	   indicated	   for	   YpTIR,	   GST	   Pull	   down	   assay	   confirmed	   a	   positive	  interaction	  between	  purified	  BpTIR	  produced	  using	  pET26b	   (Fig	  3.12a;	  E)	   and	  GST-­‐MyD88-­‐TIR	  (Fig	  3.12b;	  E).	  
	  
Fig	  3.12	  Pull	  down	  assay	  using	  BpTIR	  and	  GST-­MyD88-­TIR	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Positive	  interaction	  between	  BpTIR	  and	  GST-­‐MyD88-­‐TIR	  was	  analysed	  by	  Western	  blot.	  Samples	  were	  probed	  with	  (a)	  anti-­‐His	  and	  (b)	  anti-­‐GST	  antibodies.	  M	  indicates	  molecular	  weight	  marker,	  P	  indicates	  protein,	  L	  indicates	  lysate,	  W	  indicates	  wash	  and	  E	  indicates	  eluate	  
	  
3.3.4	  GST	  Pull	  Down	  for	  GB1-­YpTIR-­His	  
	   YpTIR	   was	   produced	   with	   considerably	   improved	   yield,	   solubility	   and	  purity	  when	  expressed	  in	  GEV2	  as	  fusions	  with	  N-­‐terminal	  GB1	  tags	  (Chapter	  2;	  Sections	   2.3.13	   and	   2.3.14).	   It	   was	   important	   to	   determine	   that	   despite	   the	  presence	   of	   the	   GB1	   tag,	   YpTIR	  was	   functional	   and	   able	   to	   interact	  with	   GST-­‐MyD88-­‐TIR.	   GST	   Pull	   down	   assay	   using	   GB1-­‐YpTIR-­‐His	   constructs	   confirmed	  retained	   ability	   to	   interact	   with	   GST-­‐MyD88-­‐TIR	   (Fig	   3.13a-­‐b;	   Eluate).	   The	  amount	  of	  GB1-­‐YpTIR1	  and	  GB1-­‐YpTIR2	  loaded	  onto	  the	  column	  was	  5	  mg	  while	  only	   0.5	   mg	   of	   GB1-­‐YpTIR3	   was	   loaded	   onto	   the	   column	   owing	   to	   its	   low	  expression	  and	  soluble	  yield	  after	  Co2+	  IMAC	  purification.	  As	  a	  result,	  the	  eluate	  fraction	  for	  GB1-­‐YpTIR3	  was	  concentrated	  10-­‐fold	  more	  than	  the	  eluate	  fractions	  for	  GB1-­‐YpTIR1	  and	  GB1-­‐YpTIR2	  to	  enable	  Western	  blot	  detection.	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Fig	  3.13	  Pull	  down	  assays	  using	  GB1-­YpTIR-­His	  proteins	  with/out	  GST-­MyD88-­TIR	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Western	  blot	  analysis	  confirmed	  (a-­‐b)	  the	  positive	  interaction	  between	  GB1-­‐YpTIR	  proteins	  and	  GST-­‐MyD88-­‐TIR	  and	  (c)	  the	  negative	  interaction	  of	  GB1-­‐YpTIR	  with	  glutathione	  resin.	  Samples	  were	  probed	  with	  (a-­‐c)	  anti-­‐His	  antibody	  and	  (b)	  anti-­‐GST	  antibody.	  M	  indicates	  molecular	  weight	  marker,	  lanes	  1-­‐3	  correspond	  to	  GB1-­‐YpTIR-­‐His	  proteins	  1-­‐3	  respectively.	  All	  samples	  were	  concentrated	  3x	  except	  the	  GB1-­‐YpTIR3	  eluates	  in	  (a)	  and	  (c)	  that	  were	  concentrated	  30x	  	  A	  series	  of	  control	  experiments	  were	  also	  performed	  which	  showed	  that	  the	   interaction	   was	   specific.	   The	   GB1-­‐YpTIR	   proteins	   did	   not	   interact	   non-­‐specifically	  with	  unbound	  glutathione	  resin	  (Fig	  3.13c;	  Eluate).	  GB1-­‐YpTIR1	  did	  not	   interact	  with	  GST-­‐bound	   resin	   (Fig	  3.14a,c;	   E)	  while	   it	   indicated	   a	  positive	  interaction	  with	  GST-­‐MyD88-­‐TIR	  (Fig	  3.14b,d;	  E).	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Fig	  3.14	  Pull	  down	  assay	  using	  GB1-­YpTIR1	  and	  control	  GST	  	  Western	  blot	  confirmed	  that	  GST	  was	  not	  interacting	  with	  GB1-­‐YpTIR1-­‐His.	  Samples	  were	  probed	  with	  (a-­‐b)	  anti-­‐His	  antibody	  for	  GB1-­‐YpTIR1-­‐His	  and	  (c-­‐d)	  anti-­‐GST	  antibody	  for	  GST	  and	  GST-­‐MyD88-­‐TIR	  respectively.	  M	  indicates	  molecular	  weight	  marker,	  P	  indicates	  protein,	  L	  indicates	  lysate,	  W	  indicates	  wash,	  E	  indicates	  eluate	  and	  EC	  indicates	  concentrated	  eluate	  	  	  In	  addition,	  the	  control	  protein	  GB1-­‐SV40-­‐His	  (5	  mg)	  did	  not	  interact	  (Fig	  3.15a;	  E)	  with	  GST-­‐MyD88-­‐TIR	  (Fig	  3.15b;	  E)	  under	  the	  same	  assay	  conditions,	  confirming	  that	  the	  GB1	  tag	  was	  not	  interacting	  non-­‐specifically.	  	  
	  
Fig	  3.15	  Pull	  down	  assay	  using	  control	  GB1-­SV40-­His	  and	  GST-­MyD88-­TIR	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	  	  Western	  blot	  analysis	  confirmed	  that	  GB1	  was	  not	  interacting	  with	  GST-­‐MyD88-­‐TIR.	  Samples	  were	  probed	  with	  (a)	  anti-­‐His	  antibody	  to	  detect	  GB1-­‐SV40-­‐His	  control	  protein	  and	  (b)	  anti-­‐GST	  antibody	  for	  GST-­‐MyD88-­‐TIR.	  M	  indicates	  molecular	  weight	  marker,	  P	  indicates	  protein,	  L	  indicates	  lysate,	  W	  indicates	  wash	  and	  E	  indicates	  eluate	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3.3.5	  The	  Pro173His	  Mutants	  of	  GB1-­YpTIR-­His	  GST	   pull	   down	   assay	   indicated	   that	   the	   Pro173His	   mutant	   of	   the	   GB1-­‐YpTIR1-­‐His	   and	   GB1-­‐YpTIR2-­‐His	   proteins	   (5	   mg)	   do	   not	   interact	   with	   GST-­‐MyD88-­‐TIR	  (Fig	  3.16a-­‐b;	  EC).	  Subsequent	  1D	  (1H)	  NMR	  spectra	  of	  the	  wild-­‐type	  	  
	  
	  
Fig	  3.16	  Interaction	  of	  the	  P173H	  mutants	  of	  GB1-­YpTIR-­His	  with	  GST-­MyD88-­TIR	  	  GST	  Pull	  down	  samples	  were	  probed	  with	  (a)	  anti-­‐His	  and	  (b)	  anti-­‐GST	  antibodies.	  M	  indicates	  molecular	  weight	  marker,	  P	  indicates	  protein,	  L	  indicates	  lysate,	  W	  indicates	  wash,	  E	  indicates	  eluate	  and	  EC	  indicates	  concentrated	  eluate.	  1D	  NMR	  analysis	  of	  the	  wild-­‐type	  and	  P173H	  mutant	  forms	  of	  (c-­‐d)	  GB1-­‐YpTIR1-­‐His	  and	  (e-­‐f)	  GB1-­‐YpTIR2-­‐His	  in	  20	  mM	  Tris-­‐HCl,	  150	  mM	  NaCl,	  pH	  7.0.	  YpTIR	  peaks	  for	  tertiary	  structure	  indicated	  by	  arrows	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and	  mutant	   forms	   of	   both	   GB1-­‐YpTIR1-­‐His	   (Fig	   3.16c-­‐d)	   and	   GB1-­‐YpTIR2-­‐His	  (Fig	  3.16e-­‐f)	  confirmed	  a	  very	  similar	  fold	  state	  for	  these	  proteins.	  This	  indicates	  that	   the	   loss	   of	   interaction	   was	   not	   due	   to	   disruption	   of	   the	   TIR	   domain	  introduced	  by	  the	  Pro173His	  point	  mutation	  and	  confirms	  the	  specificity	  of	  the	  interaction	  between	  the	  wild-­‐type	  proteins	  and	  MyD88.	  	  
3.3.6	  Summary	  of	  the	  GST	  Pull	  Down	  Assays	  
	   The	   results	   from	   the	   GST	   pull	   down	   assays	   used	   in	   this	   study	   are	  summarised	  in	  Table	  3.3.	  
Table	  3.3	  GST	  pull	  down	  assay	  results	  from	  this	  study	  
Prey	  Protein	   Bait	  Protein	   Interaction	  YpTIR-­‐His	   GST-­‐MyD88-­‐TIR	   Positive	  BpTIR-­‐His	   GST-­‐MyD88-­‐TIR	   Positive	  GB1-­‐YpTIR-­‐His	  (Constructs	  1,	  2	  and	  3)	   GST-­‐MyD88-­‐TIR	   Positive	  GB1-­‐YpTIR1-­‐His	  (Constructs	  1,	  2	  and	  3)	   Glutathione	  resin	   Negative	  GB1-­‐YpTIR1-­‐His	   GST	   Negative	  GB1-­‐SV40-­‐His	   GST-­‐MyD88-­‐TIR	   Negative	  P173H	  mutant	  of	  GB1-­‐YpTIR-­‐His	   GST-­‐MyD88-­‐TIR	   Negative	  P173H	  mutant	  of	  GB1-­‐YpTIR2-­‐His	   GST-­‐MyD88-­‐TIR	   Negative	  
	  
	  
3.3.7	  GB1-­YpTIR	  and	  GST-­MyD88-­TIR	  Interaction	  by	  NMR	  	   1D	  (1H)	  NMR	  spectra	  of	  the	  interacting	  proteins	  were	  analysed	  to	  confirm	  their	  folded	  states.	  The	  spectrum	  of	  GB1-­‐YpTIR1-­‐His	  indicates	  peaks	  in	  addition	  to	  those	  from	  GB1	  (>9	  ppm),	  indicating	  that	  the	  YpTIR	  domain	  is	  folded	  (Chapter	  4;	  Fig	  4.6).	  The	  spectrum	  of	  GST-­‐MyD88-­‐TIR	   indicates	  broadened	  peaks	  of	  GST	  that	   may	   arise	   from	   the	   increased	   molecular	   weight	   and/or	   self-­‐association	  under	  the	  conditions	  used	  (Fig	  3.17a-­‐b;	  black	  arrows).	  However	  some	  additional	  structural	   peaks	   are	   present	   (Fig	   3.17b;	   green	   arrows)	   that	   indicates	   the	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presence	  of	   some	   tertiary	   structure	   in	   addition	   to	  GST,	   suggesting	   that	  MyD88	  contains	  folded	  domain	  in	  this	  construct.	  	  
	  
Fig	  3.17	  1D	  (1H)	  NMR	  spectra	  of	  GST	  and	  GST-­MyD88-­TIR	  1D	  NMR	  analysis	  of	  (a)	  GST	  and	  (b)	  GST-­‐MyD88-­‐TIR	  in	  20	  mM	  Tris-­‐HCl,	  150	  mM	  NaCl,	  pH	  7.0.	  Black	  arrows	  indicate	  GST	  peaks	  and	  green	  arrows	  indicate	  additional	  structured	  peaks	  	  
	  Subsequently,	  2D	  (1H/15N)	  TROSY-­‐type	  HSQC	  spectra	  were	  recorded	   for	  15N-­‐GB1-­‐YpTIR1	   in	   the	   absence	   and	   presence	   of	   1.7	   M	   equivalent	   unlabelled	  GST-­‐MyD88-­‐TIR	  (Fig	  3.18).	  Some	  peaks	  in	  the	  potentially	  flexible	  regions	  (~7.8–8.8	  ppm)	  of	  the	  15N-­‐GB1-­‐YpTIR1	  spectra	  were	  broadened	  (Fig	  3.18b;	  arrows)	  in	  the	  presence	  of	  GST-­‐MyD88-­‐TIR.	  However	  it	  is	  difficult	  to	  conclude	  whether	  this	  is	  due	  to	  complex	  formation	  because	  of	  poor	  signal	  to	  noise	  ratio	  of	  the	  majority	  of	  peaks	  from	  GB1-­‐YpTIR1	  in	  the	  presence	  of	  GST-­‐MyD88-­‐TIR.	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Fig	  3.18	  2D	  (1H/15N)	  HSQC	  spectra	  of	  GB1-­YpTIR	  with/out	  GST-­MyD88-­TIR	  15N-­‐GB1-­‐YpTIR	  titrated	  with	  1.7	  M	  equivalent	  of	  unlabelled	  GST-­‐MyD88-­‐TIR.	  The	  2D	  (1H/15N)	  TROSY-­‐type	  HSQC	  spectra	  of	  15N-­‐GB1-­‐YpTIR	  (a)	  in	  the	  absence	  and	  (b)	  presence	  of	  GST-­‐MyD88-­‐TIR,	  were	  analysed	  for	  protein	  interaction.	  Arrows	  indicate	  the	  possible	  broadened	  peaks	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3.3.9	  Preparation	  of	  Cleaved	  MyD88-­TIR	  	  In	   an	   attempt	   to	   improve	   the	   sample	   quality	   for	   NMR	   titration,	   GST-­‐MyD88-­‐TIR	  was	  treated	  with	  Factor	  Xa	  in	  order	  to	  cleave	  the	  GST	  tag.	  A	  Factor	  Xa:	  protein	  ratio	  (unit:	  µg)	  of	  1:50	  is	  known	  to	  cleave	  >95%	  of	  a	  53.1	  kDa	  control	  protein	  (50	  µg)	  after	  incubation	  for	  16	  hr	  at	  20-­‐21	  °C	  (GE	  Healthcare).	  One	  unit	  of	  Factor	  Xa	  almost	  completely	  cleaved	  10	  µg	  of	  GST-­‐MyD88-­‐TIR	  after	  16	  hr	  at	  18	  °C	   (Fig	   3.19a;	   Lane	   1).	   Reverse	   glutathione-­‐AC	   was	   performed	   in	   order	   to	  separate	  the	  cleaved	  MyD88	  from	  GST.	  However	  MyD88	  was	  contaminated	  with	  GST	   (results	   not	   shown).	   The	   sample	   containing	   cleaved	   MyD88-­‐TIR	   and	   GST	  were	  loaded	  onto	  a	  Superdex	  75	  column	  (Fig	  3.19b)	  and	  analysed	  by	  SDS-­‐PAGE	  (Fig	  3.13c).	  Despite	  the	  difference	  in	  size,	  the	  cleaved	  MyD88	  (~17	  kDa)	  and	  GST	  (~26	  kDa)	  eluted	  together	  in	  the	  same	  fraction	  (Fig	  3.19b-­‐c;	  Peak	  3).	  
	  
Fig	  3.19	  Preparation	  of	  Cleaved	  MyD88-­TIR	  sample	  (a)	  GST-­‐MyD88-­‐TIR	  was	  treated	  with	  Factor	  Xa	  for	  16	  hr	  at	  18	  °C	  to	  cleave	  the	  GST	  tag.	  M	  indicates	  molecular	  weight	  marker,	  E	  indicates	  glutathione-­‐AC	  eluate,	  lanes	  1-­‐4	  correspond	  to	  the	  Factor	  Xa:	  protein	  ratios	  (unit:µg)	  of	  1:10,	  1:20,	  1:50	  and	  1:100	  respectively.	  The	  cleaved	  MyD88-­‐TIR	  sample	  was	  loaded	  onto	  a	  Superdex	  75	  column	  and	  analysed	  by	  (b)	  UV	  trace	  at	  280	  nm	  and	  (c)	  SDS-­‐PAGE.	  Lanes	  1-­‐4	  correspond	  to	  the	  protein	  peaks	  labelled	  on	  the	  SEC	  profile	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3.3.9	  Expression	  and	  Purification	  of	  GB1-­MyD88-­TIR	  MyD88-­‐TIR	   (Phe163	   to	  Pro296)	  was	  expressed	  with	  an	  N-­‐terminal	  GB1	  tag	  using	  GEV2	  in	  order	  to	  produce	  a	  smaller	  stable	  protein	  (devoid	  of	  GST)	  more	  suitable	  for	  NMR	  titration	  studies.	  GB1-­‐MyD88-­‐TIR	  was	  expressed	  when	  induced	  using	   1	   mM	   IPTG	   at	   the	   temperatures	   of	   37	   °C,	   25	   °C	   and	   15	   °C	   (Fig	   3.20a).	  Subsequent	  Co2+	  IMAC	  purification	  on	  the	  soluble	  fraction	  of	  cultures	  expressing	  GB1-­‐MyD88-­‐TIR	   induced	   at	   all	   three	   temperatures	   yielded	   pure	   protein	   (Fig	  3.20b;	  E).	  Large-­‐scale	  expression	  of	  GB1-­‐MyD88-­‐TIR	  was	  performed	  by	  inducing	  at	  25	  °C,	  based	  on	  the	  highest	  soluble	  protein	  yield	  (Fig	  3.20c).	  	  
	  
Fig	  3.20	  Expression	  and	  purification	  of	  GB1-­MyD88-­TIR	  (a)	  Expression	  of	  GB1-­‐MyD88-­‐TIR	  using	  1	  mM	  IPTG	  at	  37	  °C,	  25	  °C	  and	  15	  °C	  for	  4	  hr.	  M	  indicates	  molecular	  weight	  marker,	  T	  indicates	  total	  cell,	  S	  indicates	  soluble	  and	  I	  indicates	  insoluble	  fractions.	  (b)	  Co2+	  IMAC	  purification	  of	  soluble	  proteins	  expressed	  by	  IPTG	  induction	  at	  37	  °C,	  25	  °C	  and	  15	  °C	  for	  4	  hr.	  L	  indicates	  lysate,	  W	  indicates	  wash	  and	  E	  indicates	  eluate.	  (c)	  Final	  yields	  of	  purified	  proteins	  are	  tabulated	  	   	  
3.3.10	  The	  Folded	  State	  of	  GB1-­MyD88-­TIR	  	  Large-­‐scale	  (2	  litre)	  expression	  of	  GB1-­‐MyD88-­‐TIR	  with	  subsequent	  Co2+	  IMAC	   purification	   produced	   pure	   protein	   (Fig	   3.21b;	   E)	  with	   a	   relatively	   good	  soluble	  yield	  of	  1	  mg/l.	  Subsequent	  SEC	  purification	  of	  the	  sample	  revealed	  pure	  GB1-­‐MyD88-­‐TIR,	  which	  eluted	  as	  three	  different	  peaks	  (Fig	  3.21a,c;	  Lanes	  1-­‐3).	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Fig	  3.21	  Co2+	  IMAC	  and	  subsequent	  SEC	  purification	  of	  GB1-­MyD88-­TIR	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  GB1-­‐MyD88-­‐TIR2	  was	  loaded	  onto	  the	  Superdex	  200	  column	  and	  analysed	  by	  (a)	  UV	  trace	  at	  280	  nm	  following	  (b)	  Co2+	  IMAC	  purification.	  M	  indicates	  molecular	  weight	  marker,	  L	  indicates	  lysate,	  W	  indicates	  wash,	  E	  indicates	  eluate	  and	  EC	  indicates	  concentrated	  eluate.	  The	  protein	  peaks	  1-­‐3	  labelled	  on	  the	  SEC	  chromatogram	  was	  analysed	  by	  (c)	  SDS-­‐PAGE	  	  
	  GB1-­‐MyD88-­‐TIR	   samples	   contained	   in	   three	   fractions	   (1-­‐3)	   were	  analysed	  by	  1D	  NMR	  analysis	   to	  reveal	  varying	  peak	   intensities.	  The	  sample	   in	  fraction	  3	  gave	  the	  best	  NMR	  signals	  (Fig	  3.22),	  which	  was	  most	   likely	  because	  the	   monomeric	   protein	   (in	   fraction	   3)	   was	   self-­‐associating	   to	   form	   higher	  molecular	  weight	  oligomers	  (as	  seen	  in	  fractions	  1	  and	  2)	  (Fig	  3.21	  and	  Fig	  3.22).	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Fig	  3.22	  1D	  (1H)	  NMR	  spectra	  of	  GB1-­MyD88-­TIR	  1D	  NMR	  was	  used	  to	  analyse	  the	  GB1-­‐MyD88-­‐TIR	  samples	  in	  fractions	  (a)	  1	  (b)	  2	  and	  (c)	  3	  as	  separated	  by	  SEC	  purification.	  The	  samples	  were	  present	  in	  buffer	  containing	  20	  mM	  Tris-­‐HCl,	  150	  mM	  NaCl,	  pH	  7.0.	  Arrows	  indicate	  the	  NMR	  peaks	  for	  comparison	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The	  SEC	  purification	  of	  GB1-­‐MyD88-­‐TIR	  was	  repeated	  in	  the	  presence	  of	  10	  mM	  DTT	  to	  examine	  its	  effect	  on	  oligomerisation.	  As	  a	  result,	  the	  higher	  states	  of	   the	  protein	  were	  reduced	   to	   the	  monomeric	   state	   in	   the	  presence	  of	  10	  mM	  DTT	  giving	  a	  single	  monodisperse	  peak	  on	  the	  SEC	  chromatogram	  eluting	  with	  a	  low	  retention	  volume	  for	  a	  ~25	  kDa	  protein	  (Fig	  3.23a).	  The	  1D	  NMR	  spectrum	  of	  the	  protein	  in	  the	  presence	  of	  10	  mM	  DTT	  was	  the	  same	  as	  for	  fraction	  3	  (Fig	  3.22c)	  containing	  monomeric	  protein	  in	  the	  absence	  of	  DTT.	  
	  
Fig	  3.23	  SEC	  Purification	  of	  GB1-­MyD88-­TIR	  in	  the	  presence	  of	  DTT	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  GB1-­‐MyD88-­‐TIR	  was	  purified	  by	  Co2+	  IMAC	  purification.	  The	  IMAC-­‐eluate	  was	  loaded	  onto	  a	  Superdex	  200	  column	  and	  eluted	  in	  the	  presence	  of	  10	  mM	  DTT.	  The	  purified	  sample	  was	  analysed	  by	  (a)	  UV	  trace	  at	  280	  nm	  and	  (b)	  SDS-­‐PAGE.	  M	  indicates	  molecular	  weight	  marker,	  L	  indicates	  lysate,	  W	  indicates	  wash,	  E	  indicates	  eluate	  and	  G	  indicates	  gel	  filtration	  eluate	  
	  
3.3.11	  GB1-­YpTIR1	  and	  GB1-­MyD88-­TIR2	  Interaction	  by	  NMR	  GB1-­‐MyD88-­‐TIR	  and	  GB1-­‐YpTIR1	  samples	  were	   individually	  assessed	   in	  the	  presence	  of	   10	  mM	  DTT	  using	  1D	  NMR	   to	   confirm	   the	   folded	   states	   of	   the	  protein.	   Subsequently,	   2D	   (1H/15N)	   TROSY-­‐based	   HSQC	   spectra	   of	   15N-­‐GB1-­‐YpTIR1	  were	   recorded	   in	   the	  absence	  and	  presence	  of	  unlabelled	  GB1-­‐MyD88-­‐TIR	   (Fig	   3.24	   and	   Fig	   3.25).	   The	   YpTIR1	   peaks	   indicative	   of	   signals	   from	   the	  structured	  domains	  (>9	  ppm),	  broadened	  when	  GB1-­‐MyD88-­‐TIR	  was	  added	  (Fig	  3.24b	  and	  Fig	  3.25b)	  indicating	  protein	  binding	  to	  these	  domains.	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Fig	  3.24	  2D	  (1H/15N)	  HSQC	  spectra	  of	  15N-­GB1-­YpTIR	  with/out	  GB1-­MyD88-­TIR	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  The	  2D	  (1H/15N)	  TROSY-­‐type	  HSQC	  spectra	  of	  15N-­‐GB1-­‐YpTIR	  were	  recorded	  (a)	  in	  the	  absence	  and	  (b)	  presence	  of	  1	  M	  equivalent	  of	  unlabelled	  GB1-­‐MyD88-­‐TIR.	  The	  2D	  spectra	  of	  GB1	  is	  superimposed	  (in	  red)	  and	  the	  broadened	  YpTIR	  peaks	  (>9ppm)	  are	  indicated	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Fig	  3.25	  2D	  HSQC	  spectra	  of	  15N-­GB1-­YpTIR	  with/out	  GB1-­MyD88-­TIR	  (9.5–10.5	  ppm)	  	  The	  zoomed	  in	  view	  (9.5-­‐10.5	  ppm)	  of	  2D	  (1H/15N)	  TROSY-­‐type	  HSQC	  spectra	  of	  15N-­‐GB1-­‐YpTIR	  (a)	  in	  the	  absence	  and	  (b)	  presence	  of	  1	  M	  equivalent	  of	  unlabelled	  GB1-­‐MyD88-­‐TIR.	  The	  2D	  spectra	  of	  GB1	  is	  superimposed	  (in	  red)	  and	  the	  broadened	  YpTIR	  peaks	  are	  indicated	  by	  arrows	  
	  	   127	  
The	  superimposition	  of	  the	  2D	  (1H/15N)	  spectra	  of	  GB1	  (in	  red)	  on	  that	  of	  unbound	  and	  bound	  15N-­‐GB1-­‐YpTIR1	  (Fig	  3.25	  and	  Fig	  3.26)	  confirmed	  that	  the	  observed	  peak	  broadening	  suggestive	  of	  complex	  formation	  is	  indeed	  related	  to	  YpTIR	   peaks	   rather	   than	   GB1	   peaks.	   GB1	   peaks	   are	   relatively	   less	   broadened,	  which	   might	   be	   due	   to	   tethering	   of	   these	   peaks	   to	   interacting	   domains.	  Unfortunately,	  without	  NMR	  assignments	   it	   is	  not	  possible	   to	  map	  the	  residues	  on	  YpTIR	  involved	  in	  the	  interaction.	  Thus,	  structural	  characterisation	  of	  YpTIR	  is	  crucial,	  which	  was	  attempted	  using	  NMR	  and	  XRD	  (Chapter	  4).	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3.4	   Discussion	  
A	   number	   of	   experiments	   were	   performed	   in	   order	   to	   confirm	   and	  characterise	   the	   interaction	   between	   YpTIR/BpTIR	   proteins	   and	   hMyD88.	   The	  purified	  YpTIR	  and	  BpTIR	  (produced	  using	  pET26b)	  proteins	  were	  sub-­‐optimal	  in	   terms	   of	   their	   purity,	   stability	   and	   solubility.	   Despite	   these	   factors,	   positive	  interactions	   between	   YpTIR/BpTIR	   and	   hMyD88-­‐TIR	   were	   consistently	   (n=3)	  observed.	  Co-­‐expression	  and	   co-­‐purification	  of	   the	  YpTIR-­‐His	   and	  GST-­‐MyD88-­‐TIR	   suggested	   the	   formation	   of	   an	   in	   vivo	   complex.	   It	   is	   possible	   that	   complex	  formation	   stabilises	   both	   proteins	   however	   the	   low	   yields	   (<100	   µg/l)	   meant	  that	  further	  analysis	  of	  the	  complex	  was	  not	  possible.	  This	  approach	  has	  yet	  to	  be	  repeated	   using	   the	   GB1-­‐tagged	   YpTIR	   constructs.	   Due	   to	   the	   poor	   quality	   of	  YpTIR	   (produced	  using	  pET26b)	   in	   terms	  of	   purity,	   solubility	   and	   stability,	   1D	  NMR	   analysis	   of	   YpTIR	   in	   the	   presence	   of	   GST-­‐MyD88-­‐TIR	   remained	  inconclusive	  in	  indicating	  interaction.	  In	  addition,	  the	  possible	  broadened	  peaks	  were	  present	  in	  the	  potentially	  flexible	  regions	  (~7.8	  –	  8.8	  ppm)	  of	  the	  spectra.	  Optimisation	   of	   expression	   and	   purification	   using	   the	   GB1-­‐YpTIR	  constructs	   greatly	   facilitated	  protein	   interaction	   studies.	  GST	  pull	   down	  assays	  revealed	  that	  all	   the	  three	  GB1-­‐YpTIR	  proteins	  interacted	  with	  GST-­‐MyD88-­‐TIR	  despite	  the	  tag	  and	  varying	  construct	  lengths.	  This	  suggests	  that	  residues	  within	  the	   core	   YpTIR	   domain	  mediate	   this	   interaction.	   A	   set	   of	   control	   experiments	  confirmed	   the	   specificity	   of	   the	   interaction,	   which	  was	   further	   emphasised	   by	  loss	   of	   interaction	   between	   hMyD88-­‐TIR	   and	   the	   Pro173His	   mutant	   forms	   of	  GB1-­‐YpTIR.	   Previous	   studies	   have	   identified	   the	   importance	   of	   this	   Proline	  residue	   in	   box	   2	   region	   of	   TIR	   domains,	   crucial	   for	   mediating	   signalling.	   The	  equivalent	  point-­‐mutation	  in	  the	  TIR	  domains	  of	  human	  TLR2	  (Pro681His)	  and	  human	  TLR10	   (Pro674His)	   have	   abolished	   interaction	  with	   the	  TIR	   domain	   of	  human	  MyD88	  (Xu	  et	  al.,	  2000;	  Nyman	  et	  al.,	  2008).	  	  1D	   NMR	   spectra	   of	   the	   Pro173His	   mutants	   of	   GB1-­‐YpTIR1	   and	   GB1-­‐YpTIR2	  do	  not	   indicate	   loss	  of	  structure	  when	  compared	  to	   their	  wild-­‐types	  as	  reported	  for	  the	  Pro681His	  mutant	  of	  the	  TIR	  domain	  of	  hTLR2	  (Xu	  et	  al.,	  2000).	  This	  indicates	  that	  the	  Proline	  residue	  lacks	  a	  major	  structural	  role	  but	  serves	  as	  
	  	   129	  
a	  specific	  and	  direct	  point	  of	  contact	  with	  other	  TIR	  domains.	  In	  addition,	  the	  in	  
vitro	  analyses	  are	  supported	  by	  cell	  based	  assays,	  which	  show	  that	  the	  full-­‐length	  YpTLP	  inhibits	  NFκB	  activation	  (Spear	  et	  al.,	  unpublished	  work).	  In	  order	  to	  fully	  understand	  the	  role	  of	  pathogenic	  bacterial	  TIR	  domains,	  it	  is	  important	  to	  gain	  insight	  into	  the	  interaction	  mechanisms	  with	  the	  host	  TIR	  domains.	   One	   of	   the	   methods	   to	   achieve	   this	   is	   high-­‐resolution	   NMR	   titration	  study	  complemented	  with	  NMR	  assignments	  of	  one	  of	  the	  interacting	  proteins	  in	  order	   to	   understand	   the	   specificities	   and	   dynamics	   of	   this	   TIR-­‐mediated	  interaction.	   Although	   this	   study	   includes	   NMR	   analysis	   to	   assess	   interaction	  between	  the	  TIR	  domains	  of	  YpTLP	  and	  hMyD88,	  it	  has	  not	  so	  far	  been	  possible	  to	  map	   the	   interaction	  domain	  of	   YpTIR.	   Further	  work	   is	   required	   to	   generate	  more	   stable	   GB1-­‐YpTIR	   constructs.	   The	   full-­‐length	   YpTLP	   could	   be	   expressed	  and	  purified	  as	  GB1	  fusion	  protein	  with	  subsequent	  proteolytic	  digestion	  thereby	  producing	   a	   stable	   TIR	   domain	   construct.	   Alternatively,	   GB1-­‐YpTIR	   constructs	  could	   be	   designed	   with	   longer	   insert	   sequences	   between	   the	   GB1	   and	   TIR	  domains	  (Chapter	  4).	  	  The	   results	   outlined	   in	   this	   chapter	   indicate	   that	   the	   BpTIR	   forms	  interactions	   with	   Myd88.	   In	   vitro	   reporter	   assays	   revealed	   a	   specific	   and	  significant	  signalling	  effect	  of	  YpTLP	  in	  reducing	  activation	  of	  NFκB	  however	  the	  signalling	   effect	   by	   BpTLP	   was	   insignificant	   (Spear	   et	   al.,	   unpublished	   work).	  Subsequent	   to	   the	   research	   outlined	   in	   this	   analysis	   detailed	   bioinformatics	  analyses	   failed	   to	   identify	   BpTIR	   as	   a	   TIR	   domain	   (Spear	   et	   al.,	   2009).	   The	  potential	  function	  of	  the	  BpTIR	  protein	  remains	  unclear.	  	  In	   summary,	   in	   vitro	  GST	  pull	  down	  assays	  and	  NMR	   titration	   reveal	   an	  interaction	  between	  YpTIR	  and	  MyD88-­‐TIR.	  Although	  BpTIR	  is	  not	  a	  TIR	  domain,	  it	   also	   interacts	   with	   hMyD88-­‐TIR	   (further	   discussed	   in	   Chapter	   5).	   It	   seems	  likely	   that	   YpTLP	   plays	   a	   subversive	   role	   as	   reported	   for	   other	   pathogenic	  bacterial	  TIR	  homologues	  in	  the	  literature	  (Cirl	  et	  al.,	  2008;	  Newman	  et	  al.,	  2006;	  O'Neill,	  2008;	  Underhill,	  2004).	  Based	  on	  the	  indeterminate	  nature	  of	  BpTIR	  and	  better	  expression	  levels	  obtained	  for	  YpTIR	  further	  studies	  focussed	  exclusively	  on	  YpTIR.	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Chapter	  4	  	  
Towards	  Structural	  Characterisation	  
of	  YpTIR	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
4.1	   Introduction	  
4.1.1	  Structural	  Characterisation	  of	  TIR	  Domains	  As	  described	  in	  the	  previous	  chapters,	  it	  was	  possible	  to	  obtain	  pure	  and	  stable	  YpTIR	   that	   interacts	  with	  human	  MyD88-­‐TIR.	  However	   in	   order	   to	   fully	  elucidate	  its	  mechanism	  of	  action,	  it	  is	  necessary	  to	  structurally	  characterise	  the	  YpTIR	  protein	  both	  individually	  and	  in	  complex	  with	  human	  interaction	  partners	  such	   as	  MyD88.	  Paracoccus	   denitrificans	   TIR	   containing	  protein	   (PdTLP)	   is	   the	  best	   characterised	   bacterial	   TIR	   homologue	   to	   date	   (Low	   et	   al.,	   2007).	  Biophysical	  characterisation	  of	  PdTLP	  using	   limited	  proteolysis	  and	  differential	  scanning	  calorimetry	  revealed	  that	   it	   is	  comprised	  of	  two	  independently	   folded	  domains,	  with	  the	  N-­‐terminal	  domain	  less	  stable	  than	  the	  C-­‐terminal	  TIR	  domain	  (Low	  et	  al.,	  2007).	  Further	  analysis	  of	  the	  N-­‐terminal	  domain	  of	  PdTLP	  by	  far	  UV	  circular	  dichroism	  spectroscopy	   suggested	  a	  high	  α-­‐helical	   content	   (Low	   et	   al.,	  2007).	  The	  C-­‐terminal	  TIR	  domain	  of	  PdTLP	  indicated	  a	  compact	  folded	  domain	  using	  1D	  NMR	  spectroscopy	  (Low	  et	  al.,	  2007).	  	  The	   TIR	   domain	   (PdTIR)	   of	   the	   full-­‐length	   PdTLP	   was	   subjected	   to	  proteolytic	   digest	   by	   chymotrypsin	   and	   the	   stable	   core	   domain	   subsequently	  crystallised.	   The	   resultant	   structure	   solved	   at	   2.5	   Å	   resolution	   revealed	   a	   core	  domain	   consisting	   of	   centrally	   placed	   five-­‐strands	   of	   parallel	   β-­‐sheets	  surrounded	  by	  five	  α-­‐helices	  (Chan	  et	  al.,	  2009a).	  This	  overall	  fold	  is	  conserved	  among	  all	  the	  known	  structures	  of	  the	  TIR	  domains	  of	  human,	  bacterial	  and	  plant	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proteins.	  However	  certain	  conformational	  differences	  exist	   (Chan	   et	  al.,	  2009b;	  Chan	  et	  al.,	  2009a;	  Xu	  et	  al.,	  2000;	  Khan	  et	  al.,	  2004;	  Nyman	  et	  al.,	  2008;	  Ohnishi	  
et	   al.,	   2009;	   Tao	   et	   al.,	   2002),	   which	   may	   relate	   to	   variations	   in	   TIR	   domain	  specificity	   and	   function.	   For	   instance,	   in	   the	   case	   of	   PdTIR,	   the	   region	   of	  most	  structural	   difference	   is	   the	   functionally	   relevant	  BB	   loop	   that	   lies	   closer	   to	   the	  CC-­‐loop	  and	  αC-­‐helix	  instead	  of	  extending	  away	  as	  in	  the	  case	  of	  the	  human	  TIR	  domains	   (Xu	   et	   al.,	   2000;	  Khan	   et	   al.,	   2004;	  Nyman	   et	   al.,	   2008;	  Ohnishi	   et	   al.,	  2009;	   Chan	   et	   al.,	   2009a).	   The	   highly	   exposed	   BB	   loop	   region	   in	   PdTIR	   is	  suggested	  to	  potentially	  interact	  with	  human	  TIR	  domains	  (Chan	  et	  al.,	  2009a).	  It	  is	  therefore	  important	  to	  study	  the	  structure	  of	  specific	  TIR	  domains	  in	  detail	  to	  draw	  meaningful	  conclusions.	  	  The	  tertiary	  structure	  models	  for	  the	  bacterial	  TIR	  containing	  proteins	  in	  
Brucella	   melitensis	   	   (TcpB)	   and	   Escherichia	   coli	   strain	   CFT073	   (TcpC)	   were	  predicted	  to	  be	  similar	  to	  the	  structure	  of	  the	  TIR	  domain	  of	  human	  TLR1	  (Cirl	  et	  
al.,	  2008).	  In	  addition,	  PdTIR,	  TcpB	  and	  TcpC	  have	  been	  shown	  to	  interact	  with	  human	  MyD88-­‐TIR	  (Cirl	  et	  al.,	  2008;	  Chan	  et	  al.,	  2009a).	  These	  analyses	  support	  the	   suggestion	   that	   bacterial	   TIR	   proteins	   subvert	   the	   host	   TLR	   signalling	   on	  account	  of	  molecular	  mimicry	  (Low	  et	  al.,	  2007;	  Chan	  et	  al.,	  2009a;	  Newman	  et	  
al.,	  2006;	  Cirl	  et	  al.,	  2008).	  However	  this	  does	  not	  explain	  the	  role	  of	  bacterial	  TIR	  containing	  proteins	  in	  non-­‐pathogens	  as	  in	  the	  case	  of	  PdTIR.	  	  It	   is	   possible	   that	   the	   TIR	   domains	   in	   pathogenic	   bacteria	   have	   evolved	  subversive	  roles.	  However	  their	  exact	  roles	  and	  mechanisms	  remain	  unclear.	  It	  is	  therefore	  crucial	  to	  obtain	  high-­‐resolution	  structures	  of	  pathogenic	  bacterial	  TIR	  domains	  if	  possible	  in	  complex	  with	  human	  TIR	  domains	  in	  order	  to	  gain	  insight	  into	   their	   specific	   interaction	   modes.	   This	   chapter	   describes	   attempts	   to	  structurally	   characterise	   the	   expressed	   YpTIR	   proteins.	   A	   combination	   of	  approaches	  using	  NMR	   spectroscopy	   and	  X-­‐ray	   crystallography	  has	  been	  used.	  The	  principles	  of	  NMR	  spectroscopy	  were	  given	  in	  Chapter	  3	  and	  the	  principles	  of	   X-­‐ray	   crystallography,	   (Rhodes,	   2000;	   Blow,	   2005)	   are	   outlined	   in	   the	  following	  sections.	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4.1.2	  X-­Ray	  Crystallography	  
	   Protein	  crystals	  contain	  many	  identical	  molecules	  in	  an	  ordered	  array.	  X-­‐ray	   diffraction	   from	   these	   identical	   protein	  molecules	   in	   the	   crystal	   forms	   the	  basis	  of	  protein	  structure	  determination	  by	  X-­‐ray	  crystallography.	  The	  clouds	  of	  electrons	   in	   the	  molecules	   of	   the	   crystal	   contribute	   to	   the	   diffraction	   spots	   or	  reflections.	   Therefore,	   these	   reflections	   reveal	   the	   electron	   density	   of	   the	  molecules.	  Each	   reflection	   can	  be	   represented	  by	   three	  parameters:	   amplitude,	  frequency	   and	   phase.	   Though	   it	   is	   possible	   to	  measure	   the	   amplitude	   and	   the	  frequency	  of	  the	  reflections	  from	  the	  diffraction	  data,	  the	  phase	  of	  the	  reflections	  is	  not	  recorded	  during	  the	  experiment.	  This	  problem	  is	  overcome	  by	  calculating	  the	   phase	   angles	   using	   additional	   experiments	   (Section	   4.1.7).	   The	   electron	  density	   map	   is	   generated	   for	   the	  molecules	   from	   the	   three	   parameters	   of	   the	  diffraction	   reflections,	   followed	   by	   building	   and	   iterative	   refinement	   of	   a	  chemically	  realistic	  model	  of	  the	  protein	  that	  fits	  this	  map.	  	  	  
4.1.3	  X-­rays	  and	  Sources	  	  
	   X-­‐rays	   are	   penetrating	   electromagnetic	   radiation	   of	   wavelengths	   (λ)	   of	  0.1-­‐100	  Å,	  where	  one	  Ångström	  unit	  (Å)	   is	  0.1	  nm.	  In	  order	  to	  view	  the	  atomic	  structure	  of	  a	  protein	  molecule	  comprised	  of	  atoms	  1-­‐2	  Å	  apart	  when	  covalently	  bonded,	   and	   atoms	   2.5-­‐3.5	   Å	   apart	   when	   bonded	   by	   strong	   polar	   interactions	  and	  hydrogen	  bonds,	   X-­‐rays	  with	   a	   short	  wavelength	   of	   0.5-­‐1.6	  Å	   are	   used	   for	  protein	  X-­‐ray	  crystallography.	  X-­‐rays	  in	  this	  range	  are	  produced	  most	  commonly	  by	  two	  methods:	  rotating	  anodes	  and	  electron	  synchrotrons.	  Laboratory	  X-­‐ray	  generators	  use	  metal	  anodes	  (usually	  copper	  λ(CuKα)	  =	  1.54	  Å	  or	  molybdenum	  λ(MoKα)	  =	  0.71	  Å).	  Bombardment	  of	   the	  metal	   anodes	  with	   electrons	   causes	   displacement	   of	   the	   low-­‐energy	   electrons	   in	   the	   atomic	  orbital	   of	   the	   metal	   atom	   on	   collision.	   Then	   the	   high-­‐energy	   electrons	   fill	   the	  resulting	  vacancy	  in	  the	  orbital	  of	  the	  metal	  atom.	  The	  excess	  energy	  released	  by	  this	   replacement	   is	   emitted	   as	   X-­‐ray	   photons.	   Synchrotron	   facilities	   produce	   a	  continuous	  X-­‐ray	  spectrum	  (0.5-­‐1.6	  Å)	  in	  which	  electrons	  circulate	  at	  a	  velocity	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close	   to	   the	   speed	   of	   light.	   An	   intense	   X-­‐ray	   beam	   is	   emitted	   in	   the	   tangential	  direction,	   which	   can	   be	   modulated	   by	   systems	   like	   focussing	   mirrors.	   	   X-­‐ray	  detectors	  identify	  the	  energy	  or	  the	  intensity	  of	  the	  diffracted	  beam,	  which	  at	  a	  certain	   wavelength	   is	   proportional	   to	   the	   number	   of	   incident	   X-­‐ray	   photons.	  Charge-­‐coupled	  device	  (CCD)	  detectors	  are	  the	  commonly	  used	  X-­‐ray	  detectors.	  	  
4.1.4	  Protein	  Crystallisation	  
	   Protein	  crystals	  are	  formed	  by	  slow	  and	  controlled	  precipitation	  of	  highly	  purified	  proteins,	  from	  aqueous	  solutions	  in	  non-­‐denaturing	  conditions.	  A	  range	  of	  factors	  influences	  the	  formation	  and	  growth	  of	  protein	  crystals.	  Crystallisation	  conditions	   are	   screened	   for	   optimal	   buffers	   and	   pH	   (Tris-­‐HCl,	   HEPES-­‐NaOH),	  precipitants	   (polyethylene	   glycol	   PEG),	   salt	   concentrations	   (NaCl,	   MgCl2),	  additives	  (DTT,	  glycerol)	  and	  temperatures	  (4	  °C,	  20	  °C).	  One	  of	  the	  most	  applied	  methods	  of	  crystallisation	  is	  the	  vapour	  diffusion	  method.	  Generally	  the	  protein	  solution	   is	   mixed	   1:1	   (v/v)	   with	   the	   reservoir	   solution	   (containing	   the	  precipitant)	   and	   allowed	   to	   incubate	   in	   a	   closed	   system,	  with	   an	   excess	   of	   the	  reservoir	  solution	  in	  the	  bottom	  pool.	  The	  lower	  concentration	  of	  the	  precipitant	  in	   the	  protein	  drop	  causes	  vapour	  diffusion	  resulting	   in	   transfer	  of	  water	   from	  the	   protein	   droplet	   to	   the	   reservoir	   until	   equilibrium	   is	   reached.	   This	   gradual	  increase	  of	  the	  precipitant	  and	  the	  protein	  concentrations	  in	  the	  drop	  eventually	  finds	   an	   optimal	   condition	   for	   the	   crystals	   to	   form	   and	   grow	   (Fig	   4.1a).	  Crystallisation	   trials	   in	   this	   study	   have	   been	   performed	  by	   vapour	   diffusion	   in	  hanging	  and	  sitting	  drops	  (Fig	  4.1b).	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Fig	  4.1	  Phase	  diagram	  and	  the	  vapour	  diffusion	  method	  for	  protein	  crystallisation	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  (a)	  Phase	  diagram	  of	  crystal	  growth	  indicating	  the	  nucleation	  zone	  where	  new	  protein	  crystals	  nucleate	  and	  the	  metastable	  zone	  where	  existing	  crystals	  grow.	  (b)	  Schematic	  representation	  of	  vapour	  diffusion	  method	  of	  protein	  crystallisation	  in	  hanging	  and	  sitting	  drops	  	  
4.1.5	  Protein	  Crystals	  and	  Symmetry	  	   A	  protein	  crystal	  is	  a	  3D	  array	  of	  a	  repeating	  unit,	  named	  the	  unit	  cell.	  The	  unit	  cell	  dimensions	  are	  described	  by	  three	  vectors	  a,	  b,	  c	  and	  the	  angles	  α,	  β,	  γ	  between	   these	   vectors	   (Fig	   4.2a).	   The	   three	   vectors	   represent	   the	   lengths	   of	  three	  unique	  edges	  a,	  b,	  c	  along	  the	  lattice	  directions	  x,	  y,	  z,	  respectively.	  The	  unit	  cell	  volume	  is	  comprised	  of	  protein	  molecules	  and	  solvent	  content,	  typically	  40-­‐
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60%	   for	   soluble	   protein	   crystals.	   The	   unit	   cell	   can	   be	   further	   subdivided	   into	  identical	   smaller	  units,	  named	   the	  asymmetric	  unit	   (Fig	  4.2b),	  which	  possesses	  no	   symmetry	   elements.	   It	   can	   be	   juxtaposed	   on	   other	   identical	   units	   by	  symmetry	  operations.	  	  
	  
Fig	  4.2	  Schematic	  illustration	  of	  the	  crystal	  unit	  cell	  and	  the	  asymmetric	  unit	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  (a)	  Section	  of	  a	  3D	  lattice	  showing	  the	  crystal	  unit	  cell.	  The	  unit	  cell	  dimensions	  are	  designated	  by	  the	  vectors	  a,	  b	  and	  c	  along	  the	  lattice	  directions	  x,	  y	  and	  z	  respectively	  and	  the	  angles	  α,	  β	  and	  γ	  between	  the	  vectors.	  The	  lattice	  points	  in	  the	  upper	  and	  the	  lower	  layers	  are	  in	  red	  and	  black	  respectively.	  (b)	  A	  unit	  cell	  comprising	  of	  one	  copy	  of	  the	  asymmetric	  unit	  (Blow,	  2005)	  
	   Translation,	   rotation	   and	   screw	   axes	   are	   the	   possible	   symmetry	  operations	   in	  protein	  crystals	   composed	  of	   chiral	  molecules.	  Translation	   refers	  to	  movement	  of	  the	  unit	  cell	  by	  a	  specified	  distance.	  Rotation	  operates	  about	  n-­‐fold	  symmetry	  axes	  where	  n	  is	  an	  integer	  (1,	  2,	  3,	  4	  and	  6)	  such	  that	  a	  unit	  cell	  possessing	  2-­‐fold	  symmetry	  (360°/2	  =	  180°)	  remains	  identical	  when	  rotated	  by	  180°.	  The	   screw	  axis	  of	   symmetry	  combines	  a	   rotation	  with	  a	   fractional	   lattice	  translation.	  There	  are	  65	  space	  groups	  allowed	  for	  protein	  crystals,	  which	  define	  all	   the	  combinations	  of	  the	  possible	  symmetry	  operations	  on	  protein	  molecules	  in	   a	   unit	   cell.	   The	   space	   groups	   can	   be	   categorized	   into	   the	   following	   seven	  crystal	   systems	   in	   the	   order	   of	   ascending	   symmetry:	   triclinic,	   monoclinic,	  orthorhombic,	  trigonal,	  tetragonal,	  hexagonal	  and	  cubic.	  	  
	  
	  	   136	  
4.1.6	  The	  Diffraction	  Theory	  	  
	   Each	   crystal	   lattice	   can	   be	   described	   by	   the	   Miller	   indices	   (hkl),	   which	  allows	   the	   distinct	   identification	   of	   each	   set	   of	   parallel	   diffracting	   planes.	   For	  example	  the	  (100)	  plane	  intersects	  the	  x-­‐axis	  only	  once.	  When	  a	  protein	  crystal	  is	  exposed	  to	  X-­‐rays,	  the	  electrons	  in	  the	  protein	  molecules	  scatter	  the	  X-­‐ray	  beam	  in	   all	   directions.	  However	   the	   crystal	   lattice	  defines	  directions	   for	  which	  X-­‐ray	  scattering	  is	  reinforced	  based	  on	  constructive	  interference.	  X-­‐ray	  diffraction	  can	  be	   explained	   by	   the	   reflection	   of	   an	   X-­‐ray	   beam	   from	   layers	   of	   parallel	  equidistant	  atomic	  planes,	  termed	  as	  Bragg	  planes.	  At	  each	  atomic	  plane,	  a	  small	  portion	  of	  the	  X-­‐ray	  beam	  is	  reflected.	  If	  these	  reflected	  beams	  are	  not	  absorbed	  by	   the	   crystal	   itself	   and	   do	   not	   cancel	   out	   by	   destructive	   interference,	   then	   a	  diffracted	  beam	  is	  observed.	  Bragg’s	  law	  gives	  the	  condition	  where	  the	  reflected	  beams	  interfere	  positively	  or	  are	  in	  phase,	  to	  give	  strong	  diffraction	  spots:	  	  
€ 
nλ = 2d sinθ 	  where	   n	   is	   an	   integer	   number,	   	   λ	   is	   the	   X-­‐ray	   wavelength,	   d	   is	   the	   distance	  between	   the	  Bragg	  planes	  and	  θ	   is	   the	  angle	  made	  by	   the	  primary	  X-­‐ray	  beam	  with	  respect	  to	  the	  Bragg	  lane	  (Fig	  4.3).	  	  
	  
Fig	  4.3	  Schematic	  representation	  of	  Bragg’s	  law	  X-­‐ray	  diffraction	  is	  observed	  when	  the	  difference	  in	  path	  length	  between	  X-­‐rays	  reflected	  by	  two	  parallel	  lattice	  planes	  (hkl)	  in	  the	  crystal	  separated	  by	  a	  distance	  dhkl	  	  (2dhkl	  sin	  θ)	  is	  equal	  to	  an	  integer	  number	  (n)	  of	  the	  incident	  wavelength	  λ.	  The	  incident	  and	  reflected	  beams	  are	  at	  an	  angle	  θ	  to	  the	  lattice	  planes	  (Blow,	  2005)	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   There	   is	  an	   inverse	  relationship	  between	   the	  spacing	  of	  unit	   cells	   in	   the	  crystal	   lattice	  (real	   lattice)	  and	  the	  spacing	  of	  observed	  reflections	  produced	   in	  the	  X-­‐ray	  diffraction	  (reciprocal	  lattice).	  The	  concept	  of	  reciprocal	  space	  is	  used	  to	  describe	  the	  diffraction	  pattern.	  Ewald	  devised	  a	  geometrical	  theory	  using	  the	  reciprocal	  lattice	  to	  help	  visualise	  those	  Bragg	  lanes	  in	  the	  correct	  orientation	  to	  diffract	  X-­‐rays	  (Ewald,	  1969).	  The	  Ewald	  sphere	  is	  a	  mathematical	  construction	  with	  radius	  1/λ	   and	  centred	  on	   the	  crystal	   (C)	   (Fig	  4.4).	  The	  distance	  between	  the	   reciprocal	   lattice	   planes	   is	   1/d.	   The	   Bragg’s	   equation	   and	   thereby	   the	  diffraction	  conditions	  are	  met	  when	  a	  reciprocal	  lattice	  point	  P	  (vector	  1/d)	  lies	  on	   the	  surface	  of	   the	  Ewald	  sphere.	  This	   results	   in	  a	  diffracted	  beam	  along	   the	  centre	  C	  of	  the	  sphere,	  the	  diffracted	  lattice	  point	  P	  on	  the	  surface	  of	  the	  sphere	  and	   the	   origin	   O	   of	   the	   reciprocal	   lattice	   positioned	   at	   the	   point	   where	   the	  incident	  beam	  emerges	  from	  the	  sphere	  (Fig	  4.4).	  
	  
Fig	  4.4	  Schematic	  representation	  of	  the	  Ewald	  Sphere	  The	  incident	  X-­‐ray	  enters	  the	  Ewald	  sphere	  at	  point	  I	  and	  is	  diffracted	  by	  an	  angle	  2θ	  at	  the	  centre	  of	  the	  sphere	  C	  where	  the	  crystal	  is	  positioned.	  The	  sphere	  has	  a	  radius	  of	  1/λ	  where	  λ	  is	  the	  incident	  wavelength	  and	  the	  distance	  between	  the	  reciprocal	  lattice	  planes	  is	  1/dhkl.	  A	  reflection	  hkl	  occurs	  in	  the	  direction	  CP	  when	  reciprocal	  lattice	  point	  Phkl	  lies	  on	  the	  surface	  of	  the	  sphere.	  According	  to	  Bragg’s	  law,	  reflection	  hkl	  is	  the	  result	  of	  the	  reflection	  from	  the	  set	  of	  equidistant	  real-­‐space	  planes	  parallel	  to	  vector	  IP	  (Blow,	  2005)	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4.1.7	  The	  Phase	  Problem	  
	   During	  an	  X-­‐ray	  diffraction	  experiment,	  the	  intensities	  of	  waves	  scattered	  from	   planes	   (denoted	   by	   hkl)	   in	   the	   crystal	   are	   measured.	   The	   sum	   of	   the	  contributions	   of	   all	   atoms	   in	   the	   unit	   cell	   that	   describes	   a	   diffracted	   ray/	  recorded	  reflection	  is	  called	  a	  structure-­‐factor	  (F)	  equation:	  
	  
€ 
F(hkl) = f j
j
atoms
∑ exp 2π(hx j + ky j + lz j )[ ] 	  
where	  fj	  is	  the	  diffraction	  contribution	  of	  the	  individual	  atoms.	  F(hkl)	  is	  related	  to	  the	  electron	  density	  ρ(xyz)	  over	  the	  volume	  of	  the	  unit	  cell	  (V)	  by	  a	  mathematical	  procedure,	  Fourier	  transform:	  
	  
€ 
ρ(xyz) = 1V F(hkl)hkl
∑ exp −2πi(hx + ky + lz) + iα(hkl)[ ] 	  
The	   structure	   factor	   F(hkl)	   specifies	   frequency,	   amplitude	   and	   phase.	   The	  frequency	  is	  a	  property	  of	  the	  X-­‐ray	  and	  the	  amplitude	  |F(hkl)|	  is	  calculated	  from	  the	  measured	  intensities	  I(hkl):	  
	  
€ 
F(hkl) = k I(hkl) 	  	  	  where	  k	  is	  a	  scale	  factor.	  However	  the	  phase	  α(hkl)	  cannot	  be	  determined	  from	  diffraction	  experiments;	  best	  described	  as	  the	  ‘phase	  problem’.	  	  
	  
4.1.8	  Solving	  the	  Phase	  Problem	  Additional	   experiments	   are	   performed	   to	   obtain	   the	   phase	   angles	  α	   for	  the	   structure	   factors.	   These	   include	   direct	   methods,	   molecular	   replacement,	  isomorphous	   replacement	   and	   anomalous	   dispersion	  methods.	  Direct	  methods	  rely	   on	   the	   positivity	   and	   atomicity	   of	   electron	   density.	   However	   very	   high	  resolution	   data	   (<1.2	   Å)	   is	   required	   for	   this	   method	   (Taylor,	   2003).	   Thereby	  direct	  methods	   have	   been	   used	   to	   phase	   proteins	   up	   to	  ~1000	   atoms	   and	   are	  mainly	   applied	   to	   find	   the	   heavy-­‐atom	   substructure	   (Taylor,	   2003).	   Molecular	  replacement	   (MR)	   methods	   are	   applied	   when	   a	   homology	   model	   is	   available	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ideally	  with	  a	  sequence	  identity	  of	  >25%	  and	  a	  root	  square	  mean	  (rms)	  deviation	  of	  <2	  Å	  between	  the	  Cα	  atoms	  of	  the	  model	  and	  query	  structures	  (Taylor,	  2003).	  Molecular	  replacement	  involves	  two	  steps:	  rotation	  and	  translation	  (Fig	  4.5).	  The	  rotational	   function	  determines	   the	   correct	  orientation	  of	   the	  model	   in	   the	  new	  unit	  cell.	  The	  subsequent	  translation	  function	  positions	  the	  model	  in	  the	  crystal	  unit	  cell	  with	  respect	  to	  the	  crystallographic	  symmetry	  axes.	  The	  known	  model	  structure	   is	   moved	   through	   the	   asymmetric	   unit	   and	   the	   calculated	   structure	  factors	   are	   compared	   with	   the	   observed	   values.	   The	   resulting	   translation	  solutions	   are	   refined.	   MR	   is	   particularly	   useful	   to	   solve	   structures	   of	   proteins	  with	   high	   sequence	   homology	   to	   known	   structures	   and	   those	   of	   ligand-­‐bound	  proteins	  where	  the	  native	  structures	  are	  known.	  
	  
Fig	  4.5	  Schematic	  representation	  of	  the	  molecular	  replacement	  method	  	  The	  molecular	  replacement	  (MR)	  method	  is	  divided	  into	  two	  steps:	  rotation	  and	  translation.	  The	  rotational	  function	  finds	  the	  correct	  orientation	  of	  the	  model	  in	  the	  new	  unit	  cell.	  The	  subsequent	  translation	  function	  positions	  the	  model	  in	  the	  crystal	  unit	  cell	  with	  respect	  to	  the	  crystallographic	  symmetry	  axes.	  The	  resulting	  translation	  solutions	  are	  refined	  (Taylor,	  2003)	  	   The	   isomorphous	   replacement	   (IR)	   and	   anomalous	   dispersion	   (AD)	  methods	  rely	  on	  heavy	  metal	  derivatives	  of	  the	  native	  crystal.	  Ideally	  the	  heavy	  metal	  is	  bound	  to	  a	  number	  of	  specific	  sites	  in	  the	  protein	  molecule	  leaving	  the	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arrangement	  in	  the	  unit	  cell	  intact	  otherwise.	  Multiple/single	  (M/S)	  wavelengths	  can	   be	   used	   to	   locate	   heavy	   atoms	   in	   the	   unit	   cells.	   Collectively,	  MIR/SIR	   and	  MAD/SAD	  methods	  can	  be	  used	  to	  obtain	  phase.	  The	  IR	  method	  uses	  derivative	  crystals	  of	  at	  least	  more	  than	  one	  heavy	  metal.	  The	  drawbacks	  of	  this	  method	  can	  be	   isomorphism	   between	   crystals	   including	   unit	   cell	   changes,	   reorientation	   of	  the	   protein	   and	   conformational	   changes	   (Taylor,	   2003).	   The	   use	   of	   MAD/SAD	  methods	  overcomes	  this	  problem	  as	  it	  is	  possible	  to	  use	  a	  single	  crystal	  to	  collect	  complete	   datasets	   provided	   there	   is	   sufficiently	   strong	   anomalously	   scattering	  atoms	   in	   the	   protein	   structure	   itself.	   Furthermore,	   a	   combination	   of	   these	  methods	   such	   as	   multiple/single	   isomorphous	   replacement	   with	   anomalous	  scattering	  (MIRAS/SIRAS)	  can	  also	  be	  used.	  	  
	  
4.1.9	  Model	  Building,	  Refinement	  and	  Validation	  	  With	   an	   experimental	   set	   of	   phases,	   a	   3D	   electron	   density	   map	   of	   the	  protein	   structure	   is	   calculated.	   Subsequently,	   it	   is	  possible	   to	  build	   the	  protein	  structure	  model	  into	  the	  electron	  density.	  This	  process	  includes	  optimisation	  to	  reduce	   the	   difference	   between	   the	   experimental	   |Fobs|	   and	   calculated	   |Fcalc|	  structure	   factor	   amplitudes	   using	   the	   phase	   information.	   Refinement	   is	   the	  iterative	  process	  of	  adjusting	  the	  model	  for	  a	  fit	  between	  the	  atomic	  coordinates	  and	   the	   electron	   density.	   This	   enables	   a	   closer	   agreement	   between	   |Fobs|	   and	  |Fcalc|	   and	   considers	   the	   stereochemical	   restraints.	   Statistical	   analyses	   are	  used	  throughout	   the	   iterative	   refinement	   to	   validate	   the	   structure	  model.	   The	  most	  widely	  used	  measures	  include	  the	  R-­‐factor	  and	  the	  Rfree	  values.	  Additionally,	  the	  Ramachandran	   plot	   (Ramachandran	   et	   al.,	   1963)	   is	   also	   used	   to	   validate	   the	  stereochemical	  quality	  of	  the	  protein	  structures.	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4.2	   Materials	  and	  Methods	  	  
4.2.1	  Bioinformatics	  Analysis	  of	  YpTLP	  and	  YpTIR	  	  Secondary	   structure	   and	   disorder	   predictions	   of	   the	   YpTLP	   sequence	  primarily	  helped	  in	  designing	  the	  GEV2	  constructs	  for	  YpTIR.	  In	  addition,	  these	  predictions	   searched	   for	   structural	   homologues	   of	   the	   YpTIR1	   protein,	   which	  might	   serve	   as	   MR	   probes	   in	   solving	   the	   structure	   of	   YpTIR.	   The	   applied	  bioinformatics	   prediction	   tools	   included	   (a)	   FUGUE	   (Ver	   2.0)	   (http://www-­‐cryst.bioc.cam.ac.uk/fugue/),	   (b)	   Protein	   Homology/	   Analogy	   Recognition	  Engine	   (Phyre;	   Ver	   2.0)	   (http://www.sbg.bio.ic.ac.uk/phyre/index.cgi)	   and	   (c)	  Regional	  Order	  Neural	  Network	  (RONN)	  (http://www.strubi.ox.ac.uk/RONN).	  	  FUGUE	   calculates	   the	   sequence-­‐structure	   compatibility	   scores	   and	  produces	  a	  list	  of	  potential	  homologues	  for	  a	  given	  sequence	  (Shi	  et	  al.,	  2001).	  Its	  key	   features	   include	   combined	   information	   from	   both	  multiple	   sequences	   and	  structures,	   environment-­‐specific	   substitution	   and	   structure-­‐dependent	   gap	  penalties,	   where	   scores	   for	   amino	   acid	   matching	   and	   insertions/deletions	   are	  evaluated	  based	  on	  the	  local	  environment	  of	  each	  residue	  in	  a	  known	  structure,	  thereby	   recognizing	   distant	   homologues	   (Shi	   et	   al.,	   2001).	   Phyre	   models	   are	  based	   on	   re-­‐labelling	   the	   coordinates/residues	   of	   a	   known	   structure,	   down-­‐selected	  by	  sequence	  alignment	  to	  the	  template	  sequence	  whilst	  considering	  the	  alignment	   to	   predict	   secondary	   structure	   (Bennett-­‐Lovsey	   et	   al.,	   2008).	   RONN	  disorder	   prediction	   relies	   on	   alignment	   scores	   of	   the	   template	   sequence	   to	   an	  ensemble	  of	  protein	  sequences	  of	  known	  folding	  state	  (ordered,	  disordered	  or	  a	  mixture),	  using	  an	  appropriate	  neural	  network	  (Yang	  et	  al.,	  2005).	  	  	  	  
4.2.2	  Protein	  Folded	  State	  using	  NMR	  Spectroscopy	  	  
	   Sample	   preparation	   for	   NMR	   spectroscopy	   and	   NMR	   data	   processing	  were	  performed	  as	  described	  in	  Section	  3.2.7.	  Attempts	  were	  made	  to	  cleave	  the	  GB1	   tag	   off	   the	   GB1-­‐YpTIR1-­‐His	   and	   GB1-­‐YpTIR2-­‐His	   proteins	   in	   order	   to	  analyse	   the	   folded	   state	  of	   the	  YpTIR	  proteins	   in	   the	  absence	  of	   the	   stabilising	  GB1	   domain.	   Thrombin	   protease	   (GE	   Healthcare)	   was	   added	   according	   to	   the	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manufacturer’s	   recommendations	   of	   1	   unit	   per	   100	   µg	   fusion	   protein	   and	  incubated	   at	   18	   °C	   for	   16	   hr.	   Following	   unsuccessful	   cleavage,	   the	   amount	   of	  thrombin	  protease	  was	  increased	  up	  to	  20	  times	  the	  recommended	  amount.	  
	  
4.2.3	  Crystallisation	  Trials	  of	  GB1-­YpTIR-­His	  
	   Purified	   GB1-­‐YpTIR1-­‐His	   and	   GB1-­‐YpTIR2-­‐His	   proteins	   were	  concentrated	   to	   10	   mg/ml	   in	   buffer	   [20	   mM	   Tris-­‐HCl,	   150	   mM	   NaCl,	   pH	   7.0]	  using	   10	   kDa	   molecular	   weight	   cut-­‐off	   (MWCO)	   concentrators	   (Millipore).	  Protein	   concentration	  was	   estimated	   using	   the	   UV	   absorption	  method	   (Aitken	  and	   Learmonth,	   2002).	   Initial	   crystallisation	   trials	   were	   set	   up	   using	   the	  Mosquito	   sitting	   drop	   crystallisation	   robot,	   programmed	   to	   dispense	   200	  nl	   of	  protein	   solution	   and	   200	   nl	   of	   the	   crystallisation	   reagent	   in	   each	   drop.	  Innovadyne/Wilden	   96-­‐well	   plates	   were	   used	   for	   crystallisation,	   which	   were	  prefilled	   with	   85	   µl	   of	   screen/reservoir	   solutions	   from	   Hampton	   Research,	  Emerald	   BioSystems	   and	   Molecular	   Dimensions	   Ltd.	   (drop	   solutions	   listed	   in	  Appendix	  5).	  The	  crystallisation	  plates	  were	  incubated	  at	  20	  °C.	  Purified	  protein	  was	   flash	   frozen	   in	   liquid	   nitrogen	   and	   stored	   at	   -­‐80°C	   prior	   to	   use	   in	  optimisation	  trials.	  
	  
4.2.4	  Optimisation	  of	  GB1-­YpTIR2-­His	  Native	  Crystals	  Protein	   crystals	   for	   GB1-­‐YpTIR2-­‐His	   (10	  mg/ml)	  were	   optimised	   in	   24-­‐well	  plates	  using	  the	  hanging-­‐drop	  vapour-­‐diffusion	  method	  at	  20	  °C.	  1	  µl	  each	  of	  the	  protein	  and	   the	   reservoir	   solution	  were	  pipetted	   into	  each	  drop,	   incubated	  with	   500	  µl	   of	   the	   reservoir	   solution.	   Grid	   screens	  were	  made	   to	   optimise	   the	  condition	   which	   yielded	   initial	   protein	   crystals:	   condition	   A	   [0.2	   M	   sodium	  malonate,	  0.1	  M	  Bis	  Tris-­‐HCl	  propane	  pH	  6.5,	  20%	  w/v	  PEG	  3350]	  across	  PEG	  concentrations	   14%-­‐24%	   with	   2%	   increments	   and	   15%-­‐25%	   with	   5%	  increments	  along	  with	  varying	  buffer	  pH	   (6.0,	  6.5,	  7.0).	  Grid	   screens	  were	  also	  set	   across	   PEG	   concentrations	   20%-­‐24%	   with	   2%	   increments,	   with	   different	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buffer	  pH	  (6.0,	  6.5,	  7.0)	  and	  varying	  salt	  concentrations	  0.05M-­‐0.3M	  with	  0.05M	  increments.	  The	  composition	  of	  the	  grid	  screens	  used	  is	  tabulated	  in	  Appendix	  5.	  Optimum	   conditions	   were	   further	   explored	   in	   order	   to	   increase	   the	  crystal	   size	   by	   keeping	   the	   initial	   hit	   condition	   A	   constant	   and	   varying	   the	  equilibrium	  dynamics.	  Protein	  drops	  were	  set	  in	  24-­‐well	  plates	  using	  500	  µl	  and	  1	  ml	  of	  the	  reservoir	  solution	  using	  both	  hanging-­‐drop	  and	  sitting-­‐drop	  vapour	  diffusion	  methods.	   Paraffin	   and	   silicone	   oils	  were	   used	   either	   separately	   or	   in	  combination	   on	   top	   of	   the	   reservoir	   solution	   in	   order	   to	   lower	   the	   rate	   of	  equilibrium.	  Crystal	  plates	  were	  incubated	  at	  different	  temperatures:	  4	  °C,	  14	  °C	  and	   20	   °C.	   Protein	   concentration	   was	   also	   varied:	   5	   mg/ml,	   7.5	   mg/ml,	   10	  mg/ml,	   20	  mg/ml	   and	   40	  mg/ml.	   In	   addition,	   the	   protein	   solution	  was	  mixed	  with	   the	   reservoir	   solution,	   and	   centrifuged	   at	   50,000	  g	   for	   30	  min	   at	   4	   °C	   to	  decrease	   nucleation	   points.	   Both	   microseeding	   and	   macroseeding	   were	  performed	   using	   crystals	   obtained	   at	   20%(w/v)	   PEG	   3350	   and	   inoculated	   in	  reservoir	  solutions	  with	  PEG	  concentrations	  of	  18%	  and	  20%.	  	  Additive	   screen	   HR2-­‐428	   (Hampton	   Research)	   was	   also	   used	   in	  combination	  with	  condition	  A	  in	  a	  96-­‐well	  plate	  using	  the	  Mosquito	  sitting	  drop	  crystallisation	  robot	  and	  the	  subsequent	  crystals	  obtained	  were	  further	  repeated	  in	   24-­‐well	   plates	   using	   both	   sitting-­‐drop	   and	   hanging-­‐drop	   vapour-­‐diffusion	  methods.	  The	  crystallisation	  plates	  were	  incubated	  at	  20	  °C.	  The	  additive	  screen	  conditions	  are	  listed	  in	  Appendix	  5.	  All	  the	  crystals	  intended	  for	  X-­‐ray	  diffraction	  experiements	   were	   cryoprotected	   in	   a	   stepwise	   manner	   in	   reservoir	   solution	  containing	   10%,	   20%	   and	   33%	   (v/v)	   glycerol	   prior	   to	   flash	   freezing	   in	   liquid	  nitrogen.	  Loops	  of	  size	  0.05-­‐0.1	  mm	  were	  used	  for	  fishing	  the	  crystals.	  
	  
4.2.5	  Selenomethionine	  Labelled	  GB1-­YpTIR2-­His	  
	   The	   GB1-­‐YpTIR2-­‐His	   construct	   was	   transformed	   into	   BL21(DE3)Star™	  expression	   strain.	   GB1-­‐YpTIR2-­‐His	   was	   the	   protein	   expressed	   using	   standard	  induction	   conditions	   (Chapter	   2;	   Section	   2.2.12)	   in	   100	   mM	   phosphate	   auto-­‐inducing	  media	  (PASM-­‐5052)	  (Studier,	  2005;	  Appendix	  2)	  containing	  125	  µg/ml	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of	   selenomethionine	   (SeMet)	   in	   order	   to	   obtain	   SeMet	   labelled	   protein.	   SeMet	  labelled	   protein	  was	   purified	   as	   described	   in	   Chapter	   2;	   Section	   2.2.13	   for	   the	  unlabelled	  protein.	  	  Purified	  SeMet	  labelled	  GB1-­‐YpTIR2-­‐His	  was	  concentrated	  to	  10	  mg/ml	   in	   buffer	   [20	  mM	  Tris-­‐HCl,	   150	  mM	  NaCl,	   pH	  7.0]	   and	   submitted	   to	  crystallisation	   trials	   using	   crystallisation	   condition	   A	   [0.2	  M	   sodium	  malonate,	  0.1	  M	  Bis	  Tris-­‐HCl	  propane	  pH	  6.5,	  20%	  w/v	  PEG	  3350].	  Crystallisation	   conditions	   were	   optimised	   in	   24-­‐well	   plates	   using	   both	  sitting-­‐drop	  and	  hanging-­‐drop	  vapour-­‐diffusion	  methods	  at	  20	  °C.	  Optimisation	  trials	   included	   additive	   screening,	   grid	   screening	   across	   PEG	   concentrations	  20%-­‐24%	  with	   2%	   increments	   and	   15%-­‐25%	  with	   5%	   increments	   along	  with	  varying	  pH	  (6.0,	  6.5,	  7.0)	  and	  temperature	  screening	  (4	  °C,	  14	  °C).	  Grid	  screens	  were	   also	   set	   across	   varying	   PEG	   concentrations	   (20%,	   22%,	   24%),	   different	  buffer	  pH	  (6.0,	  6.5,	  7.0)	  along	  with	  varying	  salt	  concentrations	  0.05	  M-­‐0.3	  M	  with	  0.05	   M	   increments.	   SeMet	   labelled	   protein	   crystals	   were	   cryoprotected	   as	  described	  in	  Section	  4.2.4.	  
	  
4.2.6	  Heavy	  Metal	  Soaking	  for	  GB1-­YpTIR2-­His	  Crystals	  
	   GB1-­‐YpTIR2-­‐His	  protein	  crystals	  obtained	  in	  the	  condition	  [0.2	  M	  sodium	  malonate,	  0.1	  M	  Bis	  Tris-­‐HCl	  propane	  pH	  6.5]	  at	  20	  °C	  with	  22%	  and	  24%	  w/v	  PEG	  3350	  were	  soaked	  in	  5mM	  potassium	  platinum	  tetrachloride	  (K2PtCl4)	  and	  5mM	   mercury	   chloride	   (HgCl2)	   solutions	   for	   1	   hr.	   Following	   poor	   diffraction	  images,	   the	   protein	   crystals	   were	   soaked	   in	   lower	   solution	   concentrations	   of	  HgCl2	  as	  follows:	  0.1	  mM,	  0.25	  mM,	  0.5	  mM,	  1	  mM	  and	  2	  mM	  for	  22	  hr	  at	  20	  °C.	  All	  the	  crystals	  were	  cryoprotected	  as	  described	  in	  Section	  4.2.4.	  	  Protein	   crystals	  obtained	   in	   condition	  A	   in	  24-­‐well	  plates	  at	  20	   °C	  were	  also	  soaked	  in	  solutions	  containing	  0.5	  M	  and	  1	  M	  sodium	  iodide	  (NaI)	  for	  30	  sec	  and	  1	  min	  prior	   to	   cryoprotection.	  Additional	   crystal	   plates	  were	  prepared	   for	  co-­‐crystallisation	   in	   the	   initial	  hit	   condition	  A	  with	  heavy	  metals	   in	   the	  protein	  drop	  and	  reservoir	  solutions	  using	  10	  mM,	  25	  mM,	  45	  mM,	  65	  mM,	  85	  mM	  and	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100	   mM	   caesium	   chloride	   (CsCl),	   cobalt	   chloride	   hexahydrate	   (CoCl2.6H20),	  rubidium	  chloride	  (RbCl),	  sodium	  bromide	  (NaBr)	  and	  NaI.	  	  
4.2.7	   Iodotyrosine	  Labelled	  GB1-­YpTIR2-­His	  
	   GB1-­‐YpTIR2-­‐His	  was	  transformed	  into	  BL21(DE3)Star™	  expression	  cells.	  GB1-­‐YpTIR2-­‐His	   was	   expressed	   in	   100	   mM	   phosphate	   auto-­‐inducing	   media	  (PASM-­‐5052)	  (Studier,	  2005;	  Appendix	  2)	  containing	  25	  mg/ml	  of	   	  glyophosate	  and	  25	  mg/ml	  of	  iodotyrosine	  to	  replace	  its	  6	  unlabelled	  tyrosine	  residues	  with	  iodotyrosine.	  The	  expression	  protocol	  was	  as	  described	  in	  Section	  2.2.12	  for	  the	  unlabelled	  protein	  in	  LB	  media,	  including	  induction	  with	  1	  mM	  IPTG	  at	  25	  °C	  for	  4	  hr.	  Iodotyrosine	  labelled	  protein	  was	  purified	  as	  described	  in	  Section	  2.2.13	  for	  the	   unlabelled	   protein,	   and	   concentrated	   in	   buffer	   [20	   mM	   Tris-­‐HCl,	   150	   mM	  NaCl,	  pH	  7.0].	  Labelled	  purified	  proteins	  (10	  mg/ml	  and	  20	  mg/ml)	  were	  set	  for	  crystallisation	   using	   the	   initial	   hit	   condition	   for	   the	   unlabelled	   protein	   [0.2	   M	  sodium	   malonate,	   0.1	   M	   Bis	   Tris-­‐HCl	   propane	   pH	   6.5,	   20%	   w/v	   PEG	   3350].	  Crystallisation	   conditions	  were	   set	   in	   24-­‐well	   plates	   using	   sitting-­‐drop	   vapour	  diffusion	  method	  at	  20	  °C.	  	  	  
	  
4.2.8	  Data	  Collection	  and	  Processing	  	  
	   Protein	   diffraction	   and	   datasets	   in	   this	   study	   were	   collected	   using	   a	  Rigaku	  X-­‐ray	  generator,	  the	  Diamond	  Light	  Source	  (DLS,	  Didcot,	  UK)	  Microfocus	  beamline	  I24	  and	  the	  European	  Synchrotron	  Radiation	  Facility	  (ESRF,	  Grenoble,	  France)	  Microfocus	  beamline	   ID23-­‐2.	  Datasets	   from	  the	  SeMet	   labelled	  crystals	  and	   the	   heavy	  metal	   derivatives	  were	   collected	   at	   the	   DLS.	   Diffraction	   images	  and/or	  datasets	  from	  the	  NaI	  crystal	  derivatives	  were	  collected	  using	  the	  Rigaku	  X-­‐ray	   generator	   and	   at	   ESRF.	   Collaborative	   Computational	   Project,	   Number	   4	  (CCP4,	   1994)	   software	   was	   used	   to	   process	   the	   crystallographic	   data.	   Mosflm	  (Leslie,	  1992)	  was	  used	  to	  index	  and	  integrate	  the	  data	  followed	  by	  scaling	  using	  Scala	  (Evans,	  2006).	  The	  processed	  data	  was	  then	  submitted	  to	  Phaser	  (McCoy	  et	  
al.,	  2007;	  McCoy,	  2007;	  1994)	  for	  molecular	  replacement	  to	  obtain	  phase.	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4.3	   Results	  	  
4.3.1	  Bioinformatics	  Analysis	  of	  YpTLP	  and	  YpTIR1	  	  Secondary	   structure	   analysis	  of	   the	  YpTLP	  and	  YpTIR1	   sequences	  using	  FUGUE	  (Ver	  2.0)	   indicated	  a	  high	  sequence-­‐structure	  homology	  to	  the	  bacterial	  TIR	   domain	   in	  Paracoccus	   denitrificans	   (Table	   4.1).	   In	   addition,	   Phyre	   analysis	  predicted	   that	   the	   YpTLP	   and	   YpTIR1	   sequences	   have	   a	   TIR	   domain	   fold	   and	  human	   MyD88-­‐TIR	   as	   the	   best	   homologue	   (Table	   4.1).	   Phyre	   also	   predicts	  disordered	   regions.	   Varying	   stretches	   of	   disordered	   regions	   (1-­‐10	   residues)	  were	   predicted	  mainly	   at	   the	   N-­‐	   and	   C-­‐	   terminal	   ends	   of	   the	   YpTLP	   sequence	  including	  the	  presence	  of	  relatively	  long	  stretches	  of	  disordered	  region	  spanning	  I116	   to	   R134	   and	   F311	   to	   L330.	   Disordered	   regions	   (5-­‐7	   residues)	   were	   also	  predicted	  at	  the	  N-­‐	  and	  C-­‐	  terminal	  ends	  of	  the	  YpTIR1	  sequence.	  RONN	  disorder	  prediction	  for	  the	  full-­‐length	  YpTLP	  sequence	  suggests	  that	   less	  than	  3%	  of	  the	  protein	  is	  disordered	  (M1	  to	  P10	  and	  S345).	  	  	  
Table	  4.1	  Secondary	  structure	  analysis	  of	  YpTLP	  and	  YpTIR	  using	  FUGUE	  and	  Phyre	  
Protein	   PDB	  hit	   Name/	  Source	   Score	   Alignment	  
FUGUE	  YpTLP	   	  3h16	   	  Bacterial	  TIR	  domain	  (Paracoccus	  denitrificans)	   CERTAIN	  21.62	   Yp	  P134	  to	  G263	  	   1fyw	   TIR	  domain	  of	  TLR2	  (Homo	  sapiens)	   9.76	   W132	  to	  R267	  	   1fyv	   TIR	  domain	  of	  TLR1	  (Homo	  sapiens)	   9.76	   N125	  to	  S274	  YpTIR1	   3h16	   Bacterial	  TIR	  domain	  (Paracoccus	  denitrificans)	   17.65	   P134	  to	  G263	  	   1fyx	   P681H	  mutant	  of	  the	  TIR	  domain	  TLR2	  (Homo	  sapiens)	   9.05	   K133	  to	  R267	  	   1fyw	   TIR	  domain	  of	  TLR2	  (Homo	  sapiens)	   8.99	   W132	  to	  R267	  
Protein	   Estimated	  
Precision	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  SCOP	  code	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Fold/	  PDB	  descriptor	  	   Family	   Alignment	  Yp	  
Phyre	  YpTLP	   	  100%	   	  2JS7:	  161	  aa,	  13%	  identity	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  MyD88-­‐TIR	   	  TIR	  domain	   	  V123	  to	  I262	  YpTIR1	   100%	   2JS7:	  161	  aa,	  13%	  identity	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  MyD88-­‐TIR	   TIR	  domain	   P134	  to	  I262	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Secondary	   structure	   and	   disorder	   predictions	   of	   the	   YpTLP	   and	   YpTIR	  sequences	   primarily	   confirmed	   their	   homology	   to	   the	   TIR	   superfamily	   and	  helped	   in	   designing	   of	   the	   GEV2	   constructs	   in	   combination	   with	   the	   3D	   Jury	  predictions	   of	   secondary	   structure	   elements	   (Appendix	   3).	   Furthermore,	   it	  suggested	  the	  possibility	  of	  using	  molecular	  replacement	  for	  phase	   information	  in	  solving	  the	  YpTIR	  structure	  using	  X-­‐ray	  crystallisation.	  
	  
4.3.2	  Analysis	  of	  the	  Folded	  State	  of	  YpTIR	  using	  1D	  NMR	  	  1D	   (1H)	   NMR	   spectroscopy	  was	   used	   to	   analyse	   the	   folded	   state	   of	   the	  protein	  once	  it	  was	  possible	  to	  isolate	  the	  purified	  protein	  and	  obtain	  adequate	  amounts	   (~10	  µM)	   of	   purified	   protein	   in	   a	   relatively	   stable	   and	   soluble	   (non-­‐aggregated)	   form.	   The	   1D	   NMR	   spectra	   of	   YpTIR-­‐His	   (Ser130	   to	   Ala285)	  expressed	  using	  pET26b	  (Fig	  4.6a)	  indicate	  the	  presence	  of	  flexible	  regions	  and	  a	  small	  globular	  domain.	  The	  spectra	  suggest	  that	  the	  protein	  is	  largely	  unfolded.	  The	  YpTIR	  peaks	  displayed	  improvement	  in	  intensity	  and	  linewidth	  in	  the	  case	  of	  GB1-­‐YpTIR1	  protein	  expressed	  using	  GEV2	  (Fig	  4.6b).	  However	  the	  comparative	  broadness	   of	   the	   folded	   peaks	   suggest	   the	   protein	   may	   be	   self-­‐associating	   or	  non-­‐globular	   in	   shape.	  The	   spectra	  of	  GB1-­‐YpTIR1-­‐His	   (Ser130	   to	  Ala285)	  was	  compared	   to	   that	  of	   the	  GB1	  protein	   to	   confirm	   that	   the	   improved	  peaks	  were	  indeed	  from	  YpTIR	  (Fig	  4.6).	  The	  GB1	  (~6	  kDa)	  peaks	  (Fig	  4.6c)	  were	  much	  more	  intense	   and	   narrower	   compared	   to	   the	   broader	   YpTIR	   (~50	   kDa	   as	   dimers)	  peaks	  supporting	  the	  suggestion	  that	  YpTIR	  is	  self-­‐associating.	  
	  	   148	  
	  
Fig	  4.6	  1D	  (1H)	  NMR	  spectra	  of	  YpTIR1-­His,	  GB1-­YpTIR1-­His	  and	  GB1	  (a)	  YpTIR1-­‐His	  (b)	  GB1-­‐YpTIR1-­‐His	  and	  (c)	  GB1	  in	  20	  mM	  Tris-­‐HCl,	  150	  mM	  NaCl,	  pH	  7.0.	  Buffer	  for	  YpTIR1-­‐His	  also	  contained	  10	  mM	  BME.	  Black	  and	  red	  arrows	  indicate	  YpTIR	  and	  GB1	  peaks	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The	   1D	   NMR	   spectra	   of	   GB1-­‐YpTIR2-­‐His	   (Ile137	   to	   Ile273)	   suggests	  domain	   overlap.	  Due	   to	   the	   shorter	   sequence	   insert	   between	   the	  GB1	   and	  TIR	  domains	  in	  GB1-­‐YpTIR2-­‐His,	  the	  resultant	  peaks	  exhibited	  shifts	  as	  compared	  to	  the	   GB1-­‐YpTIR1-­‐His	   peaks	   indicating	   that	   the	   GB1	   and	   YpTIR2	   domains	   are	  interacting	  (Fig	  4.7a).	  The	  effect	  of	  this	  shorter	  sequence	  insert	  in	  GB1-­‐YpTIR2-­‐His	  was	   further	   evident	  when	   thrombin-­‐assisted	   digestion	   of	   the	   GB1	   tag	  was	  attempted	   (Fig	  4.7b).	   It	  was	  difficult	   to	   cleave	   the	  GB1	   tag	  off	  GB1-­‐YpTIR1-­‐His	  using	  20x	  thrombin	  and	  it	  was	  not	  possible	  to	  cleave	  GB1-­‐YpTIR2-­‐His.	  
	  
Fig	  4.7	  Analysis	  of	  domain	  overlap	  in	  GB1-­YpTIR2-­His	  by	  NMR	  and	  SDS-­PAGE	  	  (a)	  1D	  (1H)	  NMR	  spectra	  of	  GB1-­‐YpTIR2-­‐His	  in	  20	  mM	  Tris-­‐HCl,	  150	  mM	  NaCl,	  pH	  7.0.	  Peaks	  with	  shift	  changes	  suggesting	  putative	  domain	  overlap	  indicated	  by	  arrows.	  (b)	  SDS-­‐PAGE	  analysis	  of	  the	  digestion	  of	  GB1-­‐YpTIR1-­‐His	  and	  GB1-­‐YpTIR2-­‐His	  using	  20x	  thrombin	  protease	  at	  18	  °C.	  M	  indicates	  molecular	  weight	  marker,	  Lanes	  1,	  3,	  5,	  7	  and	  25	  correspond	  to	  incubation	  time	  in	  hr	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4.3.3	  Optimisation	  of	  the	  GB1-­YpTIR1-­His	  Spectra	  	  Due	   to	   domain	   overlap	   observed	   for	   GB1-­‐YpTIR2-­‐His,	   GB1-­‐YpTIR1-­‐His	  was	  selected	  for	  further	  NMR	  studies.	  Although	  it	  proved	  impossible	  to	  separate	  the	  GB1	  tag	  and	  YpTIR1-­‐His	  in	  order	  to	  produce	  spectra	  for	  the	  cleaved	  YpTIR1-­‐His,	  the	  NMR	  peak	  resolution	  was	  sufficient	  to	  explore	  varying	  buffer	  conditions	  in	  an	  attempt	  to	  improve	  the	  linewidth	  and	  intensity	  of	  the	  YpTIR	  peaks.	  These	  conditions	  included	  different	  buffer	  pH:	  20	  mM	  NaH2PO4	  pH	  5.0	  (Fig	  4.8b)	  and	  20	   mM	   Tris-­‐HCl	   pH	   9.0	   (Fig	   4.8c).	   However	   neither	   the	   linewidth	   nor	   the	  intensity	   of	   the	   YpTIR	   peaks	   were	   improved	   in	   comparison	   with	   the	   spectra	  obtained	   using	   the	   standard	   buffer	   20	  mM	  Tris-­‐HCl	   pH	   7.0	   (Fig	   4.8a).	   The	   1D	  NMR	  spectra	  of	  GB1-­‐YpTIR1-­‐His	  were	  further	  analysed	  in	  20	  mM	  Tris-­‐HCl	  pH	  7.0	  in	  the	  presence	  of	  up	  to	  225	  mM	  NaCl	  (Fig	  4.9b)	  and	  up	  to	  10	  mM	  DTT	  (Fig	  4.9c).	  The	   intensity	   and	   resolution	   of	   the	   YpTIR	   peaks	   showed	   improvement	   in	   the	  presence	  of	  up	   to	  225	  mM	  NaCl	   (Fig	  4.9b)	  when	  compared	  with	   the	  spectra	   in	  the	  sample	  buffer	  condition	  without	  NaCl	  (Fig	  4.9a).	  In	  the	  presence	  of	  up	  to	  10	  mM	  DTT	   (Fig	   4.9c),	   there	  were	  no	   spectral	   differences	   observed.	  GB1-­‐YpTIR1-­‐His	  was	  subjected	  to	  2D-­‐NMR	  analysis	  in	  the	  optimised	  buffer	  condition	  [20	  mM	  Tris-­‐HCl,	  225	  mM	  NaCl,	  pH	  7.0]	  for	  further	  characterisation.	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Fig	  4.8	  1D	  (1H)	  NMR	  spectra	  of	  GB1-­YpTIR1-­His	  in	  differing	  pH	  buffers	  	  GB1-­‐YpTIR1-­‐His	  was	  analysed	  by	  1D	  NMR	  in	  the	  following	  buffer	  conditions	  (a)	  20	  mM	  Tris-­‐HCl	  pH	  7.0	  (b)	  20	  mM	  NaH2PO4	  pH	  5.0	  and	  (c)	  20	  mM	  Tris-­‐HCl	  pH	  9.0.	  Arrows	  indicate	  YpTIR	  peaks	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Fig	  4.9	  1D	  (1H)	  NMR	  spectra	  of	  GB1-­YpTIR1-­His	  in	  differing	  buffer	  conditions	  	  GB1-­‐YpTIR1-­‐His	  was	  analysed	  by	  1D	  NMR	  in	  (a)	  20	  mM	  Tris-­‐HCl	  pH	  7.0	  (b)	  including	  225	  mM	  NaCl	  and	  (c)	  10	  mM	  DTT.	  Arrows	  indicate	  YpTIR	  peaks	  in	  comparison	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4.3.4	  Analysis	  of	  GB1-­YpTIR1-­His	  using	  2D	  NMR	  	  	   2D	   (1H/15N)	   TROSY-­‐type	   HSQC	   spectra	   were	   recorded	   for	   15N-­‐GB1-­‐YpTIR1	   in	   20	  mM	  Tris-­‐HCl,	   225	  mM	  NaCl,	   pH	   7.0.	   The	   experiments	   had	   to	   be	  performed	   over	   an	   extended	   period	   owing	   to	   poor	   signal	   to	   noise	   ratio.	   The	  protein	   sample	  was	   unstable	   as	   it	   showed	   heavy	   precipitation	   after	   the	   18	   hr	  recording	  period	  at	  30	  °C.	  However,	  the	  2D	  NMR	  spectra	  indicated	  folded	  protein	  by	  the	  presence	  of	  peaks	  in	  addition	  to	  GB1	  outside	  unfolded	  regions	  of	  plot	  (>9	  ppm)	  (Fig	  4.10).	  
	  
	  
Fig	  4.10	  2D	  (1H/15N)	  HSQC	  NMR	  spectra	  of	  GB1-­YpTIR1-­His	  	  15N-­‐GB1-­‐YpTIR1-­‐His	  was	  analysed	  by	  2D	  NMR	  in	  20	  mM	  Tris-­‐HCl,	  225	  mM	  NaCl	  pH	  7.0	  using	  a	  Bruker	  600	  spectrometer	  at	  303	  K.	  Green	  arrows	  indicate	  peaks	  suggestive	  of	  tertiary	  structure,	  which	  are	  in	  addition	  to	  GB1	  resonances	  (see	  Chapter	  3)	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In	  addition	   to	   the	  problems	  encountered	  during	   the	  recording	  of	   the	  2D	  NMR	  spectra	  of	  15N-­‐GB1-­‐YpTIR1,	  only	  approximately	  270	  residues	  were	  seen	  in	  the	   2D	   spectra	   (Fig	   4.10).	   This	   is	   out	   of	   a	   total	   of	   410	   residues,	   taking	   into	  account	  the	  size	  of	  the	  dimer.	  Considering	  the	  self-­‐associated	  state	  of	  the	  protein,	  the	   reason	   for	   the	  missing	   residues	  was	  most	   likely	   the	  upper	   size	   limit	  of	   the	  multimeric/aggregated	   protein	   for	   NMR	   spectroscopy.	   At	   this	   stage,	   it	   was	  deemed	  impossible	  to	  structurally	  characterise	  YpTIR	  using	  the	  existing	  protein	  constructs	  by	  NMR.	  
	  
4.3.5	  Crystallisation	  of	  GB1-­YpTIR2-­His	  
	   Concomitant	   crystallisation	   trials	   of	   GB1-­‐YpTIR1-­‐His	   and	   GB1-­‐YpTIR2-­‐His	   proteins	   yielded	   crystals	   of	   GB1-­‐YpTIR2-­‐His	   (10	   mg/ml)	   crystallised	   in	  condition	  A	   [0.2	  M	   sodium	  malonate,	   0.1	  M	  Bis	   Tris-­‐HCl	   propane	   pH	  6.5,	   20%	  w/v	   PEG	   3350]	   of	   the	   PACT	   Suite	   (Molecular	   Dimensions	   Ltd.)	   at	   20	   °C.	   The	  crystals	   were	   obtained	   in	   a	   200	   nl	   volume	   sitting	   drop	   (Fig	   4.11)	   and	   was	  confirmed	  as	  a	  protein	  crystal	  using	  a	  PX-­‐scanner	  at	  the	  DLS	  (results	  not	  shown).	  The	  size	  of	  the	  crystal	  was	  40	  µm	  X	  48	  µm.	  
	  
Fig	  4.11	  Initial	  crystals	  of	  GB1-­YpTIR2-­His	  Initial	  crystals	  of	  GB1-­‐YpTIR2-­‐His	  in	  0.2	  M	  sodium	  malonate,	  0.1	  M	  Bis	  Tris-­‐HCl	  propane	  pH	  6.5,	  20%	  w/v	  PEG	  3350,	  sitting	  drops	  set	  in	  96-­‐well	  plates	  at	  20	  °C.	  Crystal	  size	  indicated;	  50	  µm	  scale	  is	  used.	  Crystals	  viewed	  under	  (a)	  non-­‐polarised	  light	  and	  (b)	  polarised	  light.	  Crystals	  were	  viewed	  under	  polarised	  light	  using	  a	  Polaroid	  filter	  under	  the	  microscope.	  This	  was	  to	  distinguish	  between	  isotropic	  protein	  crystals	  (usually	  monochromatic)	  and	  anisotropic	  salt	  crystals	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Although	  the	  crystallisation	  conditions	  were	  screened	  using	  a	  grid	  screen	  of	  the	  initial	  buffer	  condition	  A	  including	  additive	  screen,	  the	  initial	  condition	  A	  was	  the	  best	  condition.	  This	  was	  based	  on	  the	  size,	  sharp	  features	  and	  singularity	  of	  the	  obtained	  crystals.	  The	  bigger	  hanging	  drop	  volume	  (2	  µl)	  in	  a	  24-­‐well	  plate	  increased	   the	   crystal	   size	   to	   ~47	   µm	   X	   48	   µm	   (Fig	   4.12a).	   It	   was	   possible	   to	  further	  increase	  the	  size	  of	  the	  crystals	  to	  ~47	  µm	  X	  64	  µm	  using	  a	  sitting	  drop	  rather	  than	  a	  vapour	  diffusion	  set	  up	  (Fig	  4.12b),	  and	  also	  increase	  the	  size	  of	  the	  crystals	  to	  ~68	  µm	  X	  68	  µm	  when	  the	  protein	  concentration	  was	  increased	  to	  20	  mg/ml	  (Fig	  4.12c-­‐d).	  The	  biggest	  crystals	  were	  submitted	  to	  X-­‐ray	  diffraction.	  
	  
Fig	  4.12	  Optimisation	  of	  GB1-­YpTIR2-­His	  crystals	  in	  sitting	  drops	  Optimised	  crystals	  of	  GB1-­‐YpTIR2-­‐His	  in	  0.2	  M	  sodium	  malonate,	  0.1	  M	  Bis	  Tris-­‐HCl	  propane	  pH	  6.5,	  20%	  w/v	  PEG	  3350	  set	  in	  24-­‐well	  plates	  at	  20	  °C	  using	  (a)	  10	  mg/ml	  protein	  in	  hanging	  drop	  (b)	  10	  mg/ml	  protein	  in	  sitting	  drop	  (c)	  20	  mg/ml	  protein	  in	  sitting	  drop	  viewed	  under	  non-­‐polarised	  light	  and	  (d)	  viewed	  under	  polarised	  light.	  Crystal	  sizes	  indicated;	  50	  µm	  scale	  is	  used	  	  	  	  	  
	  	   156	  
4.3.6	  Diffraction	  Pattern	  of	  GB1-­YpTIR2-­His	  Crystals	  
	   The	  GB1-­‐YpTIR2-­‐His	  crystals	  (Fig	  4.13a)	  diffracted	  maximally	  up	  to	  3.5	  Å	  resolution	   (Fig	   4.13b)	   using	   the	   Microfocus	   beamline	   I24	   at	   the	   DLS.	   Initial	  crystallographic	   analysis	   indicated	   that	   the	   crystals	   had	   a	   C2	   space	   group	  requiring	  180	  images	  for	  a	  complete	  dataset.	  However	  the	  crystals	  suffered	  from	  radiation	  damage	  and	  only	  partial	  datasets	  with	  <90	  images	  could	  be	  collected.	  	  
	  
Fig	  4.13	  A	  typical	  GB1-­YpTIR2-­His	  crystal	  and	  corresponding	  diffraction	  pattern	  GB1-­‐YpTIR2-­‐His	  crystals	  were	  obtained	  in	  0.2	  M	  sodium	  malonate,	  0.1	  M	  Bis	  Tris-­‐HCl	  propane	  pH	  6.5,	  20%	  w/v	  PEG	  3350	  set	  in	  24-­‐well	  plates	  at	  20	  °C	  using	  20	  mg/ml	  protein	  in	  sitting	  drops.	  The	  reservoir	  volume	  was	  500	  µl.	  The	  crystal	  was	  (a)	  cryoprotected	  and	  mounted	  on	  a	  0.5-­‐0.1	  mm	  loop	  and	  (b)	  diffraction	  images	  obtained	  using	  Microfocus	  beamline	  I24	  at	  DLS,	  Didcot	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4.3.7	  Further	  Optimisation	  of	  GB1-­YpTIR2-­His	  Crystals	  	  In	  order	  to	  collect	  a	  complete	  diffraction	  dataset	  (~180	  images)	  for	  data	  processing	   it	   was	   necessary	   to	   further	   optimise	   the	   GB1-­‐YpTIR2-­‐His	   crystals.	  This	   was	   done	   using	   the	   fixed	   crystallisation	   condition	   (condition	   A)	   and	  modulating	   the	   equilibrium	   dynamics	   of	   protein	   crystallisation.	   Neither	   the	  addition	  of	  paraffin	  and	  silicone	  oils	  on	  top	  of	  the	  reservoir	  solutions	  nor	  altering	  the	   crystallisation	   temperature	   to	   4	   °C/14	   °C	   showed	   any	   improvement.	   The	  protein	  solution	  was	  mixed	  with	  the	  reservoir	  solution	  and	  centrifuged	  at	  50,000	  
g	  prior	  to	  setting	  drops	  in	  order	  to	  decrease	  nucleation	  points.	  However	  this	  did	  not	  result	  in	  further	  size	  growth	  of	  the	  fewer	  obtained	  crystals.	  In	  addition,	  both	  macroseeding	  and	  microseeding	  attempts	  resulted	  in	  a	  large	  number	  of	  smaller	  protein	  crystals.	  Subsequently,	  the	  optimal	  reservoir	  volume	  was	  screened	  with	  respect	  to	  the	   corresponding	   drop	   volumes	   using	   20	   mg/ml	   protein.	   The	   criteria	   for	  screening	   best	   crystallisation	   conditions	   were	   again	   improved	   size,	   sharp	  features	   and	   singularity	  of	   the	  obtained	   crystals.	   It	  was	  observed	   that	   the	  best	  crystals	  were	  obtained	  in	  a	  2	  µl	  drop	  (crystal	  size	  75	  µm	  X	  68	  µm)	  using	  500	  µl	  reservoir	  solution	  rather	  than	  1	  ml	  (crystal	  size	  62	  µm	  X	  65	  µm),	  300	  µl	  (crystal	  size	  65	  µm	  X	  70	  µm)	  or	  250	  µl	  volumes	  (crystal	  size	  71	  µm	  X	  65	  µm)	  (Fig	  4.14a-­‐d).	  In	  terms	  of	  drop	  sizes,	  the	  best	  crystals	  were	  obtained	  in	  a	  2	  µl	  drop	  (crystal	  size	  75	  µm	  X	  68	  µm)	  rather	  than	  4	  µl	  (crystal	  size	  75	  µm	  X	  71	  µm),	  6	  µl	  (crystal	  size	  61	  µm	  X	  59	  µm)	  or	  8	  µl	   drops	   (crystal	   size	  79	  µm	  X	  77	  µm)	  using	  500	  µl	  reservoir	  solution	  (Fig	  4.14b,e-­‐g).	  	  Although	  crystals	  of	  sizes	  similar	  to	  or	  larger	  than	  the	  optimal	  2	  µl	  drop	  in	  500	   µl	   reservoir	   condition	   were	   obtained	   using	   250	   µl	   or	   300	   µl	   reservoir	  volumes	   or	   6	   µl	   drops,	   crystals	   obtained	   in	   these	   latter	   conditions	   were	   not	  singular	  (Fig	  4.14h).	  Overall,	   the	  best	  crystallisation	  condition	   for	  GB1-­‐YpTIR2-­‐His	  was	   the	   2	   µl	   sitting	   drop	   condition	  using	  500	  µl	   reservoir	   solution	   and	  20	  mg/ml	  protein.	  However	  the	  crystals	  were	  incubated	  at	  20	  °C	  for	  a	  longer	  period	  of	   ~20	   days	   instead	   of	   ~5	   days	   prior	   to	   cryoprotection	   and	   flash	   freezing.	  Subsequently,	  these	  crystals	  were	  submitted	  to	  X-­‐ray	  diffraction	  in	  an	  attempt	  to	  collect	  better	  datasets.	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Fig	  4.14	  Optimisation	  of	  equilibrium	  dynamics	  for	  GB1-­YpTIR2-­His	  crystals	  GB1-­‐YpTIR2-­‐His	  (20	  mg/ml)	  crystals	  in	  0.2	  M	  sodium	  malonate,	  0.1	  M	  Bis	  Tris-­‐HCl	  propane	  pH	  6.5,	  20%	  w/v	  PEG	  3350	  at	  20	  °C	  using	  (a)	  1	  ml	  (b)	  500	  µl	  (c)	  300	  µl	  (d)	  250	  µl	  reservoir	  solutions	  set	  in	  2	  µl	  drops.	  	  Crystals	  attained	  in	  (e)	  4	  µl	  (f)	  6	  µl	  (g)	  8	  µl	  drop	  sizes	  using	  500	  µl	  reservoir	  solutions.	  50	  µm	  scale	  is	  used.	  (h)	  Enlarged	  crystal	  views	  to	  indicate	  twinning	  in	  conditions	  c,d,f.	  Approximate	  crystal	  sizes	  are	  indicated	  for	  the	  corresponding	  conditions	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4.3.8	  Native	  Diffraction	  Pattern	  and	  Data	  Analysis	  The	  optimised	  GB1-­‐YpTIR2-­‐His	  crystals	  diffracted	  maximally	  up	  to	  2.7	  Å	  resolution	  (Fig	  4.15)	  using	  the	  Microfocus	  beamline	  ID23-­‐2	  at	  ESRF,	  Grenoble.	  It	  was	  possible	  to	  collect	  diffraction	  datasets	  (>180	  images)	  suitable	  for	  processing.	  
	  
Fig	  4.15	  Diffraction	  image	  of	  the	  optimised	  GB1-­YpTIR2-­His	  crystal	  	  GB1-­‐YpTIR2-­‐His	  crystals	  were	  grown	  in	  condition	  A	  at	  20	  °C	  for	  ~20	  days	  prior	  to	  flash	  freezing.	  The	  frozen	  crystal	  gave	  (a)	  good	  diffraction	  images	  (b)	  up	  to	  2.7	  Å	  resolution	  using	  the	  Microfocus	  beamline	  ID23-­‐2	  at	  ESRF,	  Grenoble,	  France	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Datasets	  of	   the	  GB1-­‐YpTIR2-­‐His	  crystals	  were	  processed	  using	   the	  CCP4	  software	  package	  (summarised	   in	  Table	  4.2).	  GB1-­‐YpTIR2-­‐His	  crystals	  possibly	  belong	   to	   the	   monoclinic	   space	   group	   C2.	   The	   diffraction	   limit	   for	   data	  processing	  was	  cut-­‐off	  at	  2.95	  Å	  to	  ensure	  good	  quality	  diffraction	  indicated	  by	  a	  mean	   signal	   to	   noise	   ratio	   (I/σI)	   >1,	   the	   merging	   R-­‐factor	   (Rmerge)	   related	   to	  redundancy	  close	   to	  <0.5	  and	  a	  near	   to	  100%	  completeness	  of	   the	  data	   for	   the	  highest	  resolution	  shell.	  Evaluation	  of	   the	  crystal	  packing	  parameters	   indicated	  that	   the	   space	   groups	   most	   likely	   accommodate	   two	   protein	   molecules	   per	  asymmetric	  unit	  to	  give	  a	  solvent	  content	  of	  46.4%.	  
Table	  4.2	  Diffraction	  data	  analysis	  of	  GB1-­YpTIR2-­His	  crystals	  
Native	  Data	  Collection	   	  Beamline	   ESRF	  ID23-­‐2	  Wavelength	  (Å)	   0.8726	  Maximum	  resolution	  (Å)	  	   2.95	  Space	  group	   C2	  Unit	  cell	  dimensions	  a,	  b,	  c	  (Å)	   61.35,	  84.72,	  83.95	  Unit	  cell	  dimensions	  α,	  β,	  γ	  (°)	   90,	  101.05,	  90	  Unit	  cell	  volume	  (Å3)	   423279.125	  Matthews	  coefficient	   2.29	  Solvent	  content	  (%)	   46.42	  Mol/asymmetric	  unit	   2	  Resolution	  (Å)	   82.39	  -­‐	  2.95	  Rmerge	  a	  	   0.038	  (0.823)	  Total	  number	  of	  observations	   1004	  (4684)	  Total	  number	  unique	   296	  (1314)	  Mean	  (I/σI)	   21.5	  (1.5)	  Completeness	  	  (%)	   99.9	  (100)	  Multiplicity	  	  	  	   3.4	  (3.6)	  
Values	  in	  parentheses	  refer	  to	  the	  highest	  resolution	  shell	  
a	   	  	  
where	  Ihkl	  is	  the	  mean	  symmetry-­related	  intensity	  of	  the	  reflection	  
! 
Rmerge = hkl i"" Ii(hkl) # I(hkl) / hkl iIi(hkl)""
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4.3.9	  Phasing	  Trials	  of	  GB1-­YpTIR2-­His	  Data	  using	  MR	  It	   is	   possible	   that	   the	   solvent	   content	   of	   the	   crystals	   were	   as	   high	   as	  73.21%	  with	  one	  molecule	   in	   the	  asymmetric	  unit	  given	   the	   limited	  diffraction	  quality	   for	   a	   small-­‐sized	   soluble	   protein.	   Molecular	   replacement	   (MR)	   was	  attempted	  using	  Phaser	  (Storoni	  et	  al.,	  2004)	  in	  the	  CCP4	  suite	  to	  search	  for	  both	  one	  and	   two	  molecules	  per	  asymmetric	  unit.	  The	  datasets	  were	   integrated	  and	  scaled	  using	  Mosflm	  and	  Scala	  in	  the	  CCP4	  software	  package	  prior	  to	  submitting	  to	   Phaser.	   It	   was	   not	   possible	   to	   find	   an	  MR	   solution	   for	   the	   GB1-­‐YpTIR2-­‐His	  dataset	  when	  the	  TIR	  domain	  of	  human	  TLR1	  (amino	  acid	  sequence	   identity	  of	  11.7%)	   and	   the	   PdTIR	   protein	   (amino	   acid	   sequence	   identity	   of	   21.9%)	   were	  used	  as	  MR	  probes	  possibly	  due	  to	  low	  sequence	  homology	  to	  GB1-­‐YpTIR2-­‐His.	  Subsequently,	   the	   B1	   immunoglobulin-­‐binding	   domain	   of	   streptococcal	  protein	  G	  (GB1)	  (Huth	  et	  al.,	  1997)	  (amino	  acid	  sequence	  identity	  of	  25.9%	  to	  the	  GB1-­‐YpTIR-­‐His)	  was	  used	  as	  a	  starting	  model.	  Though	  solutions	  were	  generated	  using	  Phaser	  for	  both	  cases	  of	  searches	  for	  one	  and	  two	  copies	  of	  GB1-­‐YpTIR2-­‐His	  molecules	  per	  asymmetric	  unit,	  the	  Z-­‐scores	  for	  the	  solutions	  were	  lower	  in	  each	  case	  than	  those	  expected	  for	  correct	  solutions.	  In	  both	  cases,	  density	  maps	  were	  generated	  only	  for	  symmetry-­‐related	  units.	  Results	  are	  included	  for	  the	  MR	  search	  made	  with	  two	  copies	  of	  GB1-­‐YpTIR2-­‐His	  molecules	  per	  asymmetric	  unit	  (Fig	   4.16).	   The	   fast	   function	   table	   Z-­‐scores	   for	   the	   correct	   solution	   was	   5.40	  (translation)	  and	  3.49	  (rotation).	  The	  minimal	  Z-­‐scores	  for	  the	  correct	  solutions	  are	   8	   (translation)	   and	   5	   (rotation)	   (McCoy	   et	   al.,	   2007).	   In	   addition	   to	   the	  presence	  of	  only	  symmetry-­‐related	  units	  in	  the	  density	  maps	  of	  the	  MR	  solution	  (Fig	   4.16a;	   in	   green),	   the	   observed	   density	   maps	   for	   the	   GB1	   domain	   were	  randomly	  distributed	  possibly	  containing	  model-­‐biased	  connections	  (Fig	  4.16b).	  The	  discontinuous	  and	   fragmented	  density	  maps	  can	  be	  observed	  around	  both	  copies	  of	   the	  GB1	  domain	  (Fig	  4.16b;	   in	  pink	  and	  yellow).	  Unfortunately,	   it	  has	  not	  been	  possible	  to	  obtain	  the	  phase	  information	  for	  YpTIR	  using	  MR.	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Fig	  4.16	  Density	  map	  of	  the	  MR	  solution	  for	  GB1-­YpTIR2-­His	  dataset	  using	  Phaser	  MR	  solutions	  were	  generated	  for	  the	  GB1-­‐YpTIR2-­‐His	  datasets	  using	  Phaser	  in	  the	  CCP4	  suite.	  (a)	  Density	  map	  of	  the	  MR	  solution	  indicating	  the	  two	  copies	  of	  the	  GB1	  domain	  in	  pink	  and	  yellow	  and	  the	  symmetry-­‐related	  units	  in	  green.	  (b)	  A	  zoomed-­‐in	  view	  of	  the	  GB1	  domain	  copies	  to	  indicate	  observations	  of	  discontinuous	  and	  model-­‐biased	  density	  maps	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4.3.10	  SeMet	  Labelled	  GB1-­YpTIR2-­His	  Crystals	  	  Alternative	  approaches	  to	  obtain	  phase	  include	  isomorphous	  replacement	  and/or	  anomalous	  scattering	  methods	  using	  heavy	  metal	  derivatives	  of	  the	  GB1-­‐YpTIR2-­‐His	  crystals.	  SeMet	  labelled	  GB1-­‐YpTIR2-­‐His	  crystals	  of	  sizes	  to	  ~34	  µm	  X	   39	   µm	   were	   obtained	   in	   hanging	   drops	   using	   condition	   A	   [0.2	   M	   sodium	  malonate,	   0.1	   M	   Bis	   Tris-­‐HCl	   propane	   pH	   6.5,	   20%	  w/v	   PEG	   3350],	   the	   same	  condition	  that	  yielded	  initial	  crystals	  for	  the	  unlabelled	  protein	  (Fig	  4.17a-­‐b).	  In	  contrast	  to	  the	  unlabelled	  protein,	  the	  SeMet	  protein	  crystals	  were	  smaller	  when	  the	  sitting	  drop	  condition	  was	  used	  (Fig	  4.17c-­‐d;	  crystal	  sizes	  ~34	  µm	  X	  35	  µm	  and	  ~26	  µm	  X	  29	  µm).	   In	  addition,	  no	  crystals	  were	  obtained	  when	   the	  SeMet	  labelled	  protein	  concentration	  was	  increased	  to	  20	  mg/ml.	  
	  
Fig	  4.17	  Optimisation	  of	  the	  SeMet	  labelled	  GB1-­YpTIR2-­His	  crystals	  SeMet	  labelled	  GB1-­‐YpTIR2-­‐His	  (10	  mg/ml)	  crystals	  were	  obtained	  in	  condition	  A;	  0.2	  M	  sodium	  malonate,	  0.1	  M	  Bis	  Tris-­‐HCl	  propane	  pH	  6.5,	  20%	  w/v	  PEG	  3350	  at	  20	  °C	  set	  in	  hanging	  drops.	  Crystals	  were	  viewed	  under	  (a)	  non-­‐polarised	  and	  (b)	  polarised	  light.	  	  Crystals	  obtained	  in	  sitting	  drops	  in	  (c)	  0.2	  M	  sodium	  malonate,	  0.1	  M	  Bis	  Tris-­‐HCl	  propane	  pH	  6.0,	  22%	  w/v	  PEG	  3350	  (d)	  initial	  condition	  A	  with	  additive	  1	  mM	  L-­‐Glutathione.	  Crystal	  sizes	  indicated;	  50	  µm	  scale	  is	  used	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The	   SeMet	   labelled	   GB1-­‐YpTIR2-­‐His	   crystals	   diffracted	  maximally	   up	   to	  3.5	   Å	   resolution	   (Fig	   4.18)	   using	   the	   Microfocus	   beamline	   I24	   at	   DLS,	   Didcot.	  However	   the	   crystals	   gave	   anisotropic	   diffraction	   over	   prolonged	   exposure	   to	  the	   X-­‐ray	   beamline	   during	   data	   collection	   (Fig	   4.18b).	   As	   a	   result,	   it	   was	   not	  possible	  to	  collect	  full	  diffraction	  datasets	  suitable	  for	  processing,	  most	  likely	  as	  a	  consequence	  of	  severe	  radiation	  damage.	  
	  
Fig	  4.18	  Diffraction	  images	  of	  the	  SeMet	  labelled	  GB1-­YpTIR2-­His	  crystals	  SeMet	  labelled	  GB1-­‐YpTIR2-­‐His	  crystals	  were	  obtained	  in	  0.2	  M	  sodium	  malonate,	  0.1	  M	  Bis	  Tris-­‐HCl	  propane	  pH	  6.5,	  20%	  w/v	  PEG	  3350	  at	  20	  °C	  using	  10	  mg/ml	  protein	  in	  hanging	  drops.	  The	  reservoir	  volume	  was	  500	  µl.	  The	  crystal	  was	  cryoprotected	  and	  subjected	  to	  X-­‐ray	  diffraction	  using	  Microfocus	  beamline	  I24	  at	  DLS,	  Didcot	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The	  Pt	  and	  Hg-­‐soaked	  GB1-­‐YpTIR2-­‐His	  crystals	  diffracted	  poorly	  to	  ~	  5	  Å	  resolution	  (results	  not	  shown)	  using	  the	  Microfocus	  beamline	  I24	  at	  DLS,	  Didcot.	  Datasets	   for	   these	   crystals	   were	   not	   collected.	   It	   was	   not	   possible	   to	   obtain	  crystals	   of	   iodotyrosine-­‐labelled	   GB1-­‐YpTIR2-­‐His	   protein.	   Co-­‐crystallisation	  attempts	   with	   heavy	   metals	   CsCl,	   CoCl2.6H20,	   RbCl,	   NaBr	   and	   NaI,	   produced	  crystals	  of	  GB1-­‐YpTIR2-­‐His	  supplemented	  with	  25	  mM,	  45	  mM,	  65	  mM	  and	  100	  mM	  NaBr.	  These	  crystals	  are	  awaiting	  X-­‐ray	  diffraction	  analysis.	  All	  crystals	  were	  obtained	  in	  condition	  A	  [0.2	  M	  sodium	  malonate,	  0.1	  M	  Bis	  Tris-­‐HCl	  propane	  pH	  6.5,	  20%	  w/v	  PEG	  3350]	  set	   in	  24-­‐well	  plates	  at	  20	  °C	  using	  20	  mg/ml	  protein	  and	  500	  µl	  reservoir	  volume.	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4.4	   Discussion	  
The	   recently	   published	   structures	   of	   the	   bacterial	   PdTIR	   (Chan	   et	   al.,	  2009a)	   and	   the	   plant	   TIR	   containing	   protein	   in	   Arabidopsis	   thaliana	   (AtTIR)	  (Chan	  et	  al.,	  2009b)	  together	  with	  the	  structures	  of	  human	  TIR	  domain	  proteins	  (Tao	  et	  al.,	  2002;	  Xu	  et	  al.,	  2000;	  Khan	  et	  al.,	  2004;	  Ohnishi	  et	  al.,	  2009;	  Nyman	  et	  
al.,	  2008),	  have	  revealed	  an	  overall	  conserved	  global	  fold	  for	  TIR	  domains.	  This	  conserved	   fold	   is	   predicted	   for	   YpTLP	   and	   YpTIR	   by	   bioinformatics	   analysis.	  Nevertheless,	   the	   sequence	   conservation	   among	   TIR	   domains	   is	   relatively	   low	  (20-­‐30%)	  whilst	  the	  sizes	  of	  these	  domains	  vary	  in	  different	  proteins	  (Xu	  et	  al.,	  2000;	  Spear	  et	  al.,	  2009).	  This	  sequence	  diversity	  is	  thought	  to	  be	  important	  for	  the	   specificity	   of	   various	   TIR	   domains	   in	   the	   signalling	   processes	   (Xu	   et	   al.,	  2000).	   For	   instance,	   the	   TIR	   domains	   of	   human	   TLR1	   and	   TLR2	   sharing	   50%	  amino	   acid	   sequence	   identity	   exhibit	   large	   conformational	   differences	   in	   their	  structures,	  notably	  in	  the	  helices	  αB,	  αC’	  and	  αD	  (Xu	  et	  al.,	  2000).	  The	  sequence	  diversity	   among	   TIR	   domains	   relating	   to	   structural	   diversity	   emphasises	   the	  importance	   of	   studying	   each	   TIR	   domain	   in	   order	   to	   gain	   insight	   into	   its	  molecular	  mechanisms	  of	   action.	  This	   chapter	  described	   the	   attempts	  made	   so	  far	  in	  order	  to	  solve	  the	  structure	  of	  YpTIR.	  	  NMR	  spectroscopy	  proved	   to	  be	  an	   invaluable	   tool	   in	  guiding	   structural	  studies	   of	   YpTIR.	   Initial	   1D	   NMR	   analysis	   on	   YpTIR	   produced	   using	   pET26b	  indicated	  largely	  unfolded	  protein	  with	  a	  small	  globular	  domain.	  The	  presence	  of	  an	  N-­‐terminal	  GB1	  tag	  drastically	  improved	  the	  folded	  state	  of	  YpTIR.	  However	  it	  was	  not	  possible	  to	  structurally	  characterise	  GB1-­‐YpTIR1-­‐His	  using	  NMR	  due	  to	  poor	   signal	   to	   noise	   ratio	   and	   instability	   of	   the	   protein	   during	   the	   extended	  recording	  periods	  of	  2D	  NMR	  spectra	  at	  30	   °C.	  This	   is	  possibly	  due	   to	   the	  self-­‐association	   suggested	  by	   the	  broad	   linewidths	  of	   the	  1D	  NMR	  spectra,	   and	   the	  lower	  than	  expected	  retention	  volume	  on	  SEC	  analysis	  indicating	  a	  dimeric	  state	  of	  the	  protein.	  Although	  further	  studies	  are	  required	  to	  support	  this,	  it	  is	  possible	  that	  this	  dimeric	  state	  of	  the	  protein	   is	  physiologically	  relevant	   in	  forming	  TIR-­‐TIR	  protein	  interactions.	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It	   is	   interesting	   to	  note	   that	  after	  solving	   the	   first	  human	  TIR	  domain	  of	  TLR1	  by	  the	  SeMet	  MAD	  method,	  this	  model	  has	  been	  used	  successfully	  as	  an	  MR	  probe	  to	  solve	  the	  subsequent	  structures	  of	  the	  human	  TIR	  domains	  of	  TLR2	  and	  TLR10	  but	  not	  IL-­‐1RAPL	  (Xu	  et	  al.,	  2000;	  Nyman	  et	  al.,	  2008;	  Khan	  et	  al.,	  2004).	  The	   structures	   of	   the	   TIR	   domain	   of	   hIL-­‐1RAPL,	   PdTIR	   and	   AtTIR	   have	   been	  solved	  using	  the	  SeMet	  MAD	  method	  (Khan	  et	  al.,	  2004;	  Chan	  et	  al.,	  2009a;	  Chan	  
et	  al.,	  2009b).	  In	  this	  study,	  it	  has	  not	  been	  possible	  so	  far	  to	  find	  a	  correct	  phase	  solution	  using	  any	  of	  the	  known	  TIR	  structures	  as	  MR	  probes,	   in	  order	  to	  solve	  the	  structure	  of	  YpTIR	  using	  the	  existing	  construct.	  Unfortunately,	  MR	  using	  the	  GB1	  domain	  as	  probe,	  which	   forms	  one-­‐quarter	  of	   the	   single	  molecule	  of	  GB1-­‐YpTIR2-­‐His	   was	   also	   insufficient.	   The	   heavy	   metal	   derivatives	   of	   the	   GB1-­‐YpTIR2-­‐His	   crystal	   including	   the	   SeMet	   labelled	   crystals	   diffracted	   poorly	   in	  order	  to	  proceed	  towards	  alternative	  phase	  solving	  approaches.	  In	  addition,	  the	  current	  crystals	  have	  the	  low	  symmetry	  space	  group	  C2,	  which	  requires	  a	  large	  (~180)	  number	  of	  diffraction	  images	  in	  order	  to	  obtain	  a	  complete	  dataset.	  This	  proved	  challenging	  with	  the	  small,	  radiation-­‐sensitive	  crystals	  obtained.	  The	  NMR	  spectra	  of	   the	  GB1	   fused	  proteins	   indicated	  self-­‐association	  of	  the	  protein	  and	  possibly	  overlap	  of	  NMR	  signals	  from	  the	  GB1	  and	  TIR	  domains.	  Although	   these	   factors	  were	  not	  unfavourable	   for	   crystallisation	  of	   the	   shorter	  construct,	   it	   is	  possible	  that	  there	  is	  a	  certain	  amount	  of	   flexibility	  between	  the	  two	   domains.	   This	   could	   negatively	   affect	   crystal	   packing,	   thereby	  making	   the	  crystals	   small	   and	   prone	   to	   the	   radiation	   damage	   observed.	   Further	   crystal	  optimisation	  using	   the	   current	   construct	   is	   still	   ongoing	  however	   further	  work	  includes	  designing	  of	  alternative	  constructs	  with	  an	  extended	  linker	  between	  the	  GB1	   tag	   and	   YpTIR	   in	   an	   attempt	   to	   effectively	   removing	   the	   GB1	   tag.	   It	   is	  anticipated	   that	   the	   resultant	   cleaved	  YpTIR	   construct	  will	  maintain	   its	  overall	  three-­‐dimensional	  fold	  for	  subsequent	  structural	  studies	  using	  NMR	  and/or	  XRD.	  	  	  	  	  




5.1	  	   Bacterial	  TIR	  Domains	  	  
	   Bacteria	  use	  various	  mechanisms	  to	  evade	  host	   innate	   immunity.	  One	  of	  the	  evasion	   strategies	   is	   to	   subvert	  host	  TLR	  signalling.	  Recently,	  bacterial	  TIR	  homologues	  were	  identified	  in	  search	  of	  potential	  virulence	  factors	  that	  interfere	  with	   host	   innate	   immunity	   (Newman	   et	   al.,	   2006).	   Subsequent	   studies	   have	  revealed	  that	  bacterial	  TLPs	  reduced	   in	  vivo	  TIR-­‐dependent	  NFκB	  activation.	   In	  addition	   the	   TLP	   mutants	   exhibit	   decreased	   virulence	   in	   animal/cell	   culture	  models	  compared	  to	  wild-­‐type.	  The	  bacterial	  TLPs	  have	  also	  been	  shown	  to	  form	  interactions	  with	  mammalian	  TIR	  domains	   in	  vitro	  (Radhakrishnan	  et	  al.,	  2009;	  Low	  et	  al.,	  2007;	  Cirl	  et	  al.,	  2008;	  Salcedo	  et	  al.,	  2008;	  Sengupta	  et	  al.,	  2010;	  Chan	  
et	  al.,	  2009a).	  Furthermore,	  the	  recent	  crystal	  structure	  of	  PdTIR	  was	  suggested	  to	   provide	   evidence	   that	   bacterial	   TIR	   proteins	   act	   as	   mimics	   of	   human	   TIR	  proteins	   attenuating	   the	   heterotypic	   TIR	   interactions	   key	   for	   initiating	   TLR	  signalling	  (Chan	  et	  al.,	  2009a).	  To	   date,	   922	   bacterial	   proteins	   have	   been	   identified	   as	   containing	   TIR	  domains	  (Spear	  et	  al.,	  2009).	  A	  recent	  study	  has	  revealed	  that	  the	  distribution	  of	  TIR	  domains	  is	  sporadic	  among	  pathogenic	  and	  non-­‐pathogenic	  bacteria	  and	  that	  TIR	  domains	  are	  present	  in	  combinations	  with	  a	  variety	  of	  different	  domains	  in	  individual	  bacterial	  proteins	  (Spear	  et	  al.,	  2009).	  Thereby	  bacterial	  TIR	  domains	  were	  suggested	  as	  general	  protein-­‐protein	   interaction	  domains	  playing	  diverse	  roles	   in	  bacterial	   cells	   (Spear	   et	  al.,	  2009).	  Subversion	  of	  host	   innate	   immunity	  was	  suggested	  as	  a	  possible	  exceptional	  role,	  especially	  since	  most	  bacterial	  TIR	  domains	  were	  present	   in	  non-­‐pathogenic	  bacterial	   species	   (Spear	   et	   al.,	   2009).	  Preliminary	   bioinformatics	   analysis	   identified	   TLPs	   in	   the	   highly	   pathogenic	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species	  Yersinia	  pestis	  and	  Burkholderia	  pseudomallei.	  	  The	  aim	  of	  this	  study	  was	  to	  functionally	  and	  structurally	  characterise	  these	  proteins.	  	  	  	  
5.2	   Expression	  of	  the	  Target	  Proteins	  
One	  of	  the	  major	  questions	  regarding	  the	  bacterial	  TLPs	  is	  as	  to	  how	  they	  are	  secreted	  into/taken	  up	  by	  the	  host	  cells.	  TcpC	  from	  the	  uropathogenic	  strain	  CFT073	  of	  E.	  coli	  has	  been	  reported	  as	  a	  secretory	  protein	  that	  it	  is	  taken	  up	  by	  host	  macrophages	  and	  that	  limits	  MyD88-­‐mediated	  innate	  immunity	  (Cirl	  et	  al.,	  2008).	   Although	   exact	  mechanisms	   are	   as	   yet	   unknown,	   secretion	   of	   TcpC	   has	  been	  linked	  with	  the	  type	  I	  secretion	  system	  (Cirl	  et	  al.,	  2008).	  TcpC	  lacks	  the	  sec	  leader	   sequence	   important	   for	   type	   II	   secretion	  while	   this	   particular	   bacterial	  strain	  does	  not	  encode	  the	  genes	  for	  the	  type	  III	  secretion	  system	  (Welch	  et	  al.,	  2002;	  Cirl	  et	  al.,	  2008).	  It	  has	  been	  suggested	  that	  the	  Salmonella	  tlpA	  either	  uses	  type	  III	  or	  IV	  secretion	  system	  based	  on	  the	  location	  of	  the	  encoding	  gene	  in	  the	  serovar	  Enteritidis	  genome	  (Newman	  et	  al.,	  2006).	  The	  Type	  III	  secretion	  system	  in	  Y.	  pestis	  has	  been	  well	  studied	  in	  regards	  to	  its	  role	  in	  virulence	  (Navarro	  et	  al.,	  2005a;	  Lemaitre	  et	  al.,	  2006b).	  The	   expression	   and	   purification	   of	   the	   full-­‐length	   YpTLP	   and	   BpTLP	  resulted	   in	  very	   low	  yields	  of	   folded	  protein.	   It	   is	  possible	   that	  YpTLP	  uses	   the	  type	  III	  secretion	  system,	  in	  which	  case	  it	  requires	  the	  host	  environment	  to	  fully	  fold	   into	   a	   functional	   protein.	   This	   would	   explain	   the	   difficulties	   in	   initial	  expression	  of	  both	  the	  full-­‐length	  proteins	  and	  the	  TIR	  only	  domain/homologue	  regions.	   	   However	   currently	   there	   is	   no	   evidence	   to	   support	   this.	   Attempts	   to	  isolate	  both	  the	  BpTLP	  expressed	  as	  a	  GFP	  fusion	  and	  the	  YpTIR	  as	  a	  His-­‐tagged	  construct	   resulted	   in	   co-­‐purification	   with	   bacterial	   chaperones	   HSP60	   and	  HSP70	   respectively.	   These	   results	   raise	   the	   question	   whether	   molecular	  chaperones,	  possibly	  of	  the	  host	  type,	  are	  required	  to	  fully	  fold	  bacterial	  TLP/TIR	  into	   the	  active	  conformation	  or	  whether	   their	   interactions	  with	   the	  human	  TIR	  counterparts	  play	  a	  part	  in	  stabilising	  these	  bacterial	  proteins.	  	  In	   this	   study,	   it	   has	   been	   possible	   to	   co-­‐express	   and	   co-­‐purify	   YpTIR	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(using	  pET26b)	  and	  MyD88-­‐TIR	  (using	  pGEX-­‐5x-­‐2).	  However	  due	   to	   low	  yields	  the	  complex	  has	  not	  been	  submitted	  to	  further	  analyses.	  Dramatically	  improved	  expression	  yields	  of	   folded	  bacterial	  TIR	  domain/homologue	  were	  obtained	  by	  incorporating	  an	  N-­‐terminal	  GB1	  tag	  using	  GEV2.	  It	  may	  be	  that	  co-­‐expression	  of	  MyD88-­‐TIR	  with	  one	  of	  the	  GB1-­‐tagged	  constructs	  would	  produce	  a	  higher	  yields	  of	  complex	  suitable	  for	  further	  studies.	  	  
5.3	   Role	  of	  YpTLP	  
Using	   an	   in	   vitro	  NFκB	   reporter	   assay	   (Spear	   et	   al.,	   unpublished	   data),	  YpTLP	  was	   shown	   to	   inhibit	   the	   IL-­‐1R	   and	   TLR	   signalling	   pathways.	   This	  was	  observed	  as	  a	  reduction	  in	  IL-­‐1β-­‐induced	  NFκB	  activity	  to	  approximately	  46%	  of	  control	  signalling	  however	  there	  was	  no	  significant	  effect	  in	  TNFα-­‐induced	  NFκB	  activity	   (IL-­‐1R	   mediated	   pathways).	   The	   specificity	   of	   these	   results	   was	  confirmed	  by	  assessing	  dose-­‐dependent	  effects	  of	  YpTLP.	  Similarly,	  YpTLP	  was	  shown	   to	   inhibit	   LPS-­‐induced	   NFκB	   activity	   to	   approximately	   83%	   of	   control	  signalling	   (TLR-­‐mediated	   pathway).	   Thereby,	   YpTLP	   indicated	   a	   specific	   and	  significant	   effect	   on	   both	   IL-­‐1β-­‐	   and	   LPS-­‐induced	   activation	   of	   NFκB	   (TIR-­‐dependent),	   but	   not	   TNFα-­‐induced	   NFκB	   activation	   (TIR-­‐independent).	   This	  overall	  emphasised	  the	  role	  of	  YpTLP	  in	  subverting	  host	  TLR	  signalling	  through	  specific	  TIR-­‐mediated	  interactions.	  The	   results	   presented	   in	   this	   thesis	   indicate	   a	   positive	   interaction	  between	  the	  TIR	  domains	  of	  YpTLP	  and	  human	  MyD88	  that	  is	  dependent	  on	  the	  Pro173	  predicted	  to	  be	  located	  on	  the	  BB	  loop.	  These	  data	  strongly	  suggest	  that	  the	  BB	   loop	  has	   a	   key	   role	   in	   the	   interactions	   between	   the	  YpTIR	   and	  MyD88.	  This	  is	  in	  agreement	  with	  the	  structure	  of	  PdTIR,	  which	  is	  a	  dimer	  although	  the	  BB	  loop	  remains	  exposed	  and	  therefore	  available	  for	  interaction	  with	  the	  human	  adaptor	  proteins	  (Chan	  et	  al.,	  2009a).	  It	  will	  be	  interesting	  to	  further	  assess	  the	  functional	   activity	   of	   YpTIR	   with	   the	   TIR	   domains	   of	   different	   IL-­‐1R/TLR	  proteins	   and	   adaptor	   proteins	   in	   order	   to	   identify	   all	   its	   potential	   host	   target	  proteins.	   In	   addition,	   interaction	   studies	   using	   the	   full-­‐length	   constructs	   of	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YpTLP	   and/or	   MyD88	   will	   allow	   further	   understanding	   of	   the	   mechanisms	   of	  pathogenic	  bacterial	  TLPs.	  	  
5.4	   What	  is	  BpTLP?	  
Bioinformatics	   analyses	   initially	   identified	   a	   putative	   bacterial	   TIR	  homologue	  in	  the	  highly	  pathogenic	  bacterium	  B.	  pseudomallei	  (BpTLP)	  (Spear	  et	  
al.,	  unpublished	  data).	  The	  gene	  contains	  a	  highly	  conserved	  box	  2	  region	  crucial	  for	   mediating	   TLR	   signalling	   but	   lacks	   the	   box	   1	   region	   common	   to	   all	   TIR	  domains.	  In	  contrast	  to	  YpTLP,	  the	  BpTLP	  protein	  had	  no	  significant	  effect	  on	  IL-­‐1β	   and	   TNFα	   induced	   activation	   of	   NFκB.	   However	   the	   GST	   pull	   down	   assay	  revealed	  a	  positive	  interaction	  between	  the	  TIR	  domains	  of	  BpTLP	  and	  MyD88.	  Mutational	  analysis	  of	  the	  box	  2	  residues	  including	  the	  Pro	  residue	  of	  the	  BB	  loop	  of	  BpTIR	  will	  clarify	  the	  specificity	  of	  this	  interaction.	  	  Subsequent	  bioinformatics	  analyses	  using	  Position	  Specific	  Iterated	  (PSI)	  Blast	   excluded	   BpTLP	   as	   a	   TIR	   domain	   containing	   protein	   (Spear	   et	   al,	   2009).	  BpTLP	  was	   initially	   regarded	   as	   a	   distant	   TIR	   homologue	   comparable	  with	  VV	  A46R,	   the	  only	  viral	  TIR	  domain	   identified	   (Stack	   et	   al.,	   2005).	  Recently,	   it	   has	  been	   confirmed	   that	   VV	   A46R	   is	   not	   a	   TIR	   domain	   containing	   protein	   and	  contains	  a	  Bcl-­‐2	  fold	  (Spear	  et	  al.,	  2009).	  The	  inclusion	  of	  VV	  A46R	  in	  the	  earlier	  search	   for	  bacterial	  TIR	   targets	  possibly	  promoted	   the	   selection	  of	  BpTLP	  as	   a	  false	   positive	   (Spear	   et	   al.,	   unpublished	   data).	   Bioinformatics	   analyses	   do	   not	  reveal	   any	   known	   homologous	   domains/proteins	   for	   BpTLP	   with	   significant	  levels	  of	   confidence	  making	   this	  protein	  an	   interesting	   target	   for	   further	   study	  especially	  in	  light	  of	  its	  highly	  homologous	  box	  2	  region	  and	  identified	  functional	  activity	  with	  MyD88-­‐TIR.	  	  	  
5.5	   NMR	  Titration	  	  
The	  incorporation	  of	  the	  GB1	  tag	  greatly	   improved	  the	  overall	  quality	  of	  the	   truncated	  TIR	  domain/homologue	  proteins.	  One	  of	   the	  main	  advantages	  of	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using	   the	  GB1	  tag	  apart	   from	   its	  small	   size	   (~6	  kDa)	   in	  comparison	  with	  other	  solubility	   tags	   such	   as	   GST	   (~26	   kDa)	   and	  maltose-­‐binding	   protein	  MBP	   (~42	  kDa)	   is	   that	   it	  allows	  rapid	  NMR	  assessment	  without	  post-­‐purification	  cleavage	  of	   the	   tag	   (Huth	   et	   al.,	   1997).	  The	   folded	   state	   of	  GB1-­‐YpTIR	   showed	  dramatic	  improvement	   compared	   to	   YpTIR	   expressed	   using	   pET26b	   as	   analysed	   by	   1D	  NMR.	  In	  addition,	  GB1-­‐YpTIR	  was	  successfully	  probed	  with	  GST-­‐MyD88-­‐TIR	  and	  GB1-­‐MyD88-­‐TIR	  to	  further	  analyse	  the	  interaction	  using	  1D	  and	  2D	  NMR.	  	  Optimised	  NMR	   titration	  conditions	   indicated	  peak	  broadening	   for	  GB1-­‐YpTIR	  in	  the	  presence	  of	  GB1-­‐MyD88-­‐TIR	  suggesting	  interaction	  between	  these	  two	   proteins.	   However	   it	   was	   not	   possible	   to	   use	   the	   existing	   GB1-­‐YpTIR	  constructs	  to	  further	  map	  the	  interaction	  domain	  in	  the	  presence	  of	  GB1-­‐MyD88-­‐TIR.	   This	   is	   because	   the	   GB1-­‐YpTIR	   peaks	   were	   broader	   than	   expected	   for	   a	  monomeric	  (~25	  kDa)	  molecule	  suggesting	  a	  dimer	  formation,	  also	  supported	  by	  its	   SEC	   profile.	   Although	   the	   dimeric	   state	   of	   GB1-­‐YpTIR	   may	   reflect	   its	  physiological	   role	   in	   mediating	   TIR-­‐TIR	   protein	   interactions,	   this	   complicates	  NMR	   titration	   studies	   particularly	   upon	   complex	   formation	   resulting	   in	   broad	  peaks	   even	  beyond	  NMR	  detection.	   It	  may	  be	  possible	   to	  utilise	  perdeuterated	  YpTIR	   protein	   for	   future	   work	   if	   the	   dimeric	   protein	   proves	   to	   be	   a	   difficult	  sample	  for	  titration	  studies	  using	  standard	  NMR	  techniques.	  	  	  	  	  	  
5.6	   Structural	  Studies	  	  
A	   combination	   of	   high-­‐resolution	   techniques	   using	   NMR	   and	   XRD	   has	  proved	  invaluable	  in	  the	  structural	  characterisation	  of	  YpTIR	  to	  date.	  The	  initial	  structural	   analysis	   of	   YpTIR	   by	   1D	   NMR	   proved	   invaluable	   in	   assessing	   the	  folded	   state	   of	   the	   protein	   when	   expressed	   using	   different	   E.	   coli	   systems.	  However	   subsequent	  2D	  NMR	  analysis	   of	  GB1-­‐YpTIR	  proved	  difficult	   owing	   to	  poor	   signal	   to	   noise	   ratio	   and	   protein	   instability	   during	   overnight	   recording	  periods	  at	  30	  °C.	  This	  is	  most	  likely	  due	  to	  the	  increased	  size	  of	  the	  protein	  due	  to	  self-­‐association,	   as	  mentioned	   earlier.	   However	   the	   increased	   size	   of	   the	   GB1-­‐YpTIR	  protein	  did	  not	  prove	  disadvantageous	  for	  crystal	   formation.	   It	  has	  been	  possible	  so	  far	  to	  collect	  native	  datasets	  and	  process	  the	  diffraction	  data	  of	  GB1-­‐
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YpTIR	  protein	   to	  2.95	  Å.	   In	  addition	  Se-­‐Met	  crystals	  have	  been	  obtained	  which	  diffract	   to	   3.5	   Å.	   These	   crystals	   are	   currently	   too	   small	   and	   prone	   to	   rapid	  radiation	  damage	  for	  full	  datasets	  to	  be	  collected.	  	  	  	  
5.7	   Future	  Work	  	  
Although	   the	   studies	   outlined	   in	   this	   thesis	   have	   made	   significant	  progress	   in	   understanding	   the	   structure	   and	   function	   of	   the	   YpTIR,	   much	  remains	  to	  be	  done.	  The	  current	  derivative	  crystals	  will	  continue	  to	  be	  optimised	  in	  order	   to	  obtain	  crystals	  of	   sufficient	  size	   to	  allow	  collection	  of	   full	  data	  sets.	  However	   alternative	   constructs	   with	   longer	   linkers	   between	   the	   GB1	   and	   TIR	  domains	   to	   facilitate	   cleavage	   of	   the	   tag	   will	   also	   be	   generated.	   Provided	   the	  cleaved	  YpTIR	  sample	  forms	  a	  stable	  independent	  domain,	  it	  will	  be	  submitted	  to	  analysis	   by	  NMR	  and	   crystallisation	   trials.	   The	   structure	   of	   YpTIR	  will	   provide	  the	   model	   of	   a	   pathogenic	   bacterial	   TIR	   domain	   allowing	   insights	   into	   the	  molecular	   mechanisms	   of	   NFκB	   inhibition	   and	   provide	   information	   on	   the	  evolutionary	  conservation	  of	  TIR	  domains.	  It	  will	  also	  facilitate	  the	  analysis	  of	  its	  interaction	   domain	   with	   MyD88-­‐TIR	   using	   NMR.	   It	   is	   anticipated	   that	   the	  structural	   and	   dynamical	   information	   on	   YpTIR	   will	   provide	   a	   further	  understanding	  of	  the	  subversive	  role	  of	  pathogenic	  bacterial	  TIR	  domains.	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Chapter	  6	  	  
Novel	  MNG	  Amphiphiles	  for	  
Membrane	  Protein	  Stabilisation	  	  	  
6.1	   Introduction	  
6.1.1	  Membrane	  Proteins	  Membrane	  proteins	   perform	   a	  wide	   range	   of	   key	   cellular	   functions.	   For	  example,	  membrane	  proteins	  are	  involved	  in	  ATP	  synthesis,	  uptake	  of	  essential	  nutrients	  and	  efflux	  of	  toxins,	  production	  and	  transmission	  of	  electrical	  signals	  in	  nerve	  and	  muscle	  cells,	  and	  sensing	  external	  signals	  as	  receptors.	  It	  is	  estimated	  that	  more	   than	  50%	  of	  all	   currently	  available	  drugs	  exert	   their	  effects	   through	  membrane	   proteins	   (Klabunde	   et	   al.	   2002).	   Our	   understanding	   of	   the	   precise	  molecular	  mechanism	  of	  action	  of	  most	  membrane	  proteins	  remains	  limited	  due	  to	   a	   lack	   of	   high-­‐resolution	   structures.	  Membrane	   proteins	   comprise	   less	   than	  1%	  of	  the	  structures	  in	  the	  Protein	  Data	  Bank	  (Liu	  and	  Rost,	  2001;	  Granseth	  et	  
al.,	  2005).	  	  Low	   expression	   levels,	   low	   stability	   in	   solution	   and	   difficulties	   in	  obtaining	  crystals	  hamper	  the	  study	  of	  membrane	  proteins.	  Even	  if	  crystals	  can	  be	   obtained	   they	   tend	   to	   be	   small	   and	   poorly	   diffracting.	   Currently,	   most	  membrane	  proteins	  are	  overexpressed	  as	  recombinant	  proteins;	  however	  yields	  of	  pure	  functional	  and	  stable	  protein	  suitable	  for	  structural	  studies	  are	  typically	  low	   owing	   to	   functional	   instability	   in	   solution	   and	   problems	   caused	   by	  aggregation	  of	  the	  protein	  (Seddon	  et	  al.,	  2004;	  Drew	  et	  al.,	  2003).	  	  One	   of	   the	   key	   issues	   in	   attaining	   high-­‐resolution	   structures	   is	   that	  membrane	  proteins	  are	  comprised	  of	  a	  solvent-­‐exposed	  hydrophilic	  surface	  and	  
	  	   175	  
a	  hydrophobic	  region	  naturally	  embedded	  within	  the	  mosaic,	  heterogeneous	  and	  dynamic	  lipid	  bilayer	  environment	  (Fig	  6.1)	  (Iwata,	  2003;	  Seddon	  et	  al.,	  2004).	  It	  is	  usually	   impossible	  to	  determine	  membrane	  protein	  structures	  in	  their	  native	  environment	  using	  most	  of	  the	  standard	  biophysical	  techniques	  including	  X-­‐ray	  crystallography,	   nuclear	   magnetic	   resonance	   (NMR)	   and	   electron	   microscopy	  (Seddon	  et	  al.,	  2004;	  Postis	  et	  al.,	  2008).	  Consequently,	  detergents	  are	  employed	  to	   both	   extract	   membrane	   proteins	   and	   stabilise	   membrane	   proteins	   for	  subsequent	   structural	   characterisation	   methods.	   The	   research	   in	   this	   chapter	  describes	   the	   characterisation	   of	   novel	   detergents	   for	   the	   stabilisation	   of	  membrane	  proteins	  in	  solution.	  	  
	  
Fig	  6.1	   Schematic	  to	  illustrate	  the	  formation	  of	  membrane	  protein-­detergent	  complexes	  The	  amphiphilic	  membrane	  proteins	  within	  the	  lipid	  bilayer	  are	  detergent-­‐solubilised	  to	  form	  protein-­‐detergent	  complexes;	  adapted	  from	  (Iwata,	  2003)	  	  
6.1.2	  Detergents	  Detergents	  are	  amphiphilic	  surfactants	  that	  self-­‐assemble	  to	  form	  micelles	  and	  associate	  with	  hydrophobic	  surfaces	   in	  a	  concentration-­‐dependent	  manner	  (Garavito	   and	   Ferguson-­‐Miller,	   2001;	   Seddon	   et	   al.,	   2004;	   Prive,	   2007).	   A	  characteristic	   detergent	   property	   is	   the	   threshold	   concentration	   required	   for	  detergent	  monomers	   to	   form	  micelles,	   termed	  the	  critical	  micelle	  concentration	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(CMC),	   a	   value	   specific	   to	   individual	   detergents.	   Detergents	   serve	   as	   effective	  solubilisers	   above	   their	   CMC,	   and	   produce	   water-­‐soluble	   protein-­‐detergent	  complexes	   (PDC)	   (Fig	  6.1)	   by	   covering	   the	  hydrophobic	   surfaces	   of	  membrane	  proteins	   (Iwata,	   2003;	   Garavito	   and	   Ferguson-­‐Miller,	   2001;	   Prive,	   2007).	   The	  number	  of	  detergent	  monomers	  present	   in	  a	  micelle	   is	   termed	  the	  aggregation	  
number,	   a	   characteristic	   detergent	  property,	  which	   influences	   the	  micellar	   size	  and	  shape	  (le	  Maire	  et	  al.,	  2000;	  Prive,	  2007).	  	  There	   are	   four	   types	   of	   detergents	   commonly	   used	   to	   solubilise	  membrane	   proteins:	   ionic,	   nonionic,	   zwitterionic	   and	   steroid-­‐bile	   acid	   salts	  (Seddon	   et	   al.,	   2004;	   le	  Maire	   et	   al.,	   2000).	   Detergents	   that	   have	   been	   used	   in	  membrane	   protein	   structure	   determination	   include	   ionic	   or	   zwitterionic	  detergents	  such	  as	  sodium	  dodecyl	  sulphate	  (SDS)	  and	  dodecyl	  phosphocholine	  (DPC)	   for	   NMR	   spectroscopy,	   and	   mostly	   non-­‐ionic	   detergents	   for	   X-­‐ray	  crystallography	   like	   n-­‐decyl-­‐β-­‐D-­‐maltopyranoside	   (DM),	   octyltetraoxyethylene	  (C8E4),	   n-­‐dodecyl-­‐β-­‐D-­‐maltopyranoside	   (DDM),	   lauryl	   dimethylamine	   oxide	  (LDAO)	  and	  n-­‐octyl-­‐β-­‐D-­‐glucopyranoside	  (OG)	  (Prive,	  2007;	  Iwata,	  2003).	  	  
	   Although	   detergents	   are	   indispensable	   tools	   for	   membrane	   protein	  studies,	  detergent-­‐solubilised	  membrane	  proteins	  tend	  to	  be	  relatively	  unstable.	  The	  detergent-­‐solubilised	  state	  is	  a	  comparatively	  poor	  mimic	  of	  the	  natural	  lipid	  bilayer	  environment,	  which	  provides	  curvature	  stress	  and	  lipid	  lateral	  pressure	  for	   structural	   stabilisation,	   and	   also	   maintains	   membrane	   protein	   topology	  (Booth,	   2005).	   Membrane	   proteins	   aggregate	   when	   detergents	   are	   unable	   to	  completely	   cover	   the	   hydrophobic	   surfaces	   of	   the	   protein,	   leading	   to	  precipitation	   and	   denaturation.	   Aggregation	   can	   also	   be	   initiated	   by	   increased	  protein	   unfolding	   in	   the	   detergent-­‐solubilised	   state,	   exposing	   the	   normally	  buried	   hydrophobic	   surfaces	   and	   leaving	   them	   available	   to	   form	   non-­‐specific	  interactions	   (Prive,	   2007).	   In	   addition	   detergent-­‐mediated	   extraction	   may	  remove	  essential	  lipids	  bound	  to	  the	  membrane	  protein.	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6.1.3	  MNG	  Amphiphiles	  	  	   Recent	   advancements	   in	   enhancing	   membrane	   protein	   stability	   include	  the	  use	  of	  detergent-­‐lipid	  micelles	  and	  bicelles,	  and	  alternative	  classes	  of	  milder	  solubilising	   agents	   including	   amphiphols.	   Alternative	   systems	   using	   tethered	  lipid	  membranes	  and	  phospholipid	  bilayer-­‐based	  nanodiscs	   serving	  as	  bicelles,	  have	   been	   described	   to	   immobilise	   membrane	   proteins	   without	   denaturation	  (Sevin-­‐Landais	   et	   al.,	   2000;	   Borch	   et	   al.,	   2008).	   Amphiphols	   are	   amphiphilic	  polymers	   bearing	   hydrophobic	   linkages,	   shown	   to	   serve	   as	   adaptors	   for	   the	  hydrophobic	  surfaces	  of	  a	  range	  of	  membrane	  proteins	  in	  order	  to	  solubilise	  and	  biochemically	  stabilise	  them	  in	  the	  absence	  of	  detergents	  (Charvolin	  et	  al.,	  2009).	  However,	   these	  alternative	  approaches	  have	  not	  yet	   found	  wide	  acceptance	   for	  solubilisation	   and	   stabilisation	   of	   membrane	   proteins.	   Previous	   work	   has	  described	   the	  generation	  of	   another	   group	  of	   amphiphiles,	   the	   so-­‐called	   tripod	  amphiphiles	  (TPAs).	  	  Tripod	   amphiphiles	   (TPA)	   are	   shown	   to	   extract	   and	   solubilise	   both	  bacteriorhodopsin	   (bR)	   and	   bovine	   rhodopsin	   (Rho)	   from	   the	   native	  membranes,	   and	  maintain	   these	   proteins	   in	  monomeric	   native-­‐like	   forms	   over	  several	   weeks	   following	   delipidation	   (Yu	   et	   al.,	   2000).	   Moreover,	   it	   was	   also	  shown	   that	   bR	   crystals	   attained	  with	   TPA	  were	   smaller	   but	   diffracted	   slightly	  better	  (2.5	  Å)	  than	  the	  2.9	  Å	  diffraction	  limit	   for	  bR	  crystals	  solubilised	  with	  n-­‐octyl-­‐β-­‐d-­‐glucopyranoside	   (OG)	   (Theisen	   et	   al.,	   2005).	   This	   is	   explained	   by	  probable	   higher	   internal	   order	   in	   bR/TPA	   crystals,	   thus	   supporting	   the	   initial	  hypothesis	   that	  amphiphile	   rigidity	  could	  promote	  crystallisation	  of	  membrane	  proteins	  by	  enhancing	  regular	  crystal	  packing	  (Theisen	  et	  al.,	  2005;	  McQuade	  et	  
al.,	  2000;	  Chae	  et	  al.,	  2008).	  	  The	   use	   of	   a	   novel	   class	   of	   amphiphiles	   derived	   from	   the	   TPA	   were	  investigated	  in	  this	  study	  as	  a	  tool	  for	  membrane	  protein	  stabilisation.	  Maltose-­‐Neopentyl	  Glycol	   (MNG)	  amphiphiles	  are	  named	  after	   the	  quarternary	   carbons	  derived	  from	  neopentyl	  glycol	  and	  the	  hydrophilic	  groups	  derived	  from	  maltose	  (Chae	   et	   al.,	   Submitted).	   These	   amphiphiles	   feature	   a	   tetrasubstituted	   carbon	  atom	  projecting	  two	  maltose	  units	  which	  comprise	  the	  hydrophilic	  domain	  and	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two	  alkyl	  chains	  which	  comprise	  the	  hydrophobic	  domain	  (Fig	  6.2)	  (Chae	  et	  al.,	  Submitted).	   Quarternary	   centres	   impose	   conformational	   constraints	   on	   the	  lipophilic	   portion	   of	   MNG	   amphiphiles	   and	   are	   thus,	   included	   to	   enhance	  amphiphile	  rigidity	  (Alder	  et	  al.,	  1990).	  	  	  
6.1.4	  Membrane	  Protein	  Stability	  and	  Functionality	  	  The	  stability	  of	  a	   range	  of	  membrane	  proteins	  was	  assessed	  both	   in	   the	  novel	   MNG	   amphiphiles	   and	   the	   standard	   detergents	   DDM	   and	   DM.	   The	   test	  membrane	   proteins	   included;	   two	   prokaryotic	   respiratory	   complexes,	  Succinate:quinone	  oxidoreductase	  (SQR)	  and	  cytochrome	  bo3	  ubiquinol	  oxidase	  (Cyt	  bo3)	   from	  E.	  coli	  and	   the	  eukaryotic	  Cytidine-­‐5’-­‐monophosphate-­‐sialic	  acid	  transporter	   (CMP-­‐Sia)	   from	   mouse.	   SQR	   is	   an	   integral	   membrane	   protein	  complex	  comprised	  of	  four	  (SdhA,	  SdhB,	  SdhC	  and	  SdhD)	  sub-­‐units.	  It	  couples	  the	  oxidation	   of	   succinate	   to	   fumarate	   in	   the	   matrix	   or	   the	   cytoplasm	   and	   the	  reduction	  of	  quinone	  to	  quinol	  in	  the	  membrane,	  a	  function	  that	  directly	  links	  the	  Krebs	   cycle	   and	   the	  aerobic	   respiratory	   chain	   (Maklashina	   et	   al.,	   1998).	  The	  E.	  
coli	  SQR	  used	  for	  this	  study	  is	  a	  mutant	  construct,	  incorporating	  a	  point	  mutation	  His84Met	  in	  the	  SdhC	  subunit,	  and	  contains	  32	  Cys.	  	  Cytochrome	  (Cyt)	  bo3	  is	  a	  macromolecular	  membrane	  complex	  belonging	  to	  the	  superfamily	  of	  heme-­‐copper	  respiratory	  oxidases.	  It	  couples	  the	  reduction	  of	  molecular	  oxygen	   to	  water	  and	   the	  vectorial	   transport	  of	  protons	  across	   the	  membrane	   (Babcock	   and	   Wikstrom,	   1992).	   The	   construct	   used	   for	   this	   study	  contains	  3	  Cys.	  The	  CMP-­‐sialic	  acid	  transporter	  construct	  used	  is	  a	  solute	  carrier	  protein	  containing	  3	  Cys.	  CMP-­‐Sia	  is	  an	  antiporter	  that	  transports	  CMP-­‐sialic	  acid	  into	   the	   lumen	  of	   the	  Golgi	  complex	  and	  also	  CMP	   into	   the	  cytosol	   (Zhao	   et	  al.,	  2006).	   Preliminary	   studies	   on	   MNG	   amphiphiles	   involved	   long-­‐term	   stability	  assays	  combined	  with	  SDS-­‐PAGE	  using	  SQR.	  Subsequently,	  protein	  stability	  has	  been	  assessed	  extensively	  using	   thiol-­‐dye-­‐based	   thermal	   stability	   assay	   for	   the	  three	   test	   membrane	   proteins,	   complemented	   with	   circular	   dichroism	   (CD)	  spectroscopy,	  size	  exclusion	  chromatography	  (SEC)	  and	  functional	  activity	  assay	  on	  SQR.	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6.2	   Materials	  and	  Methods	  
6.2.1	  MNG	  Amphiphiles	  	  The	  MNG	  amphiphiles	  were	  designed,	  synthesized	  and	  provided	  by	  Dr.	  Pil	  Seok	   Chae	   and	   Prof.	   Sam	   Gellman	   (University	   of	   Wisconsin	   Madison).	   The	  amphiphiles	   vary	   in	   their	   lipophilic	   unit	   attachments,	   such	   that	   MNG-­‐Am-­‐10	  (MNG-­‐1)	   bear	   amide	   linkages,	   MNG-­‐Et-­‐10	   (MNG-­‐2)	   bear	   ether	   linkages	   and	  MNG-­‐Alk-­‐10	  (MNG-­‐3)	  connect	  directly	  to	  the	  quaternary	  carbon	  atom	  (Fig	  6.2).	  Reference	  detergents	  have	  also	  been	   included	   in	   the	  study	   in	  order	   to	  evaluate	  the	   significance	   of	   the	   MNG	   architecture	   (such	   as	   central	   branching).	   These	  include	   Linear-­‐Et-­‐3-­‐10	   (MPA-­‐12)	   to	   evaluate	   MNG-­‐2,	   n-­‐dodecyl-­‐β-­‐D-­‐maltopyranoside	  (DDM)	  to	  evaluate	  MNG-­‐3	  and	  sodium	  dodecyl	  sulphate	  (SDS).	  All	   the	   MNG	   amphiphiles	   are	   water-­‐soluble	   >20%	   and	   have	   CMC	   values	  significantly	   lower	   than	   the	   CMC	   of	   DDM,	   which	   is	   used	   most	   extensively	   in	  membrane	  protein	  studies	  (Table	  6.1).	  	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Table	  6.1	  CMC	  and	  physical	  properties	  of	  detergents	  
Detergent	   MW	   CMC	  (mM)	   CMC	  (%)	  MNG-­‐Am-­‐10	  (MNG-­‐1)	   1119.3	   0.017	   0.0019	  MNG-­‐Et-­‐10	  (MNG-­‐2)	   1065.2	   0.009	   0.001	  MNG-­‐Alk-­‐10	  (MNG-­‐3)	   1005.2	   0.01	   0.001	  L-­‐Et-­‐3-­‐10	  (MPA-­‐12)	   540.6	   0.66	   0.0357	  SDS	   288.38	   2.6	   0.075	  DM	   482.6	   1.8	   0.087	  DDM	   510.6	   0.17	   0.0087	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Fig	  6.2	  Chemical	  structures	  of	  amphiphiles	  The	  chemical	  structures	  of	  SDS,	  DM	  and	  DDM	  were	  derived	  from	  the	  Anatrace	  catalogue.	  The	  chemical	  structures	  of	  the	  MNG	  amphiphiles	  (1-­‐3)	  were	  provided	  by	  Dr.	  Pil	  Seok	  Chae	  
	  
6.2.2	  Test	  Membrane	  Proteins	  	  Purified	  SQR	  (from	  Dr.	  Jonathan	  Ruprecht,	  MPC)	  and	  purified	  Cyt	  bo3	  and	  CMP-­‐Sia	  (from	  Dr.	  David	  Drew,	  MPC)	  were	  kindly	  provided	  as	  the	  test	  membrane	  proteins.	  SQR	  was	  purified	   in	   the	  presence	  of	  polyoxyethylene(9)dodecyl	  ether	  (C12E9	   or	   Thesit)	   and	   exchanged	   into	  DM,	   and	   both	   Cyt	  bo3	   and	   CMP-­‐Sia	  were	  purified	   in	   the	   presence	   of	   DDM.	   Purified	   proteins	  were	   flash	   frozen	   in	   liquid	  nitrogen	  and	  stored	  in	  the	  -­‐80°C	  freezer	  prior	  to	  further	  use.	  
	  
6.2.3	  Long-­term	  Stability	  Assay	  	  SQR	   (20	   mg/ml)	   was	   buffer	   exchanged	   (1000x)	   into	   Buffer	   A	   [20	   mM	  Tris-­‐HCl	  pH	  7.5,	  150	  mM	  NaCl]	  supplemented	  with	  3x	  CMC	  MNG-­‐1	  using	  100	  kDa	  molecular	  weight	  cut-­‐off	  (MWCO)	  filters	  at	  4	  °C.	  The	  sample	  was	   loaded	  onto	  a	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PD-­‐10	   column	  pre-­‐equilibrated	  with	  Buffer	  A	   supplemented	  with	  3x	  MNG-­‐1	   to	  ensure	  complete	  buffer	  exchange	  into	  MNG-­‐1.	  Aliquots	  of	  SQR	  with	  DM	  or	  MNG-­‐1	  were	  stored	  at	  20	  °C	  for	  a	  period	  of	  20	  days.	  Samples	  were	  taken	  every	  5	  days,	  mixed	  1:1	  with	  SDS-­‐loading	  buffer	  and	  stored	  in	  the	  -­‐20	  °C	  freezer.	  Additionally,	  sample	  aliquots	  taken	  after	  15	  days	  were	  incubated	  overnight	  with	  SDS-­‐loading	  buffer	  at	  room	  temperature.	  Samples	  were	  separated	  on	  4-­‐12%	  Bis-­‐Tris	  NuPAGE	  gels	  (Invitrogen)	  prior	  to	  staining	  with	  Coomassie	  Blue.	  
	  
6.2.4	  Thermal	  Stability	  Assay	  	  The	  thermal	  stability	  assay	  method	  used	  was	  as	  described	  in	  (Alexandrov	  
et	   al.,	   2008;	  Hanson	   et	   al.,	   2008)	  with	   the	   following	  minor	  modifications.	   CPM	  (Invitrogen)	  dye	  aliquots	  stored	  in	  DMSO	  (Sigma),	  were	  diluted	  in	  dye	  buffer	  [20	  mM	  Tris-­‐HCl	   pH	  7.5,	   150	  mM	  NaCl,	   0.03%	  DDM,	  5	  mM	  EDTA].	  The	  detergents	  and	  amphiphiles	  were	  used	  at	  a	  range	  of	  concentrations	  (3x	  CMC,	  10x	  CMC,	  50x	  CMC,	  0.05	  mM,	  0.2	  mM,	  0.35	  mM,	  0.017%)	  in	  test	  buffer	  [20	  mM	  Tris-­‐HCl	  pH	  7.5,	  150	   mM	   NaCl].	   Greiner	   96-­‐well	   plates	   were	   used	   and	   the	   volume	   of	   selected	  buffer	  solutions	  was	  150	  µl.	  The	  test	  protein	  (10	  mg/ml)	  was	  diluted	  in	  the	  assay	  buffer	   solutions	   (1:150)	   in	  Greiner	  96-­‐well	  plates,	   and	  3	  µl	  of	  diluted	  CPM	  dye	  was	  added	  to	  each	  test	  condition.	  	  The	  reaction	  was	  monitored	  for	  130	  min	  at	  a	  fixed	  temperature	  of	  40	  °C	  using	  a	  microplate	  spectrofluorometer	  set	  at	  an	  excitation	  wavelength	  of	  387	  nm	  and	  an	  emission	  wavelength	  of	  463	  nm.	  Readings	  were	  taken	  every	  5	  min	  after	  automatic	  agitation	  of	  the	  plate.	  The	  relative	  maximum	  fluorescence	  counts	  were	  used	  to	  calculate	  percentage	  of	  relative	  folded	  protein	  remaining	  after	  130	  min	  at	  40	  °C.	  Relative	  unfolding	  profiles	  of	  proteins	  were	  plotted	  against	  time	  fitting	  the	   one-­‐phase	   decay	   equation	   using	   GraphPad	   Prism	   (Version	   5.01).	   Protein	  samples	   were	   analysed	   for	   aggregation	   using	   4-­‐12%	   Bis-­‐Tris	   NuPAGE	   gel	  (Invitrogen)	  before	  and	  after	  ultracentrifugation	  at	  18,000	  g	  for	  10	  min	  at	  4	  °C.	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6.2.5	  Circular	  Dichroism	  Spectra	  of	  SQR	  Circular	   dichroism	   (CD)	   spectra	   were	   recorded	   every	   5	   °C	   over	   a	  temperature	   range	   of	   20	   °C	   to	   100	   °C	   between	   200	   and	   260	   nm	   using	   a	  Chirascan™	  circular	  dichroism	  spectrometer.	  All	  the	  detergents	  and	  amphiphiles	  were	  used	  at	  10x	  CMC	  values	   in	   test	  buffers	   [20	  mM	  Tris-­‐HCl	  pH	  7.5,	  150	  mM	  NaCl],	  and	  DDM	  was	  also	  used	  at	  3x	  CMC.	  SQR	  (10	  mg/ml)	  was	  diluted	  (1:150)	  in	  the	  appropriate	  buffer	  solutions	  in	  a	  final	  volume	  of	  250	  µl	  and	  transferred	  to	  a	  quartz	   cuvette	  with	   a	   pathlength	   of	   1	  mm.	  Melting	   temperatures	   of	   SQR	  were	  calculated	  by	  taking	  an	  average	  (220-­‐225	  nm)	  of	   the	  CD	  values	  at	  220	  nm	  as	  a	  measure	   of	   α-­‐helical	   content.	   These	   average	   CD	   values	   for	   SQR	   at	   220	   nm	  (millidegrees)	  were	  plotted	  against	  varying	  temperatures	  using	  GraphPad	  Prism	  and	  the	  data	  were	  fitted	  using	  the	  sigmoidal	  non-­‐linear	  regression	  equation.	  	  	  
6.2.6	  Size	  Exclusion	  Chromatography	  of	  SQR	  SQR	  (10	  mg/ml)	  was	  diluted	  1:100	  in	  Buffer	  A	  supplemented	  with	  either	  DDM	  or	  MNG-­‐3	  at	  10x	  CMC	  values.	  Aliquots	  (500	  μl)	  of	  the	  diluted	  protein	  were	  individually	   loaded	   onto	   a	   gel	   filtration	   column	   (Superose	   200	   10/300	   GL;	   GE	  Healthcare)	   pre-­‐equilibrated	   in	   buffer	   A	   supplemented	   with	   the	   appropriate	  detergent/amphiphile	   at	   time	   (t)	   =	   0.	   The	   remaining	   diluted	   protein	   samples	  (~700	   µl)	   were	   heated	   in	   a	   thermomixer	   at	   40	   °C	   at	   500	   rpm	   for	   2	   hr.	   The	  samples	   (500	   μl)	   were	   then	   individually	   loaded	   onto	   the	   gel	   filtration	   column	  and	   the	   chromatograms	   compared	   with	   those	   of	   the	   sample	   at	   t	   =	   0.	   The	  fractions	  containing	  the	  protein	  were	  then	  analysed	  by	  SDS-­‐PAGE.	  	  	  
6.2.7	  Functional	  Assay	  of	  SQR	  Functionality	   of	   SQR	   was	   estimated	   based	   on	   succinate-­‐Q1-­‐DCIP	  reductase	  activity.	  SQR	  was	  activated	  in	  activation	  buffer	  [30	  mM	  K2PO4,	  0.2	  mM	  EDTA,	  10	  mM	  malonate]	  to	  remove	  bound	  oxaloacetate	  from	  the	  active	  site.	  DDM	  and	  MNG-­‐3	  were	  used	  at	  10	  and	  50	  times	  their	  CMC	  values.	  The	  activated	  SQR	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was	   then	   diluted	   (1	  mg/ml)	   in	   activation	   buffer	   to	   a	   final	   concentration	   of	   20	  μg/ml.	   Enzyme	   activation	   was	   performed	   at	   30	   °C	   for	   20	   min,	   and	   then	   the	  samples	  were	  heated	  at	  40	  °C	  for	  1	  hr	  and	  2	  hr.	  	  The	   functional	   activity	   was	   monitored	   at	   600	   nm	   as	   a	   decrease	   of	  absorbance	  of	  2,6-­‐dichloroindophenol	  (DCIP)	  (extinction	  coefficient	  =	  21.8	  mM-­‐1	  cm-­‐1)	   when	   50	   μM	   DCIP,	   10	   mM	   succinate,	   varied	   amount	   of	   coenzyme	   Q1	  (including	   blank)	   and	   0.6	   μl	   of	   SQR	   enzyme	   samples	  were	   added	   to	   the	   assay	  buffers	   to	  give	  a	   final	  volume	  of	  100	  µl.	  The	  enzyme	  activity	  was	  monitored	   in	  Greiner	  96-­‐well	  plates	  for	  at	  least	  60	  min	  at	  a	  fixed	  temperature	  of	  30	  °C/	  40	  °C	  using	  a	  microplate	  spectrofluorometer	  set	  at	  an	  absorbance	  wavelength	  of	  600	  nm.	  Readings	  were	  taken	  every	  minute	  after	  automatic	  agitation	  of	  the	  plate.	  	  	  Once	   the	   saturation	   concentration	   (20	   µM)	   of	   CoQ1	   was	   obtained	   the	  functional	   assay	   was	   repeated	   in	   1	   ml	   volumes	   using	   1.5	   ml	   cuvettes.	   The	  background	  activity	  was	  monitored	  for	  10	  sec	  before	  the	  addition	  of	  the	  enzyme.	  The	   change	   in	   absorbance	   over	   the	   first	   3	   min	   of	   the	   reaction	   was	   used	   to	  calculate	   the	   initial	   velocity	   of	   the	   reaction	   in	   order	   to	   estimate	   the	   specific	  activity	  of	  SQR.	  The	  Michaelis-­‐Menten	  equation,	  using	  GraphPad	  Prism,	  was	  used	  to	  calculate	  catalytic	  parameters	  for	  SQR-­‐catalysed	  succinate-­‐Q1-­‐DCIP	  reductase	  activity.	  The	  slope	  of	  the	  reaction	  (up	  to	  20	  min)	  was	  used	  to	  calculate	  the	  initial	  velocity	  (Vo),	  using	  the	  linear	  regression	  equation	  for	  a	  range	  of	  concentrations	  of	   coenzyme	   Q1	   (CoQ1)	   (0,	   0.25,	   0.5,	   1,	   5,	   10,	   20	   and	   30	   µM)	   and	   the	   Beer-­‐Lambert’s	  law	  (A	  =	  εcl).	  The	  respective	  background	  activities	  (without	  CoQ1)	  for	  each	   detergent/amphiphile	   condition	   were	   then	   subtracted	   from	   the	   initial	  velocities	  (Vo).	  The	  Vo	  values	  were	  plotted	  against	  CoQ1	  concentrations	  for	  each	  detergent/amphiphile	  condition	  to	  fit	  the	  Michaelis-­‐Menten	  equation.	  	  The	   specific	   activity	   (Kcat)	   for	   SQR	   was	   calculated	   from	   the	   1	   ml	   assay	  results	  as	  follows.	  On	  addition	  of	  the	  enzyme,	  the	  change	  in	  absorbance	  over	  the	  initial	  3	  min	  of	  the	  reaction	  at	  20	  µM	  CoQ1	  was	  converted	  to	  rate	  of	  the	  reaction	  using	  Beer	  Lambert’s	   law.	  Since	  the	  rate	  of	  this	  reaction	  at	  20	  µM	  CoQ1,	   is	  also	  the	  Vmax	  (from	  the	  Michaelis	  Menten	  plots),	  the	  Kcat	  values	  were	  calculated	  as	  rate	  per	  amount	  of	  enzyme.	  	  
	  	   184	  
6.3	   Results	  	  
6.3.1	  Long-­term	  Stability	  of	  SQR	  
	   Long-­‐term	  stability	  of	  SQR	  with	  DM	  and	  MNG-­‐1	  at	  3x	  CMC	  revealed	  that	  SQR	  aggregated	  significantly	  with	  DM	  over	  a	  period	  of	  20	  days	  when	  stored	  at	  20	  °C,	   as	   assessed	   by	   a	   reduction	   in	   the	   amount	   of	   protein	   visible	   on	   the	   gel	   (Fig	  6.3a).	   In	   comparison	  MNG-­‐1	  maintained	  much	  more	   of	   the	   protein	   in	   solution	  (Fig	  6.3b).	  Protein	  samples	  can	  be	  seen	  retained	  on	  the	  top	  of	  the	  gels	  as	  a	  result	  of	   protein	   aggregation.	   When	   the	   sample	   aliquots	   taken	   after	   15	   days	   were	  incubated	  with	  SDS	  buffer	  overnight	  at	  room	  temperature,	  a	  major	  band	  with	  a	  significantly	   lower	  size	  was	  observed	   for	   the	  protein	  sample	  with	  DM,	  possibly	  the	   result	   of	   protein	   degradation	   (Fig	   6.3c).	   In	   contrast	   the	   SQR	   sample	   with	  MNG-­‐1	  retained	  the	  same	  SDS-­‐PAGE	  profile	  as	  the	  sample	  on	  day	  0	  (Fig	  6.3d).	  
	  
Fig	  6.3	  SDS-­PAGE	  analysis	  of	  the	  long-­term	  stability	  of	  SQR	  The	  long-­‐term	  stability	  of	  SQR	  at	  20	  °C	  over	  20	  days	  was	  analysed	  in	  buffers	  containing	  (a)	  DM	  and	  (b)	  MNG-­‐1.	  M	  indicates	  molecular	  weight	  marker,	  lanes	  0,	  5,	  10,	  15	  and	  20	  correspond	  to	  incubation	  period	  in	  days.	  Sample	  aliquots	  with	  (c)	  DM	  and	  (d)	  MNG-­‐1,	  at	  day	  15	  were	  incubated	  with	  SDS	  buffer	  overnight	  at	  room	  temperature.	  C	  indicates	  sample	  at	  day	  0	  and	  15S	  indicates	  sample	  at	  day	  15	  incubated	  with	  SDS	  buffer.	  DM	  and	  MNG-­‐1	  were	  used	  at	  3x	  CMC	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Fig	  6.4	  Thermal	  stability	  profiles	  for	  Cyt	  bo3,	  CMP-­Sia	  and	  SQR	  Test	  proteins	  (a)	  Cyt	  bo3	  (b)	  CMP-­‐Sia	  and	  (c)	  SQR	  were	  incubated	  with	  CPM	  dye	  at	  40	  °C	  for	  130	  min	  to	  analyse	  thermal	  stability.	  All	  detergents	  were	  used	  at	  10x	  CMC	  
	  Among	   the	   tested	   detergent/amphiphiles,	   MNG-­‐2	   served	   as	   the	   best	  condition	   for	  Cyt	  bo3	   and	  MNG-­‐3	  provided	   the	  most	  optimal	   condition	   for	   SQR	  and	   CMP-­‐Sia	   (Fig	   6.4a,	   Table	   6.2).	   The	   results	   for	   the	   MNG	   amphiphiles	   were	  relatively	  similar	  within	  each	  protein	  profile.	  	  
	  
Table	  6.2	  Relative	  percent	  (%)	  of	  folded	  protein	  over	  time	  using	  detergents	  at	  10x	  CMC	  	  
Proteins	   Time	  (Min)	   SDS	   DM	   DDM	   MPA-­12	   MNG-­1	   MNG-­2	   MNG-­3	  
Cyt	  bo3	   0	   88.5	   90.7	   96.1	   95.8	   97.1	   97.3	   97.4	  
	   60	   12.8	   36.5	   62.4	   61.5	   72.7	   74.0	   73.7	  
	   130	   2.4	   24.4	   53.2	   47	   65.4	   *68.3	   67.8	  
CMP-­Sia	   0	   86.6	   90.7	   95.1	   94.4	   96.8	   96.7	   97.0	  
	   60	   15.5	   53.0	   61.2	   62.6	   71.2	   71.4	   73.1	  
	   130	   2.1	   41.4	   51.2	   52.2	   63.6	   64.8	   *67.1	  
SQR	   0	   74.4	   92.8	   98.9	   95.1	   98.3	   94.8	   97.8	  	   60	   7.2	   54.3	   73.8	   63.0	   88.5	   88.3	   90.2	  	   130	   5.0	   49.0	   70.5	   58.8	   86.2	   87.5	   *88.5	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   Following	   thermostability	  analysis,	   samples	  of	  SQR	  (with	  DDM,	  MPA-­‐12,	  MNG-­‐1,	   2,	   3	   and	   DM)	   were	   harvested,	   ultracentrifuged	   and	   analysed	   by	   SDS-­‐PAGE	   to	   assess	   the	   aggregation	   status.	  When	  protein	   samples	   form	  aggregates	  due	  to	  destabilisation,	  the	  thiol	  groups	  are	  not	  accessible	  to	  react	  with	  the	  CPM	  dye,	  resulting	  in	  decreased	  fluorescence.	  Therefore,	  it	  is	  important	  to	  know	  that	  decreased	   fluorescence	   is	   definitely	   the	   result	   of	   stable	   folded	   protein	   rather	  than	  aggregation.	   Samples	  of	   protein	  before	   and	  after	  ultracentrifugation	  were	  analysed.	  The	  data	  confirmed	  that	  the	  low	  level	  of	  unfolded	  protein	  observed	  for	  SQR	  with	  the	  MNGs	  was	  not	  a	  result	  of	  aggregation	  and	  only	   in	   the	  case	  of	  DM	  was	  any	  protein	  aggregation	  detected	  (Fig	  6.5).	  
	  
Fig	  6.5	  SDS-­PAGE	  analysis	  of	  protein	  aggregation	  post	  SQR	  thermostability	  assay	  SQR	  samples	  after	  thermal	  stability	  assay	  were	  ultracentrifuged	  at	  18,000	  g	  at	  4	  °C	  for	  10	  min	  to	  analyse	  protein	  aggregation.	  M	  indicates	  molecular	  weight	  marker,	  Lanes	  1	  and	  2	  indicate	  samples	  before	  and	  after	  spin	  respectively	  
	  
6.3.3	  Circular	  Dichroism	  Spectra	  of	  SQR	  CD	  spectroscopy	  allowed	  comparison	  of	  the	  melting	  temperatures	  (Tm)	  of	  SQR	  in	  a	  range	  of	  different	  MNG	  amphiphiles	  and	  conventional	  detergents.	  MNG	  amphiphiles	   confer	   greater	   thermostability	   than	   conventional	   detergents,	   in	  agreement	  with	  the	  results	  from	  the	  CPM	  thermal	  stability	  analysis	  (Fig	  6.6a-­‐b).	  	  	  




Fig	  6.6	  Melting	  temperatures	  (°C)	  of	  SQR	  using	  circular	  dichroism	  	  The	  CD	  spectra	  of	  SQR	  were	  recorded	  every	  5	  °C	  over	  the	  range	  20-­‐100	  °C	  and	  average	  CD	  values	  at	  220	  nm	  indicative	  of	  α-­‐helices,	  were	  calculated.	  (a)	  The	  average	  values	  were	  plotted	  against	  temperatures	  and	  (b)	  the	  Tm	  (°C)	  was	  calculated	  using	  sigmoidal	  non-­‐linear	  regression	  equation.	  All	  detergents/amphiphiles	  were	  used	  at	  10x	  CMC	  unless	  stated	  otherwise	  
	  
6.3.4	  Size	  Exclusion	  Chromatography	  of	  SQR	  
	   Size	   exclusion	   chromatography	   (SEC)	   of	   SQR	   with	   MNG-­‐3	   revealed	   a	  single	  monodisperse	  peak	  for	  both	  the	  samples	  before	  and	  after	  heat	  treatment	  (Fig	   6.7a).	   In	   contrast,	   the	   sample	   with	   DDM	   appeared	   to	   have	   lost	   overall	  quaternary	   structure	   after	   heat	   treatment,	   eluting	   as	   a	   number	   of	   peaks	   with	  higher	   retention	   volumes	   (Fig	   6.7b).	   It	   is	   likely	   that	   these	   correspond	   to	  individual	  SQR	  subunits	  as	  analysed	  by	  SDS-­‐PAGE	  (Fig	  6.7c).	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Fig	  6.7	  SEC	  analysis	  of	  the	  quaternary	  structure	  of	  SQR	  upon	  heating	  SQR	  was	  loaded	  onto	  Superdex	  200	  at	  t	  =	  0	  and	  2	  hr	  after	  heating	  at	  40	  °C	  in	  buffers	  containing	  (a)	  MNG-­‐3	  and	  (b)	  DDM,	  used	  at	  10x	  CMC.	  (c)	  Samples	  from	  protein	  peaks	  on	  SEC	  chromatogram	  were	  analysed	  by	  SDS-­‐PAGE.	  M	  indicates	  molecular	  weight	  marker,	  lanes	  0	  and	  2	  indicate	  samples	  at	  t	  =	  0	  and	  2	  hr,	  lane	  2’	  indicates	  the	  second	  protein	  peak	  for	  sample	  at	  t=	  2	  hr	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6.3.5	  Functional	  Activity	  of	  SQR	  	   The	   succinate-­‐Q1-­‐DCIP	   reductase	   activity	   of	   SQR	  with	  DDM	   and	  MNG-­‐3	  was	   assessed	   by	   comparison	   of	   catalytic	   rate	   constants	   (Kcat).	   Upon	   heat-­‐activation,	   (t	   =	   0	   hr)	   SQR	   activity	  was	   comparable	   for	   all	   conditions;	   however,	  upon	  heating	  the	  samples	  at	  40	  °C	  for	  1	  and	  2	  hr,	  protein	  with	  DDM	  eventually	  lost	   activity	  while	  protein	  with	  MNG-­‐3	  maintained	   functional	   activity	   (Fig	  6.8),	  and	  even	  displayed	  slightly	  increased	  activity	  in	  the	  case	  of	  10x	  MNG-­‐3.	  	  
	  
Fig	  6.8	  Analysis	  of	  the	  succinate-­Q1-­DCIP	  reductase	  activity	  of	  SQR	  The	  functional	  activity	  of	  SQR	  was	  recorded	  with	  DDM	  and	  MNG-­‐3	  used	  at	  10x	  CMC	  and	  50x	  CMC.	  SQR	  activity	  was	  analysed	  based	  on	  its	  Kcat	  values.	  The	  three	  time-­‐points	  include	  t	  =	  0	  for	  heat-­‐activation	  at	  30	  °C	  for	  20	  min,	  and	  t	  =	  1	  and	  2	  hr	  for	  subsequent	  heating	  of	  the	  samples	  at	  40	  °C	  	  
	  
6.3.6	  Efficacies	  at	  Equivalent	  Concentration	  above	  CMC	  	  	  In	   order	   to	   further	   explore	   the	   efficacies	   of	  MNG	   amphiphiles	   against	   a	  standard	   conventional	   detergent	   such	   as	  DDM,	   the	  mass	   concentrations	   of	   the	  detergent/amphiphile	   micelles	   in	   solution	   were	   considered	   for	   comparison.	  Thermal	  stability	  assay	  and	  SEC	  was	  performed	  on	  SQR	  at	  an	  equivalent	  micelle	  concentration	  0.017%	  above	  the	  CMCs	  of	  the	  MNGs	  and	  DDM	  (Table	  6.3).	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Table	  6.3	  Equivalent	  concentrations	  of	  the	  micellar	  MNGs	  and	  DDM	  
Detergent	   MW	   CMC	  (mM)	   CMC	  (%)	   Micelle	  Conc.	  (%)	   CMC	  
DDM	   510.11	   0.17	   0.0087	   0.017	   3x	  
MNG-­1	   1119.3	   0.017	   0.0019	   0.017	   10.2x	  
MNG-­2	   1065.2	   0.009	   0.0010	   0.017	   19.1x	  
MNG-­3	   1005.2	   0.01	   0.001	   0.017	   18.3x	  
	   Consistent	   with	   the	   thermal	   stability	   results	   for	   SQR	   using	   equivalent	  multiples	   (10x)	   of	   the	   CMC	   of	   the	  MNGs	   and	   DDM,	  MNG-­‐3	   served	   as	   the	   best	  thermally	   stabilising	   condition	   for	   SQR	   followed	   by	   MNG-­‐2,	   MNG-­‐1	   and	   DDM	  successively	  when	  used	  at	  0.017%	  above	  the	  respective	  CMC	  values	  (Fig	  6.9a-­‐b).	  
	  	  
Proteins	   Time	  (Min)	   DDM	   MNG-­1	   MNG-­2	   MNG-­3	  
SQR	   0	   99.6	   98.6	   99.1	   99.8	  	   60	   54.6	   58.6	   63.0	   64.5	  	   130	   48.6	   52.6	   57.9	   *60.0	  
*Most	  stabilising	  conditions	  to	  maintain	  folded	  protein	  states	  (%)	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SEC	  chromatograms	  of	  SQR	  with	  MNG-­‐3	  at	  0.017%	  concentration	  above	  its	  CMC	  revealed	  that	  the	  overall	  quaternary	  structure	  of	  the	  protein	  was	  largely	  retained	  after	  heating	  at	  40	  °C	  for	  2	  hr	  (Fig	  6.10a;	  Peak	  2).	  SQR	  with	  DDM	  eluted	  as	  peaks	  with	  higher	  retention	  volumes	  upon	  heating	  at	  40	  °C	  for	  2	  hr	  (Fig	  6.10b;	  Peaks	  3-­‐4),	  when	  compared	  to	  the	  chromatogram	  at	  t	  =	  0	  possibly	  indicating	  the	  degradation	  of	  the	  complex	  into	  its	  subunits.	  Samples	  after	  the	  SEC	  run	  were	  not	  analysed	   by	   SDS-­‐PAGE.	   The	   additional	   peak	   (~8	  ml	   corresponding	   to	   the	   void	  volume)	  in	  the	  SEC	  chromatograms	  using	  both	  MNG-­‐3	  and	  DDM	  at	  t	  =	  0	  and	  2	  hr	  corresponds	  to	  aggregated	  protein	  (Fig	  6.10;	  Peak	  1).	  	  
	  
Fig	  6.10	  SEC	  analysis	  of	  SQR	  at	  equivalent	  micelle	  concentrations	  of	  MNG-­3	  and	  DDM	  SQR	  was	  loaded	  onto	  Superdex	  200	  at	  t	  =	  0	  and	  2	  hr	  after	  heating	  at	  40	  °C	  in	  buffers	  containing	  (a)	  MNG-­‐3	  and	  (b)	  DDM,	  used	  at	  0.017%	  micelle	  concentration.	  Peak	  1	  indicates	  the	  void	  at	  8	  ml	  for	  aggregated	  protein,	  Peak	  2	  indicates	  the	  SQR	  complex,	  Peaks	  3-­‐4	  presumably	  indicate	  the	  SQR	  subunits	  falling	  apart	  from	  the	  intact	  structure	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6.4	   Discussion	  
The	   data	   in	   this	   chapter	   describes	   the	   characterisation	   of	   a	   number	   of	  novel	  amphiphiles	  developed	  to	  confer	  greater	  stability	  to	  MPs	  in	  solution	  than	  standard	   detergents.	   The	  MNG	   amphiphiles	   assessed	   in	   this	   study,	   MNG	   (1-­‐3)	  were	  selected	  based	  on	  an	  initial	  screening	  of	  the	  effect	  of	  these	  amphiphiles	  on	  the	  stability	  of	  a	  human	  β2	  adrenergic	  receptor-­‐T4-­‐lysozyme	  (β2AR-­‐T4L)	   fusion	  protein	   upon	   heating.	   	   The	   aim	   of	   this	   study	   was	   to	   further	   characterise	   the	  effectiveness	   of	   the	   amphiphiles	   using	   different	   MPs	   in	   order	   to	   explore	   the	  general	  utility	  of	   these	  amphiphiles.	   So	   far,	   there	  have	  been	  a	   small	  number	  of	  amphiphiles	  that	  can	  be	  generally	  applicable	  to	  a	  wide	  range	  of	  MPs.	  Due	  to	  the	  different	   characteristics	   of	   MPs	   it	   is	   challenging	   to	   achieve	   this	   goal.	   The	  preliminary	   work	   with	   the	   respiratory	   complex	   SQR	   showed	   that	   MNG-­‐1	   was	  better	  at	  maintaining	   the	  protein	   in	  solution	   for	  20	  days	  at	  20	  °C	   than	  DM.	  Far	  less	  protein	  was	  lost	  as	  a	  result	  of	  aggregation	  with	  MNG-­‐1.	  Long-­‐term	  stability	  assays	  of	  membrane	  proteins	  can	  be	  useful	  in	  assessing	  optimal	  conditions	  that	  could	  increase	  chances	  of	  attaining	  high-­‐quality	  crystals,	  as	  protein	  crystals	  often	  grow	  over	  weeks	  (Yu	  et	  al.,	  2000).	  	  Although	  long-­‐term	  stability	  assay	  is	  a	  reliable	  method	  of	  screening	  buffer	  conditions	   for	  protein	  stability,	   it	  produces	  non-­‐quantitative	  results	  and	  can	  be	  time-­‐consuming	   and	   cumbersome	   especially	   when	   dealing	   with	   a	   range	   of	  samples	  and	  conditions.	  The	  use	  of	  the	  thiol-­‐specific	  dye,	  N-­‐[4-­‐(7-­‐diethylamino-­‐4-­‐methyl-­‐3-­‐coumarinyl)phenyl]maleimide	  (CPM),	  which	  binds	  to	  the	   free	  thiols	  of	  Cys	  residues	  has	  been	  evaluated	  as	  a	  reliable	  and	  rapid	  screening	  method	  for	  the	  specific	  assessment	  of	  membrane	  protein	  thermal	  stability	  (Alexandrov	  et	  al.,	  2008).	   As	   the	   membrane	   protein	   unfolds,	   the	   normally	   buried	   Cys	   residues	  become	  available	  to	  interact	  with	  the	  dye	  and	  the	  level	  of	  fluorescence	  gives	  an	  indication	  of	  the	  extent	  of	  unfolding.	  The	  CPM	  dye	  is	  virtually	  non-­‐fluorescent	  in	  the	  unbound	  form	  and	  exhibits	  low	  non-­‐specific	  binding	  to	  detergent	  and	  folded	  membrane	  protein.	  Cys	   residues	  are	  considered	  reliable	  markers	  of	  membrane	  protein	   structure	   integrity	   and	   stability	   owing	   to	   their	   relatively	   high	   packing	  value	  in	  helical	  membrane	  proteins,	  resulting	  in	  a	  comparatively	  high	  occurrence	  in	  helix-­‐helix	  interfaces	  (Eilers	  et	  al.,	  2002).	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Hanson	   et	   al.	   (2008)	   have	   used	   this	   approach	   successfully	   to	   identify	  suitable	   conditions	   for	   crystallisation	   of	   the	   human	   β2-­‐adrenergic	   receptor	  (β2AR).	   A	  modified	   thermal	   stability	   screening	  method	   has	   been	   described	   for	  the	  human	  β2AR	  employing	  the	  CPM	  dye,	  by	  using	  a	  fixed	  temperature	  of	  35	  °C	  for	   3	   hr.	   	   This	   analysis	   indicated	   that	   β2AR	   was	   most	   thermally	   stable	   in	   the	  presence	   of	   both	   cholesterol	   and	   the	   receptor	   agonist,	   timolol	   (Hanson	   et	   al.,	  2008).	  A	  structure	  of	  the	  human	  β2AR	  (Hanson	  et	  al.,	  2008)	  was	  obtained	  using	  protein	  prepared	  in	  the	  presence	  of	  both	  cholesterol	  and	  timolol,	  which	  revealed	  high-­‐resolution	  molecular	  detail	  for	  the	  cholesterol	  binding	  sites.	  In	   this	   study,	   the	   CPM-­‐based	   assay	   was	   used	   to	   compare	   the	   thermal	  stability	   of	   SQR,	   Cyt	   bo3	   and	   CMP-­‐Sia	   in	   a	   range	   of	   MNG	   amphiphiles	   and	  standard	   detergents.	   A	  modified	   approach	   was	   used	   to	   include	   screening	   at	   a	  fixed	  temperature	  of	  40	  °C	  for	  130	  min,	  which	  has	  been	  validated	  using	  a	  wide	  range	  of	  MPs	  and	  detergents	  (Drew	  et	  al.,	  manuscript	  submitted).	  The	  results	  of	  this	  study	  indicate	  that	  the	  relative	  percent	  of	  folded	  protein	  (130	  min)	  is	  a	  good	  measure	   of	   the	   relative	   stability	   of	   a	   protein	   in	   a	   given	   set	   of	   conditions,	  compared	  to	  relative	  half-­‐life	  estimation	  of	  MPs	  (Table	  6.3).	  However	  the	  overall	  trend	  of	  relative	  half-­‐lives	  somewhat	  agrees	  with	  the	  relative	  percents	  of	  folded	  protein	  indicating	  SDS	  and	  MNGs	  as	  the	  worst	  and	  best	  conditions	  respectively	  in	  thermostabilising	  the	  MPs.	  The	  previous	  study	  by	  Hanson	  et	  al.	  (2008)	  used	  a	  Tm	  calculated	   from	   the	   ‘unfolding	   curve’	   obtained	   by	   an	   increasing	   temperature	  gradient.	  However	  in	  the	  case	  of	  some	  of	  the	  MP	  and	  amphiphile	  concentrations	  used	   in	   this	   study,	   very	   little	   unfolding	  was	   observed	  making	   it	   impossible	   to	  calculate	  reliable	  protein	  half-­‐lives.	  	  CD	   spectroscopic	   analysis	   was	   used	   to	   obtain	   the	   Tm	   values	   of	   SQR	   in	  different	  detergent/amphiphiles	  and	  confirm	  the	  trend	  observed	  from	  the	  CPM	  assay	   data.	   CD	   spectroscopy	   assesses	  MP	   stability	   on	   account	   of	   its	   secondary	  structure	  integrity	  (Soulie	  et	  al.,	  1998)	  over	  a	  range	  of	  elevated	  temperatures.	  In	  addition,	  the	  SEC	  analysis	  on	  SQR	  further	  complemented	  the	  findings.	  SEC	  is	  both	  a	   simple	   and	   powerful	   way	   to	   identify	   stabilising	   detergents	   by	   assessing	   the	  self-­‐associated	   state	   of	   protein-­‐detergent	   complex	   as	   monomeric,	   oligomeric	  and/or	  aggregated	  (le	  Maire	  et	  al.,	  2000;	  Prive,	  2007).	  The	  quaternary	  structure	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of	   SQR	   was	   retained	   with	   MNG-­‐3	   after	   the	   heat	   treatment	   confirming	   its	  stabilising	  effect	  in	  comparison	  to	  DDM	  with	  which	  SQR	  appears	  to	  have	  broken	  down	   into	   its	   component	   subunits	   	   (Fig	   6.7	   and	   6.10).	   The	   presence	   of	   an	  aggregation	  peak	  at	  t	  =	  0	  and	  2	  hr	  with	  the	  use	  of	  0.017%	  concentrations	  above	  the	  CMCs	  of	  MNG-­‐3	  and	  DDM	  was	  due	  to	  the	  relatively	  impure	  batch	  of	  SQR	  used.	  This	  was	  confirmed	  when	  the	  SEC	  analysis	  on	  this	  batch	  with	  DDM	  at	  10x	  CMC	  indicated	  protein	  aggregation	  (results	  not	  shown).	  The	   assessment	   of	   the	   detergent/amphiphile	   on	   SQR	   functional	   activity	  further	   explored	   their	   effectiveness	   in	   maintaining	   the	   functional	   stability	   of	  SQR.	  Monodisperse	  and	  stable	  protein	  does	  not	  necessarily	  guarantee	  fully	  active	  protein	   since	   the	   protein	   could	   be	   stabilised	   in	   inactive	   forms/misfolded	  conformations	  with	   the	  detergent/amphiphiles.	  The	  enzyme	  retains	   its	   activity	  with	   MNG-­‐3	   at	   10x	   CMC	   upon	   heating	   in	   contrast	   to	   DDM.	   Further,	   it	   can	   be	  inferred	  that	  MNG	  micelles	  are	  less	  disruptive	  than	  DDM	  micelles	  based	  on	  their	  stabilisation	  effects	  at	  a	  high	  concentration	  of	  50x	  CMC	  upon	  heating.	  A	  similar	  trend	   was	   observed	   for	   β2AR-­‐T4L	   where	   the	   MNG	   amphiphiles	   were	   more	  favourable	   at	   50x	   CMC	   rather	   than	   10x	   CMC,	   while	   the	   opposite	   effect	   was	  observed	  in	  the	  case	  of	  DDM	  (Chae	  et	  al.,	  Submitted).	  MNG-­‐3	  also	  retained	  ~90%	  of	   the	   functional	   activity	   of	   LeuT	   over	   12	   days	   compared	   to	  DDM	   (Chae	   et	   al.,	  Submitted),	  which	  complements	  its	  better	  efficiencies	  during	  solubility	  assays.	  The	   concentrations	   of	   MNG	   amphiphiles	   used	   in	   this	   study	   have	   been	  selected	  by	   screening	   the	   following	   conditions	   against	   that	  of	  DDM:	   equivalent	  multiples	   of	   the	   CMC	   values	   (3x,	   10x	   and	   50x),	   fixed	   detergent	   concentrations	  (0.05,	   0.2,	   0.35	   and	   0.5)	   mM	   and	   equivalent	   micelle	   concentrations	   (0.017%).	  The	  use	  of	  3x	  CMC	  was	  selected	  close	  to	  the	  general	  recommendation	  of	  2x	  CMC	  to	   maintain	   MPs	   in	   solutions.	   This	   was	   to	   facilitate	   crystallisation	   by	   both	  stabilising	   the	   protein	   and	   allowing	   greater	   protein-­‐protein	   contacts	   to	   form	  crystals	   (Iwata,	  2003).	  However	   it	   seemed	  unfair	   to	  assess	   the	  efficacies	  of	   the	  MNGs	   at	   3x	   CMC	   against	   DDM	   owing	   to	   their	   relatively	   low	   CMC	   values.	   The	  amount	  of	  MNGs	  at	  3x	  CMC	  would	  be	  too	  low	  to	  stabilise	  MPs.	  Thus	  most	  of	  this	  study	  included	  the	  use	  of	  detergent/amphiphiles	  at	  10x	  CMC	  to	  ensure	  that	  the	  amounts	  were	   sufficient	   to	   supply	  monomers	   and	  MP-­‐associated	  micelles.	   The	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use	  of	  50x	  CMC	  was	  to	  analyse	  the	  detrimental	  effects	  of	  excess	  micelles	  on	  MP	  stabilisation.	  Fixed	  detergent	  concentrations	  gave	  mixed	  results.	  However	  it	  was	  possible	  to	  obtain	  a	  shared	  trend	  of	  detergent/amphiphiles	  efficacies	  at	  0.017%	  concentration	  above	  their	  CMCs	  with	  data	  analysed	  at	  10x	  CMC.	  Overall,	  it	  was	  shown	  that	  the	  MNG	  amphiphiles	  are	  promising	  molecules	  for	  MPs	  based	  on	  the	  studies	  on	  long-­‐term	  stability	  and	  thermal	  stability	  in	  terms	  of	   tertiary	  and	  quaternary	  structure,	  and	  functional	  activity	  performed	  on	  SQR.	  These	  results	  are	  supported	  by	  thermal	  stability	  of	  MPs	  from	  other	  families,	  Cyt	  
bo3	  and	  CMP-­‐Sia	  suggesting	  a	  wider	  general	  utility	  of	  MNG	  amphiphiles.	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Schematic	  Representation	  of	  pWaldo-­GFPe	  
	  
	  
(Waldo	  et	  al.,	  1999)	  
	  
Vector	  Map	  indicating	  the	  Features	  of	  GEV2	  
	  
(Huth	  et	  al.,	  1997)	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Auto-­inducing	  ZYM-­5052	  Media	  Composition	  Per	  litre:	  957	  ml	  ZY,	  2	  ml	  1	  M	  MgSO4,	  1	  ml	  0.1	  M	  FeCl3,	  20	  ml	  50x	  5052,	  20	  ml	  50x	  M	  (for	  use	  with	  BL21-­‐AI	  cells,	  2.5	  ml	  20%	  arabinose	  is	  added)	  	  ZY:	  10	  g	  N-­‐Z-­‐amine	  AS,	  5	  g	  yeast	  extract,	  1	  litre	  H2O	  50x	  5052:	  250	  g	  glycerol,	  25	  g	  glucose,	  100	  g	  α-­‐lactose	  monohydrate,	  730	  ml	  H2O	  	  50x	  M:	  177.5	  g	  Na2HPO4,	  170	  g	  KH2PO4,	  134	  g	  NH4Cl,	  35.5	  g	  Na2SO4,	  800	  ml	  H2O	  
	  	  
M9	  Minimal	  Media	  Composition	  Per	  litre:	  6	  g	  Na2HPO4,	  3	  g	  KH2PO4,	  0.5	  g	  NaCl,	  0.7	  g	  NH4Cl,	  pH	  adjusted	  and	  autoclaved.	  Add	  filtered:	  2	  ml	  1	  M	  MgSO4,	  10	  µl	  1	  M	  CaCl2,	  100	  µl	  0.1	  M	  FeSO4,	  2	  g	  glucose,	  1	  ml	  Vitamins	  solution,	  1	  ml	  micronutrients	  (Vitamins	  and	  micronutrients	  stocks	  prepared	  in	  the	  NMR	  group	  were	  used)	  Vitamins	  1000x:	  0.4	  g	  choline	  chloride,	  0.5	  g	  folic	  acid,	  0.5	  g	  pantothenic	  acid,	  0.5	  g	  nicotinamide,	  1	  g	  myo-­‐inositol,	  0.5	  g	  pyridoxal	  HCl,	  0.5	  g	  thiamine	  HCl,	  0.05	  g	  riboflavin,	  1	  g	  biotin	  Micronutrients	  1000x:	  3x	  10-­‐6	  M	  ammonium	  molybdate,	  4x	  10-­‐4	  M	  H3BO3,	  3x	  10-­‐5	  M	  CoCl2,	  1x	  10-­‐5	  M	  CuSO4,	  8x	  10-­‐5	  M	  MnCl2,	  1x	  10-­‐5	  M	  ZnSO4	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PASM-­5052	  Media	  for	  Labelling	  with	  SeMet	  Per	  litre:	  901	  ml	  H2O,	  2	  ml	  1	  M	  MgSO4,	  1	  ml	  0.1	  M	  FeCl3,	  20	  ml	  50x	  5052,	  50	  ml	  20x	  P,	  20	  ml	  17	  aa	  (10	  mg/ml	  each),	  400	  μl	  Met	  (25	  mg/ml),	  5	  ml	  SeMet	  (25	  mg/ml),	  1	  ml	  1	  mM	  vitamin	  B12	  20x	  P:	  142	  g	  Na2HPO4,	  136	  g	  KH2PO4,	  66	  g	  (NH4)	  2SO4,	  900	  ml	  H2O	  17	  aa:	  1	  g	  of	  amino	  acids	  except	  C,	  Y,	  M	  were	  added	  to	  90	  ml	  H2O	  to	  make	  100	  ml	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3D-­Jury	  Results	  for	  YpTLP
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  4	  
	  




Proteins	   Residues	  







Cysteines	  YpTLP	   M1	  to	  V358	   358	   41.06	   5.63	   5	  (1.4%)	  YpTIR1	   S130	  to	  A285	   156	   17.46	   5.35	   2	  (1.3%)	  YpTIR2	   I137	  to	  I273	   137	   15.34	   5.55	   2	  (1.5%)	  YpTIR3	   I137	  to	  N246	   110	   12.43	   5.31	   2	  (1.8%)	  BpTLP	   M1	  to	  V352	   352	   39.86	   5.84	   5	  (1.4%)	  BpTIR1	   A228	  to	  V352	   125	   13.82	   5.87	   1	  (0.8%)	  BpTIR2	   D220	  to	  V352	   117	   12.94	   5.75	   1	  (0.9%)	  
	  	   218	  
Appendix	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Imperial	  College	  Crystallisation	  Screening	  Plates	  	  
Plates	   Screen	   Company	   Composition	  
ICL1	   Crystal	  Screen	  1	  &	  Crystal	  Screen	  2	   Hampton	  Research	   Crystal	  Screen	  1	  &	  2	  
ICL2	   Wizard	  Screen	  1	  &	  2	   Emerald	  BioSystems	   Wizard	  Screen	  1	  (A1-­‐D12)	  	  &	  Screen	  2	  (E1-­‐H12)	  
ICL3	   PEG/Ion	  &	  Natrix	   Hampton	  Research	   PEG/Ion	  (A1-­‐D12)	  &	  Natrix	  (E1-­‐H12)	  
ICL4	   Index	   Hampton	  Research	   Index	  
ICL5	   SaltRX	   Hampton	  Research	   SaltRX	  
ICL6	   Mem-­‐Start	  &	  Mem-­‐Sys	   Molecular	  Dimensions	  Ltd	   Mem-­‐Start	  &	  Mem-­‐Sys	  
*ICL7	   PACT	   Molecular	  Dimensions	  Ltd	   PACT	  Premier	  
ICL8	   JCSG+	   Molecular	  Dimensions	  Ltd	   JCSG+	  
ICL9	   MemGold	   Molecular	  Dimensions	  Ltd	   MemGold	  
ICL10	   Wizard	  Screen	  3	  &	  PEG/Ion	  2	   Emerald	  BioSystems	  &	  Hampton	  Research	   Wizard	  Screen	  3	  (A1-­‐D12)	  	  &	  PEG/Ion	  2	  (E1-­‐H12)	  
ICL11	   JBScreen	  Cryo	  1-­‐4	   Jena	  Bioscience	   JBScreen	  Cryo1-­‐4	  
ICL12	   ProPlex	   Molecular	  Dimensions	  Ltd	   ProPlex	  
*Details	  of	  solutions	  are	  only	  given	  for	  ICL7	  PACT	  Screen	  and	  Hampton	  Research	  Additive	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  ICL7	  PACT	  Screen	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Hampton	  Research	  Additive	  Screen	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